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Stroke is common and is associated with high levels ofmortality and morbidity. There have
been significant advances in acute stroke treatments and stroke rehabilitation in the past few
decades. One example is stroke unit care, which has been proven to be effective in reducing
death and dependency after stroke. However, there are significant variations in the medical
and nursing care of stroke patients in hospital, access to stroke unit care, organisation of
care, and clinical outcome. The relationship between these variations is unclear.
In the last twenty years, stroke integrated care pathways (ICPs) have been introduced as a
tool to promote organised and efficient patient care that is based on the best-available
evidence and clinical guidelines. There are potential advantages and disadvantages with
using ICPs, and the evidence to support their widespread use is unclear. ICPs are complex
interventions and there are important methodological considerations when conducting
evaluation studies - conventional randomised trials are often not possible. Consequently,
evaluation of the effects of ICPs may require multiple approaches.
Aims of this thesis
1) To evaluate the effects of ICPs for acute stroke using multiple approaches.
2) To explore the methodological issues concerning the different research designs that are
used to evaluate the effects of ICPs for acute stroke.
Methods and results
I sought to evaluate the effects of ICPs for acute stroke using four approaches:
1) Assessment of the evidencefromprevious studies ofICPsfor non-stroke conditions. I
performed a review of the recent literature and found that there were a large number of
randomised and non-randomised studies of ICPs for non-stroke conditions. Positive,
neutral and negative findings have been reported.
2) Assessment of the evidencefromprevious studies of ICPsfor acute stroke. I performed
a Cochrane systematic review and found three randomised trials and seven non-
randomised studies. There were substantial heterogeneity between the studies and most
III
of the evidence came from non-randomised studies. I found that ICP care may
significantly improve the process of care and reduce in-hospital complications, but
patient satisfaction and quality of life may be lower.
3) Undertaking of two non-randomised studies of the ICP introducedfor acute stroke at
the Western General Hospital (WGH). 1)1 performed a before-and-after study (total of
351 patients) to assess the effects of introducing an ICP in a stroke unit. I found that,
after its introduction, there were significant improvements in the quality of
documentation and certain aspects of patient care, and the risk of urinary tract infection
was reduced. However, there was no significant difference in death or discharge
destination. 2) I also performed a prospective comparative study (total of 285 patients) to
assess the difference in the process of care and outcome between stroke unit care after
the introduction of the ICP and general medical ward care. The results were consistent
with those of the before-and-after study and previous evidence.
4) Undertaking of two questionnaire surveys to assess the experience of the stroke unit
staff regarding the use of the ICPfor acute stroke at the WGH. I found that, when the
ICP was first introduced, the staff expected the ICP to improve the process and quality of
care, communication and the general working environment. I repeated the survey six
months later and found that, although certain aspects of care were felt to have improved,
many of the staffs expectations were not realised.
Conclusion
Using these four approaches, I found evidence from previous studies that patient care with a
stroke ICP may be associated with both benefit and harm. The non-randomised studies
conducted at the WGH confirmed the beneficial effects, but patient satisfaction and quality
of life were not assessed. The questionnaire surveys highlighted the importance of being
realistic about what an ICP could achieve in clinical practice. The limitations of each of
these four approaches are discussed in detail. In summary, the evidence is accumulating that
patient care using a stroke ICP may be beneficial, and the beneficial effects may be most
apparent in hospitals where the basic structure of the stroke service is in place but the patient
care is poorly organised. Further research should provide more information regarding the
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1.1 Stroke is a major public health problem
Stroke can be a devastating condition which places a heavy burden on the patient,
their family, and the community. Stroke is the second commonest cause of death,
accounting for 10 to 12% of all deaths in industrialised countries, and is the leading
cause of long-term disability (Bonita 1992; Murray & Lopez 1997a; WHO 1999).
Stroke is a growing public health problem as the number of older people in the
population increases rapidly (Ostfeld & Wilk 1990; The Office for National Statistics
2001; Help the Aged 2001). In the United Kingdom (UK), the recently published
National Service Framework for Older People has highlighted the importance of
prevention and treatment of stroke in older people (DoH 2001a).
Stroke is primarily a clinical diagnosis. Stroke can be defined using the World Health
Organisation definition: "a clinical syndrome typified by rapidly developing clinical
signs offocal or global disturbance ofcerebralfunctions, lasting more than 24 hours
or leading to death, with no apparent causes other than ofvascular origin" (Hatano
1976; WHO 1978). In practice, this definition includes strokes that are due to
cerebral infarction, intracerebral haemorrhage and subarachnoid haemorrhage
(SAH), but excludes: transient ischaemic attacks (TIAs, which last for less than 24
hours); subdural and extradural haemorrhages; and cerebral infarction or
haemorrhage secondary to infection or malignancy (Bonita 1992). More recently,
experts have suggested that SAH should not be included in this definition since the
management of patients with SAH is quite distinct from those of other forms of
stroke (Bamford 2001).
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Stroke can be divided into different subtypes. Community-based incidence studies,
such as the Oxfordshire Community Stroke Project (OCSP), have found that about
80% of first-ever strokes were due to cerebral infarction, 10% to primary
intracerebral haemorrhage (PICH), 5% to SAH, and 5% were of uncertain type
(Bamford et al 1990a).
Ischaemic strokes can be further divided into different aetiological subtypes.
Proportion of strokes due to each of the aetiological subtype varies widely between
different studies (MacKenzie 2000). In general, about 20% of ischaemic strokes are
caused by large vessel atherothrombosis (involving the aortic arch, intracranial or
extracranial large arteries), 20% by small vessel atherothrombosis, 30% by
cardioembolism, 5% by miscellaneous causes (e.g. carotid artery dissection, arteritis,
or sudden hypotension), and 25% are of undetermined aetiology (Petty et al 1999;
Anon. 1999; Moulin et al 2000; MacKenzie 2000). Since atherothrombotic strokes
occur most commonly in older people, and as the number of older people in the
population increases, atherothrombotic strokes are likely to account for large
proportion of strokes (Ostfeld & Wilk 1990).
Stroke is common
Stroke is a common condition. The prevalence of stroke in the UK was recently
estimated to be 17.5 per 1000 people (O'Mahony et al 1999). This means that there
are currently over half a million stroke survivors in the UK (Isard & Forbes 1992;
Miyai & Reding 1998), and almost one in ten people aged over 75 years has a history
of stroke (Geddes et al 1996).
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The incidence of first-ever stroke in the UK is 2 to 3 per 1000 people (Bamford et al
1988; Sudlow & Warlow 1997; Wolfe et al 2002). The age-specific incidence rate of
first-ever strokes rises exponentially with age for both sexes, such that the incidence
rate for people aged over 85 years is about 100 times that for those aged between 35
and 44 years (Bonita et al 1984; Bamford et al 1988; Williams et al 1999). Almost
one in four men and one in five women aged 45 years can expect to have a stroke if
they live to their 85th year (Bonita et al 1984; Bonita 1992). In the UK, about
130,000 people suffer a stroke each year, nearly three quarters of them occur over the
age of 65 and nearly half occur over the age of 75 (Bamford et al 1988; Weir &
Dennis 1997). Recurrent strokes account for about 30% of all stroke events, but for
patients aged over 75 years, this figure could be as high as 50 to 70% (Bonita 1992;
Thorvaldsen et al 1995; Thorvaldsen et al 1999; Williams et al 1999). As the
proportion of older people in the population grows rapidly, the absolute numbers of
new strokes occurring each year is predicted to rise by as much as a third over the
next two decades (Ostfeld & Wilk 1990; Thorvaldsen et al 1999; Wolfe 2000; The
Office for National Statistics 2001).
Stroke causes many deaths
About 4.5 million people world-wide die from stroke each year (Murray & Lopez
1997b; Murray & Lopez 1997c). In industrialised countries, stroke accounts for
about one in eight of all deaths (Wolfe 2000). Deaths from stroke can be examined in
two ways: case fatality rate and stroke mortality rate. Case fatality rate is the
proportion of people who die within a specified period after an event (Bonita 1992).
In the OCSP, the overall case fatality rate was 19% for the first month and 31% for
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the first year (Bamford et al 1990a). Older people and those with recurrent strokes
are significantly more likely to die after a stroke (Bamford et al 1990b; Samsa et al
1999).
Stroke mortality rate is the number of deaths caused by stroke in a specified period,
which is usually one year (Mas & Zuber 1993). In the UK, the stroke mortality rate
rises exponentially with age, from 7 per 100,000 people aged 35 to 44 years to about
1400 per 100,000 people aged over 75 years (WHO 1994). In the UK, as in many
other parts of the world such as North America and Western Europe, stroke mortality
rate has declined by about 40% in the past 40 years (Khaw 1996; Thorvaldsen et al
1999; Sarti et al 2000). Studies have demonstrated that this fall in mortality could
have resulted from either a decline in incidence, a decline in case fatality, or a
combination of the two (Broderick et al 1989; Bonita 1992; Bonita & Beaglehole
1996; Thorvaldsen et al 1999; Morikawa et al 2000).
Stroke causes much long-term disability and burden
Stroke is the most common cause of long-term disability in the adult population
(Wolfe 2000). Stroke is the sixth leading cause of global disability-adjusted life years
in the world; about 9 million people world-wide are estimated to be living with
disability as a result of stroke; (Murray & Lopez 1997b; Murray & Lopez 1997c). At
one year after stroke, about 40% of the survivors would need regular help from
others for activities of daily living (Warlow et al 2000). In the UK, stroke patients
occupy about 8% of all hospital bed days and stroke hospital costs account for up to
6% of total hospital costs (Isard & Forbes 1992; Roberts et al 2000). Furthermore, up
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to a quarter of nursing home residents are stroke survivors; thus there are about
51,000 stroke survivors in residential or long-term care in the UK (Wade 1994;
Bosanquet & Franks 1998).
The total cost of stroke to the NHS and social services has been estimated at £2.3
billion in England in 1995-6, which is equivalent to about 6% of the total NHS and
social service expenditure (Bosanquet & Franks 1998). Stroke also results in
substantial indirect costs, for example due to loss of earnings by the patient or their
carer (about £31 million per year), and the enormous psychological burden on carers
and relatives. The total burden and cost of stroke care in industrialised countries has
been predicted to rise by 30% to over £3 billion in the year 2023 (Bonita &
Beaglehole 1996; Bosanquet & Franks 1998; Di Carlo et al 1999).
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1.2 Development of stroke care
I shall briefly describe the development of stroke care (stroke therapy in general, and
stroke unit care) in this section. It is not meant to be an exhaustive account but a brief
outline.
Development of stroke therapy: a brief history
Acute stroke as a medical condition
Stroke has always existed and the development of stroke care can be traced back to
the ancient times. Stroke was first described in ancient Greek medical writing as
'apoplexy' in 400 BC by Hippocrates (Clarke 1963). In the last few centuries,
autopsy studies provided physicians with more detailed knowledge about apoplexy,
which was later termed 'stroke' in the English language (Schiller 1970). In the 17th
century, Johann Wepfer concluded from his autopsy studies on stroke patients that
"apoplexy was produced because the afflux ofblood through the arteries is denied to
the brain''' (Fraser et al 1999).
Development ofstroke rehabilitation
In the fifth century, Caelius Aurelianus suggested treating patients with apoplexy by
"active, assistive andpassive motion of the weakened muscles" (Fraser et al 1999). In
the 18th century, Joseph-Clement Tissot wrote a book on therapeutic exercise,
suggesting an aggressive approach in mobilising hemiplegic patients (Tissot 1780).
Another century passed before Robert Todd emphasised the importance of exercise
as a treatment of hemiplegic patients. The first reference to speech and language
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therapy was also in the mid-1850's, when Thomas Hun recommended exercises in
reading, spelling and repeating words for stroke patients (Kabat 1947). At the end of
the 19th century, more and more stroke patients were treated with daily sessions of
active exercises as recommended by Sebastian Frenkel, who was later invited to
Paris to promote his methods of "reeducation des movementsor what is now regard
as functional rehabilitation (Frenkel 1890; Fraser et al 1999). However, many
physicians were not convinced that patients should receive any form of rehabilitation
after stroke. This nihilistic attitude persisted for the next half a century, during which
many stroke patients were confined to a bed or chair for the duration of their hospital
stay. Enthusiasm was even lower to retrain patients with dysphasia or visual-spatial
dysfunction because the rehabilitative process was considered unrewarding.
In the early 1940s, physicians regained their interest in stroke rehabilitation and
several new approaches to rehabilitation emerged. Restoring movement and
preventing disabling contractures became the primary goals; examples of approaches
included those described by Rood, Knott and Kabat, Brunstrom, and Bobath (Rood
1954; Kabat & Knott 1954; Brunstrom 1956; Bobath 1990). Physicians and
therapists believed that functional recovery represented neuronal recovery of an
injured brain, the mechanisms of which could include the 're-routing' of neuronal
pathways, reorganisation of neuronal connections, and even neuronal regrowth
(Pomeroy & Tallis 2000; Johansson 2000). Wade recently described rehabilitation as
"an active problem-solving and education process, focused on disability and
aiming to maximise the patient's participation in society and his or her well-being
while reducing stress on the family. In addition to interventions aimed at improving
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function, rehabilitation includes assessment....the setting ofgoals, andprovision of
care to maintain the patient's state" (Wade 1999). Rehabilitation therefore became
regarded as much more than mobilisation and giving of therapy.
Use ofearly rehabilitation after acute stroke
At the beginning of the 20th century, Brissaud recommended that stroke patients
should perform exercises as soon as possible after the event - during the first week if
the medical condition permitted - everyday, twice a day. He suggested that nurses
should "walk the patient and make him use his handpurposefully (Fraser et al
1999). However, this approach of early mobilisation was not widely adopted at the
time because many physicians thought that it could lead to contractures (Fraser et al
1999).
It was only during the last three or four decades that the role of the therapists (e.g.
physiotherapists, occupational therapists, speech therapists) became more prominent.
Together with the physicians and nursing staff, they made up the multidisciplinary
team. Nowadays, multidisciplinary management by a specialist stroke team is the
mainstay of hospital treatment (Miyai & Reding 1998). Despite numerous recent
practical innovations, advances in stroke rehabilitation have occurred almost entirely
in service delivery and organisation rather than any single treatment (Wade & de
Jong 2000).
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Development ofmedical and surgical therapiesfor stroke
Medical care of stroke patients entered a new era in the 1920s and 1930s, when
articles began appearing describing the association between high blood pressure,
atherosclerosis and stroke (Fields & Lemak 1989). After the second world war,
pharmaceutical companies began developing and testing new pharmacological agents
for stroke treatment and prevention. In 1941, Per Hedenius, a Scandinavian, reported
the first study of heparin in stroke patients, some ofwhom had good outcomes
(Hedenius 1941). In 1950, Lawrence Craven reported the prophylactic use of aspirin
for coronary and cerebral thrombosis and advised his male friends and patients to
take one or two aspirin tablets daily (Fields & Lemak 1989). Craven also
experimented with administration of dicoumarol to patients who were intolerant of
aspirin and found that a small amount of dicoumarol might also be effective in stroke
prophylaxis (Fields & Lemak 1989). In 1954, Eastcott performed the first carotid
reconstruction operation in St Mary's Hospital, London (Fields 1998). Nowadays,
the use of antithrombotics and carotid endarterectomy are the two major strategies
for the secondary prevention of ischaemic stroke.
Since the 1950s, physicians became less inclined to use a particular treatment just
because it was the norm, and were more likely to be persuaded by evidence from
high quality clinical trials; the randomised controlled trial methodology began to be
used to evaluate the effects of pharmacological agents. The first (quasi-) randomised
trial in acute stroke was of corticosteroids, conducted by Dyken and White in 1956.
This trial was important for two reasons: firstly, it was the first randomised trial of a
medical therapy for stroke; and secondly, it identified many methodological issues
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associated with performing such trials (Warlow et al 2000). The last half a century
saw an explosion in the number of clinical trials of acute stroke interventions, with
increasing sample sizes, improving methodological quality, and a reduction in delay
between stroke onset and patient recruitment (Kidwell et al 2001). The use of trial
evidence in the medical care of stroke patients is now well-established (Sackett &
Rosenberg 1995).
Development of stroke unit care
Emergence ofstroke units from coronary care units
In the USA, organised patient care in stroke units was introduced in the 1960s. This
was widely believed to be in response to the perceived success of coronary care units
(CCUs) (Blecic & Bogousslavsky 1995; Diez-Tejedor & Fuentes 2001). An
understanding of how the CCU evolved and the methods of evaluating CCU care
might provide insight into the evolution and evaluation of stroke units. A comparison
of the major stages of the development of CCU and stroke unit care is summarised in
Table 1.1.
The development of the CCU consisted of several key stages. In the 1960s, the
mortality for patients with acute myocardial infarction (AMI) was over 30% and
almost half of the deaths were primarily due to arrhythmia (Lown et al 1967; Lee &
Goldman 1988). At around that time, Lown et al found that refractory arrhythmia
could be successfully terminated by electrical cardioversion (Lown et al 1986), and
external cardiac massage was found to be effective (Kowenhouven et al 1960). These
two important developments were accompanied by the introduction of a specialised
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ward to which patients with AMI were admitted for cardiac monitoring and prompt
treatment of arrhythmia (Lee & Goldman 1988). The first CCU opened in 1962.
In the 1970s and 1980s, with the introduction ofmore aggressive treatments for AMI
(e.g. intravenous nitroglycerine and thrombolysis, emergency coronary angioplasty)
and congestive cardiac failure (e.g. intra-aortic balloon pump), CCUs became more
like cardiac intensive care units (Andriange et al 1969; Gialloreto et al 1969; Nager
et al 1969). However, the major drawback of CCU care was the high costs. More
recently, research has been conducted to find more cost-effective alternatives to
CCUs, such as the 'intermediate care unit' (Fineberg et al 1984; Tosteson et al 1996).
Evidence to support the use ofcoronary care units is weak
Although the number of CCUs grew rapidly across the world, evidence from
randomised trials to support its implementation was lacking (Lee & Goldman 1988).
The only two randomised controlled trials failed to demonstrate any extra benefit of
CCU care over conventional home care (Mather et al 1976; Hill et al 1978).
However, both studies excluded the most severe patients and the sample sizes were
small (450 and 349 patients respectively). Resistance to perform randomised
controlled trials ofCCU care grew as evidence of benefit came from several non-
randomised studies (MacMillan & Brown 1971; Chia 1982). In 1971, a non-
randomised controlled study found that patients with AMI admitted to CCU were
less likely to die and more likely to survive a cardiac arrest (MacMillan & Brown
1971). In the 1980s, the support for CCU care was further strengthened by
epidemiological studies showing a dramatic decline in in-hospital mortality rates for
12
AMI by almost a third (Gillum et al 1983). Although the evidence to support the use
ofCCUs was weak, the justification for its existence was no longer an issue after the
publication of large randomised trials of thrombolysis in the late 1980s (GISSI 1986;
ISIS-2 1988).
Early development ofneurovascular intensive care units
In the USA, early stroke units which were created from the CCU model were known
as neurovascular intensive care units (Norris & Hachinski 1976). The aims of such
units were broadly similar to those ofCCUs, although CCU care was never meant to
be multidisciplinary. These intensive stroke units offered comprehensive and early
investigations (e.g. brain scan, electroencephalogram, lumbar puncture), one-to-one
nursing, and early rehabilitation (Norris & Hachinski 1976). The main objectives
were prevention and early treatment ofmedical complications by concentrating
facilities and personnel for optimal care (Millikan 1979).
A few early reports of non-randomised studies showed that care within these units
reduced the risk of death and in-hospital complications such as pneumonia and
pulmonary embolism (Drake, Jr. et al 1973; Norris & Hachinski 1976). However,
other non-randomised studies failed to confirm these positive findings (Kennedy et al
1970; Pitner & Mance 1973). Some physicians also tried combining CCU and stroke
unit into one type of specialised unit, known as a 'coronary and cerebrovascular
intensive care unit'. Cooper et al described the experience with one of these units and
found three specific qualities that could have benefited patient care: a) improved
efficiency of care; b) increased staffs interest in stroke; and c) provision of a focal
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area for stroke education (Cooper et al 1972). These qualities of the early intensive
stroke units continued to be some of the main virtues of the later, less intensive,
stroke units.
Due to a lack of evidence of benefit for these intensive stroke units, and the fact that
operational costs were very high, efforts were put into developing less intensive units
for managing stroke patients (Pitner & Mance 1973; Briggs et al 2001). Nowadays,
intensive stroke units only exist in a small number of countries, but the physicians in
charge of these units still insist that they are indispensable (Hacke 2000).
Development ofless intensive stroke units
As early as the 1950s and 1960s, it was recognised that the care of a stroke patient
should be 'organised' (Adams 1974). Feldman published the first randomised trial of
a 'system' of stroke rehabilitation in 1962 and reported no significant difference in
outcome (Feldman et al 1962). Adams described their experiences before (1948-
1956) and after (1956-1958) the introduction of a stroke rehabilitation ward, and
found that stroke patients treated in the ward were more likely to be alive at two
months and to be discharged home, as compared to those treated before its
introduction (Adams 1974). Further small observational studies in the 1960s also
reported improvements in outcome with organised stroke care (Waylonis et al 1973;
Dow et al 1974).
A move to introduce 'stroke units' in the UK came in the early 1970s. In 1971, the
editor of the British Medical Journal urged the physicians to "accept the lessons
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offered by the transatlantic experience, and to consider the creation ofregional
stroke units along the lines ofthe recently developed coronary care units. These units
would need both to care for the patients in the acute phase ofhis illness and to have
full rehabilitation services..." (Anon. 1971). However, Isaacs wrote in response to
say that, in the UK, stroke rehabilitation units should be "organised along the lines of
a standard geriatric rehabilitation ward, with close collaboration between doctors,
nurses, physiotherapists..." (Isaacs 1971). It was evident that, even three decades
ago, different people have different ideas about how stroke units should operate and
this debate has continued up to the present time. While Bonner (1973) defined a
stroke unit as a specialist team comprising a stroke physician, nurses and therapists
who cared for stroke patients around the hospital, others such as Garraway (1980)
defined a stroke unit as a special area where stroke patients were cared for by a
specialist stroke team (Bonner 1973; Garraway et al 1980a; Wood-Dauphinee 1984).
As stroke units evolved in the 1970s, it became established that most of them were
staffed by a specialist multidisciplinary team which usually comprised medical,
nursing, therapy (physiotherapy, occupational therapy, speech and language therapy),
and social worker staff (Langhorne & Dennis 1998). Some units also involved
professionals from other disciplines such as dieticians, psychologists, neurologists,
and neurosurgeons (see Figure 1.1) (Feigensen et al 1979). The main objectives of
stroke rehabilitation unit were to provide coordinated and individualised patient care
based on the four following key elements (Garraway 1985):
■ Comprehensive assessment of all aspects of the patient's illness and disability;
■ Close collaboration between the disciplines;
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■ Identification and awareness of the objectives of rehabilitation;
■ Education and research on stroke disease.
Different styles ofstroke units
By the late 1970s and early 1980s, different styles of stroke units became established.
When physicians recognised that continuity of care was important, units which
combined acute stroke care and rehabilitation were created; patients were admitted
soon after stroke onset and remained there for some time during rehabilitation
(Garraway et al 1980a; Garraway et al 1980b). Other units were established as purely
stroke rehabilitation units, where patients were admitted once they were medically
stable - usually one or two weeks after onset (Isaacs 1977; Stevens et al 1984). In the
1980s, other forms of organised stroke care also emerged; one example was mobile
stroke teams, which aimed to provide stroke patients with multidisciplinary care
wherever the patients were located (Bonner 1973; Wood-Dauphinee et al 1984).
Evidence to support the use ofstroke units was strong
From a fairly early stage, stroke units were evaluated by randomised controlled trials,
a marked contrast to the evaluation of CCUs. In 1980, Garraway et al published the
first large randomised trial and found that patients managed in the stroke
rehabilitation unit had better functional outcomes and reduced delay to starting
rehabilitative therapy (Garraway et al 1980a; Garraway et al 1980b). As further
randomised trials were conducted throughout the next two decades, the Scandinavian
countries such as Norway and Sweden were moving rapidly towards a more uniform
provision of stroke unit care, whereas such provision was more haphazard in other
16
countries such as the UK (Indredavik et al 1991; Glader et al 2001). Until 1990, it
was believed that although stroke unit care might speed up recovery, it probably
could not improve survival or long-term functional outcomes (Langton-Hewer 1990;
Ebrahim 1990). However, in 1993, results from the first published systematic review
of ten randomised trials (with 1586 patients) suggested that patients managed in a
stroke unit were less like to die within the first year (Langhorne et al 1993). This
apparent benefit was confirmed in subsequent updates of the systematic review
(Stroke Unit Trialists' Collaboration 1997; Stroke Unit Trialists' Collaboration 2002).
Effectiveness of stroke unit care: evidence from a systematic review
It is widely accepted that the highest level of evidence about healthcare interventions
is that obtained from a systematic review of well-conducted randomised controlled
trials (US DoH & Human Services 1993; Harbour & Miller 2001). Systematic
reviews can provide a less biased and more precise estimate of treatment effect, and
hence they are generally regarded as the best source of evidence to inform clinical
practice (Mulrow 1995).
The Stroke Unit Trialists' Collaboration (SUTC) performed a Cochrane systematic
review to assess the effect of stroke unit care compared with conventional medical
care (Stroke Unit Trialists' Collaboration 2002). The first review was published in
1997, and the review has since been updated inl998 and 2001. For this review, the
reviewers sought all published and unpublished randomised and quasi-randomised
trials. "Stroke unit care" was defined simply as "care coordinated by
multidisciplinary team through regular team meetings" to include stroke units of
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different styles. The reviewers then divided the stroke units into three major
subtypes:
1. Stroke wards - those that exclusively provided care for stroke patients in a
dedicated ward. This category included three sub-divisions:
■ Acute stroke units (admission of patients acutely), including intensive units
■ Stroke rehabilitation units (admission of patients for stroke rehabilitation)
■ Comprehensive stroke units (combined acute stroke and rehabilitation)
2. Mixed rehabilitation wards - those that managed all patients needing
rehabilitation and not exclusively stroke patients
3. Mobile stroke teams - a multidisciplinary team providing care in a variety of
settings
The control groups were usually patients managed in general medical wards, where
there was no specialised stroke care.
Results ofthe Cochrane systematic review
The Cochrane systematic review was last updated in April 2001 and it now contains
the combined data from 23 trials and 4911 patients. Compared with alternative forms
of care, stroke unit care:
■ significantly reduced the odds of death by the end of follow-up (Odds ratio, OR
0.86, 95% confidence interval, CI 0.71 to 0.94);
■ significantly reduced the odds of death or dependency by the end of follow-up
(OR 0.78, 95% CI 0.68 to 0.89). See Figure 1.2;
■ significantly reduced the odds of death or requiring institutional care by the end
of follow-up (OR 0.80, 95% CI 0.71 to 0.90). See Figure 1.3.
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Thus, the number needed to treat (95% CI) to prevent one death is 33 (20-100), to
prevent one patient being unable to live at home was 20 (12-50), and to prevent one
patient failing to regain independence was 20 (12-50). There was evidence that the
benefit was similar among patients of all ages, males and females, and irrespective of
stroke severity. The review included five randomised trials that compared different
forms of stroke unit care. Three trials found that dedicated stroke rehabilitation units
may be more effective than mixed rehabilitation wards in preventing bad outcomes
(non-significant trend) (Stevens et al 1984; Kalra et al 1993; Lincoln et al 2000). One
UK trial showed that their comprehensive stroke unit was significantly more
effective than a mobile stroke team (Kalra et al 2000). Finally, one Finish trial
comparing an acute stroke unit with a mixed rehabilitation ward found no significant
difference in outcome (Ilmavirta et al 1994).
Recommendation: acute stroke patients should be admitted to a stroke unit
The reviewers concluded by recommending that all acute stroke patients should be
offered stroke unit care which includes a substantial period of rehabilitation if
required, provided by a coordinated multidisciplinary team. All current UK and
European stroke guidelines support this recommendation (SIGN 1997a; Kaste et al
2000; RCP 2001a). In the UK, the Royal College of Physicians (RCP) guidelines
also recommend that stroke patients should be the responsibility of a specialist stroke
service, which should include the following four elements: a) an inpatient stroke unit;
b) a coordinated multidisciplinary stroke team; c) educational programmes for staff,
patients and carers; and d) agreed protocols for common problems (RCP 2001b).
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Why is stroke unit care effective?
Stroke unit care is differentfrom conventional care
A few studies have suggested that the benefits of stroke unit care may persist for up
to ten years (Jorgensen et al 1999; Indredavik et al 1999a; Lincoln et al 2000).
However, it remains unclear why stroke unit care is associated with such a
significant benefit - is it the result of the whole package of care, or the effects of
individual components? (Dennis & Langhorne 1994) The Cochrane systematic
review tried to identify the major differences between stroke unit care and
conventional care by surveying the trialists' experiences (Stroke Unit Trialists'
Collaboration 2002). The following is a summary of the characteristics of a stroke
unit which were perceived to be important; whether these characteristics play any
role in explaining the apparent beneficial effects remains to be elucidated.
■ Care by a coordinated multidisciplinary team
■ Routine involvement of carers in management decisions and rehabilitation
■ Staffing by medical and nursing staff with an interest in stroke and rehabilitation
■ Routine provision of information to patients and carers
■ Provision of staff education programmes
So, stroke unit care can perhaps be more appropriately defined according to these
five special characteristics. In one randomised study of stroke unit care, Indredavik et
al also identified from post-hoc analysis three features of patient care that they felt
were related to improved outcome. These were: a) early mobilisation of the acute
stroke patient; b) avoidance of dehydration by routine intravenous fluid therapy; and
c) monitoring and correction of physiological disturbances (Indredavik et al 1999b).
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Observational studies have also highlighted several qualities that were special to
stroke unit care, for example, patients in stroke units spent more time out of bed and
had more opportunities for independent activities than patients in general medical
wards (Pound et al 1999a).
The 'black box' ofstroke unit care
The data so far have established that stroke unit care should be well-organised and
coordinated by a multidisciplinary team of professional staff who are interested,
enthusiastic and knowledgeable about stroke (Dennis & Langhorne 1994), but they
do not provide clear guidance on exactly how care should be organised or
coordinated. Although the beneficial effects of stroke unit care have been shown to
be reproducible in the 'usual clinical setting' (Stegmayr et al 1999; Jorgensen et al
2000; Collins et al 2000), some experts suggest that more trials are needed to unpack
the 'black box' of stroke unit care and identify the key organisational elements
(Stone 1999). However, clinical trials of this kind are difficult to conduct.
Development of acute stroke units
What is an acute stroke unit?
Every stroke unit is unique in style and infrastructure (Sinha & Warburton 2000).
Although the Cochrane systematic review found no clear evidence of difference in
outcome between the different styles of stroke units, interest in one particular style
has recently intensified - the acute stroke unit (Bath et al 1996; Dayno & Mansbach
1999). An acute stroke unit is usually defined as a stroke unit where patients are
admitted directly from home, emergency department, or another acute medical
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admission unit, and where patient care is often more intensive; patients are usually
discharge or transferred out of the unit within one week of admission (Morris et al
1993; Dennis & Langhorne 1994; Stroke Unit Trialists' Collaboration 2002). In the
USA, where there are no acute stroke units per se - acute stroke patients are admitted
to 'stroke centres' (Skolnick 1999). A stroke centre encompasses more than the ward
where patients are admitted, but the whole organisational system that is involved in
managing the patient. There are national guidelines on the minimal standards for the
different components of such centres, for example, in terms of the ward, emergency
department, and neuroimaging (Alberts et al 2000; Kareem 2001).
Why are acute stroke units needed?
There are four major reasons to develop acute stroke units (Morris et al 1993; Dayno
& Mansbach 1999). Firstly, acute stroke is a complex condition. In order to provide
an efficient and effective patient care in the first few hours, complex organisational
systems are required; such systems must involve highly trained and enthusiastic
healthcare staff. Secondly, acute stroke patients are at high risk of developing
neurological, cardiac, metabolic and other complications, each ofwhich may require
carefully directed intervention. Thirdly, stroke unit care has been shown to improve
outcome, so it is conceivable that acute stroke unit care could do likewise. Lastly, an
acute stroke unit may be the ideal setting in which to give treatments that require
close monitoring (e.g. thrombolysis) and to perform clinical trials of acute medical
treatments (e.g. neuroprotective agents) (Morris et al 1993; Dayno & Mansbach
1999).
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A major advantage of caring for patients in an acute stroke unit is that it concentrates
patients, healthcare staff, resources, and expertise into one area; this may also
facilitate audit and training (Bath & Lees 2000). Dennis and Langhome stated that
"admitting all patients with acute stroke directly into a unit makes the introduction of
assessmentprotocols easier, allows skills to be focused, andfacilitates the large
randomised trials ofacute treatments..." (Dennis & Langhorne 1994).
Acute stroke units may be the best place to administer thrombolysis
In the last ten years, thrombolysis using recombinant tissue plasminogen activator
(rt-PA) has been introduced to be used for selected groups of patients with ischaemic
stroke within the first three hours of onset (Adams, Jr. et al 1996; Wardlaw et al
2002). It is widely accepted that the best place to administer thrombolysis is the acute
stroke unit where the patient can be closely monitored by a team of highly trained
staff (Koroshetz 1996; Treib et al 2000), and recent European and American
recommendations have emphasised this point (Adams, Jr. et al 1996; Hacke et al
2000).
Evidence to support the use ofacute stroke units is weak
In the Cochrane systematic review, the difference in the risk of death between stroke
unit and the control group is most evident within the first month after stroke (Stroke
Unit Trialists' Collaboration 2002). After the first month, further difference in deaths
do not emerge. In the OCSP, about two thirds of deaths within the first month after
stroke occurred within the first week and deaths were most commonly due to direct
neurological sequelae such as trans-tentorial herniation and brainstem compression
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(Bamford et al 1990b). After the first week, deaths were usually a result of medical
complications such as pneumonia and pulmonary embolism (Bamford et al 1990b).
Sinha and Warburton proposed that a major factor in the success of stroke unit care is
the better management of early medical complications (Sinha & Warburton 2000).
This argument strengthens the rationale for admitting patients with acute stroke to an
acute stroke unit, where medical complications can be detected early and managed
appropriately. Dennis and Langhorne suggested that the best model of stroke care is
"one in which patients are admitted into an acute assessment area, either on a
medical ward or as part ofan acute stroke unit..., and then moved without delay to a
stroke rehabilitation unit as soon as they can benefitfrom that environment" (Dennis
& Langhorne 1994).
Despite the potential benefit of acute stroke unit care, the Cochrane systematic
review did not find any clear evidence that it was more effective than alternative
forms of care (Stroke Unit Trialists' Collaboration 2002). This conclusion was based
on the results of one single randomised trial of 211 patients (Ilmavirta et al 1994).
Several other studies have found apparent benefits of acute stroke unit care on patient
outcome, but these studies are of less robust research designs (Ronning & Guldvog
1998a; Fagerberg et al 2000).
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1.3 Care of an acute stroke patient
In this section, I shall discuss the medical and nursing management of a patient
during the acute phase of stroke, which I will arbitrarily define in this thesis as the
first one to two weeks after stroke onset. Management thereafter is outside the scope
of this thesis. Acute stroke care can be divided into three major components: a)
treatment of the cerebral lesion itself; b) general care of the stroke patient; and c)
prevention and management of specific complications (Blecic & Bogousslavsky
1995).
Pharmacological treatments of acute ischaemic stroke
Cerebral ischaemia and optionsfor treatment
When a cerebral artery or one of its branches occludes, the area of brain tissue it
supplies experiences a sudden fall in cerebral blood flow (CBF) and the tissue
becomes ischaemic. Surrounding a core of infarcted tissue that is irreversibly
damaged is a rim of tissue called the 'ischaemic penumbra'. The ischaemic
penumbra has been documented as a severely hypoperfused, functionally impaired,
but still viable area which can regain its function and escape infarction if it is
reperfused before a certain time has elapsed (Marchal et al 1996; Baron 2001). CBF
within the ischaemic penumbra is typically reduced to 10 to 30ml/100g/min, or about
15 to 40% of normal (Back et al 1998; Fisher 1998; Kaufmann et al 1999).
The ischaemic penumbra exists in a dynamic state and its survival depends on the
severity and duration of ischaemia (see Figure 1.4) (Fisher 1997). Therefore, the
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main targets of pharmacological treatments of acute ischaemic stroke are to restore
blood flow and protect vulnerable brain tissue before it becomes infarcted (Lassen
1990; Fisher 1997). There are currently only two pharmacological agents that have
been proven to be effective in treating acute ischaemic stroke - thrombolysis and
antiplatelet therapy (Hankey 2001). Although various other acute stroke treatment
strategies are also used in other countries (e.g. immediate anticoagulation,
manipulation of intracranial pressure, surgical decompression), these have not been
supported by evidence from large randomised controlled trials.
Thrombolysisfor acute ischaemic stroke
Thrombolytic therapy aims to lyse the thrombus or embolus occluding the cerebral
artery, hence restoring blood supply to the brain and reduce the volume of brain
damaged by ischaemia. In turn, this should improve neurological function and
survival (Hacke et al 1995; NINDS 1995; Hacke et al 1998). However, intracranial
haemorrhage is a recognised and potentially fatal complication of thrombolytic
agents. The most recent Cochrane systematic review of thrombolytic therapy for
acute ischaemic stroke included 17 trials with over 5200 patients (Wardlaw et al
2002). Four different thrombolytic agents were evaluated - rt-PA, streptokinase,
urokinase and pro-urokinase - but the only one that has a license for clinical use (in
certain countries) is rt-PA. The systematic review showed that rt-PA significantly
reduced the odds of being dead or dependent (OR 0.79, 95% CI 0.32 to 0.08). In
other words, for every 1000 patients treated, there would be 57 more independent
survivors. However, rt-PA significantly increased the odds of fatal intracranial
haemorrhage (OR 3.2, 95% CI 2.0 to 5.2); this is equivalent to 29 extra fatal
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intracranial haemorrhages per 1000 patients treated. Furthermore, the effects of rt-PA
may depend on other factors such as the dose (lower doses seemed safer), time from
stroke onset to randomisation (rt-PA appeared to be more effective if given earlier),
and whether antithrombotic agents were used (co-administration of aspirin or heparin
seemed to cause more adverse events). The benefit of rt-PA was also greatest
amongst patients randomised within three hours of stroke onset (rather than six
hours), where there would be 126 more independent survivors per 1000 patients
treated (Wardlaw et al 2002).
Nevertheless, uncertainties remain about which patients should be treated with rt-PA,
and which patients should avoid it; consequently, different authors have made
different recommendations. Some suggest using rt-PA in routine clinical practice
(Adams, Jr. et al 1996; Hacke et al 2000), whereas others suggest using rt-PA only in
a clinical trial setting (CAEP Committee on Thrombolytic Therapy for Acute
Ischaemic Stroke 2001; RCP 2001b). Further differences in opinion exist in the
selection criteria for thrombolytic therapy, for example, age of the patient,
neuroimaging findings, stroke severity, and blood pressure (Adams, Jr. et al 1996;
Tanne et al 2000; Albers et al 2000; Silver et al 2001; Adams, Jr. 2001). A large-
scaled randomised controlled trial called the third International Stroke Trial (IST-3)
is being conducted to reliably assess the effects of thrombolysis for acute ischaemic
stroke, when given within six hours of onset (Hand et al 2001; Hankey 2001).
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Antiplatelet therapyfor acute ischaemic stroke
Early antiplatelet therapy may reduce the size of infarcted brain tissue and several
mechanisms of action have been proposed, including the prevention of thrombus
propagation and re-embolisation, and neuroprotection (e.g. inhibiting the release of
thromboxane and glutamate) (De Cristobal et al 2001; Hankey et al 2002).
Pharmacological agents with antiplatelet properties include aspirin, dipyridamole,
thienopyridine (clopidogrel and ticlodipine) and glycoprotein Ilb/IIIa inhibitor, but
only aspirin has been shown to be effective when administered in the acute phase of
stroke (Gubitz et al 2002). A Cochrane systematic review of antiplatelet therapy for
acute ischaemic stroke included eight trials with over 41,000 patients. Antiplatelet
therapy significantly reduced the odds of death or dependency (OR 0.94, 95% CI
0.91 to 0.98); this is equivalent to 13 more independent survivors for every 1000
patients treated. Furthermore, antiplatelet therapy increased the odds of making a full
recovery (OR 1.06, 95% CI 1.01 to 1.11), which is equivalent to 10 extra fully
recovered patients per 1000 treated. However, treatment was associated with a small
risk of symptomatic intracranial haemorrhage (OR 1.23, 95% CI 1.0 to 1.5), which is
equivalent to 2 extra haemorrhages per 1000 patients treated (Gubitz et al 2002). A
detailed individual patient data overview of the two largest randomised trials
(International Stroke Trial and the Chinese Acute Stroke Trial) found that the
benefits of aspirin were similar in a wide range of patients regardless of age, gender,
time from stroke onset to randomisation, presence of atrial fibrillation, and blood
pressure (1ST 1997; CAST 1997; Chen et al 2000). The current European and UK
recommendation is to give 300mg of aspirin to all stroke patients as soon as
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intracranial haemorrhage has been excluded, ideally by computed tomography (CT)
scanning (SIGN 1997a; Hacke et al 2000; RCP 2001b).
General care of an acute stroke patient
There are very few treatments options available in the acute phase of stroke (Hankey
2001). Trials ofmany pharmacological agents such as anticoagulants and
neuroprotectives have failed to demonstrate significant benefit (Diener et al 2000;
Horn & Limburg 2001; STAIR II 2001; Bath et al 2001). There are speculations on
the possible reasons for the negative results of these trials, but one reason might be
the inconsistent or even poor general care of acute stroke patients in some centres
(Blecic & Bogousslavsky 1995).
There are several reports suggesting that the process of acute stroke care might have
been gradually improving in different countries, for example, with an increased use
ofCT scanning (Smith et al 1998; Leys 1999; Widder 2001). Opinions differ on what
'good' acute stroke care should comprise, but there are four aspects that come
immediately to mind: a) rapid diagnosis and early transfer of the patient to hospital;
b) rapid and accurate assessment of the patient's neurological condition; c)
performance of appropriate investigations without delay; and d) rapid transfer of the
patient to a stroke unit for specialised multidisciplinary therapy.
Acute stroke is a medical emergency
The concept of treating acute stroke as a medical emergency requiring urgent,
coordinated and intensive action has developed rapidly in the past decade (Bath &
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Lees 2000; Davenport & Dennis 2000). The acceptance of this status by physicians
was helped by the fact that stroke has a rapid onset and poor prognosis, and that
thrombolysis is a potentially effective and highly time-dependent treatment
(Davenport & Dennis 2000). However, as more patients seek medical attention
within the first few hours after stroke onset, differentiation between a TIA and stroke
may become more difficult according to their traditional definitions (Bamford 2001).
Hachinski first suggested using the term 'brain attack' to describe an episode of acute
neurological deficit of very recent onset, when it is not immediately clear whether
the diagnosis might be stroke, TIA, SAH, or something else (Camarata et al 1994;
Warlow et al 2000; Bamford 2001). To the public, the term 'brain attack' highlights
the similarity between a stroke and a 'heart attack' with respect to the need to seek
immediate medical attention (Heros et al 1997; Selman et al 1997). Nowadays, this
term is widely used in the USA after the introduction of thrombolysis as a treatment
for acute stroke (American Heart Association 1999).
Pre-hospital stroke care
Stroke care starts from the moment the symptoms are first noticed by the patient or a
witness. However, many people do not know what the symptoms of stroke are and,
even if they do, they do not seek urgent medical help (Pancioli et al 1998;
Weltermann et al 2000). UK clinical guidelines state that all suspected stroke patients
should be "promptly admitted to a hospital with a well organised stroke service
including a stroke unit ...efforts should be made to accelerate hospital admission to
minimise delays." (RCP 2001a). American guidelines also emphasise the importance
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of public education, the need to call an ambulance immediately, and the valuable role
of paramedical staff at the point of first contact (Pepe 1996; Zachariah et al 1996;
Sayre et al 1996). As new treatments such as thrombolysis are introduced for use
within the first six hours of stroke onset, it is all the more important that patients with
probable or definite stroke arrive at the hospital as soon as possible (NINDS 1995).
However, observational studies have found that more than half of all stroke patients
do not arrive at the hospital within six hours (Harper et al 1992; Ferro et al 1994;
Kothari et al 1995a; Fogelholm et al 1996; Jorgensen et al 1996; Wang et al 1997).
There is a general consensus that efforts should be made to improve the efficiency of
transferring patients with suspected stroke to the hospital to receive specialist stroke
care. The Helsingborg Declaration (Pan European Consensus Meeting on Stroke
Management, November 1995) states that "stroke is an emergency and all patients
should be evaluated in hospital, preferably within six hours of the onset of
symptoms." (Aboderin & Venables 1996).
When the first medical contact (e.g. a paramedical staff) arrives at the scene of the
patient, there are several aspects of care that can be carried out in the emergency
situation. They may include: a) assessing the patient's neurological condition by
taking an accurate history from the patient and/or a bystander; b) performing a brief
physical examination, noting the vital signs (e.g. pulse, blood pressure, oxygen
saturation), conscious state and neurological deficits; c) making a diagnosis of brain
attack and recognising that the patient may be suitable for thrombolysis; d) providing
basic life support (e.g. airway, breathing and circulation) and treating the patient for
specific problems (e.g. treatment of convulsions); e) recognising and promptly
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treating reversible conditions that can mimic stroke (e.g. hypoglycaemia); and f)
notifying the emergency department staff that a patient with brain attack is arriving at
the hospital shortly (NSA 1993; Libman et al 1995; Lott et al 1999; Kaste et al 2000;
RCP 2001b).
Acute stroke care in hospital
After the patient arrives at the hospital, the care of an acute stroke patient consists of
three main elements: a) making a more accurate clinical diagnosis by bedside
assessment and investigations; b) nursing care; and c) early rehabilitative therapy.
The Helsingborg Declaration recommends that "patients with persisting impairment
should receive a diagnosis, appropriate nursing care, and have their rehabilitation
needs assessed and treated" (Aboderin & Venables 1996). In the UK, the National
Service Framework for Older People stresses the importance ofmaking an early
diagnosis and providing high quality care in the acute period (DoH 2001a). Each of
these three elements are now discussed in turn.
Making an accurate diagnosis ofstroke
To make a complete diagnostic evaluation in a patient with suspected stroke or TIA,
the following questions need to be answered from the history and physical
examination (SIGN 1997b; Warlow et al 2000; Bamford 2001):
■ Is it a vascular event?
■ Which part of the brain is affected? (anatomy)
■ Is the vascular event ischaemic or haemorrhagic? (pathology)
■ What is the cause of the vascular event? (mechanism)
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■ What are the consequences of the vascular event? (impairments, disabilities and
handicap) (WHO 1980)
■ What other medical problems co-exist?
Some answers would not be available immediately and more information may need
to be gathered when the patient is reassessed later. Misdiagnosis of stroke is common
even amongst experienced clinicians; observational studies have found that between
5 and 27% of stroke diagnoses were incorrect (Norris & Hachinski 1982; Kothari et
al 1995b; Martin et al 1997; Allder et al 1999). The most common conditions that
mimic stroke or TIA are epilepsy, migraine, infections (e.g. encephalitis), structural
intracranial lesions (e.g. brain tumours), metabolic disturbances (e.g.
hypoglycaemia), labyrinthine disorders (e.g. vestibular neuronitis), and
demyelination (Libman et al 1995; The Members of the Lille Stroke Program 1997).
Medical staff should therefore keep a high index of suspicion for these mimicking
conditions in the emergency department.
CT brain scanning is now regarded as a routine investigation in acute stroke (King's
Fund 1988; Davis et al 1997; Warlow 1998). CT scanning is a sensitive first-line
investigation for excluding intracranial haemorrhage in the acute phase, but its
sensitivity declines after the first five days (Adams, Jr. 1997; Wardlaw 2001). By ten
days, small haemorrhages may be indistinguishable from infarcts, whereas large
haemorrhages may be visible for up to three weeks (Wardlaw 2001). Furthermore,
cerebral infarction may not visible until a few hours or even up to a day after stroke,
if ever (Wardlaw 2001; Moonis & Fisher 2001). Current UK guidelines state that "a//
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physiotherapist assesses and retrains truncal control and limb function; the speech
and language therapist assesses swallowing and communication and provides
practical advice in tackling identified problems; and the dietician advises on the
nutritional status and ways to prevent or treat under-nutrition (Wojner 1996; Miyai &
Reding 1998; Warlow et al 2000). Occupational therapy, however, may be less vital
in the acute phase of stroke but early assessment of function and impairment is often
helpful in planning treatment (Ballinger et al 1999).
When should physiotherapy begin after stroke? Indredavik et al found that, when
patients were treated within the stroke unit, the earlier the patient was mobilised after
stroke, the more likely the patient was discharged home (Indredavik et al 1999b).
Evidence from other clinical trials also suggests that earlier rehabilitation leads to
improved physical and functional outcomes (Hayes & Carroll 1986; Ottenbacher &
Jannell 1993). Moreover, some studies have found that more intensive therapy may
produce better functional outcome (Kwakkel et al 1997; Kwakkel et al 1999).
Current Scottish guidelines recommend that rehabilitative therapy should be started
as soon as the patient's condition permits (SIGN 1998). However, many questions
remain to be answered, for example, what is the optimal amount, content, and style
of rehabilitative therapy? And which patient groups might benefit the most from
early rehabilitative therapy? (Shah et al 1990; SIGN 1998).
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1.4 Complications after stroke
Complications after stroke can be broadly divided into three categories:
■ Consequences of the stroke itself (e.g. immobility, reduced consciousness);
■ Secondary medical complications (e.g. pneumonia, deep vein thrombosis);
■ Physiological disturbances (e.g. hypertension, hyperglycaemia).
The major complications in each category are summarised in Table 1.2.
Medical complications after acute stroke
Reportedfrequencies ofmedical complications
Several studies reported the frequencies of a range ofmedical complications amongst
stroke patients admitted to hospital (Kalra et al 1995; Davenport et al 1996a;
Johnston et al 1998; Fieschi et al 1998; Tirschwell et al 1999; Langhorne et al 2000a;
Roth et al 2001). Several other studies reported the frequencies of single
complications (Britton & Roden 1985; Kotila & Waltimo 1992; Davenport et al
1996b; Kotila et al 1998; Brittain et al 1999; Velioglu et al 2001). The reported
frequencies of different complications vary considerably because of variations in
case ascertainment, definition of complications, method of investigation,
characteristics of patient groups, and sample sizes (see Table 1.3) (Langhorne et al
2000a). In a prospective Scottish study of 311 consecutive stroke patients, Langhome
et al found that 85% of the patients experienced complications, the most common
being urinary tract infection (23%) and chest infection (22%).
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Chest infection, which is often caused by aspiration of oropharyngeal content, is
responsible for 25 to 30% of deaths after stroke and is the commonest cause of non-
neurological death (Johnson et al 1993; Smithard et al 1996; Johnston et al 1998). In
the study by Langhorne et al (2000a), very few patients had clinically apparent deep
vein thrombosis (2%) and pulmonary embolism (1%), but an unusually high
proportion of patients had pressure sores (21%), which were defined as any skin
break or necrosis from either pressure or trivial trauma. This finding was very
different from other studies, which have rarely found rates higher than 3 to 10%
(Kalra et al 1995; Warlow et al 2000; Roth et al 2001).
Medical complications can be iatrogenic, that is, caused by medical or nursing staff
themselves or the prescribed medications (see Table 1.3). Examples include adverse
effects from withholding food (under-nutrition) or medications (e.g. anti-anginal
agents), under- or over-hydration, over-sedation, and adverse drug reactions. One
retrospective US study of 1029 consecutive stroke patients found that, whilst
undergoing rehabilitation, 10% of all patients suffered from dehydration, 10% from
adverse drug reactions, and 5% from under-nutrition (Roth et al 2001).
Adverse effects ofmedical complications on outcome
Medical complications are barriers to recovery after stroke. A prospective study
showed that occurrence of serious medical complications was related to worse
outcome as measured by the Barthel Index (OR 6.1, 95% CI 2.5 to 15.1), and that
half of all deaths may be attributed primarily to medical complications (Johnston et
al 1998). Another study found that medical complications were associated with
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increased length of hospital stay (Tirschwell et al 1999). The major difficulty with
interpreting the results from these studies is that medical complications occur more
often in patients with more severe stroke. Any relationship with outcome may
therefore be spurious if the results have not been properly adjusted for stroke severity
and other factors that could influence outcome (Davenport et al 1996c; Counsell &
Dennis 2001).
Evidence from randomised trials of stroke unit care suggests that the deaths that are
most likely to be preventable are those resulting from complications of immobility
(e.g. pneumonia, deep vein thrombosis) (Langhorne et al 2000a). Prevention, early
detection and prompt treatment of these complications could therefore lead to better
outcome. Current UK guidelines give clear recommendations on patient positioning,
prevention of deep vein thrombosis, and bladder and bowel management after stroke
(RCP 2001b). However, many of these recommendations are not based on good
quality evidence.
Physiological disturbances after acute stroke
Potential adverse effects ofphysiological disturbances after acute stroke
The fate of the ischaemic penumbra directly depends on the severity and duration of
ischaemia (see Figure 1.4). Animal studies have also demonstrated that
physiological disturbances such as hyperglycaemia and hypoxia can exacerbate
neuronal injury (Greenberg 1998; Busto & Ginsberg 1998). This may cause a
worsening of the initial stroke, which is also known as 'stroke progression'. Studies
have shown that stroke progression occurs in 26 to 43% of patients, and that about
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half of the stroke progressions occur within 24 hours of admission (Britton & Roden
1985; Davalos et al 1990; Jorgensen et al 1994; Toni et al 1995). Stroke progression
in turn is strongly correlated with bad functional outcome (Britton & Roden 1985;
Jorgensen et al 2001). The International Study of Early/Progressing Stroke (by the
European Stroke Database Collaboration and Early/Progressing Stroke Study Group)
is an ongoing study of the phenomena of stroke progression (http://www.ncl.ac.uk/
stroke-research-unit/posters/epssp.htm).
It therefore appears that the process of secondary neuronal damage can occur very
quickly and any attempts to halt the process should be made aggressively and
urgently. In an observational study, Langhorne et al found that stroke patients with
normal physiological parameters within the first three days (including glucose,
temperature, serum osmolarity, and oxygen saturation) had better functional
outcomes (Langhorne et al 2000b). The authors concluded that at least some of the
neurological impairment occurring in the acute phase of stroke may be reversible and
could be exacerbated by physiological abnormalities (Langhorne et al 2000b).
Indredavik also commented that "control ofsuch physiological parameters may be
the most important neuroprotective options in acute stroke patients" (Indredavik
2000). This perhaps forms the basis for a recent trend of increasingly intensive
management of physiological disturbances after stroke (Langhorne 1999).
Rationalefor actively treating physiological disturbances
The Scandinavian approach to stroke unit care is characterised by early mobilisation,
intensive physiological monitoring and correction of abnormal parameters such as
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fever, hyperglycaemia, hypoxia, and dehydration (Ronning & Guldvog 1998a;
Ronning & Guldvog 1998b; Indredavik et al 1999b). This style of stroke unit care
appeared to reduce the number of deaths within the first three weeks from 14% to
8%, and the authors suggested that this might have been a result of preventing stroke
progression (Ronning & Guldvog 1998a; Ronning & Guldvog 1998b; Indredavik et
al 1999b). In the USA and some countries in Europe, acute stroke care has adopted
this style so that intensive physiological monitoring and correction of abnormal
parameters are now accepted as routine (Hund et al 1995; Krieger & Hacke 1997;
Deibert & Diringer 1999). Such monitoring often detects abnormalities of blood
pressure, oxygen saturation, temperature, glucose concentration, and cardiac rhythm
(Rem et al 1985; Hacke et al 1994; Davis et al 1999; Bellagamba et al 2001).
In the UK, such intensive physiological monitoring is not widely used; this may be
because of a lack of resources, lack of evidence from randomised trials, and the
belief by some physicians that a lack of evidence of benefit equates to evidence of
lack of benefit (Sandercock & Willems 1992; Wolfe et al 2001). However, there has
been a recent call in the UK for a more active approach in managing physiological
disturbances after stroke. Wolfe et al wrote, "the current absence ofevidence from
randomised trials should not be used as an excuse for neglecting basic care for
patients with stroke'" (Wolfe et al 2001). What Wolfe et al meant by "basic care"
included active monitoring and treatment of fever, hyperglycaemia, dehydration,
hypoxia, as well as ensuring a safe airway (Wolfe et al 2001).
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Monitoring ofphysiologicalparameters after acute stroke
In conventional intensive care units, control of physiological parameters is usually
straightforward since patients are anaesthetised and ventilated, so that invasive
monitoring (e.g. intra-arterial lines for continuous blood pressure monitoring) is
possible (Indredavik 2000). This model of care is not practical in acute stroke where
early mobilisation is one of the main treatment goals (Indredavik et al 1999b;
Indredavik 2000; Langhorne et al 2000b).
So is there any direct evidence to show that intensive physiological monitoring and
correction of abnormal parameters after acute stroke is feasible and worthwhile? A
UK randomised controlled trial tested the hypothesis that acute stroke patients who
received augmented care (i.e. 72 hours of continuous physiological monitoring),
compared with standard care (i.e. 4-hourly observations), would have a better
outcome. The study found that intensive non-invasive physiological monitoring
improved the rate of detection and correction of abnormal parameters, and that
significantly fewer patients in the augmented care group experienced stroke
progression (OR 0.24, 95% CI 0.09 to 0.63) (Davis et al 1999). A non-randomised
Italian study also found that non-invasive physiological monitoring and correction of
abnormal parameters appeared to improve outcome and also reduce length of stay
(Cavallini et al 2001). However, these positive findings were not confirmed by
another non-randomised Spanish study (Silva et al 2001). There is currently a
ongoing non-randomised controlled trial (the PROCESS trial) that aims to recruit
450 patients to investigate the effectiveness of an acute care protocol with
physiological monitoring (Langhorne et al 2001).
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Any improvement in patient outcome is unlikely to be due to the physiological
monitoringper se, but more likely to be due to the corrective measures in response to
detecting abnormal parameters (Sinha & Warburton 2000). However, it is unclear
how intensive the physiological monitoring needs to be, how long a patient should be
monitored, and what 'abnormal' means for each physiological parameter. I shall now
discuss four parameters in some detail.
High bloodpressure
High blood pressure is common after stroke (Scott & Gray 2000). One study found
that almost 70% of patients admitted with stroke had a blood pressure greater than
170/100mmHg (Britton et al 1986). However, a history of high blood pressure is
only present in about half of the patients who have a high blood pressure on
admission (Sandercock et al 1989). During the first few days after stroke, the blood
pressure declines spontaneously in many patients (Britton et al 1986; Harper et al
1994).
High initial blood pressure after stroke may be associated with poor outcome
(Choong et al 2000). The recently published Perindopril Protection Against
Recurrent Stroke Study (PROGRESS), a multicentre randomised controlled trial
which recruited over 6000 patients, has found that blood pressure lowering using a
combination of perindopril and indapamide was highly effective in reducing the risk
of recurrent stroke or TIA (PROGRESS Collaborative Group 2001). However, the
optimal timing of blood pressure lowering after stroke remains unclear because there
have been no randomised trials of blood pressure reduction during the acute phase of
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stroke (Blood pressure in Acute Stroke Collaboration (BASC) 2002). Current UK
guidelines recommend not actively lowering the blood pressure within the first few
days after stroke, and keeping the patient well hydrated (SIGN 1997a; RCP 2001b).
However, if the patient suffers from hypertensive encephalopathy or acute renal
failure resulting from extreme hypertension, blood pressure should be lowered
acutely (e.g. using captopril or labetolol) (Hacke et al 2000). For the remaining
patients, most experts advise waiting one to two weeks before starting blood pressure
lowering therapy (Britton et al 1980; Warlow et al 2000). For patients who are being
considered for thrombolytic therapy, current US guidelines state that blood pressure
should be below 185/1 lOmmHg before treatment, and then kept below
180/105mmHg during treatment (Adams, Jr. et al 1996). This recommendation is not
based on any randomised trial evidence. Further research is clearly needed to assess
the effects of lowering blood pressure during the acute phase of stroke (Blood
Pressure in Acute Stroke Collaboration, BASC, 2002).
High body temperture
Fever, which is generally defined as body temperature of above 37.5° or 38°C, is
common after stroke. Frequency of occurrence of fever after stroke might vary
according to the method ofmeasurement (e.g. oral, rectal, axillary or tympanic) and
the characteristics of the patients studied. In the Copenhagen Stroke Study, 25% of
stroke patients admitted within six hours of stroke onset had temperature greater than
37.5° (Reith et al 1996). In other studies, the frequency varies from 5% to 91%
(Georgilis et al 1999; Schwarz et al 2000; Boysen & Christensen 2001). The
aetiology of fever after stroke is unclear, but of the stroke patients who develop
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fever, may be only 16% have concurrent infection, even though 50% have
leucocytosis (Reith et al 1996). Non-infection-related fever may be a result of the
cerebral lesion itself, or associated cerebral oedema (Boysen & Christensen 2001).
A systematic review including nine studies and a total of 3790 patients has shown
that fever is an independent predictor for higher mortality and morbidity after stroke
(OR for mortality 1.19, 95% CI 0.99 to 1.43) (Hajat et al 2000). Furthermore,
spontaneous hypothermia after stroke (less than 36.5°) may be associated with a
reduced risk ofmortality (Wang et al 2000). The harmful effects of fever have been
attributed to increased metabolic demands, changes in the blood-brain-barrier
permeability, acidosis, and an increased release of neurotransmitters (Busto &
Ginsberg 1998; Dippel et al 2001). However, it is unclear whether feverper se
causes poor outcome after stroke, or the fact that fever is associated with severe
strokes, which in turn is associated with poorer outcome. Boysen and Christensen
recently found evidence that the latter may be the case (Boysen & Christensen 2001).
There are two methods of reducing body temperature: mechanically-induced
hypothermia and pharmacological treatment of fever. In animal models of focal and
global ischaemia, it has been shown that high temperature within the brain (over 39°)
led to increased infarct volume and more severe histological outcome, whereas
actively reducing the temperature by mechanical and/or pharmacological means
appeared to delay and reduce neuronal injury (Coimbra et al 1996; Busto & Ginsberg
1998; Schmid-Elsaesser et al 1999).
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In humans, hypothermia has been used in patients with traumatic head injury and
there is some evidence that it may reduce mortality and severe disability (OR 0.39,
95% CI 0.2 to 0.74) (Signorini & Alderson 2002). In stroke, mechanically-induced
hypothermia has neither been proven to be easily achieved nor beneficial. Many of
the trials employed invasive methods of physiological monitoring (e.g. general
anaesthesia and insertion of arterial and central venous catheters) and use of
powerful drugs to control shivering (e.g. pethidine) (Kammersgaard et al 2000;
Krieger et al 2001). One small randomised trial of 20 consecutive patients with
severe stroke found that a combination of anti-inflammatory drug and ice-cooling
prevented the development of cerebral oedema (Moriwaki et al 2000). Although
some insist that a controlled trial comparing treatment with no treatment of fever is
no longer ethical (De Keyser 1998), one such trial has recently been carried out
(Dippel et al 2001). In this randomised trial of 75 patients with acute ischaemic
stroke, Dippel et al found that treatment with 6g of paracetamol appeared to have
reduced body temperature by 0.4°, even in patients without fever (Dippel et al 2001).
However, the study did not investigate the effect of this fall in temperature on
functional outcome. One potential adverse effect of prevention or treatment of fever
might be a delay in detecting the underlying cause, such as an infection, and hence
delaying appropriate treatment. Further randomised studies would be necessary to
determine the effects of lowering body temperature after stroke. Current guidelines
on the treatment of fever after stroke are imprecise, but they all suggest that
treatment should be considered if body temperature rises above 37.5° (Adams, Jr. et
al 1994; Hacke et al 2000; RCP 2001b).
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High blood glucose
Diabetes mellitus has long been known to be an independent modifiable risk factor
for both stroke and coronary heart disease; it increases the risk of stroke by two to
three fold (Kannel & McGee 1979; Kagan et al 1980; Fuller et al 1983). Between 8
to 20% of stroke patients have a history of diabetes and 5 to 28% may have
unrecognised diabetes or impaired glucose tolerance (i.e. those with raised
glycosylated haemoglobin concentration, HbAlc) (Scott et al 1999). In 10 to 20% of
patients with hyperglycaemia, there is no history of diabetes and HbAlc is normal. In
these cases, hyperglycaemia may be a result of raised Cortisol level due to stress
response after stroke (Scott & Gray 2000). Depending on the definition,
hyperglycaemia could be present in over half of all stroke patients (Scott & Gray
2000). This figure is similar to that in patients with acute myocardial infarction
(Capes et al 2000).
The relationship between diabetes mellitus, hyperglycaemia, and outcome after
stroke is complex and controversial (Counsell et al 1997; Kagansky et al 2001;
Counsell & Dennis 2001). Studies of the association between hyperglycaemia and
outcome after stroke may vary in their methods of adjusting for outcome, leading to
conflicting results. Several studies have found that hyperglycaemia after stroke was
an independent prognostic factor for poor outcome, but others did not confirm this
(Kiers et al 1992; Counsell et al 1997; Weir et al 1997; Kagansky et al 2001; Wang
et al 2001). In animal models of focal and global ischaemia, hyperglycaemia, both
during and after the period of ischaemia, has been shown to exacerbate neuronal
injury and increase infarct volume (Greenberg 1998). This injury is mainly due to
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tissue lactic acidosis, which results in free-radical formation and deterioration of
brain energy metabolism (Greenberg 1998; Ginsberg & Busto 1998; Kagansky et al
2001). Other mechanisms may include blood-brain barrier injury and production of
glutamate, which is an excitatory amino acid that can eventually lead to cell death
(Kagansky et al 2001). More importantly, animal studies have demonstrated that
treatment of hyperglycaemia with insulin after ischaemic stroke may be
neuroprotective and reduce neuronal damage. However, it remains unclear whether
this is due to the direct effect of insulin or the correction of hyperglycaemia
(Kagansky et al 2001).
In patients with myocardial infarction and a blood glucose of greater than 1 lmmol/L,
insulin therapy appears to reduce long-term mortality (Malmberg et al 1995;
Malmberg 1997). However, no comparable large randomised trial has been
completed in patients with acute stroke, though a pilot randomised study (Glucose
Insulin in Stroke Trial, GIST) has been performed to assess the safety of 24-hour
infusion of glucose, potassium and insulin with the aim of keeping plasma glucose
between 7 and 17mmol/L (Scott et al 1999). This pilot study of 25 acute stroke
patients showed that this regimen was safe (only one patient required intravenous
glucose for symptomatic hypoglycaemia) and effective in achieving the target range
(Scott et al 1999). The effect on functional outcome is being assessed in the ongoing
GIST study, which aims to recruit 1200 acute stroke patients (Scott et al 2001).
Meanwhile, current European guidelines suggest correcting hyperglycaemia with
insulin if plasma glucose is above 10 mmol/L, whereas UK guidelines do not
recommend any specific treatment (RCP 2001b).
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Low blood oxygen concentration
Stroke patients, especially those with hemiparesis and reduced consciousness, are
particularly likely to develop abnormal respiratory function and a low oxygen
concentration in the blood (hypoxia or hypoxaemia). Impaired chest wall and
diaphragm movements, altered central regulation of respiration, sleep apnoea,
aspiration, and other complications (e.g. pneumonia, pulmonary embolism, heart
failure) can all contribute to hypoxia (Fluck 1966; Roffe et al 2001). One
observational study showed that as many as 63% of stroke patients with hemiparesis
developed oxygen desaturations to below 96% during the first two days after
admission (Suiter et al 2000). Interestingly, in this study, all the patients with a
history of cardiac or pulmonary diseases developed oxygen desaturations (Suiter et al
2000). Another study found that a quarter of stroke patients developed oxygen
desaturations to below 90% during or after eating (Rowat et al 2000).
Animal studies have shown that hypoxia can increase cerebral damage after stroke
and traumatic brain injury (Back et al 1994; Murai et al 1998). In stroke patients,
therefore, it may seem sensible to maintain a high level of oxygen saturation (e.g.
above 95%) by administering supplemental oxygen and ensuring that the patient is
nursed at an appropriate posture (Elizabeth et al 1993; Paczynski et al 1995).
'Airway, breathing and circulation', the three components of basic life support,
should apply to every patient with an emergency condition including stroke (Kinsara
2001). However, oxygen itself can be toxic (Beckman 1998). In animal stroke
models, excessive oxygen administration can accentuate ischaemic damage (from
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free radical production and increased lipid peroxidation) and increase mortality
(Mickel et al 1987; Beckman 1998; Sinha & Warburton 2000). In humans, a quasi-
randomised trial of 550 acute stroke patients assessed the effects of routinely giving
100% oxygen for 24 hours compared with not giving oxygen (Ronning & Guldvog
1999). The study found that, amongst patients with mild to moderate stroke, routine
oxygen therapy appeared to increase the risk of death within one year (Ronning &
Guldvog 1999). The authors concluded that stroke patients should not routinely be
given oxygen. Producing a clinical guideline for the treatment of this physiological
disturbance is therefore difficult and some experts recommend giving supplemental
oxygen only when there is evidence of hypoxia (Hacke et al 2000).
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1.5 Quality of stroke care
Quality of care is an important public issue
The basis of professional practice is to provide and maintain the highest possible
quality of care to patients (GMC 2001). The quality of care that medical
professionals provide is now a subject of public debate and hence is under close
professional scrutiny (Philip 2000). League tables, such as the National Performance
Indicators, have been published by the government, ranking the Hospital Trusts and
Health Authorities across the UK according to certain clinical indicators of 'quality'
(DoH 2002). Hospital Trusts at the top of the league table are praised and those at
bottom are encouraged to improve their services. Over the past few years,
professional bodies have issued statements highlighting the problems with such
league tables, and in particular, whether the league tables truly inform the public
about the variations in the quality of care across the UK (BMA 2000; Adab et al
2002).
In the UK, the government has pledged to improve quality of care (DoH 1998; DoH
1999a; DoH 1999b). As a result, regulatory systems such as clinical governance have
been introduced with an aim to ensuring a consistently high quality of patient care
throughout the NHS (see Figure 1.5) (DoH 1998; Scally & Donaldson 1998;
Halligan & Donaldson 2001).
What is 'quality'?
Universally accepted definitions of'quality' have been difficult to achieve, and some
have even considered the term too subjective to be useful (Blumenthal 1996a; Scally
& Donaldson 1998). Definitions of quality can be divided into two types - generic or
disaggregated (Campbell et al 2000). Generic definitions of quality include
excellence (RCGP 1994), 'zero defects' (Crosby 1979), and expectations or goals
which have been met (Ellis & Whittington 1993). Disaggregated approaches, on the
other hand, recognise that quality is complex and multidimensional, and define
quality according to individual components or dimensions (Maxwell 1984). The
World Health Organisation provides an example of a disaggregated definition of
quality. It divides quality into the following four aspects (WHO 1983):
■ Professional performance (technical quality);
■ Resource use (efficiency);
■ Risk management (risk of injury or illness associated with the service provided);
■ Patients' satisfaction with the service provided.
These dimensions of quality can therefore be regarded as the attributes of an
organisation or service providing a high quality of care.
There are also aspects of quality that may be relevant to the individual groups of
stakeholders (Parsley & Corrigan 1999). To the health professionals, a high quality
of care should be effective (causing more benefit than harm) and appropriate; to the
patient and family, it should be acceptable and accessible; and to the government and
funding bodies, it should be cost-effective, equitable, and relevant (Parsley &
Corrigan 1999; Dennis 2000). In clinical practice, while the health professional
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should be technically excellent, that is 'doing the right thing', he or she should also
'do the right things right', which requires skill, judgement and timeliness of
execution (Blumenthal 1996a). Good interpersonal skills are essential if care is to be
responsive to the preferences and values of the patient. So, improving the quality of
care requires much more than just ensuring the practice is evidence-based and
efficient, it must also take the patient's entire experience within a healthcare system
into account (Parsley & Corrigan 1999).
Methods of assessing quality of care
Until recently, society has relied primarily on physician's own professional
judgement to ensure that patients received high quality care (Brook et al 1996). If,
however, the goal is to quantity, compare, and improve the quality of care, then a
different approach is needed (Blumenthal 1996b; AHA/ACC 2000). There are now
many organisations devoted to supporting research into assessing and improving the
quality of care, such as the Agency for Health Care Research and Quality
(http://www.ahcpr.gov/), which is part of the US Department of Health.
Donabedian suggested that quality of care can be assessed by examining three main
elements: a) structure of service; b) process of care; and c) patient outcome
(Donabedian 1988). This three-part approach to quality assessment illustrates the
underlying relationships between the three elements: a good structure of service may
increase the likelihood of good process of care, which may in turn increase the
likelihood of good patient outcome (Donabedian 1988). However, the assessor must
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be clear of the relationships between these elements before quality can be assessed
effectively (Donabedian 1988).
Structure ofservice as an indicator ofquality ofcare
Structure of service represents the attributes of the settings within which care occurs.
Using stroke as an example, a comprehensive acute stroke service should consist of
several essential components such as a stroke unit, CT scanner, and a
multidisciplinary team (see Table 1.4) (AHA/ACC 2000; Dennis 2000). One method
of assessing quality of care is by examining the structure of the service. However, it
must be born in mind that the existence of a particular aspect of a service does not
necessarily mean that it is carrying out the intended function. For instance, even if
there is a CT scanner in the hospital, stroke patients may not have 24-hour access to
it (Dennis 2000).
Process ofcare as an indicator ofquality ofcare
The simplest and hence the most popular method of assessing quality of care is the
examination of the process of care (Donabedian 1988; Brook et al 1996). Process of
care indicates what is done to the patient, where, when and how (Davies & Crombie
1995). Data on the process of care are relatively easy to collect and can be measured
reliably, validly, and mostly without serious bias - so long as the baseline
characteristics of the patient groups are properly defined (Davies & Crombie 1995).
Furthermore, the use of process measures can quickly identify areas where the
service is performing particularly well or poorly.
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It has been proposed that measuring an aspect of the process of care is meaningful
only if it relates to those factors that are under the control of the healthcare staff
(Giuffrida et al 1999). Others have also suggested that it is only appropriate if it
relates to interventions that have been proven to be effective (Davies & Crombie
1995). However, Davenport commented that the measurement of the process of care
in complex diseases such as stroke is not straightforward, especially when some
interventions are poorly defined (e.g. stroke unit care), making it difficult to decide
on which processes to measure, and how (Davenport & Dennis 1996). Like all non-
randomised studies, audits of the process of care are prone to case selection bias,
variation in case-mix, measurement error, and random variation (Chalmers et al
1983; Ebrahim & Harwood 1999; Dennis 2000).
Outcome as an indicator ofquality ofcare
Outcome may be defined according the five 'D's, which focuses on the five types of
negative results for the patient - namely, death, disease, disability, discomfort, and
dissatisfaction (Orchard 1994). Each of these may be measured as an indicator of
outcome. However, measures such as case fatality are dependent on a multitude of
factors (e.g. case selection, case mix, play of chance) and are not necessarily
indicative of the quality of the service (Anon. 1993; Dennis 2000). Crude hospital
statistics, therefore, need to be adjusted for case mix, but identifying and weighting
the patient characteristics which affect prognosis are problematical for conceptual,
methodological, and practical reasons (Mant & Hicks 1995; Davenport et al 1996c).
These include the inherent nature of prognosis itself and the practical difficulties of
collecting and quantifying data on the outcomes of interest for specific healthcare
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interventions and known risk factors such as severity (Orchard 1994). Orchard has
also identified five further problems: a) outcomes are multidimensional; b) many
outcomes are qualitative (e.g. satisfaction); c) assessment of outcomes can be
affected by timing; d) subgroups of diseases may have differing outcomes; and e)
outcomes may not be attributable to quality of care.
With this in mind, small-scale audits of patient outcome are therefore unlikely to
yield conclusive results about the quality of care even after adjusting for case-mix
(Kassirer 1993; Dennis 2000; Weir & Dennis 2001). However, larger-scale audits of
patient outcome, together with an assessment of the process of care and service
structure, may be informative and can generate hypotheses for future clinical
research (Dennis 2000).
Relationship between process of care and outcome after stroke
Variations in outcome after stroke
There are considerable variations in outcomes after stroke, most notably in case
fatality (Thorvaldsen et al 1995; Wolfe et al 1999; Wolfe et al 2000; Brainin et al
2000; Weir et al 2001). In the International Stroke Trial (1ST), crude case fatality
rates at six months varied from 12% in Sweden to 30% in Poland, and the proportion
of patients dead or dependent varied from 42% in Sweden to 60% in Norway (Weir
et al 2001). The WHO Monitoring Trends and Determinants in Cardiovascular
Disease (MONICA) project also found that the case fatality rates at one month
varied from 15 to 49% in men and 18 to 57% in women (Thorvaldsen et al 1995).
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The UK appeared to have some of the highest case fatality rates in Europe (Wolfe et
al 1999; Wolfe et al 2000; Weir et al 2001). Wolfe et al found in a European study
that the adjusted case fatality rate at three months in the UK was 42% (95% CI 35 to
49%), compared with 19% (95% CI 14 to 24%) in France (Wolfe et al 1999).
However, a study by Brainin et al did not confirm this finding (Brainin et al 2000).
As I have already mentioned, variations in case fatality could be a result of the
different methods of case ascertainment, case mix factors (e.g. stroke subtypes), or
differences in quality of stroke care (Wolfe et al 1999). In the UK, the apparently
high case fatality rates could possibly be due to a combination of these factors.
Variation in the process ofstroke care in Europe
Several studies have assessed the management of acute stroke and use of diagnostic
procedures between different European countries (Asplund et al 1996; Beech et al
1996; Brainin et al 2000; Weir et al 2001). One consistent finding is that the use of
diagnostic procedures is generally higher in France and Germany and lower in the
UK. In the European Study of Stroke Care, Beech et al found that in the UK,
neuroimaging was performed in 30 to 72%, and carotid duplex in 0 to 23%, of all
stroke patients (Beech et al 1996). In France, however, neuroimaging was performed
in 97%, and carotid duplex in 82%, of all stroke patients (Beech et al 1996).
Furthermore, from the results of the 1ST, Weir et al found that UK had the second
lowest rate of discharging patients with ischaemic stroke on aspirin (54% in the UK
compared with 73% in Norway) (Weir et al 2001). The data so far suggest that, in the
UK, poor process of care may at least be partially responsible for a higher case
fatality after stroke.
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Variation in the process ofstroke care in the UK
In the past decade, observational studies have found enormous variations in patient
care and stroke service provision in the UK (King's Fund 1988; Lindley et al 1995;
CSAG 1998; Rudd et al 1999; Ebrahim & Redfern 1999; Roberts et al 2000). The
report of the King's Fund Consensus Conference on the Treatment of Stroke was the
first to note that stroke services in the UK are "haphazard, fragmented andpoorly
tailored to patients' needs" (King's Fund 1988). The surveys performed by the
Clinical Standards Advisory Group (1998), The Stroke Association (1992-1993 and
1998), and the Scottish Stroke Service Audit (1997-1998) confirmed that the
organisation of stroke care was poor in many parts of the UK and many hospital
Trusts were not meeting the guideline recommendations set out by the Scottish
Intercollegiate Guidelines Network (SIGN) (Lindley et al 1995; CSAG 1998;
Ebrahim & Redfern 1999; Roberts et al 2000; Roberts 2001).
In the two surveys performed by the Stroke Association five years apart, although
improvement in some aspects of acute stroke care was found (e.g. routine aspirin use
rose from 39% to 67%), many aspects of acute care remained unsatisfactory (e.g.
under half of consultants could get a CT scan the same day or next day) (Lindley et
al 1995; Ebrahim & Redfern 1999). Furthermore, only 3% of the physicians caring
for stroke patients had a special interest in stroke (Ebrahim & Redfern 1999).
In 1998, the Intercollegiate Stroke Working Party at the Royal College of Physicians
(RCP) was commissioned to conduct a national sentinel audit of the organisation and
process of care in hospital and during the first six months after discharge (Rudd et al
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1999). This was the largest audit of stroke in the UK involving almost 7000 stroke
patients, and it used the Intercollegiate Stroke Audit tool, which had been extensively
piloted (Hancock et al 1997; Irwin & Rudd 1998; Rudd et al 1999; Irwin et al 2001).
Importantly, it showed that 67% of stroke patients spent most of their hospital stay in
general medical wards, and that there were large regional variations in both the
organisation of care and patient outcome (Rudd et al 1999). A repeat of the national
sentinel audit was conducted in 1999 and it found some improvement in certain
aspects of stroke care (e.g. proportion of patients managed in stroke units rose from
19% to 26%) but many aspects remained poor (e.g. cognitive and mood assessment)
(Rudd et al 2001).
In Scotland, an audit of the process of care and case fatality after stroke in five
Scottish hospitals was carried out between 1995 and 1997 (Weir & Dennis 2001). It
found significant differences in case fatality rate between different hospitals even
after adjusting for case mix. Furthermore, there were major deficiencies in the
organisation of care, use ofCT scanning, and documentation of care (Weir & Dennis
2001). Similar surveys of general practitioners in the UK have also demonstrated
major variations in clinical practice and access to specialist stroke services (Action
for Stroke Group 1998; Gibbs et al 2001).
Are variations necessarily undesirable?
Large variations in the access to services are generally regarded as unacceptable,
especially those services that have been proven to be beneficial (e.g. stroke units)
(Plsek & Wilson 2001). However, variations in clinical practice may be acceptable if
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the variations simply reflect a lack of evidence (e.g. artificial feeding after stroke),
and this uncertainty may suggest a need for further clinical trials (e.g. Feeding or
Ordinary Diet, FOOD, Trial). For interventions that have been proven to be effective
(e.g. thrombolysis for AMI), variations in practice may indicate unfamiliarity with
clinical guidelines and a lack of training (Awad et al 1999).
So what conclusions can be drawn about quality ofcare?
The relationship between process of care and outcome is very complex, and
conclusions regarding the quality of care cannot easily be drawn. The assessment of
this complex relationship is further hampered by the fact that the absolute benefit of
most of the processes of care are unknown (e.g. CT scanning, carotid duplex), and
the absolute benefit ofmany acute interventions are very small (e.g. use of aspirin for
ischaemic stroke) - hence even large changes in the process of care are unlikely to
significantly affect outcome. Planning a 'high quality' stroke service is therefore far
from straightforward; it is difficult to decide exactly which process of care should be
included and what standard one should aim for, especially if resources are scarce.
Quality of care from the patients' and carers' perspective
Recently, there has been a growing recognition that care must be responsive to the
preferences and values of the patient, family and carers, and that their opinion about
care are important indicators of its quality, especially regarding interpersonal skills
(Donabedian 1988; Blumenthal 1996a). Indeed, the Report ofthe Royal Commission
on the National Health Service in 1979 included "to satisfy reasonable public
expectations for health care" as one of its main objectives (NHS 1979). The
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government's efforts to meet this objective, and the focus on the patient as a
'customer' of service, have led to the publication of The Patient's Charter, which
was later updated as Your Guide to The NHS in 2001 (DoH 2001b).
Methods ofassessing patients' and carers' views
According to the patient and carer, quality of care may be judged on the following
five aspects: competence, respect, choice, accessibility and responsiveness (Larner
1997). For stroke patients, satisfaction has been an outcome of interest in clinical
trials only within the past seven years, and many studies have used very similar
questionnaires to assess satisfaction (Pound et al 1994; Pound et al 1999b). In a
randomised study of early discharge of stroke patients to community therapy, Pound
et al found that patients were more likely to be satisfied if they received more
therapy, meals-on-wheels, and home help visits (Pound et al 1999b). Furthermore,
the study found that satisfaction assessments reflected real differences in the
provision of care (Pound et al 1999b).
Another survey of stroke patients' views on their admission to hospital identified
four important components that the patients valued: being cared about (psychosocial
needs), clinical care, nursing care, and information and advice (Pound et al 1995).
The most recent survey of patients' and carers' views on hospital stroke care in
Scotland revealed several important aspects of care that were deficient: lack of stroke
units, lack of specialist training for staff, poor information provision for patients and
carers, no trained liaison person for hospital-home transition, and lack of people to
"talk to" (CHSS 2001).
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Problems with assessing patients' and carers' views
Although patient and carers should be satisfied with their care, the use of their views
as indicators of quality of stroke care is controversial. There are three main reasons
or this. Firstly, there is no single, agreed, definition of the concept of patient
satisfaction (Batchelor et al 1994). Secondly, patients and carers are often not
knowledgeable about the medical details, and the measurement of patients' and
carers' views may not always be valid or reliable (Blumenthal 1996a). Thirdly,
patient satisfaction surveys are prone to methodological problems such as case
selection bias (e.g. surveying only the patients who can communicate), variation in
case-mix, random error (e.g. small sample size), and non-response to questionnaires
(Lin & Kelly 1995). Patients and carers may also be reluctant to reveal their true
(especially negative) feeling for fear of offending the healthcare staff (Donabedian
1988). Nevertheless, patient and carer satisfaction will remain an important indicator
of stroke care, and further research is needed to improve its evaluation (Lin & Kelly
1995).
Methods of improving quality of stroke care
Many initiatives have been implemented with an aim to improve the quality of care.
Examples of these include (Bullivant 1996; Scally & Donaldson 1998; 0vretveit
2000):
■ Professional initiatives (e.g. professional self-regulation);
■ Promotion of evidence- and guideline-based practice (e.g. integrated care
pathways);
■ Use of audits (e.g. national sentinel stroke audit);
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■ Governmental regulation (e.g. clinical governance);
■ Total quality management (e.g. European Foundation for Quality Development).
It is beyond the scope of this thesis to discuss all of the above initiatives in detail.
Some of these initiatives have been implemented in stroke care, such as the use of
audits and the promotion of evidence- and guideline-based practice.
Use ofclinical guidelines may improve quality ofcare
Clinical guidelines are produced by appraising the available research evidence and
experience, and converting them into practical recommendations, which are then
used to determine what happens to a patient (Thomson et al 1995). They are intended
to be a tool to assist the healthcare professional in making clinical decisions (Field &
Lohr 1992). Clinical guidelines can either be developed locally (e.g. policy within a
hospital or stroke unit) or nationally by consensus panels (e.g. SIGN or RCP stroke
guidelines) (Rycroft-Malone 2001). National clinical guidelines can help to define
what patients or carers could expect from the healthcare professionals (DoH 2001a;
RCP 2001b). Clinical guidelines can also be regarded as a tool to make patient care
more consistent and efficient, closing the gap between what the best evidence
supports and what healthcare professionals actually do ('the evidence gap') (Woolf et
al 1999; Coleman & Nicholl 2001).
In a systematic review to assess the effectiveness of clinical guidelines, Grimshaw
and Russell found that explicit clinical guidelines were effective in improving
medical practice in the context of effective implementation (Grimshaw & Russell
1993). For that systematic review, a clinical guideline was defined as a
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"systematically developed statement to assistpractitioner decisions about
appropriate health care for specific clinical circumstances" (Grimshaw & Russell
1993). Interestingly, none of the 59 studies included in the systematic review
examined the effectiveness of stroke guidelines.
The report of the recent Scientific Forum on Assessment ofHealthcare Quality in
Cardiovascular Disease and Stroke commented that "although guidelines are
designed to suggest diagnostic and therapeutic interventions for most patients in
most circumstances, the use ofguideline recommendations in an individual patient
should be left to the discretion ofthe professional" (Hurwitz 1999; AHA/ACC
2000). In other words, the professional is not necessarily in error if a particular
guideline recommendation has not been strictly followed (AHA/ACC 2000). This
can potentially have important legal and political implications (Hurwitz 1999).
Use ofclinical guidelines is not a panacea
The quality of a guideline is directly dependent on the quality of the medical
evidence supporting its recommendation(s) (Cluzeau et al 1999; Woolf et al 1999).
The problem is that only a small percentage of evidence supporting clinical
guidelines comes from randomised controlled trials; the majority comes from 'expert
panels' (Bergman 1999). The ability of guidelines to improve clinical practice is also
dependent on the level of compliance. In a recent prospective observational study,
Duncan et al found that the level of compliance with stroke rehabilitation guidelines
was significantly associated with dependency at six months (Duncan et al 2002). The
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authors also suggested that compliance with guidelines could be regarded as an
indicator of quality of care in stroke rehabilitation.
Physicians' resistance to change their practice
Development of good clinical guidelines does not ensure the recommendations are
translated into local clinical practice; physicians are often resistant in changing their
practice (Goodpastor & Montoya 1996; Ashford et al 1999; Feder et al 1999). There
are at least three possible reasons for this phenomenon (Shekelle 2002):
a) Physicians may not agree with the criteria by which quality is being measured.
Many feel that some measures of quality represent misplaced priorities,
concentrating on those things that can be easily measured rather than those that
are truly important for producing good patient outcomes;
b) Physicians may view quality improvement programmes as an opportunity to
blame them for anything bad that may or may not happen to the patient;
c) Physicians have to participate in quality improvement programmes on top of their
already very busy schedules.
It may therefore be difficult to gain full co-operation from the physicians unless there
is agreement on the measures of quality, a shift from a culture of blame to one of
learning from mistakes, and provision of adequate resources for the tasks at hand
(Shekelle 2002).
Translating guidelines to clinicalpractice
Grimshaw and Russell found that successful introduction of guidelines is dependent
on many factors including the clinical context and the methods of developing,
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disseminating and implementing those guidelines (Grimshaw & Russell 1993). They
suggested that passive dissemination of information was generally less effective,
whereas patient-specific reminders at the time of consultation (e.g. prescription
charts with reminders) were more likely to be effective (Cohen et al 1987; Robie
1988; Schreiner et al 1988; Cummings et al 1989; Grimshaw & Russell 1993). Bero
et al also found that 'multifaceted' interventions that involved interaction with the
stakeholder (e.g. interactive educational meetings, audit and feedback, local
consensus processes, and reminders) might be effective in promoting change in
practice (Bero et al 1998).
In clinical practice, however, passive (i.e. the least effective) approaches probably
represent the most common approaches adopted by healthcare professionals and
policy makers (Bero et al 1998). In Scotland, two studies have highlighted the large
variation in the methods of implementing the SIGN guidelines, and no evidence is
yet available on the most effective method (Millard 1997; Keaney & Lorimer 1999).
Implementing national guidelines in the local setting
For national guidelines to be relevant in the local setting, they have to be tailored to
meet local circumstances. Specific operational details, such as who does what, when
and how, should be added where necessary (Feder et al 1999). This adaptation leads
to the production of clinical protocols or algorithms (CRAG 1993; Long 1994). Long
has proposed a list of desirable characteristics that guidelines and protocols should
possess (see Table 1.5) (Long 1994). For acute stroke care, protocols and algorithms
are more likely to be acceptable and followed if all the members of the
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multidisciplinary team are involved in their design and implementation, or in other
words, if every person has a sense of 'ownership' (Conroy & Shannon 1995; Langley
et al 1998; Adams et al 1999).
Integrated care pathways can promote evidence- and guideline-based stroke
care
Many interventions have been shown to reduce the risk of stroke, but the full benefits
of these interventions are not realised at the current levels of utilisation because
nearly all the evidence-based and guideline-endorsed stroke treatment strategies are
underused (Holloway et al 2000). Integrated care pathways are organisational
interventions that can promote evidence- and guideline-based care, improve the
organisation and efficiency of care, and reduce cost (Sulch et al 2000) It is a
potentially effective tool in managing patients admitted with acute stroke.
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1.6 Objectives of this thesis
In this thesis, I sought to explore in detail two major issues concerning the use of
integrated care pathways for acute stroke:
1. Should integrated care pathways be used to manage stroke patients?
■ Amongst patients admitted to hospital with an acute stroke, is there any evidence
of significant difference in patient care and outcome between management with
an integrated care pathway as compared to conventional care?
What is the evidence from previous studies?
At the Western General Hospital, did the introduction of an integrated care
pathway in the acute stroke unit influence patient care and outcome?
At the Western General Hospital, what did the stroke unit staff think were the
effects of introducing the ICP?
2. How should the effects of integrated care pathways for acute stroke be
evaluated?
■ What are the methodological considerations when evaluating the effects of
integrated care pathways?
■ What are the strengths and weaknesses of the research designs used to evaluate
the integrated care pathway for acute stroke in the Western General Hospital?
■ Is there an ideal research design that should be used to evaluate the effects of
integrated care pathways for acute stroke?
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1.7 Summary of this chapter
■ Stroke is an important public health problem. It is common, causes many deaths
and much long-term disability, and is associated with a substantial burden on
society. The burden of stroke is likely to rise over the next decade as the
proportion of older people in the population rises.
■ Diagnostic and therapeutic nihilism about the management of stroke should be a
thing of the past. Admission to a stroke unit leads to substantial improvements in
outcome.
■ Acute stroke care can be divided into three main components: treatment of the
cerebral lesion itself; general care of a stroke patient; and management of specific
complications.
■ Worsening of the initial stroke is common and may be exacerbated by
physiological disturbances. There is evidence that intensive physiological
monitoring and correction of abnormal physiological parameters may improve
outcome after stroke.
■ Quality of stroke care can be defined and assessed according to the structure of
service, process of care, and patient outcome. The quality of stroke care varies
between and within countries. In the UK, it appears that many patients are
receiving inconsistent and often low standards of care.
■ Clinical guidelines have the potential to improve patient care and standardise
practice. Guideline recommendations need to be tailored to meet local
circumstances. Some strategies, such as patient-specific reminders, are more
likely to be effective in changing practice.
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■ Integrated care pathways are an organisational intervention that aims to promote
evidence- and guideline-based care, improve the organisation and efficiency of
care, and reduce cost. It is a potentially effective tool in managing stroke patients.
■ In this thesis, I sought to explore two major issues concerning the use of
integrated care pathways for acute stroke: a) should integrated care pathways be
used to manage patients with acute stroke? and b) how should the effects of
integrated care pathways for acute stroke be evaluated?
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Table 1.3 Reported frequencies of medical complications in hospitalised stroke
patients. These data came from 23 studies included in a literature review performed
by Langhorne (2000a).
Complication Range of frequencies (%) Range of frequencies (%)
from 6 retrospective studies from 17 prospective studies
Neurological
Recurrent stroke 5 18
Epileptic seizure 2-5 3
Medical
Urinary infection 7-25 11-28
Chest infection 7-21 10-20
Other infection 4 4-31
Pressure sore 3-18 -
Fall (all) 22-25 -
Deep vein thrombosis 1-3 1-2
Pulmonary embolism 2-18 0-1




Other complications 32 -
Any complication 40-96 63-95
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Table 1.4 Components of a comprehensive acute stroke service. Adapted from
Dennis (2000).
Facilities Healthcare Personnel
■ Ambulance service ■ Paramedical staff
■ Emergency department ■ Emergency medical & nursing staff
■ Acute stroke unit ■ Stroke physician
■ CT or MRI scanner ■ Multidisciplinary team
■ Carotid duplex scanner ■ Neurology support
■ ECG and echocardiography ■ Neurosurgery support
■ Laboratory for blood tests ■ Cardiology support
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Table 1.5 Desirable characteristics that clinical guidelines and protocols should
possess. Adapted from Long (1994).
• Outcome focused
• Based on the best available evidence and professional judgement
• Reflective of the patient's perspective
. Valid
• Reliable






• Easy to evaluate
• Regularly updated
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Figure 1.1 Multidisciplinary team approach in acute stroke care. Other professionals
can also be involved but have not been shown here.
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Figure 1.2 Results from the Cochrane systematic review: stroke unit care vs
alternative forms of care. Death or dependency by the end of follow-up. Reproduced
with permission.
Revi ew: Organi sed i rpati enrt (stro ke unit) care for stro ke
Comparison: 01 Organised stroke unit oare vs Alternative service
Outcome: 03 Death or dependency by the end of scheduled follow up
Study Treatment Control Peto Odds Ratio 95% CI Weight % Peto Odds Ratio 95% CI
01 Stroke ward vs General medical ward
Akershus 103 / 271 110/279
Dover 54/98 50/89
Edinburgh 93 / 155 94/156
Goteborg-Sahlgren 108 / 166 54/83
Nottingham 63 / 98 52/76
Orpington-1993 38 / 53 39/48
x Orpington-1995 36 / 36 37/37
Perth 10 / 29 14/30
T rondheim 54 / 110 81 / 110
Umea 52 / 110 102 / 183
Subtotal (95% CI) 611 / 1126 633 / 1091
Test for heterogeneity chi-square=12.18 df=8 p=0.1432
Test for overall effect Z= •2.51 p=0.01
02 Mixed rehabilitation ward vs General medical ward
Birmingham 8 / 29 9/23
Helsinki 47 / 121 65 / 122
Illinois 20 / 56 17/35
Kuopio 31 / 50 31 / 45
New York 23 / 42 23/40
Newcastle 26 / 34 28/33
Subtotal (95% CI) 155 / 332 173/298
Test for heterogeneity chi-square=1.02 df=5 p=0.9609
Test for overall effect Z=■2.75 p=0.01
03 Mobile stroke team vs General medical ward
Montreal 58 / 65 60/65
Uppsala 45 / 60 41 / 52
Subtotal (95% CI) 103 / 125 101/ 117
Test for heterogeneity chi-square=0.04 df=1 p=0.8411
Test for overall effect Z=■0.74 p=0.50
04 Stroke ward vs Mixed rehabilitation ward
Dover 11 / 18 19/28
Nottingham 60 / 78 48/63
Orpington-1993 63 /71 69/73
Tampere 53 / 98 55/113
Subtotal (95% CI) 187 / 265 191 / 277
Testforheterogeneitychi-squa re=2.40 d^3 p=0.4033
Test for overall effect Z=0.05 p=1.00
05 Stroke ward vs Mobile stroke team
Orpington-2000 61 /152 73/152
Subtotal (95% CI) 61 /152 73/152
Test for heterogeneity ohi-square=0.00 d^O p=0.0000
Test for overall effect Z=-1.38 p=0.17
Total(95% CI) 1117/2000 1171/1935
Test for heterogeneity chi-square=19.04 df=21 p=0.58Z7
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Figure 1.3 Results from the Cochrane systematic review: stroke unit care vs
alternative forms of care. Death or institutionalisation by the end of follow-up.
Reproduced with permission.
Review: Organised inpatient (stroke unit) care for stroke
Comparison: 01 Organised stroke unit care vs Alternative service
Outcome: 02 Death or institutional care by the end of scheduled follow up
Study Treatment Control Peto Odds Ratio 95% CI Weight % Peto Odds Ratio 95% CI





























Test for heterogeneity chi-square=20.16































02 Mixed rehabilitation ward vs General medical ward
Helsinki 36 /121 46/122
Illinois 22 /56 17/35
Kuopio 22 /50 23/45
New York 15/42 17/40
Newcastle 18 /34 21 /33
Subtotal 095% CI) 113 /303 124/275
Test for heterogeneity chi-square=0.08 df=4 p=0.9992
Test for overall effect Z=-2.01 p=0.04
03 Mobile stroke team vs General medical ward
Montreal 57 /65 52/65
Uppsala 40 /60 35/52
Subtotal 095% CI) 97 /125 87/117
Test for heterogeneity chi-square=0.91 df=1 p=0.3406
Test for overall effect Z=0.71 p=0.50




Tampere 43 / 98 42/113
Subtotal (95% CI) 112 /265 125/277
Test for heterogeneity chi-square=3.33 df=3 p=0.3440
Test for overall effect Z=-0.60 p=0.50
05 Stroke ward vs Mobile stroke team
Orpington-2000 21 /152 45/152
Subtotal 095% CI) 21 /152 45/152
Test for heterogeneity chi-square=0.00 df=0 p=0.0000
Test for overall effect Z=-3.33 p=0.00
Total (95% CI) 994/2486 1077/2373
Testforheterogeneitych i-sq u a re=34.03 df=24 p=0.084?
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Figure 1.4 Survival of the brain tissue after ischaemic stroke depends on the severity
(i.e. level of cerebral blood flow) and duration of ischaemia. This is an original
drawing. Definition of the ischaemic penumbra is given in the main text.
Normal Function




Duration of ischaemia (hrs)
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Figure 1.5 A new national system to improve quality of care across the UK.
Commission for Health Improvement
National Framework for Assessing Performance
National Patient and User Survey
National Service Framework
Self-regulation Life-long learning
Black oval text box: The National Service Framework sets out common standards across the country
for the treatment ofparticular conditions. The National Institute of Clinical Excellence acts as a
national-wide appraisal body for new and existing treatments, and disseminates consistent advice on
what works and what does not.
Grey oval text box: Clinical governance is a system to ensure that national quality standards are
applied locally.
White ova! text box: Standards are monitored through three systems: the Commission for Health
Improvement, National Framework for Assessing Performance, and National Survey of Patient and
User Experience. These aim to identify and spread best practice and reduce poor performance (DoH
1998).
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integrated care pathways
2.6 Summary of this chapter
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2.1 Introduction
Integrated care pathways (ICPs) are increasingly being implemented across many
countries with an aim to improve patient care (NHS Wales 1999). Unlike other forms
of treatments (especially pharmacological agents), this relatively new organisational
tool is being developed and implemented in many UK hospitals with very little
debate about what it is and what its effects are (Norris 1998; de Luc 2000). This
relaxed approach might be because ICPs are generally regarded as harmless and, in
the current political climate of the NHS, policy makers may adopt an 'anything to
improve patient care is worth a try' attitude.
In my opinion, ICPs should be regarded as an organisational intervention that
requires a proper definition and evaluation. Thus, before introducing an ICP,
physicians and policy makers should first determine: a) what an ICP is; b) how an
ICP operates in the local setting; c) what are the effects of its introduction on the
process of care and patient outcome; and d) whether it is acceptable and feasible to
the staff using it.
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2.2 What is an integrated care pathway?
Common definitions of an integrated care pathway
'Integrated care pathway' is a fluid term. The medical literature is abundant with
articles that praise the tool and describe the many identified benefits of its
implementation (de Luc 2000). Hale argued that the multitude of benefits ascribed to
ICPs is partly due to a lack of conceptual clarity surrounding the term, what it is, and
what it does (Hale 2002).
There are many common definitions for ICPs - the majority of them are vague and
they all differ slightly. As a result, there is no universally accepted or standard
definition for an ICP (Field & Lohr 1992; Campbell et al 1998; Overill 1998). The
Department ofHealth in the UK defined an ICP as "a systematically developed
statement which assists the practitioner andpatient in making decisions about
appropriate healthcare for specific clinical conditions" (DoH 1996). Compton
defined an ICP as "an abbreviated version ofthe multidisciplinary processes which
need to occur in a timely and sequential manner to achieve quality outcomes"
(Compton et al 1995). In the USA, Hofmann described an ICP as a tool that"co¬
ordinates the delivery ofpatient care for aparticular condition. It is a guide to usual
treatment patterns, providing a visualisation ofthe bigpicture" (Hofmann 1993).
Others such as Overill have tried to define an ICP by describing its aims and
functions: "an ICP determines locally agreed, multidisciplinarypractice based on
guidelines and evidence ... itforms all or part ofthe clinical record, documents the
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care given andfacilitates the evaluation ofoutcomes for continuous quality
improvement" (Overill 1998). Nelson, on the other hand, was more precise in stating
that an ICP "specifies key events, tests and assessments occurring in a timelyfashion
to produce the best prescribed outcomes, within the resources and activities
available...'" (Nelson 1995). This type of definition, which is more explicit, is more
likely to be useful in everyday practice.
Other terms used to mean an integrated care pathway
ICPs are known by many other names, such as clinical pathways, critical pathways,
patient pathways, care path method, anticipatory recovery pathways,
multidisciplinary pathways of care, and CareMaps™ (Hunter & Fairfield 1997; de
Luc 2000). In fact, there are probably over 20 terms used to denote an integrated care
pathway (Bridge 1997). Although many of these names are often used
interchangeably, they may in fact be describing different concepts in different
settings. In the UK, it is common to use the term 'integrated care pathway' since it
emphasises the integration between different disciplines in caring for patients (Norris
1998).
Operation of an integrated care pathway
ICPs are designed to be used as a structured clinical record by every member of the
multidisciplinary team, so that it may be easier to find information and communicate
with the other members (Quigley et al 1998). The format of ICPs varies widely;
some ICPs are printed versions of clinical guidelines that are available for reference
on the ward, some are protocols or algorithms that outline the care that the patient
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should receive, while others are computer programs that guide the healthcare
professional through each step of the patient's management (Yandell 1995). In the
UK, ICPs are most commonly pre-printed care plans that contain detailed checklists
of recommended treatments for the different aspects of patient care from day to day
(Campbell et al 1998). The recommendations are usually based on the best available
evidence or clinical guidelines (Bridge et al 1997). The size of the ICP depends on
the complexity of the condition and the level of detail of the included information
(see Table 2.1); an ICP can therefore be a very small (e.g. a one-page checklist) or a
very large document (e.g. more than 50 pages long). In certain specialities such as
day surgery, where there is relatively little variation in the timing of patient outcome
(e.g. being pain-free, length of stay), the ICP can also indicate the time by which
certain outcomes are to be expected. I have summarised the four major aims of using
ICPs in Table 2.2.
Some ICPs have an in-built system to assess clinical outcomes and monitor practice
variation. The latter process is known as variance reporting or tracking (Schriefer
1995; Brown & Nemeth 1998). This system aims to gather information on the
occasions when the recommended care strategy has not been carried out (i.e. a
variance). This enables the evaluation of any divergence from the anticipated plan of
care or outcome, and informs on the possible ways of improving the process.
However, it is extremely time-consuming and is often poorly documented, especially
in complex medical conditions such as stroke (Anon. 1995).
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Overall, ICPs seem to be different from other forms of information provision systems
that aim to assist healthcare professionals with clinical decision-making, such as
guidelines, standards and policies (see Table 2.3). Furthermore, ICPs are usually
multi-faceted, which means that they are different from mono-faceted tools (e.g.
diagnostic algorithms, protocol for thrombolysis). Thus, ICPs are usually applicable
to more than one aspect of care, for example, emergency assessment plus diagnosis,
or diagnosis plus acute treatment, etc.
What are the potential benefits of using an integrated care pathway?
There are many potential benefits of using an ICP (Pearson et al 1995; Campbell et al
1998). However, whether these potential benefits become reality would depend on
the way that it is designed and implemented in the local setting (de Luc 2000). Like
clinical guidelines, the potential benefits of using ICPs can be divided into three
main categories (Thomson et al 1995): benefits to the patient; benefits to the
healthcare professional; and benefits to the healthcare system.
Benefits to the patient
A potential benefit to the patient is that the ICP may promote the use of those
treatments that are supported by good evidence and endorsed by national guidelines
(SIGN 1997; Campbell et al 1998; NHS Wales 1999). This could in theory improve
clinical outcome (e.g. by reducing the occurrence of complications). Management
with an ICP could improve the thoroughness of patient care and reduce variation in
clinical practice, unnecessary investigations, and practical errors (e.g. wrong dosage
ofmedications). If ICPs improve communication between the disciplines and the
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quality of information written in the patient record, patient care may be more
organised and efficient, and patient-staff communication may also improve (Ayestas
et al 1995; Hajewski et al 1998). This might in turn enhance patient satisfaction and
reduce the number of complaints and litigation claims (Nolin 1995).
Benefits to the healthcare professional
Members of one discipline are often unaware of the other disciplines' input into
patient care (Riches et al 1994). Multidisciplinary team meetings are therefore
commonly used as a forum to communicate, chart the patient's progress, define
future goals, and plan treatment strategies. ICPs may potentially help to improve
documentation and multidisciplinary communication, and make team meetings more
effective and efficient. Furthermore, it could make 'hand-overs' between healthcare
professionals (e.g. between early and late shifts of nurses) easier and more
informative (Zander 1988; Walsh 1997). One observational study showed that nurses
spent an average of 27% of their time documenting and only 28% of their time
providing direct patient care (Short 1997). By using a checklist-and-tickbox format,
ICPs have the potential to streamline and standardise documentation and hence
reduce the amount of time spent on paperwork (Campbell et al 1998). Since each
item of the checklist should be signed by the person carrying out the task, it is clear
who is accountable for each task. This might make it easier to respond to patient
complaints (Woodyard & Sheetz 1993). Lastly, ICPs could act as a training tool for
medical students, nursing students, and junior staff; any improvement in staff
training might in turn have a positive impact on job satisfaction (Abbot et al 1994;
Overill 1998).
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Observational studies have shown that doctors and nurses do not document the care
they deliver adequately (Gabbay & Layton 1992; Stone & Whincup 1994; Short
1997; Rudd et al 1999). In particular, there may be a substantial delay before an
event is documented (or it may be omitted altogether), and the language used can
often be repetitive and inconsistent. The United Kingdom Central Council (UKCC)
has therefore produced specific guidelines for record keeping (see Table 2.4)
(UKCC 1998). Other nursing experts have recommended 'charting by exception',
which is a non-traditional, but legal, approach of documenting care by recording only
unexpected events (Grant et al 1995; Short 1997). The General Medical Council
(GMC) has also issued some general guidelines in medical record keeping for
doctors (GMC 2001). More recently, tools such as pre-printed clerking proforma and
unitary patient records (i.e. combining medical, nursing and therapists' notes) have
been used with some success to improve the quality of documentation (Davenport et
al 1995; Goodyear & Lloyd 1995; Kidd & Stout 1996; Morrison et al 2001). An ICP
can be designed to be both a clerking proforma and a unitary patient record, hence it
may improve multidisciplinary communication, reduce duplication of effort, and
make it easier to find information (Parsley & Corrigan 1999).
Benefits to the healthcare system
Clinical governance requires the clinician to demonstrate his or her ability to
consistently deliver patient care that is safe, well-considered, and of high quality
(Scally & Donaldson 1998; Ellis & Johnson 1999). ICPs could potentially support
the administration of clinical governance in a number ofways, for example, by
encouraging individual clinicians to adhere to evidence- and guideline-based
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practice, and by improving documentation and facilitating audit, which is an essential
component of clinical governance (Ellis & Johnson 1999). The process of designing
and introducing the ICP may also be beneficial to the team, for example, by
encouraging collaboration between the members of the team (de Luc 2000).
The process of variance reporting could inform the healthcare staff on the possible
reasons why certain aspects of care may be sub-substandard (Crombie & Davies
1993; Johnson 1997), or not cost-effective (e.g. using proprietary rather than generic
drugs) (Riches et al 1994). Taking action to address the identified problems may help
to improve quality of care and to minimise hospital cost (Odderson 1996).
What are the potential concerns of using an integrated care pathway?
The most commonly voiced concern about using ICPs is that they may reduce the
level of autonomy that healthcare professionals exert over patient care (Pearson et al
1995; Sutton et al 2000). Some have used the term 'cookbook medicine' to describe
the use of ICPs (Harding 1994; Bertram et al 1996; Wilson 1999), while others
disagree (O'Malley 1997).
The use of ICPs generates two interesting paradoxes. The first one is this: on the one
hand, ICPs aim to standardise patient care (low autonomy); on the other hand, ICPs
are only meant to be 'templates' to assist clinical decision-making - the final
decision of whether or not to use specific treatment strategies should rest with the
professionals themselves (high autonomy) (Campbell et al 1998). Putting ICPs into
practice may generate a second, legal, paradox. On the one hand, evaluation
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processes such as variance reporting can identify the individuals who have deviated
from a pre-printed care plan (successful lawsuits likely)-, on the other hand,
healthcare professionals are meant to be free to exercise their clinical judgement
when using ICPs (successful lawsuits less likely) (Nolin 1995). An ICP may also
raise the expectation of the patients and relatives (especially when they can read the
document); this may be problematic if there is any deviation from the recommended
care plan.
Although ICPs aim to streamline patient care, reduce paperwork, and lower costs, the
reverse can potentially occur. ICPs can turn a routine and simple task into a
complicated and labour-intensive plan, with more paperwork to complete (Hunter &
Fairfield 1997). This may in turn leave little time for other aspects of patient care.
Alternatively, ICPs may over-simplify patient care, and healthcare professionals may
not think about clinical problems or treatments that are not mentioned in the ICP.
Junior doctors or nurses who use ICPs might become less inclined to use their own
initiative to select the most appropriate investigations and treatments according to
clinical need. Consequently, the unthinking use of all pre-stated investigations and
treatments in all patients may increase rather than cut costs (Wee et al 2000). Over
time, this might also lead to 'de-skilling' of staff. Conflicts may also arise when there
are discrepancies between the ICP protocol and the wishes of the patients and
relatives (Hunter & Fairfield 1997).
There is also concern that, even though patients might be discharged earlier when
ICPs are used (if care is more efficient and organised), some observational studies
110
have found that patients might be more likely to be readmitted to hospital or require
institutional care. Thus, patients are discharged 'quicker but sicker'. This could in
turn increase the overall cost of care (Hale 1995; Cardozo & Aherns 1999).
The process of design, implementation, and local evaluation of ICPs can take a great
deal of time, effort and resource. Since these indirect costs are difficult to quantify,
assessing the cost-effectiveness of an ICP in a given setting may therefore be
problematic (Hale 1995).
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2.3 Developing a working definition of an integrated care pathway
Problems caused by having no standard definition of an integrated care
pathway
Are all the organisations that are developing ICPs actually developing the same tool?
The answer to this question must be 'no' (de Luc 2000). It therefore seems that
different people are calling different models of ICP-like interventions by different
names. This poses several major problems. Firstly, it may be difficult to implement
an intervention that is difficult to define and understand because one cannot be sure
whether it could be applicable to one's local setting. Secondly, it is difficult to
evaluate the evidence from different studies since one cannot be sure whether the
interventions being studied are similar. So, investigators should ideally define their
intervention clearly, giving a detailed description of what the intervention is, how it
operates, and the local circumstances within which the intervention has been
implemented. Thirdly, it is difficult to design research studies for an intervention that
is poorly defined, variable and unstructured.
Integrated care pathway is a complex intervention
According to the Medical Research Council, complex interventions are those that
consist of a number of components which can act both independently and inter¬
dependent^ (Medical Research Council 2000). It is not easy to precisely define the
'active ingredients' of a complex intervention, or how they relate to each other. For
example, stroke unit care may be regarded as a complex intervention since it is
difficult to determine the 'active ingredients' that make it effective. Is it the physical
112
set-up? The mix of care providers? The skills of the providers? The technology
available? The organisational arrangements? In practice, it is important to establish
why or how a complex intervention works because it may enable others to draw
inferences about whether the intervention can be put into operation in other contexts
(Medical Research Council 2000).
ICP, like stroke unit care, is a complex intervention (Campbell et al 2000). Patient
care with an ICP can vary in terms of organisation, management, location, format
and design of the ICP, process of development and implementation, nature of the
healthcare staff (skill mix, number and disciplines), and the local circumstances
within which they operate. The Medical Research Council proposed that, before any
clinical trial is undertaken on a complex intervention, it is essential to: a) establish a
working definition for the intervention; and b) determine the probable active
components of the intervention (Medical Research Council 2000). For an ICP, it may
be possible to establish a working definition by stating the essential elements.
A working definition of an integrated care pathway
From examining the medical literature, and in my opinion, the essential elements of
an ICP could include the following:
■ An ICP is a plan of care (written or computerised);
■ An ICP is developed and used by a multidisciplinary team (i.e. a team of
members from more than one discipline);
■ An ICP is applicable to more than one aspect of care (i.e. assessment, diagnosis,
investigation, treatment).
113
Many 'experts' in the field of ICP development may also add other elements to this
list, such as variance reporting or the application of evidence-based guidelines. In my
opinion, although some of these other elements may be important for certain ICPs,
they are not essential for every ICP.
I therefore propose that an ICP can be defined as a plan of care that is developed and
used by members from more than one discipline, and is applicable to more than one
aspect of care. This simple, working, definition will be used in the rest of this thesis.
To my knowledge, no one else has used this definition of ICP before. The closest
definition to this one is by Wigfield and Boon, who stated that "care maps are a
multidisciplinary team approach to assessing, planning, implementing, monitoring
and evaluating care in collaboration with the patient" (Wigfield & Boon 1996).
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2.4 The origin of integrated care pathways
Organisational tools used in non-healthcare industries
In 1958, the US Navy planned to build the Polaris submarine. Due to the enormous
complexity of the project and the huge number of contractors involved, a new
method was developed to assist with the planning and scheduling of the project. This
new method was called the Programme Evaluation and Review Technique (PERT)
(Woolf et al 1968). PERT was used to define the tasks to be performed and the
length of time necessary to accomplish them (Modell 1996). At about the same time,
DuPont company and Remington Rand Corporation developed a similar tool, called
the Critical Path Method (CPM), to assist with the scheduling of the shutdown of
DuPont chemical plants (Landry 2001). The term 'critical' referred to the fact that
the path consisted of steps that took the longest time, so that any delay in completing
any of the steps would delay the entire project (Landry 2001). Over the next ten
years or so, these two organisational tools became widely used in non-healthcare
industries (Luttman et al 1995).
Managed care in the USA
Historically, healthcare in the USA has been provided on a fee-for-service basis. In
the 1930s, managed care emerged as an alternative to fee-for-service (Hunter 2000).
Doctors approached industries and proposed that the industry should pay a group of
doctors a fixed sum ofmoney to provide healthcare for its employees, and it was the
doctors' responsibility to provide the appropriate healthcare within the total sum
agreed (Scofield 1997). The underlying principle of managed care was this: for any
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common clinical scenario, there were numerous but predictable elements of care
which needed to be delivered on time and in the correct order. Managed care aimed
to define what these elements should be, how they may be applied and by whom, and
in some cases, the expected outcome (Fairfield et al 1997; Ellis 1997). This method
of treatment was initially resisted, especially by the American medical profession.
However, it was encouraged by the Nixon administration in the early 1970s and the
use ofmanaged care became widespread (Scofield 1997). Nowadays, managed care
functions as an organisational process which seeks to deliver high-quality and
efficient patient care whilst controlling costs (Wigfield & Gale 1998).
Case management and integrated care pathways in the USA
It was soon realised that managed care was not feasible in practice without two
things: a person (or a group of people) in charge of the process and a tool to facilitate
the process. This led to the development of: a) the case manager; and b) the ICP
(Wigfield & Boon 1996; Smith 1998). In brief, a case manager was the person who
co-ordinated the individual patient's overall care and ensured that the patient
achieved the pre-specified outcomes (Ayestas et al 1995; Compton et al 1995). The
case manager would be responsible for the continuity and consistency of care across
all the clinical settings and sectors (e.g. primary and secondary sectors) (Lee et al
1998). It was thought that the nursing profession was best placed to undertake the
function of a case manager since they often have the most intimate knowledge of the
patients (Smith 1998).
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ICPs were originally developed from the organisational tools used in non-healthcare
industries (e.g. PERT and CPM). Case managers used ICPs to determine whether
high-quality care was being delivered in a timely and cost-effective manner
(Crummer & Carter 1993). The use of ICPs by case managers to deliver the aims of
managed care is also known as 'case management'. Other organisational initiatives
such as 'disease management', 'integrated care', 'transitional care' and 'home
hospital programmes' are variants of the same theme (Hunter 2000; Boult et al
2000).
ICPs were originally developed for medical conditions or surgical procedures that
were common, 'simple' (i.e. single pathology with little variation in practice) and
costly (Nelson 1995; Bailey et al 1998). Later, the use of ICPs for more complex
medical conditions (e.g. acute stroke, diabetes, psychiatric conditions) became more
widespread - see Chapter 3. Freeland et al were the first to report the use of an ICP
for inpatient rehabilitation for patients with arthritis (Freeland et al 1986). The first
ICP to be used in acute stroke was at the New England Medical Centre, Boston
(Zander 1988).
Integrated care pathways in the UK
In the UK, where the state pays for healthcare (largely through taxation), the
government has attempted to control the costs of the NHS by the introduction of the
'internal market' (DoH 1989). Accordingly, and in contrast to the USA, the UK
approach to quality and cost-effective patient care has involved large-scaled
structural changes, such as those heralded by the White Papers Workingfor Patients
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and Health ofthe Nation (DoH 1989; DoH 1992; DoH 1998). These mainly
legislative approaches have been supplemented by other initiatives such as risk
management and clinical governance.
However, while these initiatives are all concerned with quality and performance, the
very essence of ICPs, there has been little official recognition in the UK of ICPs or
case management as a co-ordinated approach to high quality and cost-effective care
(Norris 1998). Although government publications such as the New NHS: Modem,
Dependable and A First Class Service: Quality in The New NHS have promoted
'patient-focused care' and 'integrated care', none of them have specifically
recommended the use of ICPs (DoH 1997; DoH 1998). Possible reasons may
include: a) a lack of a clear definition of what an ICP is; b) a lack of evidence that
ICPs are beneficial; and c) a lack of evidence that ICPs are cost-effective (Walsh
1997; Ellis & Johnson 1999).
From the early 1990s, however, many Health Trusts began implementing ICPs,
chiefly within the surgical specialities (NHS Wales 1999). In contrast to the US, the
primary objective of using ICPs in the UK was not to contain cost, but to assist the
healthcare professionals in making evidence-based clinical decisions, with prompts
from local protocols and national guidelines (Campbell et al 1998; Riley 1998;
Kitchiner & Bundred 1999).
The total number of Health Trusts using ICPs is difficult to estimate since new ones
are constantly being implemented and current ones are abandoned (Bridge et al 1997;
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Riley 1998). In 1998, a UK-wide survey found that 86% of all hospital Trusts (over
250 in total) were using at least one ICP in delivering patient care (Currie 1998).
Currently, ICPs are used in a huge variety of medical and surgical conditions
(Campbell et al 1998; Bryson & Browning 1999; NHS Wales 1999). In 1997, the
National Pathway Association carried out a postal questionnaire survey of its 157
UK members, with a 64% response rate. The survey found that ICPs were most
commonly used in orthopaedic surgery, general surgery, and general and geriatric
medicine (Riley 1998). In this survey, a third of respondents were using ICPs that
involved general practitioners or social services, and a quarter were using ICPs that
involved more than one hospital Trust (Riley 1998).
Integrated care pathways are one ofmany organisational tools to improve the
quality of stroke care
Apart from ICPs, the endeavour to improve the quality of stroke care has led to the
development of other organisational tools such as treatment algorithms (Effeney et al
1983; Caplan 1994; Karanjia et al 1997), 'stroke education record' (Evans 1998),
'comprehensive assessment toolbox' (Duncan et al 1999), and various 'stroke
programmes' (Dignan et al 1986). A recent systematic review has also identified
several interventions that had been introduced to overcome specific barriers to
efficient acute stroke care (Sandercock et al 2001). These included: educational
programmes for the public and healthcare professionals (Alberts et al 1992; Barsan et
al 1994); training programmes for the paramedical staff to improve the accuracy of
diagnosis (Kidwell et al 1998; Smith et al 1999); and re-organisation of in-hospital
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systems to streamline acute care (e.g. 'code stroke' system) (Gomez et al 1994;
Englander et al 1998).
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2.5 Methodological considerations when evaluating the effects of
integrated care pathways
The number of publications in the medical literature on ICP or case management has
grown dramatically over the last few years. In 1996, the NHS Wales estimated that
there were about 4000 published reports (NHS Wales 1999). I also tried to estimate
this number by searching the MEDLINE, EMBASE, CINAHL, CancerLit and
ClinPSYC databases, using "critical pathways" and "case management" as the only
two search terms. In October 2001, this search retrieved 12,994 reports. Despite this
large number of reports, it is believed that only a very small proportion of them are
likely to be controlled clinical trials (Hale 1995; Campbell et al 1998). If this were
true, what are the possible reasons why the effects of ICPs may be difficult to
evaluate using conventional trial designs?
General problems with evaluating the effects of integrated care pathways
Compared with trials of pharmacological agents or surgical procedures, the
evaluation of a health service intervention such as an ICP is more complex. In
practice, ICPs are variable in their nature and their operation depends greatly on the
local circumstances. Consequently, the results generated by studies of ICPs may have
questionable internal validity (i.e. the extent to which differences between the study
groups are real rather than a product of bias) and/or external validity (i.e. the extent
to which trial results can be generalised to a wider population) (Medical Research
Council 2000; Juni et al 2001).
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Since an ICP can contain a large number of elements, each of these elements may
contribute towards the effects of the ICP. Furthermore, each of the elements (e.g.
organisation of the multidisciplinary team) may itself be complex and so they can all
increase the overall complexity of the ICP (Medical Research Council 2000).
Randomised controlled trials are usually the gold standard for evaluating
interventions
It is widely accepted that the most effective method to evaluate a therapeutic
intervention is by comparing two groups of patients who are so similar at baseline
that their outcomes only differ by chance, or because one group received an effective
or harmful therapeutic intervention (Collins & MacMahon 2001). The best way to
construct such groups is by random allocation without the treating clinician being
able to predict which group a patient is going to be in; this is the basis of randomised
controlled trials (RCTs) (Barton 2000). Well-designed, large scale RCTs should,
therefore, minimise the effects of bias and provide the most accurate estimate of
effect for an intervention (Peto & Baigent 1998; Pocock & Elbourne 2000). There is
also some weak evidence that the process of performing an RCT per se might have a
positive effect on the outcome of the participants, regardless of the effectiveness of
the intervention (Braunholtz et al 2001). This 'trial effect' may be due to changes in
the clinicians' behaviour within a trial environment, or the fact that clinicians who
recruit patients into trials may be 'better' clinicians (Braunholtz et al 2001).
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Problems with randomised controlled trials
Despite the superiority of RCTs over other trial designs, there may be occasions
when performing an RCT (i.e. randomising at the patient level) is not feasible
(Medical Research Council 2000). For complex interventions such as ICPs, the
performance ofRCTs can be associated with many methodological difficulties. Here
are several examples.
The control intervention may also be complex
In addition to the aforementioned complexity of an ICP, the control intervention (e.g.
'standard' medical care) may be equally as, if not more, complex. This would further
increase the difficulty in interpreting and generalising the results of the trial.
Getting large numbers ofpatients may be challenging
Since the treatment effects of ICPs may only likely to be moderate, very large
numbers of patients would be needed to provide adequate power to detect a
significant difference in outcome (Peto & Baigent 1998). Getting large numbers of
patients would require substantial resources, time and effort.
Healthcare professionals may not want to take part
To many people, the theory behind the use of ICP seems so sensible (de Luc 2000).
Hence, many healthcare professionals may have a pre-formed opinion that ICPs are
beneficial, and may therefore be reluctant to recruit patients into the trial.
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Patients and carers may not give consent
ICPs are generally regarded as a safe intervention, and many patients and carers may
therefore believe that anything to improve patient care must be better than none. It
may therefore be difficult to obtain informed consent for a controlled trial where the
control is 'standard' medical care. Furthermore, trial results would be less
generalisable if it only recruits a very low proportion of eligible patients (Medical
Research Council 2000).
Lack ofblinding is a source ofbias
The purpose of blinding is to minimise bias resulting from the expectations of the
patient or caregivers regarding outcomes (Day & Altman 2000). A lack of blinding
might therefore influence outcomes of a trial; for example, patients in the standard
medical care group might be managed less intensively than usual if the caregivers
believe that the intervention is beneficial. In trials of ICPs, due to practical reasons, it
would be very difficult to blind the patient, caregivers, and assessor of outcomes to
treatment allocation.
Cross-contamination ofinterventions
Randomisation of individual patients to ICP or standard medical care would only be
meaningful if the two types of care is comparable in every way except for the use of
the ICP. If randomisation takes place within one ward, the healthcare staff from that
ward would have to 'switch' between using an ICP and not using one. This is
difficult to achieve in practice without 'cross-contamination' of treatment. Moreover,
if patients are randomised to be managed in different wards (e.g. one ward using the
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ICP and another not using the ICP), then patient care is likely to be significantly
different; this would also confound the results of the trial. The consequence of cross-
contamination may be the rejection of an effective intervention as ineffective because
the observed effect size is statistically non-significant (i.e. a type II error) (Torgerson
2001).
Other, less common, confounders
Randomisation depends on the statistical power of chance to evenly distribute
potential confounding factors among the trial arms. Where confounders are minimal
and participant numbers are high, this method should be adequate. However, if a
confounding factor is common, it may end up being more prevalent in one trial arm
over the other (Medical Research Council 2000).
Choice ofoutcome measures
It may be difficult to agree on the appropriate and meaningful outcome measures.
Some outcome measures such as patient satisfaction are also difficult to quantify and
interpret, whereas functional outcome such as mortality may not be realistic.
Furthermore, some outcomes can only be measured in certain groups of patients (e.g.
communication difficulty is usually an exclusion criteria for assessments of quality
of life).
Problems with multicentre trials
The inclusion ofmany centres to recruit patients can boost the sample size of the trial
and improve the precision of the results. However, as I have already mentioned, ICPs
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can differ significantly in their nature between hospitals, and hence the results of
such multicentre trials would have to be interpreted with a high level of caution,
taking into account the variations in the nature of the ICPs and local circumstances.
One possible way of tackling this problem is by standardising the ICPs so that they
mainly consist of just the 'essential' elements. However, this approach may make it
more difficult to generalise the trial results to the wider health service.
Problems with cluster randomised trials
Cluster randomised trials, where groups of patients rather than individuals are
randomised, are often advocated to minimise cross-contamination between
treatments when trial patients are managed within the same setting (Torgerson 2001).
Cluster randomised trials are increasingly being used in health service research
where randomising at the patient level is often not feasible (Campbell & Grimshaw
1998). In such cases, cluster randomisation at the level of the healthcare professional
or organisation is necessary.
However, cluster randomised trials are associated with methodological problems.
The major consequence of clustering is that the outcome of each patient can no
longer be assumed to be independent of that of any other patient. Patients within a
location are therefore more likely to be similar than different, and certain types of
patients or conditions may be more prevalent in certain locations. This can
significantly reduce the statistical power of the study, and hence the sample size of
cluster randomised trials would have to be much larger than individually randomised
trials (Campbell & Grimshaw 1998; Kerry & Bland 1998).
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From an ethical point of view, cluster randomisation implies that an intervention (e.g.
implementing an ICP or not) is imposed on a hospital or group of hospitals; this
raises questions about the autonomy of individual patients within each cluster (e.g.
how can they give their consent to treatment?) (Edwards et al 1999). Moreover, since
the implementation of an ICP requires time, effort and plenty of enthusiasm from all
the members of the team, an imposition of such an intervention may be unacceptable
to the people involved in its implementation. This may in turn introduce bias into the
study.
Does this mean that randomised controlled trials could not be used to evaluate
integrated care pathways?
Randomisation remains the best method to minimise bias in a trial, but there are
many methodological pitfalls that must be born in mind when planning and
conducting such a trial. In my opinion, even a well designed and large scale RCT is
unlikely to be able to obtain a precise estimate of effect of an ICP - the results would
always be influenced by bias and confounding factors.
How might one evaluate the effects of integrated care pathways?
When RCTs are not feasible, one might have to gather evidence using multiple
approaches. This could include: a) examining the evidence from previous studies; b)
conducting non-randomised quantitative studies; and c) conducting surveys and
qualitative studies. Evidence from each approach can be considered as one piece of
the jigsaw puzzle, and when they are interpreted together, they may provide a more
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complete picture about an intervention. This approach is known as 'triangulation'
(Mays & Pope 2000).
Objectives of triangulation
Triangulation aims to increase the understanding of a complex intervention by
comparing the findings from two or more different methods of evaluating an
intervention - most commonly a mixture of quantitative and qualitative studies
(Mays & Pope 2000; Malterud 2001a). The researcher looks for patterns of
convergence to develop or confirm an overall interpretation. The intention of
triangulation is to counterbalance the limitation of one research design by the
strengths of another, thereby increasing the ability to interpret the findings (Sim &
Sharp 1998; Thurmond 2001). Triangulation has been used in nursing and
sociological research where many of the interventions and issues are complex
(Connelly et al 1997; Friedemann & Smith 1997; Murray 1999; Rees & Bath 2001).
Problems with triangulation
There are several major problems with using triangulation to assess the effects of an
ICP (see Table 2.5). Firstly, triangulation assumes that any weaknesses in one
method can be compensated by the strengths in other methods. Of course, this may
not be possible in practice - it is difficult to imagine how the weaknesses of a non-
randomised controlled trial can be fully compensated by the strengths of a
questionnaire survey. Triangulation can therefore be better regarded as a way of
maximising comprehensiveness and encouraging a more flexible analysis of the data,
rather than as a method of obtaining accurate data (Mays & Pope 2000). Secondly,
128
the bringing together of quantitative and qualitative methods in triangulation tend to
ignore the fundamental question as to whether data generated by different research
methods can meaningfully be combined - it may simply compound the sources of
bias and confounding (Begley 1996; Sim & Sharp 1998). One therefore needs to
approach triangulation with extreme caution and in a critical fashion, with due regard
to the rather dubious assumptions upon which it often rests (Sim & Sharp 1998).
Non-randomised research designs
Non-randomised studies are generally regarded as having lower levels of internal
validity because the two comparison groups have not been created to be
mathematically equivalent (as it should be the case in randomised trials) (Sacks et al
1982; Chalmers et al 1983; Egger & Smith 1998). Since each patient's treatment is
deliberately chosen rather than randomly assigned, there is an unavoidable risk of
selection bias and of systematic differences in outcomes that are not due to the
treatment itself (Pocock & Elbourne 2000). Despite this, many believe that non-
randomised and randomised studies can contribute complementary evidence about
the effects of treatment, even on the major outcomes such as mortality (MacMahon
& Collins 2001). Moreover, non-randomised studies may help to identify important
but rare adverse effects of a treatment, and they may provide information about the
risks of death and disability in particular circumstances that can help to generalise the
results of a clinical trial (MacMahon & Collins 2001). Interestingly, two recent
reports identified clinical questions where both randomised and non-randomised
studies had been used to evaluate the same question, and performed a head to head
comparison of them (Concato et al 2000; Benson & Hartz 2000). In contrast to the
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belief that non-randomised studies more frequently report positive results and larger
estimates of treatment effects, both reports appeared to find that non-randomised
studies did not over-estimate the size of the treatment effect compared with the
randomised counterpart (Ioannidis et al 2001a). However, the quality of these two
reports is dubious (Ioannidis et al 2001b).
Major types of non-randomised research designs
The major types of non-randomised study designs have been summarised in Table
2.6.1 have highlighted several examples here:
Open study design
In this study design, observations are only made after an intervention. Since
observations are not made before the intervention, the researcher cannot be certain
that the intervention has resulted in change. Furthermore, since there is no control
group, allowance cannot be made for changes resulting from passage of time, season,
or external factors other than the intervention. This design, which is commonly
known as 'case series', has very limited application in informing clinical practice.
Warlow commented that "the plural ofanecdote clearly is not data" (Professor C
Warlow, personal communication, 2001). However, post-test-only design is
surprisingly common as a method of assessing the effects of ICPs (Wentworth &
Atkinson 1996; Ramachandran et al 1996; Lagoe & Aspling 1997; van Straten et al
1997; Lagoe 1998; Summers & Soper 1998; Quigley et al 1998).
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Before-and-after designs
There are two main types of before-and-after studies: controlled and uncontrolled
(HTA 1999). Uncontrolled before-and-after studies are also known as single group
pre-test/post-test studies. In this type of studies, since observations are made before
and after an intervention in one group of patients only, it is impossible for the
researcher to know what would have happened in the absence of the intervention
(Cable 2001). Changes in the outcome from pre-test to post-test could in fact be due
to many factors other than the intervention, for example, external events and cyclical
variations in the outcome (Cable 2001). Controlled before-and-after studies are
where observations are made before and after an intervention in two non-equivalent
but similar groups of patients (e.g. two hospitals in the same Health Trusts). A
variant of this type of study is when the intervention is implemented in one group,
but the other group remains totally untreated throughout the study period. The major
advantage of having a 'control' group is that external factors such as changes in
outcome with time, may be estimated (HTA 1999).
Interrupted time series designs
Like before-and-after studies, interrupted time series can either be uncontrolled (i.e.
investigating a single group of patients) or controlled (i.e. investigating two non-
equivalent groups of patients). Interrupted time series are studies that make multiple
observations (usually more than three) before and after an intervention (HTA 1999).
The advantages of interrupted time series are similar to those of before-and-after
studies, but the internal validity of interrupted time series are generally thought to be
higher (Cable 2001). One drawback of interrupted time series is that data analysis
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often involves complex mathematical modelling to determine the effects of the
intervention on the entire series of observations, whilst taking into account the
relative effects of other external factors. Another drawback of interrupted time series
is that, for the data analysis to be accurate, each period of data collection has to have
observed enough outcome events for the point estimate of effect to be precise (with a
narrow confidence interval) - although there is no strict rule for this. This may
require long periods of observations and hence considerable amount of resources. It
may be for these reasons that interrupted time series have rarely been used to
evaluate the effects of ICPs.
Qualitative research designs
The need for qualitative research rests on the fact that clinical decisions are rarely
made on the basis of quantitative data or evidence alone - the clinician also relies on
other factors such as experience, feelings, and understanding of the situation (i.e. the
'art ofmedicine') (Malterud 2001b). Qualitative research intends to explore the what,
how and why of clinical decisions and phenomena (Giacomini & Cook 2000). In
practice, qualitative research draws on text rather than numbers, applying procedures
for interpretation of meaning instead of statistics to calculate probabilities, and
aiming for wholeness rather than details - it seeks to "reach the parts that other
methods cannot reach" (Pope & Mays 1995; Malterud 2001b). The Medical
Research Council recommends that qualitative research can be useful in the
evaluation of a complex intervention (Medical Research Council 2000). A range of
qualitative methods are available, including group interviews (focus groups),
individual in-depth interviews, observational (ethnographic) research, or
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organisational case studies (Medical Research Council 2000). It is beyond the scope
of this thesis to discuss these methods.
Approaches used to evaluate the effects of integrated care pathways for acute
stroke in this thesis
The objectives of this thesis are listed in Chapter 1.1 sought to evaluate the effects
of ICPs for acute stroke using the following four approaches:
1. Assessing the evidence from previous studies of ICPs for non-stroke conditions;
2. Assessing the evidence from previous studies of ICPs for acute stroke;
3. Conducting two non-randomised studies of the ICP introduced for acute stroke at
the Western General Hospital - a before-and-after study and a prospective
comparative study;
4. Conducting two questionnaire surveys to assess the experience of the stroke unit
staff regarding the use of the ICP for acute stroke at the Western General
Hospital.
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2.6 Summary of this chapter
■ Integrated care pathways (ICPs) are being implemented across many hospitals
without much debate about their definition, nature, and effects.
■ There are many definitions of ICPs, they all differ slightly and none has been
universally accepted as standard.
■ ICPs are complex interventions with the following essential elements: a) they are
plans of care; b) they are developed and used by a multidisciplinary team; and c)
they are applicable to more than one aspect of care. A working definition of an
ICP can include all of these three elements.
■ The use of ICP can be associated with many potential advantages as well as
disadvantages to the patient, healthcare professional, and healthcare system.
■ All studies of ICPs may suffer from low levels of internal and external validity.
■ There are many methodological problems associated with randomised controlled
trials (including multicentre and cluster randomised trials) of ICPs.
■ Evaluation of the effects of ICPs may have to involve multiple approaches such
as the performance of non-randomised studies and qualitative studies.
■ In thesis, I sought to evaluate the effects of ICPs for acute stroke by: a) assessing
the evidence from previous studies of ICPs for non-stroke conditions; b)
assessing the evidence from previous studies of ICPs for acute stroke; c)
conducting two non-randomised studies of the ICP introduced for acute stroke at
the Western General Hospital; and d) conducting two questionnaire surveys to
assess the experience of the stroke unit staff regarding the use of the ICP for
acute stroke at the Western General Hospital.
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Table 2.1 Types of items that may be included in an ICP - using stroke ICP as an
example.
Process off care Items Pailemt-specifie items
□ Investigations □ History & examination findings
□ Pharmacological treatments □ Functional status (e.g. Barthel index)
□ Rehabilitative therapy □ Physiological status (e.g. BP)
□ Surgical procedures □ Neurological status (e.g. GCS)
□ Education of patient & relative □ Symptoms (e.g. pain)
□ Psychological support □ Cognitive status (e.g. mental test score)
□ Spiritual support □ Emotional status
□ Palliative support □ Quality of life (e.g. SF36)
□ Discharge planning □ Patient satisfaction
Table 2.2 Four major aims of using ICPs.
n To assist healthcare professionals in making clinical decisions according to the
best-available evidence, local policies, and national guidelines.
D To improve the quality of patient care by reducing variation in clinical practice
and improving efficiency, which may in turn reduce length of stay and cost.
D To improve communication between disciplines, and between patient and
healthcare professionals.
D To improve documentation and facilitate audit.
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Table 2.3 Different methods of providing information to assist decision-making by
healthcare professionals. Numbers 1 to 8 indicate increasing complexity and detail
of instruction. In the medical literature, ICPs have been used as a term to mean
anything from numbers 2 to 8.
Method of providing information Usual definition
1. Evidence Findings from research
2. Guideline Consensus panel reviews the evidence to
produce recommendations on what best
practice should encompass
3. Standard Specific instruction for the best practice.
Standards define the care that could be
expected by patients and carers
4. Criteria List of standards
5. Policy Adjustment and application of national
guidelines or standards to the local setting
6. Procedure or protocol Detailed instructions on exactly how to
perform a certain task according to guideline
recommendations or standards
7. Flow chart or algorithm Procedures or protocols with clearly charted
sequence (and sometimes also timing) of
tasks and/or outcomes
8. Integrated care pathway Paper or electronic care plans that contain
detailed checklists of recommended
treatments for the different aspects of patient
care from day to day
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Table 2.4 United Kingdom Central Council (UKCC) guidelines for good record
keeping. Adapted from UKCC (1998).






■ In chronological order
■ Legible
■ Permanent
■ Problem-based, describing care planned and delivered for each problem
■ Without jargons and offensive statements
■ Written with the involvement of the patient or relative
■ Written in terms that patient or relative can understand
Table 2.5 Major problems of using triangulation to evaluate the effects of complex
intervention such as ICPs. Many of these problems are not unique to triangulation.
Adapted from Begley (1996).
■ Internal and external validity of triangulation may be low
■ Triangulation may compound sources of error and bias from different studies
■ Research methods selected by the researcher may not be the appropriate ones
■ Unit of analysis may not apply to all research methods
■ Triangulation cannot compensate for researcher bias
■ Triangulation can be very expensive
■ Evaluation using triangulation is difficult to replicate
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Table 2.6 Major types of non-randomised study designs according to the nature of
the comparison groups and timing of observations. Adapted from HTA (1999).
Comparison groups Timing of observations Other names
Intervention group only ■ After only Open study
■ Before and after Uncontrolled before-and-after study
■ Interrupted time series Uncontrolled interrupted time series
Intervention group & ■ After only Comparative study
non-equivalent control ■ Before and after Controlled before-and-after study
group ■ Interrupted time series Controlled interrupted time series
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3.1 Background
Is there any evidence to support the use of ICPs in healthcare, and specifically, in the
management of patients with acute stroke? To address this, I initially assessed the
evidence from previous studies of ICPs for non-stroke conditions, and then the
evidence from previous studies of ICPs for acute stroke. I anticipated that the process
of examining the studies of ICPs for non-stroke conditions may facilitate the process
of examining the studies of ICPs for acute stroke - for example: by further refining
the search strategy; by informing about the possible outcome measures that should be
assessed; and by highlighting the potential problems of data analysis.
In this chapter, I shall discuss the methods and findings of a literature review of ICPs
for non-stroke conditions. Although the literature review was 'systematic' in nature,
it was not intended to be exhaustive. In Chapter 4,1 shall discuss the methods and
findings of a Cochrane systematic review of ICPs for acute stroke.
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3.2 Methods of the literature review
I sought all randomised controlled trials (RCTs) and non-randomised controlled trials
that compared ICP care with conventional medical care for patients with non-stroke
conditions. I searched MEDLINE from 1998 to June 2001 -1 only searched for
studies during the past three years because of the limited time and resources, and I
wanted to concentrated on the latest studies. I used a detailed search strategy (see
Table 3.1), which was designed with the help of the Cochrane Stroke Group.
Apart from controlled trials, I also considered studies of other weaker research
designs, including before-and-after studies, interrupted time series, and comparative
studies (see Table 2.6 for definitions). However, I excluded publications that did not
report original data (e.g. review articles, editorials) and studies that did not have a
comparison group (e.g. open studies). Because of the limited time and resources, I
only considered published reports written in English.
I screened all the titles and abstracts of reports identified by the search strategy and
obtained full-text publications of those that were possibly relevant. I then screened
the full-text reports and excluded the irrelevant ones.
Outcomes measures included: a) patient-specific outcomes (e.g. death, dependency,
occurrence of complications); b) process of care (e.g. delay in care, patient
education, use of appropriate tests); c) length of stay and hospital costs; and d) other
outcomes (e.g. changes in physiological parameter, changes in life-style).
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3.3 Results
Number of identified studies
I screened 476 titles, abstracts and keywords of publications, ofwhich 39 were
possible relevant. After examining the full-text version of these publications, 30
studies and two systematic reviews were included in the review. The characteristics
of the included studies and systematic reviews are summarised in Table 3.2. Seven
publications were excluded and the reasons for excluding them are presented in
Table 3.3.
Characteristics of the included studies
Nine studies examined the effects of ICPs for medical conditions, 12 for surgical
procedures, two for paediatric conditions, three for psychiatric conditions, and four
for other conditions. There were also two systematic reviews of prospective studies
of ICPs for psychiatric conditions. Of the 30 studies (a total of 28,378 patients), there
were 12 RCTs (15,516 patients), one quasi-RCT (111 patients), one non-randomised
controlled trials (349 patients), 14 before-and-after studies (11,558 patients), and two
comparative studies (844 patients).
Methodological quality of the included studies
Amongst the RCTs, only one used blinded assessments of outcomes (Dougherty et al
2000), and another employed cluster randomisation of several hospitals (Marrie et al
2000). Two of the 14 before-and-after studies used a concurrent non-equivalent
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control group (Bailey et al 1998; Chen et al 2000), but none of them has also
included a historical non-equivalent control group.
To explore the influence of research design on the results of the studies, I divided the
studies into prospective and retrospective ones. Prospective studies included the
systematic reviews, RCTs and non-randomised controlled trials (total of 14 studies
and 2 systematic reviews). Retrospective studies included the before-and-after
studies and non-randomised comparative studies (total of 16 studies).
Results of the literature review
The results of the included studies and systematic reviews are summarised in Table
3.2.1 shall therefore only provide a brief synopsis of the results for each of the four
categories of outcome measures here. For the sake of simplicity, both the studies and
systematic reviews will be known as 'reports' in this section.
Patient-specific outcomes
Ten reports found that ICPs improved patient-specific outcomes, 12 reports found
that ICPs had no significant influence, and one report found that ICP worsened
patient-specific outcomes. For example, Dougherty et al (2000) showed that ICP
improved the control of anginal symptoms and quality of life; and Dowsey et al
(1999) showed that ICP reduced the occurrence of complications after hip or knee
arthroplasty. However, Spain et al (1998) - a before-and-after study - showed that
the use of ICP was associated with a significantly higher mortality amongst patients
with severe traumatic brain injury.
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Process ofcare
Nine reports found that ICPs improved the process of care, five reports found that
ICPs had no significant influence, and five reports found that ICPs worsened the
process of care. For example, D'Amato et al (1998) showed that ICP reduced
operational delay during hysterectomy. However, Marrie et al (2000) and Gagnon et
al (1999) found that ICP increased the likelihood of being admitted to the hospital.
Length ofstay and hospital cost
Seventeen reports found that ICPs reduced the length of stay or hospital cost, nine
reports found that ICPs had no significant influence, and two reports found that ICPs
actually increased the length of stay or hospital cost. For example, Hanna et al (1999)
showed that ICP reduced the mean length of stay by 2.4 days and hospital cost by
14.4% amongst patients undergoing laryngectomy. However, Williams et al (1998a)
and Issakidis et al (1999) showed that ICP increased the mean hospital cost.
Other outcomes
Four reports found that ICPs improved other outcomes, but no study reported neutral
or negative effects of ICPs on other outcomes - this could possibly be a result of
reporting or publication bias. For example, De Busk et al (1994) showed that ICP
reduced the proportion of patients with coronary artery disease who continued to
smoke; and Aubert et al (1998) showed that ICP reduced the fasting blood glucose
level in patients with diabetes mellitus.
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Prospective vs retrospective studies
This literature review has highlighted the wide variety of research designs that have
been employed to evaluate the effects of ICPs for non-stroke conditions. Despite
using a well-designed and specific search strategy to search for prospective
controlled trials, many studies ofweaker research designs, most notably before-and-
after studies, were retrieved.
Table 3.4 summarises the nature of the results for each category of outcome for the
prospective and retrospective studies. This is an exploratory exercise to see whether
there are any significant differences in the reporting of positive, neutral and negative
results between the prospective and retrospective studies. Overall, there did not seem
to be any obvious difference. However, retrospective studies appeared to be more
likely to report positive effects of ICP on the length of stay or hospital cost,
compared with prospective studies.
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3.4 Discussion
This literature review has found many randomised and non-randomised studies that
have evaluated the effects of ICPs for non-stroke conditions. There was a
surprisingly large number of prospective studies, and especially, RCTs. However, the
majority of included studies were non-randomised and retrospective studies. Studies
conducted using these weaker research designs are invariably susceptible to many
biases and their results would therefore be less reliable and valid. This literature
review was not intended to find every published and unpublished study that has ever
been conducted, but rather it was meant to give an indication about the number and
types of studies that have recently been published on this topic, and the nature of
their reported findings.
I found that, even though there were 39 reports of positive findings, there were also
35 reports of neutral or negative effects of ICPs on the different outcomes. In
particular, a significant number of reports have not provided evidence of beneficial
effect, or have even found some evidence of harm, on patient-specific outcomes and
process of care. In contrast, many reports appeared to have found that ICPs may be
effective in reducing the length of stay and hospital cost. This finding could be
because positive results on this particular outcome may be more likely to be reported
(i.e. reporting bias), and positive reports of this outcome may in turn be more likely
to be published (i.e. publication bias). If these biases exist, then the harmful effects
of using ICPs could be under-reported in the medical literature, and any review of
literature may therefore under-estimate the true harmful effects of using ICPs.
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I found that the interventions and settings were very heterogeneous between the
studies in this literature review, so an overall estimate of the effects of ICPs would be
relatively meaningless. Nevertheless, the evidence may be accumulating that ICPs
could be of benefit, but in order to reliably assess the balance of benefit and harms,
one would need more focussed reviews with quantitative synthesis of the evidence
(see Chapter 4).
Previous review articles on the topic of ICP have presumed that there would be very
few prospective studies of ICPs, and it has been suggested that conclusions about the
effects of ICP "would have to be drawn from studies ofweaker research designs"
(Hale 1995; Ellis & Johnson 1999). However, the present review of the recent
literature has found many prospective trials of ICPs for non-stroke conditions; there
were 12 RCTs published in the last three years alone. One should therefore interpret
the conclusions of review articles with extreme caution, and if in doubt, one should
refer to the original publications.
Implications for practice and research
From this non-quantitative review of the recent literature, one cannot draw overall
conclusions about the effects of ICPs for non-stroke conditions or the balance of
benefits and harms. However, an ongoing Cochrane systematic review, which is
assessing the effects of case management on professional practice and other health-
related outcomes, is seeking to address these issues in greater detail (Zwarenstein et
al 2002).
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3.5 Summary of this chapter
■ In the last three years, there have been many published randomised and non-
randomised studies that have evaluated the effects of ICPs for non-stroke
conditions.
■ Positive, neutral and negative findings have all been reported.
■ There was no obvious difference in the nature of the reported findings between
prospective and retrospective studies.
■ An ongoing Cochrane systematic review on this topic should provide more
information.
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Table 3.1 Search strategy for the literature review of studies of ICPs for non-stroke
conditions. Note: lines 1-6 refer to the intervention, lines 7-25 to the type of studies,
and lines 26-30 to our method of refining the search.
1. critical pathway/
2. case management/
3. exp Delivery of health care, integrated/
4. Managed care programs/
5. stroke program$.tw.
6. ((care or clinical or critical) adj5 (path$ or map$)).tw.
7. randomized controlled trial.pt.
8. randomized controlled trials/
9. controlled clinical trial.pt.





15. exp clinical trials/
16. (clin$ adj25 trial$).tw.






23. (meta?analysis or systematic review or overview).tw.
24. controls.tw.
25. (controlled adj (stud$ or trial$)).tw.
26. or/1-6
27. or/7-25
28. 26 and 27
29. limit 28 to human
30. limit 29 to english language
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Table 3.4 Prospective vs retrospective studies. This table presents the nature of the
reported results according to the study design. Numbers (n) represent numbers of
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4.1 Background
Guidance on how stroke care should be organised or coordinated is lacking
Professional bodies have been calling for stroke services to be more organised and
better co-ordinated, but there is currently little guidance on how this can be achieved
(RCP 2001). Even though strategies such as holding weekly multidisciplinary team
meetings are recommended to promote organised stroke care, there are no other
practical guidelines on how to improve the organisation and co-ordination of routine
patient care. This lack of guidance may in part explain why, over five years after the
first published guidelines recommended the widespread adoption of organised stroke
care, there are still substantial variations in the process of stroke care in the UK
(Aboderin & Venables 1996; Rudd et al 2001).
Different forms of stroke integrated care pathways
ICPs for in-hospital management of stroke were originally developed in the USA
with the primary objective of cost-containment (Zander 1988). Since then, many
forms of stroke ICPs have been developed, such as those used to aid the diagnosis of
acute stroke and guide the physician in deciding whether the patient is suitable for
thrombolytic therapy (Hickman 1998; Broderick 1998). Others have been developed
to guide patient care in the community after hospital discharge (Dignan et al 1986;
Schmidt et al 1999). In general, stroke ICPs can be broadly divided into three
categories: a) those used for acute stroke management only; b) those used for stroke
rehabilitation only; and c) those used for both acute stroke management and stroke
rehabilitation.
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Integrated care pathwaysfor acute stroke management
Management of acute stroke is complex, consisting ofmany components including
thorough clinical assessment, urgent investigations, assessment of the patient for
thrombolysis, correction of deranged physiological parameters, prevention and
treatment of early complications, and commencement of secondary preventive
measures. Effective acute stroke management therefore requires an organised and
highly trained team of healthcare professionals, working efficiently within a well-
equipped and dedicated stroke service structure (Adams, Jr. et al 1996; Broderick
1998). However, recent surveys have demonstrated that many hospitals were not
providing a high quality acute stroke service (Ebrahim & Redfern 1999; Roberts
2001). It is conceivable that ICPs, with their many potential advantages as outlined in
Chapter 2, could help to improve acute stroke care and standardise practice
(Langhorne & Dennis 1998). For instance, ICPs could help to ensure that
physiological disturbances are appropriately managed soon after stroke onset, and
that aspirin is started in those patients whose CT scans have excluded haemorrhage,
in accordance with the National Service Framework for Older People (DoH 2001).
During the acute phase of stroke, individually-tailored treatment strategy is important
because stroke patients often have multiple medical problems and their course of
illness can be unpredictable (Warlow et al 2000). These factors should in theory
make ICPs for acute stroke management more difficult to design and implement
(Anon. 1995). Despite this, there are many examples of ICPs for acute stroke
management across the world (Zander 1988; Pasquarello 1990; Bowen & Yaste
1994; Odderson et al 1995; Abissi et al 1995; Wentworth & Atkinson 1996; Duryee
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et al 1996; Ramachandran et al 1996; Barch et al 1997; Ross et al 1997; Lagoe &
Aspling 1997; Hainsworth et al 1997; Baker et al 1998; Summers & Soper 1998;
Jungkind & Corish 1999; Wilkinson et al 2000). When Zander et al were designing
their stroke ICP, they found that the physicians often had individual preferences
regarding treatment strategies for certain groups of patients. Interestingly, the authors
recommended designing "a different critical path for each physician" (Zander 1988)!
Not only would this be unworkable in most hospitals, this practice would more
importantly be in direct conflict with one of the major objectives of using ICPs,
which is to use forms of healthcare interventions that are based on good evidence
(and not just on the physician's opinion), in a consistent and standardised manner.
Integrated care pathwaysfor stroke rehabilitation
One to two weeks after stroke onset, patients with significant residual neurological
deficits are usually transferred to a stroke rehabilitation unit (Dennis & Langhorne
1994). During rehabilitation, the stroke patient is usually medically more stable.
However, neurological problems (e.g. communication problems, dysphagia,
incontinence), and complications (e.g. chest infections, depression, painful shoulder),
though not immediately life-threatening, can add significantly to the patient's
impairment, disability and handicap. Meticulous attention to the prevention and early
treatment of complications is important, which may in turn lead to improved
outcome. The more efficiently and equitably such interventions are applied, the more
patients are likely to benefit. Moreover, prior to discharge, secondary preventive
treatments (Anderson et al 1994) should be given according the latest evidence and
clinical guidelines (SIGN 1997; SIGN 1998; RCP 2001).
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ICPs for stroke rehabilitation are potentially useful in enhancing the process of stroke
rehabilitation, for example, by improving organisation, increasing multidisciplinary
communication, and facilitating the application of evidence and guideline
recommendations (Langhorne & Dennis 1998). There are several reports of the use
of ICPs for stroke rehabilitation in the literature, some of which have been associated
with positive results (Romito 1990; Falconer et al 1993; Goldberg et al 1997;
Quigley et al 1998; Schmidt et al 1999; Sulch et al 2000).
Integrated care pathwaysfor acute stroke management and stroke rehabilitation
Some ICPs have been designed for both acute stroke management and stroke
rehabilitation (Dignan et al 1986; Hamrin & Lindmark 1990; Schull et al 1992;
Crawley 1996; Moloney et al 1999; Rosenberger & Wiemers 1999; Wee et al 2000;
Jones et al 2001). This type of ICP may be particularly useful in hospitals which
have a combined acute and rehabilitation stroke unit.
Effectiveness of integrated care pathways may depend on the basic structure of
the stroke service
Many experienced physicians believe that ICPs can only be effective in improving
stroke care if the basic structure of the stroke service is already in place, such as the
routine admission of patients to a stroke unit where patient care is provided by a team
ofmotivated and skilled healthcare professionals (Gainer 1996; Lanska 1998). If the
basic structure is not in place (e.g. if stroke patients are managed by different
medical teams in several general medical wards), then ICPs are less likely to
significantly influence the process of care since there would be many barriers in
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terms of the development, implementation and operation of the ICP (Luttman 1993).
It is therefore common to find that ICPs are introduced as part of an overall quality
improvement scheme, rather than as a stand-alone organisational intervention
(Ringel & Hughes 1996).
How frequently are integrated care pathways being introduced for stroke
management in the UK?
Two postal questionnaire surveys were conducted to determine how frequently
stroke ICPs were implemented in Scotland and the UK (unpublished data). The first
one, which was conducted in 2000, was a postal questionnaire survey of all the
Scottish hospitals that provided stroke care. Twenty-eight hospitals were surveyed
and all of them responded. It showed that: 5/28 (18%) hospitals were using stroke
ICPs; 11 (39%) were planning to introduce stroke ICPs in the near future; 2 (7%)
have used stroke ICPs in the past but the ICPs concerned have been abandoned; and
10 (36%) were not using stroke ICPs and had no plan to introduce them. Of the latter
10 hospitals which had no plan to introduce stroke ICPs, the reasons given were: a)
there was no convincing evidence of benefit (5 hospitals, 50%); b) discussion with
colleagues had dissuaded them from implementing stroke ICPs (3 hospitals, 30%);
and c) other reasons.
The same questions were posed in a second postal questionnaire survey in 2000,
conducted by the British Association of Stroke Physicians (BASP) as part of the
Benchmarking Survey of Stroke Services 2000. All the members of the BASP (from
40 acute stroke units) were surveyed and stroke consultants from 30 acute stroke
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units responded (75% response rate). Of the 30 acute stroke units: 14 (47%) hospitals
were using stroke ICPs; 12 (40%) were planning to introduce stroke ICPs in the near
future; 2 (7%) have used stroke ICPs in the past but the ICPs concerned have been
abandoned; and 2 (7%) were not using stroke ICPs and had no plan to introduce
them. Of the 2 latter hospitals which had no plan to introduce stroke ICPs, the
reasons were: a) there was no convincing evidence of benefit (1 hospital); and b) the
process of design and implementation would take too much time (1 hospital).
In summary, these two recent surveys showed that many of the hospitals in the
survey - 57% of the hospitals in Scotland and 87% of the hospitals in the UK - were
either already using stroke ICPs or had plans to implement them in the near future.
Is the implementation of stroke integrated care pathways supported by good
evidence?
Despite the widespread implementation of stroke ICPs, there are still many
uncertainties about their effects and how they should be developed, implemented and
evaluated (Pearson et al 1995). Underlying these concerns is that, like many other
promising technologies and organisational tools, the implementation of stroke ICPs
is recommended before well-conducted trials have provided evidence of net benefit
(Pearson et al 1995; Sulch & Kalra 2000).
There have been few attempts to review the literature for previous studies of stroke
ICPs (Lanska 1998; Sulch & Kalra 2000). Some general review articles simply stated
that there have been no controlled studies of stroke ICPs (Pearson et al 1995). A
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more recent literature review on stroke ICPs was performed by Sulch et al (2000).
The authors identified and described the results of seven studies (Odderson &
McKenna 1993; Bowen & Yaste 1994; Wentworth & Atkinson 1996; Ross et al
1997; Anon. 1998; Summers & Soper 1998). Six of these were non-randomised
studies of acute stroke ICPs, and one was a RCT of a stroke rehabilitation ICP. Three
of the non-randomised studies were before-and-after studies (Odderson & McKenna
1993; Bowen & Yaste 1994; Ross et al 1997), two were open studies (Wentworth &
Atkinson 1996; Summers & Soper 1998), and one study did not describe its study
methodology at all (Anon. 1998). Although most studies appeared to demonstrate a
reduction in length of stay, the authors of the review concluded that the effects of
stroke ICPs were unclear (Sulch & Kalra 2000).
There are three major problems with the methodology of the literature review by
Sulch et al (2000). Firstly, the search strategy described was very limited and did not
take into account of the complex nature of the intervention, and important studies
could have been missed as a result. Secondly, there was no mention of the date on
which the electronic databases were searched, making it impossible to determine
how up-to-date the review was. Finally, it was unclear whether any effort was made
to (hand-)search for unpublished or non-English articles (Kwan 2000).
With this in mind, I undertook a Cochrane systematic review to assess the effects of
ICPs, as compared to standard medical care, among patients with acute stroke who
had been admitted to hospital. This review was aimed to: a) be more up to date; b)
employ a more comprehensive search strategy; c) search for studies from a wider
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variety of bibliographic sources; and d) use the standardised methods of the
Cochrane Collaboration.
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4.2 Methods of the systematic review
Criteria for considering studies for this review
Types ofstudies
I sought unconfounded RCTs that compared ICP care versus standard medical care.
However, since I anticipated that there would only be a few of these studies, I also
sought studies with weaker research designs, i.e. quasi-randomised trials, controlled
and uncontrolled before-and-after studies, and interrupted time series. I sought
studies with at least two study groups for comparison, with due allowance for the
large number of biases that are likely to be associated with non-randomised designs.
I included only studies with an adequate description of its methodology such that
studies claiming certain effects of ICPs but without adequate information were to be
excluded.
Types ofparticipants
I used the World Health Organisation definition of stroke for this review (WHO
1989). I included all studies that recruited patients who had been admitted to hospital
with a new neurological deficit consistent with a clinical diagnosis of stroke.
However, I excluded studies that recruited only patients with subarachnoid
haemorrhage since the management of these patients would have been very different
to the generality of stroke patients. Studies that recruited all types of ischaemic and
haemorrhagic strokes (including subarachnoid haemorrhage) were included. I also
included studies that recruited patients with a mixture of conditions including stroke,
but only where the results for stroke patients could be clearly extracted.
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Types of interventions
For this systematic review, I used the definition of an ICP as described in Chapter 2,
i.e. a plan of care that: a) involved two or more disciplines; and b) involved two or
more of the following aspects of care: assessment, investigation, diagnosis, and
treatment. Furthermore, I anticipated that there would be three main clinical settings
for which ICPs were designed: a) for acute stroke only; b) for stroke rehabilitation
only; and c) for acute stroke and rehabilitation.
I also included studies that examined "case management", "disease management",
"stroke protocols", or "stroke programmes" only if the description of the intervention
satisfied the above definition. I excluded studies of ICPs that had been designed for a
single aspect of care (e.g. diagnosis, administration of thrombolytic therapy), as well
as those designed for patients undergoing carotid endarterectomy. I sought advice
from the Cochrane Effective Practice and Organisation of Care (EPOC) group
regarding the definition of an ICP for this review.
Types ofoutcome measures
The primary outcome measure was the proportion of patients who were dead or
dependent at the end of the scheduled follow-up period. For studies that did not
systematically report dependency, I sought data on the proportion of patients who
required long-term institutional care. "Independent" individuals were defined as
those who did not require regular physical assistance from another person for
activities of daily living, such as mobility, dressing, transfers, and feeding.
"Dependent" individuals were those who failed to meet one or more of these criteria.
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The criteria for independence were approximately equivalent to a modified Rankin
score of 0 to 2, or a Barthel Index of greater than 18/20 (Wade 1992). Institutional
care was defined as care within a residential home, nursing home, or hospital at the
end of scheduled follow up or at discharge.
Secondary outcome measures included:
1. Occurrence of complications during the hospital stay (e.g. pneumonia, urinary
tract infection, deep vein thrombosis, skin breakdown);
2. Readmission or emergency department attendance;
3. Use of investigations (e.g. proportion of patients having a computed tomography
brain scan or carotid duplex study);
4. Patient and carer satisfaction;
5. Duration of hospital stay;
6. Cost of hospitalisation;
7. Quality of life (using recognised scoring system such as SF36 and Euroqol).
Search strategy for identification of studies
This review drew on the search strategy developed for the Cochrane Stroke Group as
a whole. The Cochrane Stroke Group Specialised Trials Register was searched on 8th
May 2001. In addition, I undertook specialised searches of the following electronic
databases:
■ Cochrane Controlled Trials Register (CCTR/Central, Issue 4, 2001) - 159 reports
identified
■ MEDLINE (1975 to 2000) - 4503 reports identified
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■ EMBASE (1980 to 2000) - 3673 reports identified
■ CINAEIL (1982 to 2000) - 470 reports identified
■ The Index to Scientific and Technical Proceedings (ISTP, May 2001) - a database
of conference proceedings on ISI Web of Science Services (Web of Science
Proceedings, WOSP) - no report identified
■ HealthSTAR (May 2001) - an online bibliographic database that provides access
to published literature of Elealth Services Technology, administration, and
research - 54 reports identified
As I mentioned in Chapter 2, ICPs for health care have only existed since the
beginning of 1980s. I therefore only searched MEDLINE from 1975 onwards. I
handsearched the entire collection of the Journal ofManaged Care (1997 to 1998),
which was later renamed the Journal of Integrated Care (1998 to 2001). I also
checked the reference lists of the papers retrieved from the above searches and
attempted to contact authors of relevant papers where clarification of information
was needed. Personal contact with colleagues and researchers identified ongoing and
unpublished studies. The search strategy for MEDLINE can be found in Table 4.1.
Methods of the review
Selection oftrials
I screened all the titles, abstracts and keywords of publications identified by the
searches to assess their eligibility. I was blinded to the names of the authors,
institution where the work had been carried out, and the journal (by printing out the
titles, abstracts and keywords without the author names etc). Publications that clearly
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did not meet the inclusion criteria were excluded at this stage. Another reviewer (PS)
then independently checked the decisions. We then obtained a paper copy of the full
publication of every study that was possibly relevant. Both reviewers then assessed
them according to pre-specified selection criteria. We excluded articles that did not
contain results of any study (e.g. a report simply describing a new ICP). We resolved
any disagreement by discussion.
Assessment ofmethodological quality
PS and I independently assessed the methodological quality of all the included
studies and recorded the findings. We noted the important aspects of methodology:
study design, type of control, method of allocation concealment, completeness of
follow-up, and the presence ofblinding for assessments of non-fatal outcomes. We
did not use pre-printed selection forms or an overall scoring system to evaluate
methodological quality.
Data extraction
I extracted the data onto a data extraction form, and PS independently checked the
extracted data. I attempted to contact the chief investigator of the studies where
clarification or additional data were needed. Pilot testing of the data collection forms
was done on a sample of studies to improve reliability. Disagreement was resolved
by discussion and a consensus decision was made.
Data analysis
Data analysis abided by the guidelines set out by the Cochrane Collaboration
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regarding statistical methods and I also consulted a statistician throughout the review
(Mulrow & Oxman 2002). For dichotomous data, I expressed relative treatment
effects as odds ratios with 95% confidence intervals. For continuous data, I used
weighted mean difference with 95% confidence intervals. A P value of less than 0.05
was taken as significant. The denominators used in the analyses were the total
numbers of patients included in the studies; dead patients have not been removed
from any comparison groups.
Heterogeneity between studies was tested using the standard chi-squared test. I found
significant heterogeneity in 2 of the 24 main outcome measures (i.e. performance of
first or second CT scan, and duration of hospital stay). I used a 'random effects'
method for all outcome measures. However, it should be noted that the 'random
effects' method gives more weight to the smaller studies than the 'fixed effects'
method, and smaller studies are often of poorer quality and may be more susceptible
to bias (Mulrow & Oxman 2001). Because of the presence of between-study
variations for certain outcome measures, one should be cautious when interpreting
these results.
Description of studies
I screened a total of 8859 titles, abstracts and keywords of publications. I excluded
8616 of these immediately and retrieved 243 full-text publications. From these 243
publications, only 51 were descriptions of studies. I included three randomised
controlled trials (total of 340 patients) and seven non-randomised studies (total of
1673 patients) that compared ICP care with standard care. All included studies were
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published in the English language. Thirty-eight studies were excluded for the
following reasons (some studies were excluded for more than one reason) (see Table
4.2):
Excluded randomised studies:
■ Community-based intervention (1 study, Goldberg et al 1997)
■ The intervention tested did not fulfil the criteria for a ICP (1 study, Pearson et al
1988)
Excluded non-randomised studies:
■ The intervention tested in this study did not fulfil the definition criteria for a ICP
(17 studies)
■ The participants recruited in this study did not suffer a condition that fulfilled the
definition for a stroke (2 studies)
■ Claims of some beneficial effects of a new ICP but there was inadequate
information on the intervention and the methodology of the study (6 studies)
■ All data were collected after the introduction of the intervention (6 studies)
■ Community-based (or mixed hospital- and community-based) intervention (2
studies)
■ Other reasons (5 studies)
Included randomised studies
I included three randomised controlled trials. Two studies (Falconer et al 1993; Sulch
et al 2000) included patients with all types of stroke, whereas one study (Schull et al
1992) only included patients with ischaemic stroke. The intervention tested was
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generally well described and were known by different names: "critical path method"
(Falconer et al 1993), "case managed care with anticipatory comprehensive
planning" (Schull et al 1992) and "integrated (managed) ICP" (Sulch et al 2000). The
common elements of care shared by all these interventions included the involvement
ofmultiple disciplines, setting of pre-defined patient goals and therapeutic activities,
and regular multidisciplinary team meetings. In one study, the ICP was computer-
generated (Falconer et al 1993); in another study, it was a paper document that
became part of the patient's case notes (Sulch et al 2000); in the third study, it was
called an "anticipatory comprehensive planning" but it was unclear whether it
involved a paper document (Schull et al 1992). The ICPs were implemented for
stroke rehabilitation in two studies (Falconer et al 1993; Sulch et al 2000), and for
acute stroke and rehabilitation in one study (Schull et al 1992). The patient care
given to the control groups was poorly defined in every study, but in two studies, it
was simply described as multidisciplinary care with regular team meetings to discuss
patients' progress (Falconer et al 1993; Sulch et al 2000).
Included non-randomised studies
I included one retrospective comparative study (Baker et al 1998) and six before-
and-after studies (Pasquarello 1990; Hamrin & Lindmark 1990; Odderson &
McKenna 1993; Bowen & Yaste 1994; Crawley 1996; Ross et al 1997), two of
which had a concurrent control group (Bowen & Yaste 1994; Ross et al 1997). None
were truly controlled before-and-after studies (i.e. those with a non-equivalent
control group). Two studies (Hamrin & Lindmark 1990; Bowen & Yaste 1994)
included strokes of all types and transient ischaemic attacks, whereas five studies
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(Pasquarello 1990; Odderson & McKenna 1993; Crawley 1996; Ross et al 1997;
Baker et al 1998) included only ischaemic strokes. The interventions tested were
known by different names: "case managed care" (Crawley 1996; Baker et al 1998),
"clinical or critical pathway" (Odderson & McKenna 1993; Ross et al 1997),
"multidisciplinary stroke protocol or programme" (Pasquarello 1990; Bowen &
Yaste 1994), and "systematic care planning with care plans" (Hamrin & Lindmark
1990). The interventions were less well described than in randomised studies and the
common elements of care included the involvement ofmultiple disciplines and care
planning with specific care protocol. The ICPs involved paper documents in five
studies (Hamrin & Lindmark 1990; Odderson & McKenna 1993; Bowen & Yaste
1994; Ross et al 1997; Baker et al 1998), whereas it was unclear in two studies
(Pasquarello 1990; Crawley 1996). The ICPs were implemented for acute stroke in
five studies (Pasquarello 1990; Odderson & McKenna 1993; Bowen & Yaste 1994;
Ross et al 1997; Baker et al 1998) and for acute stroke and rehabilitation in two
studies (Hamrin & Lindmark 1990; Crawley 1996). Three of the acute stroke ICPs
began with treatment at the emergency department (e.g. thrombolytic therapy)
(Bowen & Yaste 1994; Ross et al 1997; Baker et al 1998). The patient care provided
by the control groups was very poorly described.
In both the randomised and non-randomised studies, the outcome measures and
length of follow-up were very variable between studies. It was therefore difficult to
perform quantitative analyses for some outcome measures. For example, one study
reported the median Barthel index as a measure of disability (Sulch et al 2000), but
another study reported the mean functional independence measure (Falconer et al
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1993). For continuous variables, some studies reported the means without standard
deviations, whereas some reported the medians. Since means are influenced by
extremes of values, our data analyses could only use means if the standard deviations
were also reported. Where cost was reported, some studies have used the actual mean
hospitalisation cost in US dollars (e.g. Schull et al 1992; Crawley 1996), whereas
some have calculated the relative reduction in percentage (e.g. Odderson &
McKenna 1993). Many studies simply reported "no difference'" for some outcome
measures but no data were presented.
Methodological quality of included studies
Randomised studies
The reporting of methodology was adequate only in one study (Sulch et al 2000). In
this study, randomisation was performed by computer in blocks of ten but the
method of concealing treatment allocation was not stated. No randomised patient was
reported to have crossed over to the other group. The medical care that the patients
received before randomisation was not defined, nor was the location of acute care
(e.g. acute stroke unit or general medical ward). The study stated that the treatment
and control groups were managed by two "separate teams ofnurses", but it did not
state whether the doctors, therapists, or social worker(s) were shared between the two
groups (which could be a source of contamination). Follow-up assessments were
undertaken by two observers who were "not directly involved in patient care", but it
was unclear whether they were blinded to the treatment allocation, and what level of
training and expertise each person had. It also did not report whether the patients or
the statistician(s) were blinded to the treatment allocation. This was the only study
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that reported a power calculation (based on reducing the mean length of stay from 53
to 46 days). Follow-up to six months was carried out in 136/136 (100%) patients.
Reliability for the primary outcome measures was moderate to high; the kappa value
for inter-observer agreement on whether the patient was independent was 0.78 for the
Barthel index and 0.86 for the Rankin scores (high).
The reporting ofmethodology in the other two randomised studies was poor. In one
study (Falconer et al 1993), there was no information on the method of
randomisation, concealment of allocation or blinding. Of the 128 randomised
patients, seven did not complete the rehabilitation programme because of "sickness
those patients were excluded from analysis. Patients were randomised within 120
days of stroke onset and some patients might already have had some rehabilitation
prior to randomisation. The group sizes were unequal because of "random
irregularities in the admission process". It did not state whether the doctors, nurses,
therapists, or social workers were shared between the two groups. Again, the medical
care that the patients received before randomisation was not defined, nor was the
location of acute care. The proportion of patients who were followed up to one year
was not reported. There was also no indication of the reliability of the primary
outcome measures.
In the other randomised study (Schull et al 1992), sixty patients were "selected
randomly" from among ischaemic stroke patients admitted to a neurology service
over a six-month period. They were then "divided randomly" into treatment and
control groups with 30 patients in each. However, there was no information on the
185
method of randomisation, allocation or blinding. Some initial selection bias could
have been present. It did not state whether the doctors, nurses, therapists, or social
workers were shared between the two groups. The ICP was for both acute stroke and
rehabilitation but there was no description of the location in which patient care was
provided during each phase of the admission. There were no follow-up assessments
after discharge.
In all of these studies, the unit of analysis was the number of patients and not stroke
events (assuming any readmission for recurrent stroke would be counted as a
separate unit of analysis). None of the trials reported major differences in observed
baseline characteristics between the two groups of patients. In some studies only
limited data were reported (e.g. no data on subtype of stroke, pre-stroke disability or
handicap).
Non-randomised studies
In the non-randomised studies, the reporting ofmethodology was generally poor. In
the only comparative study (Baker et al 1998), 273 patients were retrospectively
identified to have non-haemorrhagic stroke ("diagnosis-related group 14") and their
records were retrieved. Of these records, 30 were randomly selected for review; 15 of
these patients were by chance managed by ICP and eight by standard medical care.
Baseline characteristics only included age and gender but no other variables such as
stroke severity or subtypes. The other six non-randomised studies were before-and-
after studies, two of which included a concurrent control group (but no historical
control group). I found no quasi-randomised studies or interrupted time series. For
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the six before-and-after studies, data collection was purely prospective in one study
(Hamrin & Lindmark 1990), mixed prospective and retrospective in one study
(Crawley 1996), and purely retrospective in four studies (Pasquarello 1990;
Odderson & McKenna 1993; Bowen & Yaste 1994; Ross et al 1997). Data for all
non-randomised studies were analysed as a single group.
No study stated that the patients recruited were consecutive and none described the
location of care. Although the patient care given to each treatment group in these
non-randomised studies was described in similar detail to the randomised studies, the
care given to the control groups was poorly defined. Characteristics of the patients in
the treatment and control groups were not reported in one study (Odderson &
McKenna 1993), and in four of the remaining studies, the groups were different in
certain aspects such as race, gender, and proportions of haemorrhagic strokes
(Pasquarello 1990; Hamrin & Lindmark 1990; Bowen & Yaste 1994; Baker et al
1998). The groups were similar in only two groups (Crawley 1996; Ross et al 1997).
Due to lack of information, it was unclear in all of the non-randomised studies
whether the introduction of the ICP was independent of other organisational changes
over time.
In this review, I have compared patients managed using a ICP with a similar
historical group (a before-and-after design). For three non-randomised studies
(Odderson & McKenna 1993; Bowen & Yaste 1994; Ross et al 1997), concurrent
controls were also recruited. However, the treatment of these patients, and the
reasons for not managing them using a ICP, were not described in any of the studies.
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For instance, it was not clear whether they were managed in the same ward or by the
same team, or whether their characteristics were similar to the other groups. Due to
the huge numbers of potential biases and confounding factors that could influence
outcome in these concurrent controls, I have decided to exclude them in the data
analyses of this review.
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4.3 Results
I report 24 outcome measures in total. For each outcome measure, I have presented
the results for randomised and non-randomised studies separately and also as an
aggregate result (all using a 'random effects' method). Due to the small number of
studies in each outcome, it was not possible to break the results down according to
the clinical setting of the ICP (acute stroke, stroke rehabilitation, or both). The
detailed findings of each study are presented in Table 4.3. The results of the
dichotomous outcomes are summarised in Table 4.4.
Death by the end of follow-up
Two studies (one randomised and one non-randomised, total of 432 patients)
reported this outcome. The randomised study showed a trend toward more deaths by
the end of follow-up in the ICP group (OR 1.77, CI 0.61 to 5.14). The non-
randomised study showed a trend toward fewer deaths by the end of follow-up in the
ICP group (OR 0.62, CI 0.37 to 1.03). The aggregate result showed no significant
difference (OR 0.94, CI 0.34 to 2.57, P=0.9). Two studies (Falconer et al 1993;
Bowen & Yaste 1994) reported "no difference" in mortality but no data were given.
Death in hospital
Two non-randomised studies with 491 patients showed no significant difference (OR
0.98, CI 0.59 to 1.64, P=0.9). Two studies (Falconer et al 1993; Bowen & Yaste
1994) reported "no difference" in mortality but no data were given.
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Death or dependency at the end of follow-up
One randomised study with 152 patients showed no significant difference (OR 1.36,
CI 0.68 to 2.72, P=0.4). Two studies (Falconer et al 1993; Bowen & Yaste 1994)
reported "no difference" in mortality but no data were given.
Discharge to institutional care
Five studies (one randomised and four non-randomised, total of 716 patients)
reported this outcome. The randomised study showed a trend toward fewer patients
discharged to institutional care in the ICP group (OR 0.57, CI 0.24 to 1.35). The non-
randomised studies showed a trend toward fewer patients discharged to institutional
care in the ICP group (OR 0.66, CI 0.36 to 1.21). Overall, there was a non-significant
trend toward fewer patients discharged to institutional care in the ICP group (OR
0.64, CI 0.4 to 1.01, P=0.06). Two studies (Falconer et al 1993; Bowen & Yaste
1994) reported "no difference" in discharge destinations but no data were given.
Death in hospital or discharge to institutional care
Two non-randomised studies with 491 patients showed a non-significant trend
toward fewer deaths in hospital or discharges to institutional care in the ICP group
(OR 0.71, CI 0.49 to 1.02, P=0.07). Two studies (Falconer et al 1993; Bowen &
Yaste 1994) reported "no difference" in death or discharge destinations but no data
were given.
Discharge to home
Five studies (one randomised and four non-randomised, total of 716 patients)
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reported this outcome. The randomised study showed no significant difference (OR
1.14, CI 0.56 to 2.32). The non-randomised studies also showed no significant
difference (OR 1.38, CI 0.72 to 2.65). Overall, there was no significant difference
(OR 1.33, CI 0.82 to 2.15, P=0.3). Two studies (Falconer et al 1993; Bowen & Yaste
1994) reported "no difference" in discharge destinations but no data were given.
Occurrence of complications
Pneumonia
Two non-randomised studies with 189 patients showed no significant difference (OR
0.4, CI 0.03 to 5.11, P=0.5). One study (Bowen & Yaste 1994) reported "no
difference" in pneumonia but no data were given.
Urinary tract infection
Four non-randomised studies with 675 patients showed that significantly fewer
patients suffered urinary tract infections in the ICP group (OR 0.38, CI 0.18 to 0.79,
P=0.01).
Deep vein thrombosis
One non-randomised study with 139 patients showed no significant difference (OR
0.93, CI 0.04 to 19.91, P>0.9). One study (Bowen & Yaste 1994) reported "no
difference" in complications but no data were given.
Dehydration
One non-randomised study with 50 patients showed a non-significant trend toward
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fewer patients suffering from dehydration in ICP group (OR 0.06, CI <0.1 to 1.11,
P=0.06).
Fluid and electrolyte imbalance
One non-randomised study with 50 patients showed no significant difference (OR
0.48, CI 0.04 to 5.65, P=0.6).
Seizures
One non-randomised study with 50 patients showed no significant difference (OR
0.31, CI 0.03 to 3.16, P=0.3).
Skin breakdown orpressure sore
One non-randomised study with 50 patients showed no significant difference (OR
0.13, CI 0.01 to 2.58, P=0.18).
Falls orfractures
One non-randomised study with 50 patients showed no significant difference (OR
0.18, CI 0.01 to 4.04, P=0.3).
Myocardial infarction
One non-randomised study with 139 patients showed no significant difference (OR
1.56, CI 0.06 to 39.39, P=0.8).
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Readmission or emergency department attendance
Two studies (one randomised and one non-randomised, total of 110 patients)
reported this outcome. The randomised study showed significantly fewer
readmissions or emergency department attendance in the ICP group (OR 0.15, CI
0.04 to 0.59). The non-randomised study showed that significantly fewer
readmissions or emergency department attendance in the ICP group (OR 0.03, CI
<0.1 to 0.63). The overall result showed significantly fewer readmissions or
emergency department attendance in the ICP group (OR 0.11, CI 0.03 to 0.39,
P=0.0006).
Use of investigations
First or second computed tomography brain scan
Two non-randomised studies with 824 patients showed that significantly more
patients received a first or second CT brain scan in the ICP group (OR 3.66, CI 1.45
to 9.27, P=0.006).
Carotid duplex study
One non-randomised study with 275 patients showed that significantly more patients
received a carotid duplex study in ICP group (OR 2.45, CI 1.3 to 4.61, P=0.005).
Electrocardiography
One non-randomised study with 544 patients showed no significant difference (OR
1.02, CI 0.38 to 2.71, P>0.9). One study (Bowen & Yaste 1994) reported "no
difference" in echocardiography but no data were given.
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Therapy input by the multidisciplinary team
Two studies (one randomised and one non-randomised, total of 427 patients)
reported this outcome. The randomised study showed no significant difference in the
cumulative duration of physiotherapy or occupational therapy at various follow-up
time points. The non-randomised study found "no difference" in therapy input but no
data were given.
Patient and carer satisfaction
One randomised study with 121 patients reported this outcome. Patient satisfaction
was measured using a scale ranging from one (least satisfied) to ten (most satisfied).
Patients answered the questions wherever possible unless the patient experienced
significant communication problems (then relatives or carers would answer). Patients
were significantly less satisfied with their hospital care in the ICP group (WMD -1.1,
CI-1.91 to -0.29, P=0.008).
Quality of life
One randomised study with 152 patients reported this outcome, using Euroqol score
as a measure of quality of life. This study found no significant difference in the
Euroqol score at one or three months. However, at six months, the Euroqol score was
found to be significantly lower in the ICP group (median scores 63 vs 72, P<0.005),
which suggests a lower quality of life in the ICP group.
Length of stay
Four studies (two randomised and two non-randomised, total of 1028 patients)
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reported this outcome. The randomised studies showed a trend toward longer
hospital stay in ICP group (WMD 3.99, CI -0.29 to +8.27). The non-randomised
studies showed that hospital stay was significantly shorter in ICP group (WMD -
1.91, CI -3.19 to -0.63). Overall, there was a non-significant trend toward shorter
hospital stay in ICP group (WMD -1.19, CI -2.76 to +0.39, P=0.14). One study
(Bowen & Yaste 1994) reported "no difference" in duration of rehabilitation but no
data were given.
Hospital cost
Five studies reported this outcome. One randomised study found no significant
difference in hospital cost between ICP and control groups (Falconer et al 1993) and
another randomised study found a fall in the mean hospital cost (Schull et al 1992).
Two non-randomised studies found a fall in the mean hospital cost (Bowen & Yaste
1994; Crawley 1996), and one non-randomised study reported a 14.6% fall (no actual
cost data given) in the mean hospital cost (Odderson & McKenna 1993). No study
reported standard deviation or other measures of variance.
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4.4 Discussion
The results of this review are difficult to interpret
This systematic review was difficult to conduct since I included both randomised and
non-randomised studies. One has to interpret the results with caution because non-
randomised studies are highly susceptible to bias and there is significant statistical
heterogeneity between the studies (Sacks et al 1982; Chalmers et al 1983; Egger &
Smith 1998).
The most obvious bias is selection bias, i.e. stroke patients may have been selected to
be managed using a ICP and may have differed from those who were managed using
standard medical care. In one study, it was stated that patients were selected for ICP
care using strict screening criteria (Baker et al 1998) and I suspect that this might
also have been a common practice in other studies. Consequently, the clinicians may
have selected the stroke patients with better (or worse) prognosis and biased their
findings.
There are other potentially important biases in non-randomised studies. Five of the
seven studies were retrospective and all of them included non-consecutive cases. It is
possible that some cases were missed or excluded; this may have influenced
outcome. The investigators who assessed the outcomes were not reported to be
blinded to the treatment option and this may have biased their assessment of non¬
fatal outcomes. Moreover, publication bias may have influenced the results of the
non-randomised studies, such that those showing no benefit or worse outcome with
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ICP care may have been less likely to be published (Sutton et al 2000). Finally,
authors may have chosen to write "no difference" rather than report the actual data,
or to omit the negative results all together from their publication. This reporting bias
may have influenced the outcome.
Factors which add to the difficulty in interpreting the results of this review include
variations in the definition and components of the intervention, and the small number
of studies included in the data analysis. Since the reporting of methodology in many
studies was poor, there may be other confounding factors and sources of
contamination that have not been identified. Another factor that limited the reliability
of the quantitative meta-analyses was the presence of statistical heterogeneity in a
number of the analyses (i.e. CT scanning, duration of hospital stay). I have presented
the numerical analyses in order to make the data available, but the overall estimates
of effect in the presence of such heterogeneity are difficult to interpret.
Nature ofthe intervention varied between studies
This review has highlighted the variable definition of a ICP. No two included studies
seemed to have used the term TCP' to describe the same type of intervention. Their
ICPs appeared to have differed in terms of their components, target patient groups,
location of use, and methods of design and implementation. For two studies which
were published as abstracts, I attempted to contact the authors to clarify the details of
their interventions, study methodology and results (Abissi et al 1995; Moloney et al
1999). However, neither of them agreed to provide any extra information and both
studies were excluded in this review.
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Like stroke unit care, it may be extremely difficult to know with any degree of
certainty which components may account for which effect. By examining the ICPs
described in the included studies, I was at least able to extract their shared
components, which were basically those outlined in the definition of an ICP used for
this review. However, the relation between the components of the ICP and the effects
observed was not clarified by this review.
There was weak evidence ofbenefit
I did not find evidence that ICP care provided additional benefit over standard
medical care in terms ofmajor clinical outcomes: death (in hospital or by the end of
follow-up), dependency (at discharge or end of follow-up), or discharge to home.
There was, however, weak evidence to suggest that ICP care may be associated with
fewer patients being discharged to institutional care.
Data, chiefly from non-randomised studies, provided weak evidence that ICPs
improved the process of care, hence leading to fewer complications (urinary tract
infections, readmissions or emergency department attendance) and more thorough
investigations (more CT brain scans and carotid duplex studies). No study reported
the proportion of therapeutic activities that achieved pre-defined standards based on
the best evidence or guidelines. In the US, ICPs have primarily been implemented to
reduce duration of hospital stay and hospital costs. In the UK, their primary purpose
is to improve process of care and promote evidence- and guideline-based care (which
may lead to improved patient outcomes). However, there is no evidence that the
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latter has ever been evaluated.
There was weak evidence ofharm
I found evidence from two randomised trials that patient satisfaction and quality of
life may be lower in patients managed using a ICP (Falconer et al 1993; Sulch et al
2000). The reasons for these effects are unclear, but if the aim of the ICPs in these
studies was to shorten the duration of hospital stay, then there may be pressure for
the staff to discharge the patients as quickly as possible, but the patients or carers
might not have been ready for discharge. These outcomes should be assessed in
future studies.
Evidence on hospital cost was difficult to interpret
The chief determinant of hospital cost is the length of stay. The analyses of this
variable are difficult to interpret because of substantial heterogeneity; evidence from
the randomised studies suggests that ICP care may increase the length of stay,
whereas the non-randomised studies showed a reduction. These data therefore
provide a plausible range for the potential effects of ICP care on the length of stay,
but do not provide a reliable summary estimate.
In this review, four studies (Bowen & Yaste 1994; Crawley 1996; Schull et al 1992;
Odderson & McKenna 1993) reported a reduction in mean hospital cost and one
study found no difference in cost (Falconer et al 1993). Only one study reported the
items of costs (i.e. what items were included in the final sum) and their individual
values (Falconer et al 1993). Without knowing the cost of individual items,
comparison between studies is meaningless. Furthermore, using ICPs can be
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associated with many indirect and opportunity costs such as the time and effort
invested in designing the pathway, time and resources in promoting its use and
educating staff from different disciplines, printing costs of the paper documents and
wall posters, as well as time and effort in maintaining staff enthusiasm and
continuous quality improvement (e.g. variance analysis). All these costs are very
difficult to estimate and could account for a large proportion of the total cost of using
ICPs. More detailed assessment of the economic impact of using ICPs in future
research would be extremely helpful.
Implications for practice
This systematic review has provided the best-available evidence so far on the effects
of ICPs for the hospital management of acute stroke or stroke rehabilitation. There is
insufficient evidence currently available to support the routine implementation of
stroke ICPs.
Implications for research
Further research is necessary before widespread implementation of stroke ICPs is
recommended. In particular, well-conducted randomised and non-randomised studies
should be undertaken. The present review has included non-randomised studies
which may only represent weak evidence, but they at least suggest which variables
might be tested in future randomised trials.
This systematic review has been published in the Cochrane Library, Issue 2, 2002.
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4.5 Summary of this chapter
• I conducted a Cochrane systematic review to assess the effects of ICPs, as
compared to standard medical care, among patients with acute stroke who had
been admitted to hospital.
• There were three randomised controlled trials (total of 340 patients) and seven
non-randomised studies (total of 1673 patients) that compared ICP care with
standard medical care. There was significant heterogeneity between the studies.
• There was no significant difference between ICP and control groups in terms of
death, dependency, or discharge destination.
• Evidence from mainly non-randomised studies suggests that patients managed
using an ICP may be: a) less likely to suffer a urinary tract infection; b) less
likely to be readmitted; and c) more likely to have a CT scan or carotid duplex
study.
• Evidence from randomised trials suggests that patient satisfaction and quality of
life may be significantly lower in the ICP group.
• I conclude that the use of ICPs to manage stroke patients in hospital may be
associated with both positive and negative effects on the process of care and
clinical outcomes. Since most of the results have been derived from non-
randomised studies, they are likely to be influenced by potential biases and
confounding factors.
• Previous studies do not provide sufficient evidence to support the routine
implementation of ICPs for acute stroke management or stroke rehabilitation.
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Table 4.1 Search strategy for MEDLINE. This was also adapted to other electronic
databases. Note that: lines 1-17 = diagnosis of stroke or transient ischaemic attack;
lines 18-31 = the intervention; lines 32-61 = randomised or controlled trials; lines
62-71 = other types of non-randomised studies; and lines 72-78 = our method of
refining the search.
1. exp cerebrovascular disorders/
2. (strokeS or poststrokeS or cva$).tw.
3. (cerebrovasculars or cerebral vascular).tw.
4. (cerebral or cerebellar or brainstem or vertebrobasilar).tw.
5. (infarcts or isch?emi$ or thromboS or apoplexy or emboli$).tw.
6. 4 and 5
7. (cerebral or intracerebral or intracranial or parenchymal).tw.
8. (brain or intraventricular or brainstem or cerebellar).tw.
9. (inffatentorial or supratentorial or subarachnoid).tw.
10. 7 or 8 or 9
11. (haemorrhage or hemorrhage or haematoma or hematoma).tw.
12. (bleeding or aneurysm).tw.
13. 11 or 12
14. 10 and 13
15. transS isch?emic attackS.tw.
16. brain attack.tw.
17. 1 or 2 or 3 or 6 or 14 or 15 or 16
18. critical pathway/
19. patient care planning/
20. case management/ or disease management/
21. patient care team/ or exp patient care management/
22. clinical protocols/
23. program development/
24. exp Delivery of health care, integrated/
25. Managed care programs/
26. ((care or clinical) adj 10 map).tw.
27. stroke programs.tw.
28. ((clinical or treatment or care) adj 10 (protocol or planning)).tw.
29. managed care.tw.
30. ((multidisciplinary or interdisciplinary or integrated) adj 10 care).tw.
31. (path or paths or pathwayS or map or maps or caremap$).tw.
32. randomized controlled trial.pt.
33. randomized controlled trials/
34. controlled clinical trial.pt.






40. exp clinical trials/
41. (clin$ adj25 trial$).tw.
42. ((singl$ or doubl$ or tripl$ or trebl$) adj25 (blindS or mask$)).tw.
43. random$ .tw.
44. research design/
45. clinical trial phase ii.pt.
46. clinical trial phase iii.pt.









56. (quasi?experimental or quasi?random$).tw.
57. matched pair analysis/
58. meta-analysis.pt.
59. meta-analysis/
60. (meta?analysis or systematic review or overview).tw.
61. 32 or 33 or 34 or 35 or 36 or 37 or 38 or 39 or 40 or 41 or 42 or 43 or 44 or 45 or 46 or 47 or 48
or 49 or 50 or 51 or 52 or 53 or 54 or 55 or 56 or 57 or 58 or 59 or 60




66. ((case-control or observational) adj 10 (stud$ or evaluat$)).tw.
67. exp Quality of Health Care/
68. exp patient care/
69. exp Health Care Evaluation Mechanisms/




74. 17 and 73
75. 74 and 61
76. 74 and 72
77. 76 not 75
78. 74 not (75 or 76)
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Table4.2Reasonsforexcludingthe38studiesintsystematicr view(studi sa rang dialphabet calord r). StudyReference
Reasonforxclusio
Alberts1996
AlbertsMJ,Benne tCARutledgeVR.Hospitalcharg sf strok patients.Stroke1996;27:1825-1828.
Theinterventionhathadb ntestedi isstu ydidofulfilth definitioncriteriafoacarep hway
Bokemark1995
BokemarkL,l mstrandCFag rberg.H wreguid linesfo themanag mentofacutstrokeoptimallyimple ent dnclinical practice.In:Pan-EuropeanCo sensusMe tingOStrok Management.Helsingborg,Swede ,8-10Novemb r1995:No.
Theinterventionhathadb nt stedithisstu ydidofulfilt definitioncriteriafoaarep hway
Chui1997
ChuiL,GohMH,HungT,ShyWCC aTP.e effectivenessofsystematicstrokcare.Kaoh ungJournalf MedicalSci nces1997;3:496-502.
Theinterventionthathadb ntestedit isstu ydidofulfilth definitioncriteriafoacarep hway
Dignan1986
DignanMB,HowardG,T oleJFBeckerCMcLeroyKR. EvaluationoftheNorthCar linastrokecarpr gr m.Str k 1986;17(3):382-386.
Theinterventionstudi dwasamixedhospital-ancommu ity- based"strokeprogramme".D twerecoll ctedfrom3se ar t groupsofhospitals(19spitalsint t ),wh chhadintr duced differentprog ammesatdifferenttim s
Duryee1996
DuryeeR,CalanchiniPMiller.Thimpactofstrokc ni al pathway:measuringeffectiveness.Neurology 1996;46(Suppl):A428(AbstractS63.007).
Thetreatm ntgroupincludedpe ibefortheinterv ntionha beenintroduced
Edwards1996




EnglanderRN,MorichDHinnitiM.Acce erat ngth evaluationofac testrokp tien sinc mmunityhos i l. Neurology1998;50:A114(AbstractP02.091).
Theinterventionhathadb nt stedi isstu ydidnofulfilth definitioncriteriafoacarep thw y
Evans1995
EvansR,ConniHendrick,aselkornJ.Meta-an lysisf strokeoutc m :s vival,func i n,andre idence.Stroke 1995:26(1):156.





Friedman1990 Goldberg1997 Goldstein1998 Hainsworth1997 Horgan1996 Ivey1995 Jungkind1999 Karanjia1997 Lagoe1997
FriedmanPJ.Strokerehabilit tioninthel erly:ewpati nt managementsyste .NewZealandMedicalJour 1990;103:234-236. Goldberg,SegalME,B rkNchallRRershkoffAM. Stroketransitionfterinpatientrehab l tatio .Topicst ok RehabilitationI997;4(l):64-79. GoldsteinLB,HeyAan yR.N r hCarolinast okeprev ntion andtreatmentfacili i ssurvey.rtPAtherapyoacutestrok . Stroke1998:29:2069-2072. HainsworthDS,Lockwood-CookE,PondMgoeRJ. Developmentandimpl me tatiofclinicalpathw ysforstrok onamultihospitalbas .Jour alfNeur c encersing 1992:29:156-162. HorganF,CroweMKeati gDcN m raAL hyP.The developmentfacom rehensivestrokepr g amminthacut hospital.IrishMed calJ urn l1996:89(6):222 IveyMF,ArmitsteadJASanghaKS.C iticalpathw yst UniversityofCi cinnatihospital.Amer c nJ u lHealth- SystemPharmacy1995,52:1053-1058. JungkindK,Corish.Pilotacuteischemicstr kprogramaves $9,756percas .HospitalCasManagement1999;7:87-90. KaranjiaPN,NelsonJJ,LefkowitzDSickARTo leF ChamblessLE,H yR,owardVJ.alidationfthACAS TIA/strokealgorithm.Neurology1997;48:346-351. LagoeRJ,AsplingDL.Benchmarkingndcli ic lpathway implementationoamultihospitalbas .NursingEconomics 1997;15(3):131-137.





Lagoe1998 MacKenzie1998 Monane1996 Odderson1995 Pearson1988 Quigley1998 Ramachandran1996 Retchin1997
LagoeRJ.B sicstatisti sforclinicalp hwayevaluation. NursingEconomics1998;6(3):25-131. MacKenzieAE,ChangM.Teffectivenessofnursica :us ofaprotocoltpr motest kerehabili ati n.In:mpr vi g HealthServicesthroughR searcinongKong:ACompendi m ofAbstractsf rProjectFundedbythHealthSe vic sR sear Committee1994-1998.HongK ng:eal hServicesR searc Committee,1998:12. Monane,Ka terDS,GlynRJAvorJ.Variabilityileng hj hospitizationf rs roke.Therol fmanagedc rinaeld rly population.ArchivesfNeurol gy1996;53:875-880. OddersonIR,KeatonJCMcK nnaBS.Swallowmanageme ti patientsoacutestrokpathway:qualityic seffe ve. ArchivesofPhysicalMedicineandRe abilitation1995;76:1130- 1133. PearsonA,Durand1ntonS.Effectsofadmi sitnur i g unit.AustralianJou lfAdvancedN s g1988;6(l):38-42. QuigleyPA,WallaceSmith,tr garJ.uccessfulexperien es withclinicalpathwaysinreh bilitation.Journ lfRehabilitation 1998;64(2):29-32. RamachandranTS,CulebrasA,HainsworthD.evelopmentnd implementationofaclinicalathwayforstrokeinacuc re. Neurology1996;46(Suppl):A319(Abst actP0 .119). RetchinSM,BrowSYCJChuD,MorenoL.Outc mesf strokepatientsinmed carefeoservicandma agedc . JAMA1997;278(2):1 -124.






ReubenDB,BorokGMWolde-Tsadik,ErshokH,Flshm n LK,AmbrosiniVLuY,RubensteinZBeckJC.randomized trialofcomprehensivegeri tricassessmentinthca f hospitalizedatients.NewEngl dJ urnalfMedic ne 1995;332:1345-1350.
Theinterventionhathadb nt stedisstu ydidnotfulfilt definitioncriteriafoaarepa hway
Romito1990
RomitoD.Acriticalpathf rCVApat ents.Rehabilitation Nursing1990;5(3):53-156.
Thisarticledesc ibedomb neficialeffe tsofwc rp thway buttherewasinadequatinformationont eterv ntiond methodologyofthestu y
Rosenberger1999
RosenbergerJM,Wi m rsNE.CareM psimedical rehabilitation.Journ lfCareMan gement1999;5(2):23-37.
Thisart cledesc ibedsombeneficialeffectsofewc rep thway buttherewasinadequatinformationnt eterv ntiond methodologyofthestu y
Rossiter1995
RossiterD,ThompsonAJ.Intr ducti fi egratedcar pathwaysforp ientsw thmultiplesclerosisinannpatient neurorehabilitations tting.Di ab lityandRehabilitation 1995;7(8):443-448.
Theparticipantswhoh dbeenrecru tedyth sst dydidnosuffer
aconditionthatfulfilledtdefinitionorstroke
Schmidt1999
SchmidtM,GuoL,eerBoydst nJPelinCB rgerSK. Epidemiologicaldeterminationofco munity-basednurs gcase managementforstroke.Jou alfNursingAdministr tio 1999;29(6):40-47.
Thiswaanopenstudyfc mmunity-basednursi gc s managementforstroke,whichsdeliver dthroucpa hway
Sulch2000
SulchD,Ka raL.Integratedcarpathwaysistrok management.Aga dgei g2000;29:349-352.
Thiswaasystematicreviewcontainingorandomisedc trolled trial-Falconer1993
Summers1998
SummersD,opePA.Imple entationa dvaluationfstroke clinicalpathwaysa dtheim a tocostfstroker .Journal ofCardi vascularNur ing1998;3(l):69-87. RymerMM,Sum ersD,op rP.evelopmentfclinical pathwaysforstrokemanagement.Aex mplfrSai tLuke's Hospital,KansasCity.li iciGeriatricM d c ne 1999;5(4):741-764.
Alldatawerecoll ctedf erthintroductionfinterventio
Underwood1999
UnderwoodF,ParkerJ.Dev lopingandevaluat gcute strokecarep thwaythroughacti nresearch.Nu seResea h r 1999;6(2):27-38.





vanStraten1997 vonReutern1998 Wentworth1996 Wood-Dauphinee1984 Zander1988
vanStrateA,derMeulJHP,C velHabb ma JDF,LimburgM.Qualityofhospitalc ref strokepat entsn TheNetherlands.Cerebrov scularDise se1997;7:251-257. vonReuterGM,All nd rferJ.Schlaganfallbehandlungmit StrokeUnitandReh bilitationdurcheinTeam[Strokreatment withstrokeunita drehabilitationbyte m.Amod lfor stagedmanagement],Nervenarzt1999;70:149-154. WentworthDA,AtkinsonRP.Implementationofancu estr k programdecreaseshospitalizationc tndl ngthfst y.St k 1996;27:1040-1043. Wood-DauphineeS,hapiroB ssEFletcherCG org sP HensbyV,MendelsohnB.Arandomizedt ialofac r followingstroke.Str1984;15(5):864-872. ZanderK.Nursingcasemanagem nt:st t gicntof costandqualityoutcomes.Jour alfN singAdministrat o 1988;18:23-30.
Alldatawerecoll ct df erthin roductionferven Theinterventionathadb nst dnisstu ydiofulf l definitioncriteriafoaarep hway Alldatawerecoll ctedf erthin roductionferven i Theinterventionathadb nst dnisstu ydiofulf l definitioncriteriafoaarep hway Thisart cledescribedsomb nef ialef e tsofn wcarp thway buttherewasinadequateformationnee v na d methodologyofthestu y
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Table4.3Detailedresultsofthnincludstudi ssystematicreview(s udi sarrangedich nolo icalo rfp blic t on). StudyMe hodsNotesfCasOutcomed a Hamrin1990Uncontrolledbef re- and-afterstudyAcutestrokeand rehabilitation280MedianLOS(days):ICP=11range2-25 )vBefore= 3(range3-177). Mortalityat1week:ICP=11/173vsBefore=5/10 .M rtalitydischa ge: ICP=35/173vsBefore=24 07.M rtalityat3months:ICP=42/173 Before=29/107.M rtalityat1y ar:ICP=48/173vsBefore=41 07. Dischargehome:ICP=97/173vsBefore=51 07.Institutionalis tion: ICP=40/173vsBefore=32 07.Tscan:1CP=126/173Before 58/ 07. Pasquarello1990Uncontrolledbefore- and-afterstudyAcutestroke50MeanLOS(days):ICP=17vBefore=8.Pati ntswithcompl cation : ICP=5/25vsBefore=16/ 5.Dischargedhome:ICP=21/25Before=13 5. Institutionalisation:ICP=4/25vBefore=12/25.Readmiss on:lCP=0/25 Before=9/25.Th rapydered:ICP=18/25vsBefore=20 .Timth rapy (days):ICP=0.75vBefore=1.5.Non-compliancewithfoll w-up appointment:ICP=6/25vsBefore=15/25. Schull1992RCTAcutestrokeand rehabilitation60MeanLOS(days):ICP=11.4vControl=14.3.Readmissio<30d y : ICP=1/30vsControl=l/30.Emergencyroomvisits<90days:I P=l/3 Control=12/30.Meanfoll w-upcompliance(%):II P 79vsContr l 56. Meanhospitalcost($):IICP=195143vControl=248605.ompliancet ICPgenerallygood. 209










MeanLOS(days):ICP=7.3+/-0.5v1989=0.9+/-1.29 0= .8+/-0 9. Mortalityndischarge:1CP=11/121vs989=4/801990=6 90.Discha ged home:ICP=56/121vs1989=34/8019 0 3 /90.Institutionalisation: ICP=50/121vs1989=32/801990=47 90.UTI:ICP 8/12119 0 16 (S).Meanhospitalcosts$ :ICPv1990=reducedby4.6%PEGinsertion ICP=10/121vs1990=8 90.
Bowen1994
Uncontrolledbef re- andfterstu y,with oneconcurr ntt ol (CC)group
Acutestroke
346
MeanLOS(days):ICP=5.5vBefore=8 8C =6.7noI)arotid Dopplerperformed:ICP=37/54vsBef re=104/221C =36/ .VT prophylaxis:ICP=14/54vs9/71C =30/221.UTI:IC l/54 Before=32/221vsCC=4/71.Nodiffe nceinischargestination, mortality,complications(DVT,pneum ia,infe tions)lengthoc sf rehabilitation,n uroimag ngEEG,LP,cat etera giography,24-h urC Echocardiography,t erainput,hep inuse.Mediaos talcost($): ICP=4756vsHC=7072C =7044. 210





MeanLOS(days):ICP=7.87vBefor 12.17.UTI:ICP=3/24 Before=16/l15.Pneumonia:ICP=0/24vsB re=l/lDVT:I / Before=2/l15.MI:ICP=0/24vsBefor l/leanhospitalco t($) ICP=5759vsBefore=8894.
Ross1997
Uncontrolledbef re- andfterstu y,with oneconcurr ntt ol group
Acutestroke
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MeanLOS(days):ICP=4.5vControl=2.8.Dischargedh me:I P=4/1 Control=5/8.Institutionalisation:1CP=10/15vContr l=3/8.PT:I P=11/1






Sulch2000RCTtroke152MeanLOS(days):ICP=50+/-19vControl=45+ 23.ortalityt6months rehabilitation.ICP=10/76vsCont ol=6/76.Disch rgedh me:I =56/54/7 . Institutionalisation:CP=10/76vControl=16 6.MedianEu qola6 months:ICP=63vsContr l=72.Ndiffe e ceiBarthelndex,R nkin score,anxietyordepressioncot1,36mo ths.Nifferencein durationofPTrOinput.Compliancetcarethwaygenerallood Notes: CCConcurrentcontrolLPLumbarpuncture ICPIntegratedcarp thwayMIMyocardialinfarction CTComputedt ographyOTOccupationaltherapy DVTDeepveinthrombosisPEGPercutaneousendosc picgastrostomy ECGElectrocardiogramPTPhysiotherapy EEGElectroencephalogramRCTRandomisedcontrolltrial FIMFunctionalindepende cemeasurSAHSubarachnoidhaemorr age LOSLengthofstay(iho pital)SALTSpeechandlanguageth rapy UTIUrinaryt actinfection 212
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5.1 The integrated care pathway for acute stroke at the Western General
Hospital
In the Lothian region of Scotland, healthcare is provided by three Health Trusts: the
Lothian University Hospitals NHS Trust, Lothian Primary Care NHS Trust, and the
West Lothian Healthcare NHS Trust. The Western General Hospital (WGH) is one
of two teaching hospitals providing acute hospital stroke services within the Lothian
University Hospitals NHS Trust. The WGH serves a population of about a quarter of
a million people. It has 550 beds and treats more than 150,000 patients every year. In
this section, I shall describe how patients with acute stroke were managed at the
WGH and the ICP that was introduced in the acute stroke unit. After that, I shall
describe my evaluation of the ICP.
Patient's pathway for acute stroke at the WGH
The acute stroke service provided by the WGH has been evolving for the past few
years. During 1999 and 2000, stroke patients from North Edinburgh were brought by
ambulance to the Acute Receiving Unit (ARU) where resuscitation and acute
assessment took place. Patients referred by the general practitioner (GP) with
suspected stroke were also brought to the ARU for emergency treatment. Those with
minor strokes or transient ischaemic attacks who the GP or the ARU physician would
judge not to require hospital admission were referred to the twice weekly
neurovascular outpatient clinic at the WGH. Patients with more severe strokes were
assessed in the ARU by on-call medical staff. Those who required admission were
transferred to the acute stroke unit (if beds were available), where the patient care
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was provided by the specialist stroke team. If the stroke unit was full, the patients
were transferred instead to a general medical ward (before October 2000), or the
Acute Medical Assessment Unit (AMAU, opened in October 2000), where one of the
medical teams was responsible for their care for the initial one to two days. Such
patients might later be referred to and reviewed by one of the two stroke specialist
consultants (MSD or RIL). Depending on the clinical needs, these patients were then
transferred to the stroke unit or a rehabilitation unit. Those who were not transferred
to the stroke unit were admitted instead to a general medical ward where they usually
remained under the care of a general physician until discharge. A summary of a
typical stroke patient's pathway of care is presented in Figure 5.1.
Patient care in the stroke unit before the integrated care pathway was
introduced
At the time of the study (July 2000 to April 2001), the stroke unit was a 10-bedded
unit consisting of two 5-bedded bays, situated within a larger 25-bedded general
medical and geriatric ward; the usage of the beds was flexible depending on clinical
needs. In the stroke unit, the patients underwent a period of assessment, early
rehabilitation and medical treatment. Those who required further rehabilitation were
transferred to the 26-bedded stroke rehabilitation unit at the adjacent Royal Victoria
Hospital, where the patients remained under the care ofMSD or RIL. Occasionally
patients were transferred to one of the other three rehabilitation units in Edinburgh
depending on their age and place of residence.
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In the stroke unit and the rest of the 25-bedded ward, medical cover was provided by
two consultants (MSD and RIL), one junior house officer and one senior house
officer. Nurses rotated between the stroke unit and the rest of the ward, and the
nurse-to-bed ratio was usually between 0.15 (night shift) to 0.27 (early shift).
Therapy was provided by 1.5 working time equivalent (WTE) physiotherapist, 1.5
WTE occupational therapist, and 0.5 WTE speech therapist. A dietician and social
worker also provided input into patient care. There was informal stroke training for
the junior doctors, nurses, and other healthcare professionals. Acute stroke care was
multidisciplinary and the patients' progress and treatment aims were discussed at the
weekly multidisciplinary team meetings. All newly admitted stroke patients were
reviewed by a consultant within 12 hours of admission on weekdays and within 24
hours at weekends. The stroke service had access to neuroimaging 24 hours a day;
non-urgent CT brain scans and carotid duplex scans were usually performed within
one to two working days of admission.
Patient care in the general medical wards throughout the study
In contrast to the stroke unit, stroke care in the general medical wards was provided
by general medical consultants and nursing staff who had no special interest or
training in stroke. Acute stroke care did not have to follow a specific hospital
protocol or use specific documentation, although a handbook on emergency medical
conditions was available for reference on every ward including the stroke unit. This
A4 sized handbook contained 1V2 pages of information on stroke, which was
basically a brief summary of what would normally be contained in a medical
textbook, with some guidance on the acute management of a stroke patient (e.g.
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resuscitation, swallowing assessment), investigations to order, and the use of aspirin
in patients with ischaemic stroke. This handbook was also available as a pocket size
version and was given to every junior doctor in the WGH.
The doctors and nurses were different from those in the stroke unit, but the therapists
were shared with the stroke unit. The amount of time that each therapist spent on
each ward was not strictly divided and the decision on the intensity of therapy was
left to the individual therapist (e.g. a therapist might choose to spend more time
treating patients in the stroke unit). Stroke patients who required further
rehabilitation were transferred to the same rehabilitation units as those from the
stroke unit. Access to neuroimaging was similar to the patients in the stroke unit.
Introduction of the integrated care pathway in the stroke unit at the WGH
At the end of 1999, the multidisciplinary team on the stroke unit decided to introduce
an ICP to try and further improve patient care. The ICP was launched in March 2000.
It was a 50-page multidisciplinary patient record which was designed to guide the
management of a stroke patient over the first five days after admission (see
Appendix 1). It consisted mainly of questions and tick-box answers, which aimed to
summarise the key aspects of the relevant national and local guidelines. There were
three main sections to the ICP: the doctor's section, the nurses' section, and the
therapists' section (including physiotherapy, occupational therapy, and speech
therapy). There was also a section to document communications with the patient's
family. The doctor's section also included a clerking proforma that was based on the
Royal College of Physicians stroke audit package (1993-1994) (Rudd et al 1999).
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It was intended for all the healthcare staff to record their patient notes in the ICP so
that each discipline would be aware of the others' opinions. The pages of each
section were colour-coded for ease of identification. The whole document was bound
in one plastic folder (not the usual hospital case notes) and placed at the end of each
patient's bed. Patients and relatives were free to read the document if they wished.
The ICP was designed to be used on the stroke unit by the staff there, but copies of
the doctor's section of the ICP were also kept in the ARU so that on-call medical
staff could use them as a clerking proforma if they wished. Since its launch and
during the course of the study, there had been no major changes to the ICP. The full
details regarding the process of design and implementation of the ICP can be found
in Appendix 2.
Other significant changes to the service structure during the study
Apart from the introduction of the ICP, there were three other important changes to
the structure of services for stroke patients during the course of the study. All of
these changes could potentially have influenced patient care and outcome. Firstly, as
I have already mentioned, the Acute Medical Assessment Unit (AMAU) opened in
October 2000, three months after the start of the prospective data collection phase of
the study. AMAU received all the acute medical admissions except patients with
stroke, who normally should have been admitted directly to the stroke unit. However,
because the number of beds in the stroke unit was limited, many patients were
initially admitted to the AMAU for the first one or two days. The medical and
nursing care of stroke patients in the AMAU was similar to that in a general medical
ward. The AMAU had its own team of therapists who mainly carried out assessments
223
and commenced therapy wherever appropriate, but they did not continue to treat the
patient after his or her transfer out of the ward.
Secondly, unified patient records were introduced at the same time as the opening of
the AMAU. This was an attempt to amalgamate the written records of the medical,
nursing and therapy staff. The unified patient record was different from the ICP
because it did not contain any reference to specific stroke-related treatment
strategies. This document was based on the one used in a neighbouring teaching
hospital within the same Health Trust (the Royal Infirmary of Edinburgh), where it
has been found to improve documentation (Morrison et al 2001). Its introduction in
the AMAU initially caused some confusion for the stroke unit staff because it was
unclear whether a patient transferred to the stroke unit with the unified patient record
should also be started on the ICP. This issue was decided in a subsequent team
meeting that any patient who was transferred to the stroke unit within five days of
admission should be started on the ICP.
Thirdly, in June 2000, a senior 2 physiotherapist was appointed, increasing the
physiotherapy input from 1.5 whole time equivalent (WTE) to 2.0 WTE.
For a detailed account of the major changes in the WGH's stroke services in the past
decade, please refer to Appendix 3.
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5.2 Aims of the non-randomised studies
I sought to evaluate the effects of introducing an ICP in the stroke unit at the WGH
by conducting two non-randomised studies: a) a before-and-after study to assess the
difference in patient care and outcome before and after the introduction of the ICP;
and b) a prospective comparative study to compare the patient care and outcome
between the stroke unit after the introduction of the ICP and the general medical
wards where there was no ICP. I shall report the before-and-after study in this
chapter and the prospective comparative study in the next chapter.
When these two studies were planned, I fully acknowledged that the evidence
derived from them would not be robust, easy to interpret, or necessarily generalisable
to other settings (see Chapter 2). However, I felt that these studies would at least: a)
enhance the understanding of the nature and operation of the ICP; b) explore the
aspects of care that an ICP might influence; c) provide estimates of the effects of the
ICP on the various aspects of patient care and outcome; and d) provide some useful
information for future research studies.
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5.3 Methods of the before-and-after study
Study design
I compared the outcome and process of care between two groups of stroke patients.
For the intervention group, I prospectively collected data from consecutive stroke
patients admitted to the stroke unit (SU) during the nine months after the ICP was
introduced -1 shall call this the 'SU-after-ICP' group. For the control group, I
retrospectively collected data from consecutive stroke patients admitted to the same
stroke unit during the nine months before the introduction of the ICP -1 shall call
this the 'SU-before-ICP' group. In this study, I did not recruit a non-equivalent group
of controls - for example, patients admitted to a similar stroke unit in a nearby
teaching hospital.
Selection criteria
I used the World Health Organisation's definition for stroke in this study (WHO
1978). I included consecutive patients admitted to the WGH with a diagnosis of
stroke or TIA. All patients who were found to have non-stroke conditions such as
brain tumour, hypoglycaemia, and epilepsy were excluded. In general, patients with
subarachnoid haemorrhage were excluded. However, there was one patient who was
admitted to the stroke unit with a clinical diagnosis of stroke but a non-urgent CT
scan showed subarachnoid haemorrhage; she was not transferred to the neurosurgical




I prospectively identified every stroke patient admitted to the WGH with a stroke or
TIA between 23rd July 2000 and 22nd April 2001 (i.e. a nine month period). There
was a lag time of almost five months between the introduction of the ICP (1st March
2000) and the start of data collection. This served two purposes: a) to give the stroke
unit staff a period of time to adjust to the new way of managing patients using the
ICP; and b) to pilot the methods of case ascertainment and data collection.
I used several overlapping methods of case ascertainment: the Acute Receiving Unit
(ARU) admission record; paging by the nurses and doctors from the ARU; the
consultants in charge of the acute stroke unit; and the x-ray meeting in the
Department of Clinical Neurosciences each morning. After the opening of the Acute
Medical Admission Unit (AMAU) in October 2000,1 also inspected their admission
record. Although I did not routinely inspected the admission records in the neurology
or neurosurgery wards, I recruited some patients from these wards when I knew of
their admissions from x-ray meetings or I have been alerted by the neurology or
neurosurgical teams.
Throughout the period of prospective data collection, two research fellows (PJH and
myself) went to the ARU and AMAU each morning (Monday to Friday) to examine
their admission records. The admission records stated the personal details and
suspected diagnosis of every patient who had been assessed by the medical staff. I
retrieved and examined the case notes for all the patients who had a suspected
diagnosis of "stroke", "cerebrovascular accident" or "TIA". To maximise the
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sensitivity of our identification process, I also examined the case notes of patients
admitted with "weakness", "speech problem", "blind", "visual problem", "collapse",
"fit", "fall", "headache", and "unwell". This was an over-inclusive strategy but I
found many stroke patients who would otherwise have been missed.
I then assessed the identified patients on the ward by taking a thorough history and
performing a comprehensive physical examination. The aim was to assess the
patients as soon after admission as possible; this was usually done on the day of
admission (day 0) or the next working day (or on Monday if the patient was admitted
in the weekend). I then used the information from the history to assess the degree of
dependency prior to admission (modified Rankin score, mRS) (Bamford et al 1989).
I also used the clinical signs found on examination to assess and graded the severity
of stroke; I recorded the Glasgow coma score (GCS), National Institute of Health
stroke score (NIHSS), and the Oxfordshire Community Stroke Project (OCSP)
subtype of stroke (Jennett & Bond 1975; Goldstein et al 1989; Bamford et al 1991).
In an inter-rater study of 42 stroke patients, the research fellows (including PJH and
myself) were found to have high levels of consistency in history-taking, examination,
and diagnosis (see Appendix 4).
If the patient was still in hospital on the fifth day after admission (day 5), I would
carry out another clinical assessment. I have chosen day 5 because: a) the ICP was
designed for the patient care during the first five days, and b) many patients were
transferred to other wards or hospitals at around one week, making it practically
more difficult to perform clinical assessments after the first five days. On day 5,1
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performed the same clinical examination as the first assessment, with the addition of
the Barthel index (Mahoney & Barthel 1965). I also examined the case notes or the
ICP to extract data related to the outcome measures of interest (see below). A
summary of the scales and stroke classification system used in this study can be
found in Table 5.1.
Occasionally, the acute stroke team was alerted by the nurses or doctors in the ARU
that a stroke patient had arrived at the ARU. PJH or myselfwould then assess the
patient in the ARU and arrange for admission where necessary. For those who had
been admitted within the first six hours of stroke onset and satisfied the treatment
criteria for intravenous thrombolysis, we would arrange for an immediate CT scan to
exclude intracranial haemorrhage.
After any clinical assessment, the research fellows (PJH and myself) would
document a short summary of the history and examination findings in the case notes
(but not in the ICP). However, we would not initiate any investigations (except for
immediate CT scans if the patient was eligible for thrombolysis) or alter the
medications.
Retrospective data collection
I retrospectively identified consecutive stroke patients admitted to the stroke unit
during a nine-month period before the introduction of the ICP in March 2000
(between 1st June 1999 and 29th February 2000). Patients were identified from the
stroke unit admission record and I attempted to retrieve their case notes. Since this
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was a retrospective process, it was not possible to obtain the NIHSS or Barthel index.
The GCS on admission was usually recorded by the medical or nursing staff at the
ARU. The pre-stroke mRS was estimated from the documented social history, but
the mRS on day 5 was unobtainable. The OCSP subtype of stroke was also estimated
from the documented clinical symptoms and signs.
Outcome measures of the study
In this study, I sought to assess the effects of introducing an ICP for acute stroke on
four major categories of outcome measures (see below). Data for all of the outcome
measures were extracted from the case notes or ICP, and I recorded an outcome
measure as having occurred only if it was clearly documented. The quality of the
collected data, and hence the frequency of each outcome measure, depended on the
quality of the documentation; poor documentation may have led to under-
ascertainment of certain non-fatal outcome measures in this study.
1. Documentation within thefirst 24 hours (see Table 5.2)
I assessed the quality of documentation using the questions from the Royal College
ofPhysicians' national sentinel audit package (Rudd et al 1999). I was particularly
interested in the documentation of the neurological examination and diagnostic
description within the first 24 hours after admission.
2. Process ofcare during thefirstfive days (see Table 5.3)
These included:
■ Immediate management (e.g. measurement of blood glucose, chest x-ray);
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■ Use of investigations (e.g. CT scanning, carotid duplex); use ofmedications (e.g.
antiplatelet agent, warfarin, antibiotics);
* Use of therapy and nursing interventions (e.g. physiotherapy, speech therapy,
urinary catheterisation);
■ Length of stay at the end of hospitalisation. This was defined as the difference in
the number of days between the date of admission to the WGH and the date of
discharge from the WGH. Any period of treatment or rehabilitation in other
hospitals (e.g. Royal Victoria Hospital) was not counted.
3. Occurrence ofcomplications during thefirstfive days (see Table 5.4)
I assessed the occurrence of 13 different medical complications (e.g. chest infections,
urinary tract infections, falls, constipation). All of these complications were defined
prior to data extraction.
4. Outcome: death and discharge destination
I assessed death, discharge to institution and discharge to home by day 5 and at the
end of hospitalisation. In this study, 'institutions' included rest homes, nursing
homes, long-stay hospitals, or other hospitals (e.g. rehabilitation units); and 'end of
hospitalisation' was defined as when the patient was discharged from the WGH.
Data extraction and management
On day 0, or as soon after admission as possible, I recorded data related to the
patients' baseline characteristics (including those used to adjust for case mix) and
certain details related to the hospital admission (e.g. date and ward of admission).
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Data on the outcome measures were extracted from the patients' case notes on day 5
using pre-printed data extraction forms (see Appendix 5). Before the start of the
study, I circulated the forms amongst my supervisors (PAGS and MSD) for
comments. They were then piloted on a few stroke patients and modified where
necessary. Any information written in the case notes by PJH or myself after our
assessments was not extracted as data for the study (see Discussion).
The extracted data were then entered into a database by myself and a trained data
entry clerk (SG). For the highest level of security, the entered data were anonymised
and stored on the departmental network, which was backed up daily. The paper
copies of the data extraction forms were stored in a locked cabinet inside a locked
office.
Before data analysis, I checked all the entered data on two separate occasions to
minimise typing errors. Any missing items were sought from case notes and/or the
hospital patient data system (e.g. date of discharge). Certain variables were also
cross-checked with the database ofmy colleague (PJH), who conducted his own
study on the same patients. I was confident that the final data set was as accurate and
free ofmissing values as was practicable.
Ethical aspects
The present study was an observational study using routinely collected data and did
not involve any specific intervention. The data were stored in an anonymised format
and the patient's confidentiality was respected. Moreover, the Data Protection
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legislation was unclear the time of planning this study, and has remained unclear in
Scotland (www.show.scot.nhs.uk/csags) (A1 Shahi & Warlow 2000). After
discussing with my supervisors, it was decided this was an audit which did not need
specific approval from the ethical committee. However, the ethical committee had
previously approved the routine collection of data on hospital referral cases to
evaluate the services being developed. The committee has subsequently approved the
prospective collection of data for similar purposes.
Statistical methods
Estimation ofthe sample size required
I used two different approaches to estimate the required sample size. Firstly, I
assumed that 85% of stroke patients would suffer at least one complication in
hospital (Langhorne et al 2000), and I proposed that the ICP might reduce this
proportion to 75% (odds ratio, OR 0.53, relative risk, RR 0.88). To detect this 10%
difference at 5% significance level with 80% power would require a sample size of
250 patients per arm. Secondly, I assumed that 80% of stroke patients would receive
a CT brain scan within 48 hours, and I proposed that the ICP might increase this
proportion to 90% (Wee et al 2000). To detect this 10% difference at 5% significance
level with 80% power would require a sample size of 200 patients per arm. I
therefore sought to collect data on at least 500 patients. In the present study, I
included a total of 520 admissions (in 501 patients). There were 202 admissions in
the retrospective group and 318 in the prospective group.
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The above sample size estimations might be conservative since the Cochrane review
(see Chapter 4) found that certain beneficial effects might in fact be more
substantial. For instance, I found that ICPs could significantly reduce the risk of
urinary tract infections in hospital (OR 0.38, RR 0.43) and significantly increase the
use ofCT brain scans (OR 3.66, RR 1.45). These odds ratios are both larger than
those used in the above sample size estimations.
Statistical methods and reporting of results
All the data were exported from the original database to an Excel spreadsheet
(Microsoft® Excel, Microsoft Corporation, 1997) and statistical tests were carried
out using SPSS for Windows (version 10.1, SPSS Inc, 2000). In the results sections, I
reported the absolute numbers and percentages (absolute risks). For continuous
variables (e.g. age), I also reported the means and standard deviations. For scales and
variables that had a skewed distribution (e.g. NIHSS, length of stay), I also reported
the medians and interquartile ranges.
For comparisons of dichotomous outcomes, I calculated the risk difference and odds
ratios (OR) with their 95% confidence intervals (CI). I also presented the ORs as
summary charts for easier visual comparison (using Review Manager 4.1, Wintertree
Software, 1997). Where the OR indicated that the result was significant at the 5%
level, I performed a Yates-corrected Chi-square test or Fisher's exact test (the latter
was used when any of the expected frequencies were less than five), and calculated
the exact p values.
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I checked the continuous data for normality of distribution using standard statistical
tests of significance: the Kolmogorov-Smirnov test if the number of cases was
greater than 50, and the Shapiro-Wilk test if the number of cases was less than 50
(with p>0.05 indicating a normal distribution). For normally distributed data,
comparisons between two groups were performed using an independent t-test. For
non-normally distributed data, the non-parametric Mann-Whitney U test was used.
For reports of these results, I have specified which test has been used in each case.
Approach to data analysis
I used intention-to-treat (ITT) analysis to compare the results between groups of
patients. I have chosen to use this approach rather than treatment-received analysis
because it was more appropriate for my research question, i.e. what were the effects
of introducing the ICP on the stroke unit? In other words, I hypothesised that the
introduction of the ICP in the stroke unit might influence the outcome of all the
patients admitted to the stroke unit, including those in whom the ICP had not been
used at all. Nevertheless, I have also analysed the data using treatment-received
analysis to explore the influence of compliance; the results the latter analyses will be
reported in the Discussion section of this chapter.
Adjustmentfor case mix
For outcome measures that could be affected by case mix, I adjusted the data using a
prognostic model that had been developed in this department by Counsell et al
between 1992 and 1999 (Counsell 1999). The model contained six variables which
were independent indicators of prognosis (i.e. the probability of being alive and
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independent at 6 months). These were: 1) age in years; 2) whether the patient was
living alone before stroke; 3) whether the patient was independent before stroke; 4)
whether the GCS verbal score was 5; 5) whether the patient was able to walk
independently; and 6) whether the patient was able to lift both arms against gravity.
This model was developed using data from the 530 patients recruited in the
Oxfordshire Community Stroke Project (Bamford et al 1988), and it has been
externally validated using data from two other community-based stroke studies - the
SEPIVAC Study with 310 patients and the Perth Community Stroke Study with 228
patients (Ricci et al 1991; Anderson et al 1993).
Using logistic regression (SPSS version 10.1), I inserted the outcome as the
dependent variable and forced all the aforementioned six variables into the analysis
as covariates. I then added the 'comparison' variable (e.g. SU-after-ICP or SU-
before-ICP) as the last covariate. The adjusted ORs with 95% confidence intervals
were calculated and I have presented them as summary charts.
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5.4 Baseline characteristics
In this section, I shall describe the patients in both the before-and-after study and the
prospective comparative study because they shared a common group of patients (i.e.
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Total number of recruited patients
I identified a total of 501 patients who accounted for 520 admissions. Seventeen
patients were admitted twice and one patient was admitted three times (but one of
these was for a non-stroke condition). Of these 18 patients, five were admitted for
non-stroke conditions for one of those admissions, which means that there were 13
patients readmitted with a stroke or TIA in this study. However, three patients
appeared in both the retrospective and the prospective groups, whereas 15 patients
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appeared in only one group. This complex situation meant that there were great
difficulties with using individual patients as the basic units for calculations. Hence,
in this study, I chose to use the episode ofadmission as the basic unit for
calculations, and not the individual patients. In the remainder of this chapter, I shall
use the term 'patients' to refer to the episodes of admission and not the individual
persons.
I retrospectively identified 202 patients in the SU-before-ICP group. Of these 202
patients, four patients (2%) had been transferred to the stroke unit more than five
days after admission, and the case notes of a further 12 patients (6%) were
unobtainable despite comprehensive searching. I excluded these 16 patients, leaving
186 potentially eligible patients. Of these 186 patients, 32 (17%) had non-stroke
conditions and were also excluded. The final number of patients included in the SU-
before-ICP group was 154. In this group, 136 patients had a stroke and 18 had a TIA.
I prospectively identified 318 patients who had been admitted to the WGH with a
possible stroke. Of these, 33 (10%) had non-stroke conditions and were excluded. Of
the remaining 285 patients, 197 (69%) were admitted to the stroke unit within five
days (the SU-after-ICP group), and 88 (31%) were admitted to the general medical
wards (the GMW group). In the SU-after-ICP group, 184 patients had a stroke and
13 had a TIA. In the GMW group, 78 patients had a stroke and 10 had a TIA.
The recruitment and inclusion process is summarised in Figure 5.2. The diagnoses of
the 65 non-stroke conditions found in this study are listed in Table 5.5.
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Patients' baseline characteristics (see Table 5.6 and Figure 5.3A & B)
The three groups were similar in the distribution of age and gender. The mean age
(standard deviation, SD) was 74.5 (11.7) years in the SU-before-ICP group, 74.5
(12.2) years in the SU-after-ICP group, and 72.0 (13.8) years in the GMW group.
The proportions of males were 50%, 49%, and 48% respectively. The three groups
were also similar in terms of the pre-stroke level of independence (indicated by mRS
of <3 and whether living alone), presence ofmajor risk factors for stroke,
pathological subtype of stroke (CT scan result), and medications taken before
admission.
There were differences in the distribution ofOCSP classifications of stroke between
the groups. Compared with the SU-before-ICP group, the SU-after-ICP group had
more total anterior circulation strokes (29% vs 18%, p=0.005) and fewer partial
anterior circulation strokes (30% vs 42%, p=0.04). Compared with the GMW group,
the SU-after-ICP group had fewer posterior circulation strokes (9% vs 22%,
p=0.004), but more lacunar strokes (28% vs 17% p=0.05).
The left side of the body was affected in 42% of patients in the SU-before-ICP
group, 43% in the SU-after-ICP group, and 44% in the GMW group (not statistically
significant). The right side of the body was affected in 40%, 52%, and 47%
respectively (not statistically significant). The remaining few percentages of patients
in each group had either both sides of their bodies affected, or the side of the body
affected could not be determined, e.g. patients presenting with dysphasia only.
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Compared to the GMW group, the patients in the SU-after-ICP appeared to have
suffered more severe strokes (median NIHSS 9.5 vs 7, p=0.0005). I have not
presented the data on the GCS because its assessment was found to be inconsistent in
patients who presented with dysphasia. Using the language section of the NIHSS as a
screening tool, 41% of patients in the SU-after-ICP group and 28% in the GMW
group presented with dysphasia (overall = 37%).
Furthermore, as additional surrogate makers of stroke severity, I assessed the early
'consequences' of stroke in each group, which were classified as: a) neurological
sequelae including dysphagia, reduced consciousness and incontinence; and b)
physiological disturbances including hyperglycaemia, hypoxia and fever on
admission. I adjusted these results for case mix and compared between the three
groups (see Table 5,7). In summary, there was no significant difference between the
SU-before-ICP and SU-after-ICP groups. However, despite have a higher median
NIHSS, patients in the SU-after-ICP group were less likely to have had a fever on
admission as compared to the GMW group (p=0.01).
I recorded the place of residence before stroke, whether the patient was living alone,
and whether formal help was needed at home. Formal help was defined as the any
regular social help (e.g. home help, meals-on-wheels) or district nurse visits. The
findings are summarised in Table 5,8. There was no significant difference between
the three groups.
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I excluded 12 patients in whom their case notes could not be retrieved. These 12
patients did not differ significantly from the other groups in terms of age or gender
distribution. The mean age (SD) was 77.2 (9.7) years and 5 (42%) were males.
Furthermore, by the end of hospitalisation, 2/12 (17%) had died, 5 (42%) had been
discharged to an institution, and 5 (42%) had been discharged home. These outcomes
again did not appear to differ significantly from the other two groups.
Finally, amongst the prospectively recruited patients, there were 12 patients who
suffered a stroke whilst in hospital; stroke occurred in the medical wards in seven
patients, surgical wards in three patients, neurosurgical ward in one patient, and the
coronary care unit in one patient. Of these 12 patients, the mean age (SD) was 81.7
(4.9) years and 5 (42%) were males. All but four of the patients were transferred to
the stroke unit by day 5. By the end of hospitalisation, 3/12 (25%) had died, 7 (58%)
had been discharged to an institution, and 2 (17%) had been discharged home. It
appeared that this group of patients were older and might have a poorer prognosis.
Delay in admission to the stroke unit
Delay in admission to hospital
Although the dates of stroke and admission were known and recorded in all the
patients, the times of stroke onset and admission could not be determined accurately
in many cases. The patient may not be able to accurately recall or express clearly the
exact time of stroke onset, for instance, if the patient woke with the symptoms, if the
patient was dysphasic (with no witness available), or if the patient did not look at the
clock at the time of stroke. If an ambulance was called, I could have taken the time of
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the emergency (999) call as an estimate of the time of stroke onset, but the delay in
making that first call could have been significant; I therefore did not do this. Table
5.9 shows the numbers of patients for whom the dates and times of stroke onset and
admission could be determined, and the numbers of patients who woke with their
symptoms. I found that the time of stroke onset was not determinable in 61% of
patients in the SU-before-ICP group, as compared to only 40% in the SU-after-ICP
group (p<0.0001). This was most likely to have been a result of less detailed history
taking or documentation.
Since the dates of stroke and admission were recorded in all the patients, I have
calculated the delay from stroke onset to admission in terms of days and not hours.
There was no significant difference in the delay in admission to hospital between the
three groups (see Figure 5.4). In all three groups, about 70% ofpatients were
admitted to the hospital on the same day as the stroke onset.
Delay in transfer to the stroke unit
For the patients who were admitted to the stroke unit, not all of them were admitted
there on the day of admission. In the SU-before-ICP group, 136/154 (88%) patients
were admitted directly to the stroke unit, but 18 (12%) were transferred there from
another ward. Of these 18 patients, 11 (61%) were transferred to the stroke unit
between days 0 and 2.
In the SU-after-ICP group, 111 (56%) patients were admitted directly to the stroke
unit, but 86 (44%) patients were transferred there from another ward. Of these 86
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patients, 76 (88%) were transferred to the stroke unit between days 0 and 2, and 79
(92%) were initially admitted to the AMAIJ before being transferred to the stroke
unit.
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5.5 Compliance with the integrated care pathway document
Even with a well-designed ICP, if it is infrequently used or poorly completed, it is
less likely to have a significant impact on patient care or outcome. Any evaluation of
an ICP should therefore also include an assessment of compliance, which can be
loosely defined as the extent to which medical and nursing staff comply with the
instructions of the ICP and how well they document those actions. It is important to
assess compliance because compliance may reflect how acceptable an ICP is to the
staff, and how feasible it might be to introduce the ICP more widely. Hence, items
that are not associated with good compliance may be impractical. Previous studies of
ICP for stroke have commented on the level of compliance, but none of them have
clearly described the method of assessment (Schull et al 1992; Ross et al 1997; Sulch
et al 2000). In Sulch et al (2000), for example, the ICP recordings were divided into
"complete" and "incomplete", but it was unclear what these terms meant or who
assessed the completeness.
In the present study, I assessed compliance in two ways. Firstly, I assessed whether
the doctor's and nurses' sections of the ICP were used at all. Secondly, if the sections
were used, I assessed the completeness of the recording. I did not assessed the
compliance with the therapists' section because the therapists recorded the patients'
progress in detail in their own departmental patient records, and only a short
summary was written in the ICP. Hence, full assessment of the compliance with the
therapists' section of the ICP would not have been meaningful.
244
Use of the different sections of the ICP
The use of the different sections of the ICP is summarised in Table 5.10. Of the 197
patients in the SU-after-ICP group, 163 (83%) had a doctor's and/or nurses' sections
used, 129 (65%) had both sections used, but 34 (17%) patients had neither sections
used. I examined the possible reasons why the ICPs were not used in these 34
patients (see Table 5.11). In 23/34 (68%) patients, the reason was that the patients
were transferred to the stroke unit from another ward during the first five days, and
the staff did not initiate the ICP, probably because they thought it would have
duplicated information.
Within the SU-after-ICP group, I compared the baseline characteristics of the 163
patients who were managed using an ICP with the 34 patients who were not (see
Table 5.12). I found that patients who were not managed using the ICP were less
likely to have a history of hypertension or to be on antihypertensive medications
(p=0.001 for both), but more likely to have a higher median NIHSS (13 vs 9,
p=0.03). The reasons for these findings are unclear, but the staffmight have believed
that the ICP was less useful for patients with very severe stroke, but more useful for
patients with milder stroke.
Interestingly, the doctor's section was used in a small proportion (14/88, 16%) of
patients in the GMW group. This could have occurred because the on-call medical
staff had used them as a clerking proforma in the ARU. This highlights the potential
for cross-contamination of the intervention in clinical studies such as this one.
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Completeness of recording
I assessed the completeness of recording using a simple ordinal scale: 'complete',
'partially complete', and 'not used'. A 'complete' recording was defined as one with
every question filled in, or all but one question filled in. A 'partially complete'
record was one with more than one question missed out. A section of the ICP was
defined as 'not used' if it was left totally blank. This simple classification system was
applied to the doctor's and nurses' sections of the ICP. The completeness of
recording for the two sections is summarised in Table 5.13.1 found that 97/147
(66%) of the doctor's sections, and 82/145 (57%) of the nurses' sections, were
completely recorded. I also assessed whether completeness of recording influenced
certain outcome measures, the results ofwhich will be presented later in the
Discussion section of this chapter.
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5.6 Results of the before-and-after study
I shall now report the main results for each category of outcome measures in this
study. Table 5.14 presents the frequencies of the six variables that were used to
adjust the results for case mix.
1. Documentation in the first 24 hours
See Table 5.15 and Figure 5.5. Documentation of neurological examination was
significantly more thorough in the SU-after-ICP group. This was evident in the
documentation of sensation (p=0.01), truncal control or gait (pO.OOOl), formal
testing of the mental ability (p=0.0001), and swallowing (p=0.03). Similarly,
documentation of the diagnostic description was significantly more thorough, in
terms of the anatomical site of the lesion (pO.OOOl) and the pathological type of
stroke (p=0.0002).
2. Process of care during the first five days
i) Immediate management
See Table 5.16 and Figure 5.6. Patients in the SU-after-ICP group were significantly
more likely to: a) have their blood glucose measured (p=0.003); b) have their oxygen
saturation measured (p=0.02); and c) be informed of their diagnosis and plan of
management (p=0.0004). However, they were significantly less likely to have a chest
x-ray (p=0.0004). There were also non-significant trends to suggest that patients in
the SU-after-ICP group were more likely to have their antihypertensive medications
continued, and less likely to have been prescribed antibiotics. Overall, there was no
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significant difference in: a) measurement of blood pressure or temperature; b) use of
supplemental oxygen, insulin or thrombolytic therapy; or c) performance of
electrocardiograms, blood tests or immediate CT scans.
ii) Use of investigations during thefirstfive days
See Table 5.17 and Figure 5.7.1 have adjusted the use of investigations for case
mix. Both the adjusted and unadjusted results showed that patients in the SU-after-
ICP group were significantly more likely to have a CT brain scan between days 0 and
1 (p=0.02), and between days 0 and 2 (p=0.02). There was also a non-significant
trend to suggest that patients in the SU-after-ICP group might be more likely to have
an echocardiogram (transthoracic or transoesophageal). There was no significant
difference in the performance of carotid duplex, angiography, or other procedures;
there was also no significant difference in the proportion of patients being referred
for a neurosurgical opinion.
iii) Use ofmedications during thefirstfive days
See Table 5.18 and Figure 5.8. There was no significant difference in the proportion
of patients being newly started on antiplatelet agents (aspirin, dipyridamole or
clopidogrel), anticoagulation (heparin or warfarin), antihypertensive agents, or
statins. There was also no significant difference in the proportion of patients with
ischaemic stroke who received any antiplatelet agent within the first one or two days.
Furthermore, for the use of antipyretic therapy, oral antibiotics, intravenous
antibiotics and intravenous fluids, the results were adjusted for case mix and there
was no significant difference between the two groups.
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iv) Use oftherapy and nursing interventions during thefirstfive days
See Table 5.19 and Figure 5.9.1 have adjusted the use of therapy and nursing
interventions for case mix. Both adjusted and unadjusted results showed that patients
in the SU-after-ICP group were significantly more likely to receive physiotherapy
during the first five days of admission (p=0.0005). However, there was no significant
difference in the provision of other forms of therapy. In terms of nursing
interventions, there was no significant difference in the use of urinary catheters,
nasogastric feeding, thromboembolic deterrent (TED) stockings, or any feeding (oral
or parenteral).
v) Length ofstay at the end ofhospitalisation
See Table 5.20. There was no significant difference in the median length of stay
between the two groups (SU-before-ICP = 8 days, SU-after-ICP = 10 days, p=0.65,
Mann-Whitney U test). The distribution of the data for length of stay was positively
skewed for both groups; the maximum length of stay was 164 days for the SU-
before-ICP group and 96 days for the SU-after-ICP group.
3. Occurrence of complications during the first five days
See Table 5.21 and Figure 5.10,1 have adjusted the occurrence of complications for
case mix. Although unadjusted results did not suggest any significant difference
between the two groups, there was a general tendency for all the complications to
occur less often in the SU-after-ICP group (except DVT which only occurred in two
patients). After adjusting for case mix, I found that patients in the SU-after-ICP
group were significantly less likely to have suffered urinary tract infections (p=0.03).
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Furthermore, there were non-significant trends to suggest that patients in the SU-
after-ICP group might be less likely to have suffered fever, constipation, other
complications, or any complication. 'Other complications' suffered by both groups
included asthmatic attack, cardiac failure, cellulitis, cholecystitis, upper and lower
gastrointestinal haemorrhage, renal failure, and paraphimosis.
4. Outcome: death and discharge destination
See Table 5.22 and Figure 5.11.1 have adjusted death and discharge destination for
case mix. Both the adjusted and unadjusted results showed no significant difference
between the two groups in terms of death, likelihood of being discharged to
institution or to home (by day 5 or at the end of hospitalisation). However, after




Limitations of this study
The results of this study are likely to have been influenced by a large number of
potential biases and confounding factors. I shall discuss these in turn.
Potential sources of bias
Ascertainment bias
In this study, patient identification was unselected and consecutive. Although I used
overlapping methods of case ascertainment, I may have missed a small number of
patients, especially those who had been admitted to the neurology and neurosurgery
wards. The clinical presentation of these patients was frequently unusual (e.g.
younger patients with gradual onset or atypical neurological symptoms) or they had
suffered a catastrophic intracerebral haemorrhage that required immediate
neurosurgery and intensive care. Similarly, a small number of patients might not
have been included in the SU-before-ICP group. Although it was normal practice to
record the admission of every patient to the stroke unit, some patients may not have
been noted if they had died or were discharged within a few hours of arrival. If this
type ofmistake did occur, it is likely to have been rare.
Post-entry exclusion
In this study, I have excluded 65 patients with non-stroke conditions, 4 patients who
had been transferred beyond five days after admission, and 12 patients whose case
notes had been lost (all of them were in the SU-before-ICP group). The 12 patients
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whose case notes were missing did not differ significantly from the other two groups
in terms of age, gender, or outcome by the end of hospitalisation. However, I could
not exclude the possibility that the care of these patients was significantly different.
If that was the case, and since all the missing notes were in the SU-before-ICP group,
this might have influenced the results.
Assessment and reporting bias
Another major area for potential bias in this study is that involved with the method of
data extraction from the case notes. The occurrence of a particular outcome measure
(e.g. chest infection) was only recorded into our database if it had been documented.
If it had not been documented, it did not necessarily mean that it never occurred.
Therefore, the quality and completeness of the documentation could have influenced
the accuracy of the data extraction. I found in this study that documentation of the
initial assessment was significantly more thorough after the introduction of the ICP,
and it is likely that the documentation of other aspects of care was also better.
However, it is difficult to assess the impact of this bias because better documentation
of good outcomes would have led to bias in favour of ICP care, whereas better
documentation of bad outcomes would have led to bias against ICP care. It is also
worth noting that the documentation of certain aspects of care (e.g. occurrence of
complications) might in theory be less thorough because the ICP was in a tick-box
format and the staff rarely recorded the events in free-text. Finally, reporting bias
could have occurred for some of the outcome measures. For example, positive events
(e.g. haemoptysis, seizure) might have been more likely to be documented than
negative ones (e.g. low mood, not eating, not interacting with staff).
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No blinding of the assessor to the intervention
During data extraction, I (the assessor) could not be blinded to the intervention. It
was immediately obvious which group the patient belonged to by looking at the date
and ward of admission, and whether there was an ICP in the case notes. This lack of
blinding may have resulted in observer bias, hence influencing the quality of data
extraction and possibly outcome (Rothwell & Warlow 1995). Though the use of pre¬
printed data extraction forms might have helped, observer bias could not be
eliminated. It is worth noting that I had no direct interest in obtaining a positive
result from this study.
Using admissions rather than individual patients as units ofcalculation
I chose to analyse the data using episodes of admission rather than individual patients
as the unit for calculation. There are both advantages and disadvantages in doing so.
The main advantage is that the data from each admission were treated independently,
which would be sensible because the management of a patient during one admission
should not in any way affect their management during subsequent admissions.
Another advantage is that the age of the patient, place of residence, medications
taken on admission, pre-stroke level of dependence, and past medical history might
have changed between the first and second admissions (e.g. patient might have been
discharged to a rest home after the first stroke). The main disadvantage of using
episodes of admission as the unit for calculation is the possibility of introducing bias
because each admission might not be truly independent of each other. For example,
poor patient care during the first admission might have increased the risks of
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recurrent stroke, readmission, or poorer outcome after the second stroke (e.g. if
warfarin was not commenced for atrial fibrillation, or hypertension not treated).
Potential confounding factors
In this study, I compared data from a retrospectively identified group of patients with
data from a group that was prospectively identified. Any changes observed in this
study may have been due to factors other than the introduction of the ICP, and the
real effects of the intervention could have been obscured by these factors. Thus, to
reliably assess the effects of introducing the ICP, all other factors would have to be
comparable or held constant. These factors would include case mix, bed availability
in the stroke unit, level of staffing (medical, nursing and therapists), training and
education activity for the staff, rate of patient admission, hospital admission policy
(especially in the AMAU), and so on. Therefore, one must interpret any differences
observed in patient care and outcome against a background ofmany changes in the
stroke service over the course of the study. Although the presence of confounding
factors may reduce the external validity of the study, they do not necessarily
invalidate the assessment of their effects in the local setting. I shall discuss several
important confounding factors in greater detail.
Differences in case mix - were they real?
The baseline characteristics of the patients could have significantly influenced the
patient care and outcome. In the before-and-after study, the two comparison groups
were different in terms of the OCSP classification of stroke. Total anterior circulation
strokes (TACS) were more common, and partial anterior circulation strokes (PACS)
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were less common, amongst patients in the SU-after-ICP group. Previous
observation studies have found that the prognosis of TACS is much poorer than that
ofPACS; the 30-day case fatality is almost 40% for TACS as compared to only 4%
for PACS (Bamford et al 1990).
However, the observed differences in clinical subtype were likely to be spurious for
three main reasons. Firstly, I found that the documentation of neurological
examination was less thorough in the SU-before-ICP group; this could have reduced
the accuracy of estimating the OCSP clinical subtype in that group. In particular, a
failure to detect subtle cortical signs (e.g. dyspraxia, dyscalculia) could have led to a
systematic under-diagnosis of TACS and PACS, and many patients with TACS
might have been wrongly labelled as PACS or LACS.
Secondly, if the observed differences in clinical subtype were real, then I would have
expected the outcome to have been significantly different between the two groups.
However, I found no significant difference in the unadjusted results for death or
discharge destination (on day 5 or by the end of hospitalisation) between the two
groups.
Thirdly, adjustment of the results for case mix has made no significant difference for
the majority of outcomes, suggesting that case mix probably did not contribute
greatly towards the observed differences in the process of care and outcome. In
adjusting for case mix, I did not use the OCSP subtype as a co-variate; in retrospect,
this was the correct thing to do because it would probably have been biased.
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Effects ofchanges in service structure, research evidence and hospitalpolicy
The major changes in the service structure during the study have been described
earlier in this chapter. For example, the apparent difference in the provision of
physiotherapy was most likely to be due to the appointment of extra physiotherapy
staff after the ICP was introduced. Other changes also deserved comment. Firstly, the
third International Stroke Trial (IST-3) started recruiting patients in April 2000 (three
months before the prospective data collection of this study). This multicentre trial
aimed to assess the efficacy of intravenous thrombolysis within six hours of stroke
onset. The start of patient recruitment for this trial has meant that some patients
presenting within the first few hours of onset would have been quickly assessed by
the research fellows and 'fast-tracked' to the CT scanner. In this study, I found that
immediate CT scans were performed in 19% of the patients in the SU-before-ICP
group, as compared to 22% in the SU-after-ICP group. Similarly, thrombolysis was
used in 1% and 3% of the patients, respectively. It is possible that the (non¬
significant) observed differences were due to the 'fast-tracking' of patients by the
research fellows. Interestingly, I also found that patients in the SU-after-ICP group
were more likely to have a CT scan between days 0-1 and 0-2, but this difference is
unlikely to be due to the IST-3 since the performance of immediate CT scans was not
significantly different.
Secondly, patient care in the stroke unit might have evolved as new medical
knowledge and research evidence emerged, and as new hospital policies were
developed. For example, the Royal College of Physicians ofEdinburgh Consensus
Conference on Stroke Treatment and Service Delivery took place in November 2000.
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The proceedings of this conference contained updated research evidence and
guidelines (RCP 2001a). The distribution of publications like this might have
influenced patient care in both the stroke unit as well as the general medical wards.
Thirdly, the staff on the stroke unit knew that I was collecting data on process of care
and outcome. This knowledge might have influenced patient care and outcome; for
example, the staffmight have been more active in looking for, treating, and
documenting complications after the introduction of the ICP. On the other hand,
some staffmight have wanted the ICP (and the stroke unit) to Took good' by
choosing not to document complications. This is also known as the 'Hawthorn
effect', which is named after the experiments performed at the Hawthorn Plant of the
General Electric Company in the 1920s and 1930s (Piantadosi 1997).
Clinical assessments by the research fellows
I tried to reduce the research fellows' (PJH and myself) influence on patient care by
ignoring the information written by us when extracting the data from the case notes.
However, it seems inevitable that we have influenced patient care to a certain degree.
The research fellows, after having assessed the patients, usually wrote in the case
notes, giving a short summary of the history and examination findings. It is possible
that what we wrote might have influenced what others wrote. For example, a junior
doctor could have simply copied what we wrote without much thought.
Alternatively, a junior doctor might have chosen not to document the history or
examination findings because we had already done so. The latter might also be a
result of a recent national move to reduce the junior doctors' working hours, leading
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to many junior doctors being actively discouraged from 'duplicating effort' (e.g. re¬
taking history, re-examining the patient, re-documentation).
Seasonal effects and changes in outcome with time
Evidence from observational studies suggest that all-cause mortality may be
influenced by the season of the year (largely explained by the seasonal effects of
ischaemic heart disease), but the association between incidence of stroke, stroke
deaths, and the season of the year remain unclear (Oberg et al 2000; van Rossum et
al 2001). In our study, both the retrospective and prospective data collection lasted
exactly nine months (1/6/99 to 29/2/00, and 23/7/00 to 22/4/01). The months and
seasons covered by the periods of data collection were very similar between the two
groups and hence seasonal variation was unlikely to have significantly affected our
results. However, some outcomes might have changed with time. For example, if
patient care has gradually improved throughout the hospital during the study, patient
outcome might also have improved with time (probably in a linear fashion). In that
case, any observed difference in outcome between the comparison groups in this
study could simply reflect this change with time, rather than the effects of
introducing the ICP.
To check for change in outcome with time, I received statistical advice from the
Effective Practice and Organisation ofCare (EPOC) Group of the Cochrane
Collaboration, which had a special interest in the methodological issues surrounding
non-randomised studies, such as interrupted time series analysis. For this purpose, I
was advised to examine the results of the retrospective group in this study. This was
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done in three stages. Firstly, I divided the entire duration of the data collection (18
months) into six periods of three months. The numbers of patients admitted during
each period are reported in Table 5.23. Secondly, I assessed for any change in
outcome with time for death, discharge destination, occurrence of complication, and
CT scanning between days 0 and 2. This was done by comparing the results between
the first and third periods, and between all three periods, (see Table 5.24). There was
no significant difference in outcome between the groups, nor was there any apparent
temporal trend, suggesting that the outcomes selected had not been significantly
influenced by the passage of time. However, this type of subgroup analysis would
not have enough statistical power to provide reliable evidence of effect.
Number of patients and outcome variables
A small sample size can increase the risk of producing false positive (type I error) or
false negative results (type II error) (Piantadosi 1997). With a larger sample of
patients, the estimate of effect size would have been more precise, but a larger study
would have required greater resources (Lau et al 1992). In theory, recruiting a larger
sample of patients would have meant that the study had to last longer. This could in
turn introduce more potential confounding factors which could affect the reliability
of the results, hence further reducing the internal and external validity of the study.
To illustrate, Appendix 3 outlines the large number of changes to the structure of the
stroke service in the WGH during the past decade - a longer study may simply mean
more changes.
259
In this study, I assessed the patient care provided in 520 stroke admissions, making it
one of the largest studies ever undertaken in testing the effects of an ICP for acute
stroke. Even so, the number of patients included in each group was less than 200.
During the planning of this study, we estimated that between 400 to 500 patients
would be needed if the study was to have sufficient power to detect the effects on the
most important outcome measures.
Another issue is the large number of outcome variables that have been assessed in
this study. In general, when many variables are assessed, the results of 1/20 of them
would be significant at p<0.05 purely as a result of the play of chance. Methods of
tackling this problem would include recruiting a very large number of patients, or to
reduce the significance level (e.g. to 1%, p<0.01). However, the present study could
be regarded as exploratory and all the trends appeared to be similar for many of the
results, indicating that the study was at least internally valid.
Issues regarding outcome measures
Choice ofoutcome measures
Ideally, outcome measures should be relevant, valid, reliable, and sensitive to
change; and their assessment should be accurate and unbiased (Piantadosi 1997). In
this study, death and discharge destination were easy to collect and free from bias.
For other outcomes, I have defined the terms prior to data extraction to minimise
confusion and inaccuracy. However, the important questions is: are the outcomes
assessed in this study meaningful and informative?
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It would seem sensible to suggest that the outcomes that are most relevant to the
patient are death and discharge destination. However, previous studies have provided
conflicting evidence on whether outcome data such as case fatality were able to
indicate quality of stroke care (Dubois et al 1987; Jessee & Schranz 1990; Kahn et al
1990). There are two main problems of using case fatality as an assessment of quality
of care. Firstly, case fatality is substantially influenced by case mix (Davenport et al
1996a). Secondly, differences in case fatality, even after adjusting for case mix, does
not reliably differentiate between hospitals which provide clinically important
differences in stroke care (Weir & Dennis 2001). In a study of 4223 hospital
admissions by Weir and Dennis (2001), four of the five hospitals studied were found
to have almost identical six-month adjusted case fatalities, yet the process of care
was found to be significantly different. The authors concluded that the use of
outcome data alone (e.g. case fatality) to compare quality of care between hospitals
was unlikely to be reliable - it is also important to assess the baseline characteristics
for case mix as well as meaningful indicators of organisation and process of stroke
care (Davenport et al 1996a; Weir & Dennis 2001).
The process of care might also be a good indicator of quality of stroke care because:
a) it is relatively easy to measure; and b) for many aspects of care, there are now
national standards against which local stroke services can be compared (see Chapter
1). In the UK, the recently published National Service Framework for Older People
can be used as a benchmark (DoH 2001). Although the assessment of the process of
care can be highly susceptible to biases and confounding, studies of ICP can at least
provide some useful information on the possible ways that they could affect patient
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care. While previous studies have mainly concentrated on the effects of ICPs on
mortality and length of stay, some experts have voiced their doubt on how such an
ill-defined organisational intervention could possibly reduce the risk of death,
dependency or institutionalisation (Professor L Kalra, personal communication,
2001).
Omission ofseveral outcome measures
There were several important outcomes that I did not examined. In particular, I
would ideally have liked to have assessed the patients' quality of life, experience of
pain, and their satisfaction with the care provided in hospital. In the Cochrane
systematic review, evidence from two randomised controlled trials found that ICP
care might have adverse effects on the patients' quality of life and satisfaction with
their care (Falconer et al 1993; Sulch et al 2000). Examination of these outcomes in
this study might have been informative, but there are methodological problems
associated with their assessment. For example, they are usually poorly defined,
difficult to measure, and difficult to compare between individuals (see Chapter 1). I
was also unable to include these outcomes in this study because of limited time and
resources.
Several important physiological variables have also been omitted in this study. I
assessed whether the blood pressure, blood glucose, oxygen saturation, and
temperature had been measured immediately, and whether these physiological
parameters were deranged (according to pre-specified definitions). I also assessed
whether the patient suffered fever during the first five days of admission, and
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whether the fever was associated with infections, deep vein thrombosis, pulmonary
embolism, or pressure sores. However, I did not assess blood glucose or oxygen
saturation during the first five days of admission. This was because blood glucose or
oxygen saturation were not routinely monitored except in patients with certain pre¬
existing medical problems (e.g. pneumonia, diabetes). In the latter group,
measurements of blood glucose and oxygen saturation would invariably be more
likely to yield deranged values. Since this was a non-interventional study, I was
unable to insist on more intensive physiological monitoring of the patients in the
stroke unit.
Several other outcomes related to therapy and nursing interventions have also been
omitted in this study. They included: positioning of the patient in bed; bowel
management; patient education (e.g. risk factor management); use of equipment and
adaptations (e.g. walking aids, ankle foot orthoses); and the 'quality' of
multidisciplinary team meetings and discharge planning. It was also beyond the
scope of this study to assess the approach, amount, or intensity of physiotherapy,
occupational therapy or speech therapy during the acute period.
Finally, I did not assess the cost of hospitalisation. Accurate calculation of hospital
cost would have required data on the direct costs (e.g. nursing care, medical care,
therapy, tests, and drugs) and overheads (e.g. patient services, property maintenance,
and administration costs) (Forbes & Dennis 1999). Collection of these data would
have required a great deal of time and resources. I did, however, record the length of
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stay, which has been shown to be the main determinant of hospital cost (Isard &
Forbes 1992).
Assumptions about investigations, pharmacological agents and therapy
I was unable to determine whether every investigation, medication or therapy offered
to every patient was actually needed. Similarly, I was unable to determine whether
every patient who needed every investigation, medication, or therapy actually
received it. This was because whether a test, medication or therapy was offered or
not depended on many factors including the doctor's experience and the patient's
wishes. For example, even though a patient might have recovered well from an
anterior circulation ischaemic stroke, a carotid duplex scan might not be appropriate
if the patient does not wish to have a carotid endarterectomy. Another problem was
that several patients were admitted more than once. Hence, if a carotid duplex scan
had already been performed during the first admission, it might not need to be
repeated during the second admission.
Timing ofassessing outcomes
I collected outcome data for the first five days of admission. In addition, death was
assessed by the end of hospitalisation. One problem of assessing any outcome at the
end of hospitalisation period is that certain outcomes (e.g. occurrence of infections)
may be a result of staying in hospital for a long time, and this may in turn increase
the risk of death. Furthermore, like many outcomes, length of stay is influenced by
case mix, so that patients with moderate to severe strokes may stay for a long time in
hospital, whereas those with very severe strokes may die early leading to a shorter
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length of stay. Ideally, it would have been informative to have collected outcome
data more frequently and at later time points (e.g. at one month and three months),
but this was not possible due to financial and time constraints.
Dichotomisation ofoutcomes
I dichotomised several outcomes according to the delay to their occurrence. The
points of dichotomisation were in accordance with the national standards in the UK
(DoH 2001). In particular, the National Service Framework for Older People states
that a CT scan should be performed within two days of admission, and
multidisciplinary assessment (with formal swallowing assessment) should be
undertaken within one day of admission. In the WGH, there were also local
guidelines stating that physiotherapy should be started within one working day,
which equated to three days if the patient was admitted on a Friday. Consequently, I
dichotomised physiotherapy to 'any', '0-1 day' and '0-3 days'.
Interpretation of results
From the before-and-after study, what can I conclude about the effects of
introducing the integrated care pathway in the stroke unit?
The unadjusted comparisons of SU-before-ICP and SU-after-ICP groups did not
provide evidence that introducing the ICP has reduced the risk of death or discharge
to an institution. However, the confidence intervals were wide and included the
possibility of both benefit and harm. After adjustment for baseline stroke severity,
the point estimates appeared more favourable for ICP care, but again were not
statistically significant. The study, however, has provided some evidence that the
introduction of the ICP would not worsen outcome and might improve certain
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aspects of patient care and documentation. I recognise that the study was under¬
powered for these comparisons, and perhaps all one can conclude is that, for these
outcomes, the results are compatible with moderate benefit and do not provide clear
evidence of harm.
Did the introduction of the integrated care pathway improve compliance with
national standards?
I did not specifically set out to assess the compliance to a particular set of national
standards for stroke care. However, several outcomes were related to the standards
set by the National Service Framework for Older People and the National Clinical
Guidelines for Stroke, and their assessment in this study could be used as indicators
of compliance (DoH 2001; RCP 2001b). There were four standards that could be
assessed by this study:
1. Standard 1. "A brain scan should beperformed within 48 hours"
Patients in the SU-after-ICP group were more likely to have a CT scan within
two days.
2. Standard 2. "Multidisciplinary assessment (includingformal swallowing
testing) within 24 hours ofadmission"
Physiotherapy was more likely to be started in the SU-after-ICP group, but there
was no difference in physiotherapy given within one or three days of admission.
There was also no difference in the performance of formal swallowing
assessment within one day of admission.
3. Standard 3. "Existing antihypertensive medication should be continued"
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There was no significant difference in the likelihood of continuing the patients'
existing antihypertensive medication between the two groups.
4. Standard 4. "Immediate management should include management offever"
There was no significant difference in the use of antipyretic medication between
the two groups.
Looking at the above standards, only one out of four standards was more likely to
have been met after the introduction of the ICP. More formal assessment of
compliance with national standards should be included in future studies.
What was the influence of compliance on the results?
1. Did the use of the different sections ofthe integrated carepathway influence the
results?
To explore this question, I analysed the data using treatment-received analysis. For
this analysis, I excluded the 34 patients who were not managed with the ICP from the
SU-after-ICP group. I further specified the comparison groups according to which
sections of the ICP had been used (see Table 5.25). For example, I hypothesised that
the use of the doctor's and/or nurses' section (n=163) would influence the occurrence
of complications, whereas the use of investigations would only be influenced by the
use of the doctor's section (n=147). As I have already reported in Table 5.12, there
were slight differences in the baseline characteristics between the 34 patients who
were not managed with the ICP and the 163 patients who were (in terms of history of
hypertension and the median NIHSS). However, there were no significant difference
in the baseline characteristics between the patients in the SU-after-ICP group and
those who were actually managed with the ICP.
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In this study, the results derived from treatment-received analysis should represent
the maximal effects of the ICP since the patients who were not managed with the ICP
would be excluded. However, I found that results derived from treatment-received
analysis were not dramatically different from those already presented (see Table
5.26). For instance, using treatment-received analysis, patients managed with the ICP
were also more likely to receive physiotherapy within three days after admission
(p=0.02); and documentation of the level of consciousness and visual inattention
were also more thorough (p=0.01 and 0.05).
So what does this mean? The fact that there was no significant difference between
the results derived from the two approaches of analysis might mean that it was not
the use of the ICP that contributed to the observed effects, but the introduction of it
in the stroke unit. This is certainly plausible because the process of designing and
implementing the ICP also involved a great deal of staff education, discussion, and
team-building. All these factors might have contributed toward any influence on
patient care.
2. Did the completeness ofrecording of the integrated care pathway influence the
results?
To explore this question, I examined all the patients in the SU-after-ICP group who
had been admitted to the stroke unit for the fullfive days. I then divided the patients
into: a) those who had both the doctor's and nurses' sections of the ICP completely
recorded (n=32); b) those who had neither the doctor's or nurses' sections used
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(n=28); and c) the remainder of the group (n=30). The aim was to compare a
selection of outcomes between the 'gold standard' (the group with both sections
completely recorded) against the other two groups. The outcomes for comparison
were the same as those used to check for changes with time (minus those occurring
by day 5). They included: death in hospital, discharge to institution, discharge to
home, occurrence of any complication, and performance ofCT scans within two
days of admission. I found no significant difference between the three groups (see
Table 5.27). Overall, the data suggest that compliance might not be responsible for
any observed differences in outcome. It may also suggest that a high level of
compliance might not be as important as the actual process of introducing the ICP in
the stroke unit.
The level of compliance might have been influenced by he level of detail of the ICP.
The ICP at the WGH was very detailed and required many answers and signatures.
However, it replaced the entire medical and nursing documentation in the case notes.
The level of compliance might have been higher if the ICP was simpler and shorter,
but it would not have replaced much of the medical and nursing documentation. This
balance is an issue that should be addressed in the design and planning stage.
Was the introduction of the integrated care pathway responsible for the
observed effects?
There are many reasons why the observed differences in outcomes might not reflect
the effects of introducing the ICP. But it remains possible that the introduction of the
ICP could have improved organisation and efficiency (both difficult to measure),
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leading to better process of care and outcome. It is interesting that the introduction of
the ICP appeared to influence several outcome measures related to the immediate
management of stroke, even though most of the ICPs were initiated in the stroke unit.
Unfortunately, I did not record where the ICP was initiated in this study.
Like stroke unit care, it is very difficult to decipher which components of the ICP are
responsible for which observed effects. However, this is an important question
because a simpler ICP is theoretically more likely to be used than a more complex
one. Thus it is important to identify which components should be included in a
simpler ICP and which can be omitted. Since ICPs are unique to the environment in
which it is used, studies into the individual components of an ICP would also suffer
from similar effects of bias and confounding.
How do the results of this study compare with other studies?
I have conducted one of the largest studies ever performed to test the effects of
introducing an ICP in a stroke unit. The only other larger (non-randomised) study is
Ross et al (1997), where 554 patients were recruited. The results of the present study
were mainly consistent with those of previously published studies and with the
conclusions drawn from the Cochrane systematic review (see Chapter 4).
In the present study, the effects of introducing the ICP on the process of care are
consistent with those found in the Cochrane review in two ways: a) patients in the
SU-after-ICP group appeared to be more likely to have a CT scan within one or two
days of admission; and b) there was also no significant difference in the length of
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hospital stay. The randomised study of ICP for stroke rehabilitation by Sulch et al
(2000) also found a significant improvement in the process of care (unpublished
data).
Like other studies that have examined death and discharge destination, this study did
not find any evidence of net benefit or harm by introducing the ICP (Pasquarello
1990; Hamrin & Lindmark 1990; Odderson & McKenna 1993; Falconer et al 1993;
Baker et al 1998; Sulch et al 2000). However, this study did not assess the effects of
the ICP on other patient-specific outcomes such as patient satisfaction or quality of
life.
Previous randomised and non-randomised studies have found an apparent reduction
in urinary tract infections amongst patients managed with an ICP, and this was also
found in the present study (Pasquarello 1990; Odderson & McKenna 1993; Bowen &
Yaste 1994; Crawley 1996). The frequency of specific complications in the present
study were also largely in keeping with those from previous reports published in the
last decade (see Table 5.28) (Dromerick & Reding 1994; Kalra et al 1995;
Davenport et al 1996b; Johnston et al 1998; Langhorne et al 2000; Roth et al 2001).
However, it is not possible to compare the frequencies of complications in a
meaningful way because I have assessed the occurrence of complications during the
first five days in this study, whereas other studies have recorded complications
during stroke rehabilitation (Dromerick & Reding 1994; Kalra et al 1995; Roth et al
2001), or during acute stroke and rehabilitation (i.e. the entire hospital period)
(Davenport et al 1996b; Johnston et al 1998; Langhorne et al 2000). It is also
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difficult to compare the frequencies because the majority of these studies did not
assess or reported stroke severity or other factors that could have influenced the
findings.
Although the internal and external validity of the present study is limited, it has at
least provided a detailed audit of the ICP introduced in the stroke unit at the WGH.
This information may be used to improve the design and content of the existing ICP.
Furthermore, the findings of the present study may inform the design and sample size
calculation of future studies of this kind.
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5.8 Summary of this chapter
■ In March 2000, an ICP was introduced in the stroke unit at the WGH. It is a
multidisciplinary document that was designed to guide stroke management
during the first five days after admission.
■ I performed a before-and-afiter study to assess the impact of introducing an ICP in
the stroke unit on the following: quality of documentation; process of care;
occurrence of complications; discharge destination; and mortality.
■ After the introduction of the ICP, there were significant improvements in the
quality of documentation and certain aspects of patient care, and the risk of
urinary tract infection was reduced. However, there was no significant difference
in death or discharge destination.
■ The extent to which the results of this study could be generalised is limited
because of the many potential sources of bias and confounding factors.
■ This study has highlighted the many methodological difficulties with performing
a before-and-after study to assess the effects of introducing an ICP for acute
stroke.
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Table 5.1 Functional scales, stroke severity scales, and stroke classification system
used in this study.
Scale or classification Type of scale
Pre-stroke
Modified Rankin scale Global outcome/handicap
Day offirst assessment
OCSP classification of stroke
Glasgow coma scale




5 ' day after admission
Glasgow coma scale








Table 5.2 Items recorded to assess the quality of documentation in this study. These
items were adapted from the Royal College of Physicians' national sentinel stroke
audit package (Rudd et al 1999).
Neurological examination Diagnostic description
Level of consciousness Anatomical site of cerebral lesion
Eye movements Pathological type of lesion (e.g. infarct
Limb movements or haemorrhage, OCSP subtype)
Sensation
Truncal control or gait
Visual fields
Visual inattention
Mental ability (formally tested)
Communication
Screening for swallowing disorder
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Table 5.3 Items recorded to assess the process of care in this study.
Immediate management Within the first 5 days
Blood pressure measurement Physiotherapy
Bedside blood glucose measurement Occupational therapy
Oxygen saturation measurement Speech therapy
Temperature measurement Dietician referral
Bedside swallow test CT brain scanning
Oxygen supplementation Carotid duplex scanning
Insulin therapy Echocardiography
Intravenous fluids Cerebral angiography
Antibiotics Neurosurgical referral
Intravenous thrombolysis Other procedures
Blood pressure reduction (new agent) Use of antiplatelet agents*
Continuation of antihypertensive agent Use of anticoagulant agents*
Urgent CT brain scanning Use of antihypertensive agents
Electrocardiography Use of statin
Chest x-ray Use of antipyretic agent
Routine blood tests Use of antibiotics*
Informing patient/relative of diagnosis Use of intravenous fluids
and/or plan ofmanagement Urinary catheterisation
Nasogastric feeding
At the end ofhospitalisation Any feeding
Length of stay TED stockings
* Items were furthermore broken down according to specific agents or routes of
administration.
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Table 5.4 Definitions ofpost-stroke complications used in this study. Some of the
definitions have been modified from Langhorne et al 2000.
Complication Definition
Chest infection Clinical diagnosis of chest infection (e.g. respiratory crackles,
new purulent sputum), or radiological evidence.
Urinary tract infection Clinical diagnosis of urinary tract infection (e.g. dysuria,
frequency), or positive urine culture.
Pressure sore Any skin break or necrosis resulting from pressure or trivial
trauma (not skin trauma as a direct result of a fall).
Deep vein thrombosis Clinical diagnosis of deep vein thrombosis (e.g. painful and
swollen calf), or radiological evidence.
Pulmonary embolism Clinical diagnosis of pulmonary embolism (e.g. dyspnoea,
haemoptysis), or radiological evidence.
Fall Any documented falls, regardless of cause.
Constipation Any documented constipation, regardless of cause.
Seizure Clinical diagnosis of focal and/or generalised seizure (not
"funny turn" or simple loss of consciousness from vasovagal
attack or syncope).
Pyrexia Temperature greater than 37.5°C, regardless of method of
measurement.
1. Pyrexia - all: refers to any documented episode of pyrexia.
2. Pyrexia - no cause: refers to episodes of pyrexia for which
no cause was found (i.e. without infection, deep vein
thrombosis, pulmonary embolism or pressure sore).
Mood disturbance Any documented mood disturbance including low mood,
anxiety, emotionalism, excessive mood swings.
Other complications Any other documented medical or surgical complication
resulting in specific intervention or delay in discharge.
Any complication Any of the above
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Table 5.5 Diagnoses of the 65 non-stroke conditions in this study.
Diagnosis Number of patients
Epileptic seizure 13
Dizzy spell, syncope, or postural hypotension 12
Brain or spinal tumour (primary and secondary) 8
Infections (chest and urinary) 6








Table 5.6 Baseline characteristics. Also see Figure 5.3.
SU-before-ICP SU-after-ICP GMW
Characteristic (N=154) (N=197) (N=88)
n (%) n (%) n (%)
Age: mean (SD) 74.5 (11.7) 74.5 (12.2) 72.0(13.8)
Age: median (IQ range) 76 (68-83) 77 (68-83) 75.5 (66-82)
Male 77 (50%) 96 (49%) 42 (48%)
Pre-stroke modified Rankin 0-2 108 (70%) 144 (73%) 65 (74%)
Living alone 54 (35%) 72 (37%) 29 (33%)
Risk factors
Atrial fibrillation 29(19%) 36(18%) 12 (14%)
Hypertension 74 (48%) 94 (48%) 44 (50%)
Coronary heart disease 44 (29%) 66 (34%) 33 (38%)
Previous stroke or T1A 52 (34%) 66 (34%) 30 (34%)
Diabetes mellitus 27 (18%) 21 (11%) 8 (9%)
Peripheral vascular disease 9 (6%) 20 (10%) 10(11%)
Current smoking 34 (22%) 42 (21%) 18(20%)
Ex-smoking 35 (23%) 42 (21%) 13 (15%)
OCSP classification
TACS* 28(18%) 57 (29%) 16(18%)
PACS* 64 (42%) 60 (30%) 34 (39%)
LACS* 37 (24%) 56 (28%) 15 (17%)
POCS1 17(11%) 17(9%) 19 (22%)
OCSP class undeterminable 8 (5%) 7 (4%) 5 (6%)
Stroke severity
NIHSS: mean (median, IQR)f No data 9.5 (6, 3-14) 7.0 (4, 1-10)
Pathological type
Transient ischaemic attack 18(12%) 13 (7%) 10(11%)
Stroke: haemorrhage on CT 16(10%) 17(9%) 6 (7%)
Stroke: no haemorrhage on CT 115 (75%) 162 (82%) 68 (77%)
Stroke - no CT done 5 (3%) 5 (3%) 4 (5%)
Pre-stroke medication
Antiplatelet agent(s) 65 (42%) 96 (49%) 37 (42%)
Anticoagulant (warfarin) 10(6%) 14 (7%) 9 (10%)
Antihypertensive agent(s) 62 (40%) 87 (44%) 40 (45%)
*p<0.05 (Chi-square test) comparing SU-before-ICP and SU-after-ICP groups.
+p<0.()5 (Chi-square test) comparing SU-after-ICP group and GMW group.
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Table 5.8 Baseline characteristics (continued): pre-stroke place of residence and the
need for formal help at home.
SU-before-ICP SU-after-ICP GMW
Before stroke (N-154) (N=197) (N=88)
n (%) n (%) n (%)
Living at home (all) 145 (94%) 184 (93%) 78 (89%)
With no help 111 (72%) 148 (75%) 69 (78%)
With formal help 34 (22%) 36 (23%) 9(10%)
Living alone 54 (35%) 72 (37%) 29 (33%)
Living in an institution (all) 9 (6%) 13 (7%) 10(11%)
Rest home 4 (3%) 10(5%) 7 (8%)
Nursing home 5 (3%) 3 (2%) 3 (3%)
Table 5.9 Recording of date and time of stroke onset and admission.
SU-before-ICP SU-after-ICP GMW
(N=154) (N=197) (N=88)
n (%) n (%) n (%)
Stroke onset
Date of stroke onset known 154(100%) 197(100%) 88 (100%)
Time of stroke onset known* 60 (39%) 118(60%) 53 (60%)
On waking 39 (25%) 51 (26%) 25 (28%)
Admission to hospital
Date of admission known 154(100%) 197(100%) 88(100%)
Time of admission known 148 (96%) 191 (97%) 80 (91%)
Dates and times of stroke
onset and admission known*
57 (37%) 116(59%) 49 (56%)
*p<0.05 (Chi-square test) comparing SU-before-ICP and SU-after-ICP groups.
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Table 5.10 Use of the different parts of the ICP by the three study groups.
Section of the ICP
SU-before-ICP SU-after-ICP
(N=154) (N=197)





Doctor's and nurses' sections









Table 5.11 Possible reasons why 34 patients in the SU-after-ICP group were not
managed with the ICP.
SU-after-ICP but no ICP
Reason was used
n=34
1. Patient transferred from a general medical ward and
ICP not started by staff
2. Diagnosis of stroke initially unclear 2 (6%)
3. Patient with very severe stroke received only
palliative care
4. No copies of the ICP available when patient arrived 3 (9%)




Table 5.12 Baseline characteristics of the patients in the SU-after-ICP group




SU-after-ICP, ICP not used
n=34
Age: mean (SD) 74.7(12.3) 73.4 (12.2)
Age: median (range) 77 (68-83) 76 (65-80)
Male 76 (47%) 20 (59%)
Modified Rankin score 0-2 121 (74%) 23 (68%)
Living alone 61 (37%) 11 (32%)
Risk factors
Atrial fibrillation 28 (17%) 8 (24%)
Hypertension* 87 (53%) 7 (21%)
Coronary heart disease 50(31%) 16 (47%)
Previous stroke or TIA 54 (33%) 12 (35%)
Diabetes mellitus 17(10%) 4 (12%)
Peripheral vascular disease 17 (10%) 3 (9%)
Current smoking 38 (23%) 4 (12%)
Ex-smoking 32 (20%) 10 (29%)
OCSP classification
TACS 46 (28%) 11 (32%)
PACS 53 (33%) 7 (21%)
LACS 47 (29%) 9 (26%)
POCS 12 (7%) 5 (15%)
OCSP class undeterminable 8 (5%) 2 (6%)
Stroke severity
NIHSS: mean (median, IQR)* 9(6,3-11) 13 (12, 5-20)
Pathological type
Transient ischaemic attack 12(7%) 1 (3%)
Stroke: no haemorrhage on CT 135 (83%) 27 (79%)
Stroke: haemorrhage on CT 12 (7%) 5 (15%)
Stroke - no CT done 4 (2%) 1 (3%)
Pre-stroke medication
Antiplatelet agent(s) 79 (48%) 17 (50%)
Anticoagulant (warfarin) 11 (7%) 3 (9%)
Antihypertensive agent(s)* 81 (50%) 6(18%)
*p<0.05 (Chi-square test).
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Table 5.13 Completeness of recording of the ICP in the SU-after-ICP group
(N=197). Definitions of the 'complete' and 'partially complete' can be found in the
main text of the chapter.
Section of the ICP Number of patients (%)
Doctor's section (n=147)
Complete 97 (66%)
Partially complete 50 (34%)
Nurses' section (n=145)
Complete 82 (57%)
Partially complete 63 (43%)
Table 5.14 Distribution of the six variables in the model which was used to adjust
for case mix. Table reporting the number (%) ofpatients with each variable in each
group. There was no significant difference between the three groups.
SU-before-ICP SU-after-ICP GMW Compare
Model variables (N=154) (N=197) (N=88) all3grps
n (%) n (%) n (%) p value
1. Age
mean (SD) 74.5(11.7) 74.5 (12.2) 72.0(13.8) -
median (range) 76 (68-83) 77 (68-83) 75.5 (66-82) 0.48
2. Living at home alone 54 (35%) 72 (37%) 29 (33%) 0.84
3. Independent pre-stroke 108 (70%) 144 (73%) 65 (74%) 0.77
4. Able to lift both arms up 117(76%) 134 (68%) 70 (80%) 0.08
5. Able to walk without help 44 (29%) 57 (29%) 36(41%) 0.09
6. Normal verbal GCS score 101 (66%) 119(60%) 60 (68%) 0.38
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Table 5.15 Results of SU-before-ICP vs SU-after-ICP. Documentation within 24
hours; n (%) represents the number (percentage) of patients who had adequate











Level of consciousness 141 (92%) 188(95%) 3% (-1, 9)
Eye movements 132 (86%) 162 (82%) -4% (-11, 4)
Limb movements 152 (99%) 196(100%) 1% (-1, 3)
Sensation* 87 (56%) 138(70%) 14% (3, 24)
Truncal control or gait* 32 (21%) 134 (68%) 47% (38, 56)
Visual fields 102 (66%) 130 (66%) 0%(-10, 10)
Visual inattention 85 (55%) 116(59%) 4% (-7, 14)
Mental ability (formal test)* 37 (24%) 87 (44%) 10% (10, 30)
Communication 131 (85%) 167(85%) 0% (-8, 7)
Swallowing ability* 91 (59%) 140 (71%) 12% (2, 22)
Diagnostic description
Anatomical site of lesion* 88 (57%) 164 (83%) 26% (17, 36)
Pathological type* 87 (56%) 150(76%) 20% (10, 29)
*p<0.05 (Chi-square test).
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Table 5.16 Results of SU-before-ICP vs SU-after-ICP. Process of care - immediate












Blood pressure measurement 154(100%) 197(100%) 0% (-1, 1)
Blood glucose measurement* 103 (67%) 160 (81%) 14% (5, 24)
02 saturation measurement* 146 (95%) 195 (99%) 4% (0, 8)
Temperature measurement 149 (97%) 190 (97%) 0% (-4, 4)
Electrocardiogram 152 (99%) 192 (98%) -1% (-4, 2)
Chest x-ray* 104 (68%) 95 (49%) -19% (-29, -9)
Routine blood tests 150(97%) 196 (99%) 2% (-1,5)
Swallowing assessment 17(11%) 17(9%) -2% (-9, 4)
02 supplement therapy 19(12%) 32 (16%) 4% (-3, 11)
Insulin therapy 7 (5%) 7 (4%) -1% (-5, 3)
IV fluids 58 (38%) 72 (37%) -1% (-11, 9)
Antibiotics 13 (8%) 8 (4%) -4% (-10, 1)
Immediate CT scanning 30(19%) 44 (22%) 3% (-6, 11)
Thrombolysis 2(1%) 7 (3%) 2% (-1,5)
Continue BP medications1^ 45/62 (73%) 71/87 (82%) 9% (-5, 23)
Informing patient or relative* 32(21%) 77 (39%) 18% (9, 28)
*p<0.05 (Chi-square test).
denominators used in calculating the percentages = numbers of patients who had been on
antihypertensive medications before stroke.
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Table 5.17 Results of SU-before-ICP vs SU-after-ICP. Process of care - use of










CT scan (all) 143 (93%) 189 (96%) 3% (-2, 8)
CT scan 0-1 day* 111 (72%) 163 (83%) 11% (2, 19)
CT scan 0-2 days* 129 (82%) 182 (91%) 9% (2, 16)
Carotid duplex scan 80 (52%) 96 (49%) -3% (-14, 7)
Echocardiography 32 (21%) 55 (28%) 7% (-2, 16)
MR or catheter angiography 2(1%) 2(1%) 0% (-3, 2)
Neurosurgical referral 3 (2%) 7 (4%) 2% (-2, 5)
> 1 other procedure 8 (5%) 14(7%) 2% (-3, 7)
*p<0.05 (Chi-square test).
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Table 5.18 Results of SU-before-ICP vs SU-after-ICP. Process of care - use of
medications. There was no significant difference between the two groups. Results











Antiplatelet Rx same dayf 38/133 (29%) 48/175 (28%) -1% (-11, 9)
Antiplatelet Rx 0-1 day! 80/133 (60%) 104/175 (59%) -1% (-12, 10)
Antiplatelet Rx 0-2 days+ 101/133 (76%) 133/175 (76%) 0%(-10, 10)
Heparin - subcutaneous 5 (3%) 6 (3%) 0% (-4, 4)
Heparin - IV 5 (3%) 1 (0.5%) -3% (-6, 0)
New aspirin+ 61/133 (46%) 75/175 (49%) 3% (-14, 8)
New dipyridamole+ 8/133 (6%) 8/175 (5%) -1% (-7, 4)
New clopidogref 0/133 (0%) 3/175 (2%) 2% (-1,4)
New antihypertensive Rx 8 (5%) 6 (3%) -2% (-6, 2)
New warfarin 5 (3%) 4 (2%) -1% (-5, 3)
New statin 2 (1%) 5 (2%) 1% (-2, 4)
Antipyretic therapy* 17(11%) 30(15%) 4% (-3, 11)
Antibiotics - oral* 16(10%) 17(8%) -2% (-8, 4)
Antibiotics - IV* 9 (6%) 24(12%) 6% (0, 12)
IV fluids* 65 (42%) 81 (41%) -1% (-11, 9)
denominators used in calculating the percentages = numbers of patients who had a non-
haemorrhagic stroke (confirmed on CT scan) or a TIA.
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Table 5.19 Results of SU-before-ICP vs SU-after-ICP. Process of care - use of
therapy and nursing interventions. Results after adjustment for case mix are
presented in Figure 5.9.
SU-before-ICP SU-after-ICP








Physiotherapy - all* 79 (51%) 138(70%) 19% (9, 29)
Physiotherapy 0-1 dayf 44/79 (56%) 72/138 (52%) -4% (-17, 10)
Physiotherapy 0-3 days+ 69/79 (87%) 129/138 (93%) 6% (-2, 15)
Occupational therapy (all) 36 (23%) 51 (26%) 3% (-7, 12)
Speech therapy (all) 62 (40%) 87 (44%) 4% (-6, 14)
Speech therapy 0-1 day+ 35/62 (56%) 39/87 (44%) -12% (-28, 5)
Dietician (all) 12 (8%) 12(6%) -2% (-7, 4)
Urinary catheterisation 30(19%) 37(18%) -1% (-9, 8)
Nasogastric feeding 5 (3%) 5 (2%) -1% (-4, 3)
Any feeding 129 (84%) 161 (82%) -2% (-10, 6)
Use ofTED stockings 10(6%) 9 (4%) -2% (-7, 3)
*p<0.05 (Chi-square test).
denominators used in calculating the percentages = numbers of patients who received the
therapy.
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Table 5.20 Results of SU-before-ICP vs SU-after-ICP. Length of stay in the WGH.




Mean LOS (SD) in days 13.8(19.7) 13.4(15.1)
Median LOS (interquartile range) 8 (4-16) 10(4-16)
Minimum LOS 0 0
Maximum LOS 164 96
Table 5.21 Results of SU-before-ICP vs SU-after-ICP. Occurrence of complications.
There was no significant difference between the two groups. Results after adjustment










Chest infection 16(10%) 21 (10%) 0% (-6, 7)
Urinary tract infection 15(10%) 10(5%) -5% (-10, 1)
Pressure sore 4 (3%) 5 (3%) 0% (-3,3)
Deep vein thrombosis 0 2 (1%) 1% (-1, 3)
Fall 12 (8%) 19(10%) 2% (-4, 8)
Fever - all episodes 42 (27%) 46 (23%) -4% (-13, 5)
Fever - no cause found 26(17%) 26(13%) -4% (-11, 4)
Constipation 25 (16%) 24 (12%) -4% (-11, 3)
Mood disturbance 22(14%) 26(13%) -1% (-8, 6)
Seizure 5 (3%) 7 (3%) 0% (-4, 4)
Other complications 14(9%) 12 (6%) -3% (-9, 3)
Any complication 92 (60%) 102 (52%) -8% (-18, 2)
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Table 5.22 Results of SU-before-ICP vs SU-after-ICP. Death and discharge
destination. There was no significant difference between the two groups. Results




Death and discharge destination (N=154) (N=197)
n (%) n (%)
Death
Death by day 5 9 (6%) 11 (6%) 0% (-5,5)
Death in hospital 20(13%) 25(13%) 0%(-7,7)
Discharge destination
Discharge to institution by day 5 13 (8%) 16 (8%) 0% (-6, 5)
Discharge to institution from hospital 56 (36%) 69 (35%) -1% (-11, 9)
Discharge to home by day 5 32 (21%) 43 (22%) 1% (-8, 10)
Discharge to home from hospital 78(51%) 103 (53%) 2% (-9, 12)










23/7/00-22/10/00 - 69 36
23/10/00-22/1/01 - 65 13
23/1/01 -22/4/01 - 63 39
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Table 5.25 Treatment-received analysis. Selection of patients for comparison groups










All (n=154) Doctor's section (n=147)
All (n=154) Doctor's section (n=147)
or
Doctor's +/ nurses' section (n=163)
All (n=154) Doctor's +/ nurses' section (n=163)
All (n=154) Doctor's +/ nurses' section (n=163)
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Table 5.26 Results of the study using treatment-received analysis (comparison
groups as shown in Table 5.25) - SU-before-ICP vs SU-after-ICP. Only unadjusted







n/N as stated (%)
Risk difference
(95% CI)
Death and discharge destination
Death by day 5 9 (6%) 7/163 (4%) -2% (-6, 3
Death in hospital 20 (13%) 20/163 (12%) -1% (-8, 7
Discharge to institution by day 5 13 (8%) 15/163 (9%) 1% (-5, 7
Discharge to institution from hosp 56 (36%) 56/163 (34%) -2% (-13, 9
Discharge to home by day 5 32 (21%) 41/163 (25%) 4% (-5, 14
Discharge to home from hospital 78 (51%) 87/163 (53%) 3% (-8, 14
Occurrence ofcomplications
Chest infection 16(10%) 16/163 (10%) -1% (-7, 6
Urinary tract infection 15 (10%) 8/163 (5%) -5% (-11, 1
Pressure sore 4 (3%) 5/163 (3%) 0% (-3, 4
Deep vein thrombosis 0 1/163 (0.6%) 1% (-1, 2
Fall 12 (8%) 13/163 (8%) 0% (-6, 6
Fever - all episodes 42 (27%) 36/163 (22%) -5% (-15, 4
Fever - no cause found 26 (17%) 21/163 (13%) -4% (-12, 4
Constipation 25 (16%) 20/163 (12%) -4% (-12, 4
Mood disturbance 22 (14%) 22/163 (13%) -1% (-8, 7
Seizure 5 (3%) 2/163 (1%) -2% (-5, 1
Other complications 14 (9%) 10/163 (6%) -3% (-9, 3
Any complication 92 (60%) 82/163 (50%) -9% (-20, 1
Immediate management
Blood pressure measurement 154 (100%) 147/147(100%) 0% (0, 0
Blood glucose measurement* 103 (67%) 121/147 (82%) 15% (6, 25
02 saturation measurement 146 (95%) 145/147 (99%) 4% (0, 8
Temperature measurement 149 (97%) 141/147 (96%) -1% (-5, 3
Electrocardiogram 152 (99%) 144/147 (98%) -1% (-4, 2
Chest x-ray* 104 (68%) 66/147 (45%) -23% (-34,-12
Routine blood tests 150(97%) 147/147(100%) 3% (0, 5
Swallowing assessment 17(11%) 17/147(12%) 1% (-7, 8








n/N as stated (%)
Risk difference %
(95% CI)
Insulin therapy 7 (5%) 4/147 (3%) -2% (-6, 2)
IV fluids 58 (38%) 48/147 (33%) -5% (-16, 6)
Antibiotics 13 (3%) 5/147 (3%) -5% (-10, 0)
Immediate CT scanning 30 (19%) 37/147 (25%) 6% (-4, 15)
Thrombolysis 2 (1%) 7/147 (5%) 3% (0, 7)
Continue BP medications* 45/62 (73%) 58/73 (79%) 7% (-8, 21)
Informing patient or relative* 32 (21%) 63/147 (43%) 22% (12, 32)
Use of investigations
CT scan (all) 143 (93%) 140/147 (95%) 2% (-3, 8)
CT scan 0-1 day 111 (72%) 118/147 (80%) 8% (-1, 18)
CT scan 0-2 days* 129 (82%) 136/147 (93%) 9% (2, 16)
Carotid duplex scan 80 (52%) 79/147 (54%) 2% (-9, 13)
Echocardiography 32 (21%) 42/147 (29%) 8% (-2, 18)
MR or catheter angiography 2 (1%) 2/147 (1%) 0% (-3, 3)
Neurosurgical referral 3 (2%) 2/147 (1%) -1% (-3, 2)
> 1 other procedure 8 (5%) 6/147 (4%) -1% (-6, 4)
Use ofmedications
Antiplatelet Rx same day+ 38/133 (29%) 42/134 (30%) 3% (-8, 14)
Antiplatelet Rx 0-1 day* 80/133 (60%) 79/134 (59%) -1% (-13, 11)
Antiplatelet Rx 0-2 days+ 101/133 (76%) 104/134(78%) 2% (-8, 12)
Heparin - subcutaneous 5 (3%) 5/147 (3%) 0% (-4, 4)
Heparin - IV 5 (3%) 1/147 (0.7%) -3% (-6, 1)
New aspirin* 61/133 (46%) 65/134 (49%) 3% (-9, 15)
New dipyridamole* 8/133 (6%) 7/134 (5%) -1% (-6, 5)
New clopidogrel* 0/133 (0%) 2/134 (1%) 1% (-1, 4)
New antihypertensive Rx 8 (5%) 5/147 (3%) -2% (-6, 3)
New warfarin 5 (3%) 4/147 (3%) -1% (-4, 3)
New statin 2 (1%) 4/147 (3%) 1% (-2, 5)
Antipyretic therapy 17(11%) 18/147(12%) 1% (-6, 8)
Antibiotics - oral 16 (10%) 10/147 (7%) -4% (-10, 3)
Antibiotics - IV 9 (6%) 14/147(10%) 4% (-2, 10)
IV fluids 65 (42%) 56/147 (38%) -4% (-15, 7)
Use of therapy & nursing interven








n/N as stated (%)
Risk difference %
(95% CI)
Physiotherapy 0-1 day+ 44/79 (56%) 62/118 (53%) -3% (-17, 11)
Physiotherapy 0-3 days*+ 69/79 (87%) 114/118(97%) 9% (1, 17)
Occupational therapy (all) 36 (23%) 44/163 (27%) 4% (-6, 13)
Speech therapy (all) 62 (40%) 75/163 (46%) 6% (-5, 17)
Speech therapy 0-1 dayf 35/62 (56%) 33/75 (44%) -12% (-29, 4)
Dietician (all) 12 (8%) 9/163 (6%) -2% (-8, 3)
Urinary catheterisation 30 (19%) 27/163 (17%) -3% (-11, 6)
Nasogastric feeding 5 (3%) 3/163 (2%) -1% (-5, 2)
Any feeding 129 (84%) 135/163 (83%) -1% (-9, 7)
Use ofTED stockings 10(6%) 7/163 (4%) -2% (-7, 3)
Neurological examination
Level of consciousness* 141 (92%) 144/147 (98%) 6% (1, 11)
Eye movements 132 (86%) 128/147 (87%) 1% (-6, 9)
Limb movements 152 (99%) 147/147(100%) 1% (-1, 3)
Sensation* 87 (56%) 108/147 (73%) 17% (6,28)
Truncal control or gait* 32 (21%) 125/147 (85%) 64% (56, 73)
Visual fields 102 (66%) 101/147 (69%) 2% (-8, 13)
Visual inattention* 85 (55%) 98/147 (67%) 11% (1,22)
Mental ability (formal test)* 37 (24%) 83/147 (56%) 32% (22, 43)
Communication* 131 (85%) 138/147 (94%) 9% (2, 16)
Swallowing ability* 91 (59%) 115/147 (78%) 19% (9, 29)
Diagnostic description
Anatomical site of lesion* 88 (57%) 136/147 (93%) 35% (26, 44)
Pathological type* 87 (56%) 124/147 (84%) 28% (18, 38)
*p<0.05 using Chi-square test.
denominators for these as explained in Tables 5.15 to 5.22.
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Figure 5.2 Recruitment and inclusion of patients in this study
Retrospective Sample Prospective Sample
1/6/1999 - 29/2/2000 23/7/2000 - 22/4/2001
Stroke Unit before ICP Stroke Unit after ICP General Medical Ward
introduction introduction group - no ICP
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Figure 5.3A Comparing the baseline characteristics between the SU-before-ICP and
SU-after-ICP groups. Note: this is a forest plot; OR = odds ratio; black box = point
estimate of effect; horizontal line through black box = 95% confidence interval;
vertical black line = OR of 1 (line of unity), i.e. the point where the odds of having
the characteristic are the same between the two groups. When the 95% CI overlaps
the line of unity, then the difference between the groups is not statistically significant
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Figure 5.3B Comparing the baseline characteristics between the SU-after-ICP and
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Figure 5.4 Delay from stroke onset to admission in days. There were no significant









Same day 1 day 2 days 3 days 4 days
Delay from onset to admission
>4 days
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Figure 5.5 Results of SU-before-ICP vs SU-after-ICP. Documentation in the first 24
hours. Note: OR = odds ratio; black box = point estimate of effect; horizontal line
through black box = 95% confidence interval; vertical black line = OR of 1 (line of
unity), i.e. the point where the odds of the outcome occurring are the same between
the two groups. When the 95% CI overlaps the line of unity, then the difference
between the groups is not statistically significant at p<0.05 level; when it does not
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Figure 5.6 Results of SU-before-ICP vs SU-after-ICP. Process of care - immediate
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Figure 5.7 Results of SU-before-ICP vs SU-after-ICP. Process of care - use of
investigations. Charts showing unadjusted results (top) adjusted results (bottom).
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Figure 5.8 Results of SU-before-ICP vs SU-after-ICP. Process of care - use of
medications. Charts showing unadjusted results (top) adjusted results (bottom).
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Figure 5.9 Results of SU-before-ICP vs SU-after-ICP. Process of care - use of
therapy and nursing interventions. Charts showing unadjusted results (top) adjusted
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Figure 5.10 Results of SU-before-ICP vs SU-after-ICP. Occurrence of
complications. Charts showing unadjusted results (top) adjusted results (bottom).
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Figure 5.11 Results of SU-before-ICP vs SU-after-ICP. Death and discharge
destinations. Charts showing unadjusted results (top) adjusted results (bottom).
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CHAPTER SIX
EFFECTS OF INTRODUCING AN INTEGRATED CARE PATHWAY IN THE
STROKE UNIT AT THE WESTERN GENERAL HOSPITAL: A
PROSPECTIVE COMPARATIVE STUDY OF STOKE UNIT AFTER ICP
VERSUS GENERAL MEDICAL WARDS
6.1 Aim of the prospective comparative study
6.2 Methods of the prospective comparative study
6.3 Baseline characteristics
6.4 Results of the prospective comparative study
6.5 Discussion
6.6 Summary of this chapter
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6.1 Aims of the prospective comparative study
This prospective comparative study was performed to address two research
questions:
a) What are the differences in patient care and outcome between the stroke unit after
the introduction of the ICP and general medical wards where no ICP was used?
b) Are the observed differences in patient care and outcome consistent with the
results of the before-and-after study and other previous studies?
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6.2 Methods of the prospective comparative study
Study design
From the before-and-after study, prospective identification of patients had found 88
patients who had been admitted to the general medical wards where no ICP was used
(i.e. the GMW group). For this prospective comparative study, I compared the
outcome measures between the SU-after-ICP and GMW groups.
Other aspects of methodology
The selection criteria, methods of prospective data collection, data extraction and
data analysis were the same as that for the before-and-after study, and they have been
described in Chapter 5. However, there were several important exceptions which I
shall outline here:
Additional outcome measures
In addition to the outcome measures that were assessed in the before-and-after study,
I also assessed the following two outcomes:
1. Occurrence ofcomplication: stroke progression during thefirstfive days
As I mentioned in Chapter 1, stroke progression can be defined as worsening of the
initial stroke (Castillo 1999). More recently, objective measures have been used to
standardise the diagnostic criteria of stroke progression; for example, change by >1
point in the Canadian stroke scale, or >2 points in the Scandinavian Stroke Scale or
the NIHSS (Davalos et al 1990; Jorgensen et al 1994; Toni et al 1995; Davalos et al
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1999; Castillo 1999). In this study, I defined stroke progression as a change by >1
point in the NIHSS between day 0 (or as soon after admission as possible) and day 5.
2. Outcome: dependency on day 5
I assessed the dependency of the patients who were still in the WGH on day 5.1
defined dependency as the need for regular assistance with activities of daily living.
For this, I used the following two indicators of dependency: modified Rankin score
of 3 to 5, and Barthel index of 0 to 18. These criteria were the same as those used in
the Cochrane systematic review (see Chapter 4).
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6.3 Baseline characteristics
I have already reported the numbers and baseline characteristics of the patients in
both the SU-after-ICP and GMW groups - see Table 5.6. In summary, I included
197 in the SU-after-ICP group and 88 in the GMW group. The two groups were
similar in terms of demographics, presence ofmajor risk factors for stroke, pre-
stroke level of independence, and medications taken before stroke. However, there
were differences in the distribution of OCSP subtypes of stroke between the two
groups; the SU-after-ICP group had fewer posterior circulation strokes (9% vs 22%,
p=0.004), but more lacunar strokes (28% vs 17% p=0.05). Moreover, the patients in
the SU-after-ICP appeared to have suffered more severe strokes as compared to the
GMW group (median NIHSS 9.5 vs 7, p=0.0005).
Use of the integrated care pathway in the GMW group
The use of the different parts of the ICP in the SU-after-ICP group has been
described in Table 5.10. Fourteen of the 88 (16%) patients in the GMW group had a
doctor's section of the ICP used, probably because the doctor's section was available
in the ARU to be used as a clerking pro forma. I decided to include these 14 patients
in the GMW group for data analysis to retain the intention-to-treat approach, whilst
being fully aware of the possible confounding effect that this may have. I shall
explore the implication of this approach later in the Discussions.
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6.4 Results of the prospective comparative study
In this chapter, I shall report the results of the prospective comparative study in the
main text as well as providing summary plots of the absolute numbers and odds
ratios (with their 95% confidence intervals) for every outcome measure. For the sake
of simplicity, I did not also present the data as tables.
1. Documentation in the first 24 hours
See Figure 6.1. Documentation of neurological examination was significantly more
thorough in the SU-after-ICP group. This was evident in all but two items that were
assessed, including: the level of consciousness (p=0.0004), eye movements
(p<0.0001), truncal control or gait (p<0.0001), visual fields (p=0.04), visual
inattention (pO.OOOl), formal testing ofmental ability (p=0.01), communication
(pO.OOOl), and swallowing (pO.OOOl). Similarly, documentation of the diagnostic
description was significantly more thorough in the SU-after-ICP group, in terms of
the anatomical site of the lesion (p<0.0001) and the pathological type of stroke
(p=0.0004).
2. Process of care during the first five days
i) Immediate management
See Figure 6.2. Patients in the SU-after-ICP group were significantly more likely to:
a) have their oxygen saturation measured (p=0.0002); b) have an electrocardiogram
(p0.004); and c) have their existing antihypertensive medication continued
(p=0.004); and d) have been informed of their diagnosis and plan ofmanagement
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(p=0.0004). Overall, there was no significant difference in: a) measurement of blood
pressure, blood glucose or temperature; b) use of supplemental oxygen, insulin, iv
fluids, antibiotics or thrombolytic therapy; or c) performance of chest x-rays, blood
tests, swallowing assessments, or immediate CT scans.
ii) Use of investigations during thefirstfive days
See Figure 6.3. I adjusted the use of investigations for case mix. Both the adjusted
and unadjusted results showed that patients in the SU-after-ICP group were
significantly less likely to be referred to the neurosurgical team (p=0.02), even
though there was no significant difference in the proportion of patients with
haemorrhagic stroke (7% vs 9%). There were non-significant trends to suggest that
patients in the SU-after-ICP group might be more likely to have a CT brain scan
within the first one or two days, and less likely to have an echocardiogram. There
was no significant difference in the performance of carotid duplex, angiography, or
other procedures.
iii) Use ofmedications during thefirstfive days
See Figure 6.4. There was no significant difference in the proportion of patients
being newly started on antiplatelet agents (aspirin, dipyridamole or clopidogrel),
anticoagulation (heparin or warfarin), or statins. However, patients in the SU-after-
ICP group were significantly less likely to be started on a new antihypertensive agent
during the first five days (p=0.04). There was no significant difference in the
proportion of patients with ischaemic stroke who received antiplatelet agent within
the first one or two days. Furthermore, I found no significant difference between the
320
two groups in the use of antipyretic therapy, oral antibiotics, intravenous antibiotics
and intravenous fluids, after the results have been adjusted for case mix.
iv) Use oftherapy and nursing interventions during thefirstfive days
See Figure 6.5. I adjusted the use of therapy and nursing interventions for case mix.
After adjustment, patients in the SU-after-ICP group were significantly more likely
to receive speech therapy (p=0.006), but there was no significant difference in the
provision of other forms of therapy. In terms of nursing interventions, patients in the
SU-after-ICP group were significantly less likely to have had a urinary catheter
(p=0.003) or TED stockings (p=0.008), but there was no significant difference in the
use of nasogastric feeding or any feeding (oral or parenteral).
v) Length ofstay at the end ofhospitalisation
See Table 6.1. The median length of stay in the SU-after-ICP was significantly
longer than that in the GMW group (10 vs 5 days, p=0.02, Mann-Whitney U test).
The distribution of the data for length of stay was positively skewed for both groups;
the maximum length of stay was 96 days for the SU-after-ICP group and 169 days
for the GMW group.
3. Occurrence of complication during the first five days
See Figure 6.6.1 have adjusted the occurrence of complications for case mix.
Adjusted results showed that patients in the SU-after-ICP group were significantly
less likely to have suffered fever (any fever p=0.048; and fever where no cause was
identified p=0.042). There was a non-significant trend to suggest that patients in the
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SU-after-ICP group might be less likely to suffer urinary tract infections. Overall,
there was no significant difference in the occurrence of other complications including
stroke progression, but the general trend was favourable towards ICP care.
4. Outcome: death, discharge destinations, and dependency on day 5
See Figure 6.7.1 adjusted dependency on day 5, death and discharge destinations for
case mix. Both the adjusted and unadjusted results showed no significant difference
between the two groups in terms of death or the likelihood of being discharged to
institution or to home (by day 5 or at the end of hospitalisation). Furthermore, of the
patients who survived the first five days and had the mRS and Barthel index
measured, there was no significant difference between the two groups in terms of
dependency on day 5 (before and after adjustment for case mix).
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6.5 Discussion
Limitations of this study
Many of the potential biases and confounding factors that applied to the before-and-
after study would also apply to this prospective comparative study; the exceptions
being those related to the changes caused by the passage of time (e.g. seasonal
effects, changes in research evidence) - see Chapter 5. It is worth noting that, since
the number of patients included in this study was smaller than that in the before-and-
after study, it would be even more susceptible to random error. I shall now discuss
several additional sources of bias and confounding factors that were unique to this
study.
Potential sources of bias
Selection bias
Although the intention of the stroke service was for every acute stroke patient to be
admitted to the stroke unit (either directly or indirectly), this was not always possible
or necessary. In this study, it is possible that some patients, whether intentionally or
not, were 'selected' to be admitted to the general medical wards rather than the
stroke unit. For example, patients with milder strokes might be more likely to be
admitted to the general medical wards, as demonstrated by the finding of a lower
median NIHSS in the GMW group. Moreover, though the comparisons were non¬
significant, patients in the GMW group appeared to be somewhat younger and more
likely to live alone, and less likely to have a history of atrial fibrillation or diabetes.
So junior doctors might have believed that patients with severe stroke and more
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major risk factors were more suitable for the stroke unit. Adjusting for case mix is
unlikely to be able to fully correct for such selection bias.
Patients with missing data were excluded
The only missing data in this study came from the 26 patients who could not be
clinically assessed by the research fellows on admission because they were admitted
while both the research fellows were away. These 26 patients did not have the
NIHSS on admission: 20 of the 26 patients were in the SU-after-ICP group and 6
were in the GMW group. On day 5, there were 15 survivors still in the stroke unit
and 6 in the general medical ward. I decided not to record their NIHSS because there
was no baseline NIHSS for comparison. Table 6.2 summaries the total numbers of
patients who had the NIHSS and functional scores recorded in this study.
For a small number of patients who did not have the NIHSS, the Barthel index was
available because it was routinely recorded by the nursing staff, and the modified
Rankin score (mRS) could be estimated from the case notes or ICP (e.g. if it was
written "patient totally dependent for all activities of daily living", then the score
would be 5). I recognise that this could have biased the results because the patients
for whom the mRS or Barthel index could be estimated were often those who were
very dependent or independent (i.e. those with extreme scores). In retrospect, I
should have excluded the functional data for any patient who was not personally
examined by the research fellow.
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Assessment and reporting bias
As in the before-and-after study, the documentation in patients managed in the stroke
unit after the introduction of the ICP was significantly better than those managed in
the general medical wards. Consequently, the quality of the extracted data and the
reliability of the results could have been severely affected. This bias could have over-
or under-estimated any beneficial or harmful effect of the ICP.
Potential confounding factors
Differences in patient care
The major confounding factor in this study is the fact that one cannot differentiate
the effects of the ICP from the disparity in patient care between the stroke unit and
general medical wards. In this study, patients were admitted to any one of 14 general
medical wards, which also included two surgical wards (four patients) and three
neurology and neurosurgical wards (11 patients). Although there was a handbook on
emergency medical conditions (including stroke) in every general medical ward for
reference, this handbook was also available in the stroke unit and a smaller version
had been given to every junior doctor. However, I could not exclude the possibility
that the junior doctors working in the general medical wards might have used the
handbook more often, leading to variation in medical knowledge.
Furthermore, junior doctors frequently rotated between the medical wards including
the stroke unit (every one to two months for pre-registration house officers, and
every two to four months for senior house officers). During the study, therefore, the
knowledge and experience gained by the junior doctors whilst working in the stroke
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unit could have been 'carried over' to the general medical wards, leading to cross-
contamination of the comparison groups.
Another problem was that the junior doctors from the general medical wards
occasionally asked the research fellows for clinical advice on stroke management; for
example, whether the patient needed neurovascular clinic follow-up, or whether
further neuroimaging was necessary. Although advice regarding specific treatments
was rarely sought, provision of any clinical advice might have confounded the results
of the study.
Use ofthe integrated care pathway in GMWgroup
Intention-to-treat analysis was used in this comparative study. However, there were
14 patients in the medical control group who had the doctor's part of the ICP used.
This could have influenced the results of the study by under-estimating the effect of
SU-after-ICP care. I did not analyse the data of this study using treatment-received
analysis in order to explore the effects of using the ICP on the assessed outcomes.
This was because: a) the sample size was already low and any subgroup analysis
would reduce this number further, hence increasing the risk of random error; and b)
there were already many sources of bias and confounding factors that subgroup
analyses would be unlikely to generate meaningful or reliable results.
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Issues regarding outcome measures
Functional scores: modified Rankin score and Barthel index
I assessed the mRS, NIHSS and the Barthel index in this study. Although these
scales can help to describe in greater detail the neurological or functional status of
the patient at the time of assessment, they are also objective and their assessment can
be problematic (Lyden & Hantson 1998).
The mRS is widely used in clinical trials because researchers regard it as simple and
quick to carry out (van Swieten et al 1988; Bamford et al 1989). Although it is
intended to be a handicap scale, it is probably more appropriate to regard it as a
global functional health index with an emphasis on physical disability (De Haan et al
1995). The Barthel index is a disability scale that is intended to measure physical
dependence in personal activities of daily living, and it has been shown to be reliable
(Collin et al 1988; Wade & Collin 1988). However, both of these scores are objective
and can be influenced by the assessor's personal knowledge of the patient and the
assessor's skills at extracting information from the patient, carer or staff. The Barthel
index also suffers from the floor and ceiling effects, which can reduce its
responsiveness in examining for subtle changes at the extremes of values (Wellwood
et al 1995; Duncan et al 1997; van der Putten et al 1999). Furthermore, one can argue
that its use in stroke patients may not be entirely valid because it measures only the
basic activities of daily living, without any reference to other forms of disability that
stroke patients often suffer (e.g. visual loss, communication difficulties) (Pedersen et
al 1997).
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In this study, I have used the same definition of dependency as that used by the
Stroke Unit Trialists' Collaboration and myself in Chapter 4 (Kwan & Sandercock
2002; Stroke Unit Trialists' Collaboration 2002). However, I recognise that
definitions of dependency are not universal and clinical stroke trials often vary in
their cut-off points for dichotomisation (for both mRS and Barthel index) in defining
dependence (Hacke et al 1998; Suiter et al 1999).
Stroke severity score: NIH stroke score
The NIHSS is widely used in clinical stroke trials to describe stroke severity (Lyden
& Hantson 1998). In one clinical trial of thrombolysis for acute stroke, the NIHSS
was found to be valid when used serially over time for up to three months, and the
scale showed good agreement with other measures of outcome (Lyden et al 1999).
The use of the NIHSS also enables a more standardised definition of stroke
progression. Although some people define stroke progression as an increase in
NIHSS by two or more points, there are others who define it as an increase of three
or more points (DeGraba et al 1999; Grotta et al 2001). In this study, I analysed the
data using both of these two definitions and found no significant difference. Thus, for
the sake of simplicity, I have only presented the results according to the former
definition (i.e. increase by two or more points).
The main problem with the NIHSS is that its reliability is dependent on the
assessor's clinical skills and familiarity with the scale. In addition, despite the large
number (i.e. 15) of items assessed by the scale and a maximal score of 42, the NIHSS
is not a continuous scale. In other words, a patient with a score of 20 is not necessary
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'more impaired' than a patient with a score of 18. This means comparisons of scores
using conventional statistical tests are difficult to interpret. Another problem in this
study is that the clinical assessment was not always performed on the day of
admission. There was sometimes a delay of one to two days (e.g. if the patient was
admitted in the weekend), which may have confounded the results since the NIHSS
might have changed during the first few days. In retrospect, I should have noted the
date and time when the NIHSS was performed for each patient, but this was not
done.
Interpretation of results
What are the differences in patient care and outcome between stroke unit care
after the introduction of the integrated care pathway and general medical ward
care?
The most striking finding is the substantial difference in the quality of documentation
between the two groups. There were also significant differences in several aspects of
acute stroke care between the two groups:
■ Immediate management (measurement of oxygen saturation, performance of
ECGs, continuation of antihypertensive medication, and information provision);
■ Use of speech therapy;
■ Use of urinary catheters and TED stockings;
■ Referral to the neurosurgical team;
«
■ Length of stay in the WGH;
■ Occurrence of fever.
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Some of these findings are likely to be a result of bias, confounding, or a play of
chance. For example, patients in the SU-after-ICP group were less likely to be
commenced on new antihypertensive medications within the first five days - there
may be many explanations for this finding. Firstly, it may indicate that national
guidelines were adhered to more often in the stroke unit (i.e. not to reduce the blood
pressure within the first few days of stroke). Secondly, it might indicate that
antihypertensive therapy was administered less often in the stroke unit as a secondary
preventive measure. Thirdly, it may mean that, in the stroke unit, the blood pressure
ofmore patients declined spontaneously and no active treatment was required.
Lastly, it might have occurred by chance.
In this study, I found that fever and urinary tract infections were less likely to occur
in the SU-after-ICP group (non-significant). It is possible that these two findings
were related to the fact that urinary catheters were significantly less likely to be
inserted into the patients of this group. Similarly, in the before-and-after study, I
found that urinary tract infections were significantly less likely to occur in the SU-
after-ICP group as compared with the SU-before-ICP group. When the data for both
studies are combined, I found that having a urinary catheter during the first five days
of admission significantly increases the risk of urinary tract infection (OR 4.6, 95%
CI 2.12-9.92, p<0.0002) and fever (OR 3.54, 95% CI 2.15-5.79, p<0.0001) - see
Table 6.3. The lower usage of urinary catheters might have been the result of
introducing the ICP in the stroke unit.
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I found that speech therapy was more likely to be given to the patients in the SU-
after-ICP group as compared to the GMW group. However, this could be because the
patients in the SU-after-ICP group were more likely to present with dysphasia (41%
vs 28%, p=0.04) and dysphagia (38% vs 27%, p=0.1), and their median NIHSS was
higher (9.5 vs 7, p=0.0005). These differences in the baseline characteristics may
also explain other findings such as a shorter median length of stay in the GMW
group. The higher usage ofTED stockings in the GMW group may be the result of
the recommendation in the unitary patient records which were used in the AMAU -
there was a section stating that all immobile patients should be considered for TED
stockings; there was no such recommendation in the ICP.
Interestingly, I found no evidence to suggest that patient care or outcome were
substantially worse in the general medical wards. This is somewhat contrary to my
expectation and findings from previous randomised trials and systematic review
(Stroke Unit Trialists' Collaboration 2002). Again, this might be explained by the
differences in the baseline characteristics between the two groups - if the two groups
were balanced in every way, then a genuine difference in patient care or outcome
might have been found (i.e. there was type I error in this study).
Other findings may be more difficult to explain, such as the lower risk of developing
fever in the SU-after-ICP group. Variations in clinical practice may explain the
differences in the immediate management of stroke and the use of TED stockings,
although the introduction of the ICP might have had an impact.
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In this study, I did not find evidence to suggest that patients managed in the stroke
unit after the introduction of the ICP were less likely to be dead, dependent or
discharged to an institution. Overall, the results of this study are consistent with those
of the before-and-after study, with no evidence that stroke unit care after the
introduction of the ICP was associated with any significant harm. However, since the
confidence intervals were wide, one cannot exclude the possibility of a moderate
disadvantage to the patients in both study groups.
How do the results of the this study compare with other studies?
In the Cochrane review of stroke unit care, the reviewers collated the results of all
the randomised controlled trials of stroke unit care versus conventional medical care
(Stroke Unit Trialists' Collaboration 2002). Although the review did not specifically
examine the effects of ICP care, the reviewers had identified one ongoing study
which examined the effects of stroke unit care with an ICP, but the data of this study
were not presented (Patel et al). In the Cochrane review, the overall odds ratio (OR)
for death by the end of follow-up was 0.83 (95% CI 0.71 to 0.97). In the present
study, the OR for death by day 5 was 0.68 (95% CI 0.26 to 1.83), and the OR for
death in hospital was 1.28 (95% CI 0.57 to 2.86). The confidence intervals in the
present study are much wider than that of the Cochrane review, and they overlap the
line of unity (where OR = 1). Therefore, one can only conclude that the finding of
the present study was not inconsistent with the finding of the Cochrane review
regarding the risk of death, but one cannot exclude the possibility of a higher risk of
death in the SU-after-ICP group.
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The Cochrane review of ICPs for stroke (see Chapter 4) included two before-and-
after studies that also recruited "concurrent controls" (Bowen & Yaste 1994; Ross et
al 1997). However, these two studies did not describe the setting in which the
concurrent controls were managed (e.g. in a general medical ward or stroke unit),
and the reasons for not using an ICP to manage them were unclear. I suspect that
many of these concurrent controls were highly selected and any comparison of
outcome could be severely biased and confounded. I have therefore chosen not to
compare the results of the present study with these two studies.
In conclusion, the effects ofmanaging patients in a stroke unit (after the introduction
of the ICP) are consistent with what might be expected on the basis of external
evidence (Cochrane reviews) and from the evidence of the before-and-after study.
Whilst it may be the play of chance, it is of particular interest that patients managed
in the general medical wards had more urinary catheters and more urinary tract
infections and fever. Thus the systematic avoidance of urinary catheterisation (where
possible) may be a contributory factor in the beneficial effects of stroke unit care.
Further studies like the present one may help to determine which components of
stroke unit care may be effective.
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6.6 Summary of this chapter
■ I performed a prospective comparative study to explore the differences in patient
care and outcome between a stroke unit after the introduction of an ICP and
general medical wards where there were no ICPs.
■ There were significant differences in the quality of documentation and certain
aspects of patient care. However, there was no significant difference in death,
dependency, or discharge destination.
■ In general, the results of the prospective comparative study are consistent with
those of the Cochrane review of stroke unit care, the Cochrane review of ICPs for
stroke, and the before-and-after study.
■ Combining the data of both non-randomised studies, I found that having a urinary
catheter during the first five days of admission significantly increases the risk of
urinary tract infection and fever. Thus, the systematic avoidance ofurinary
catheterisation may possibly be a contributory factor in the beneficial effects of
stroke unit care.
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Table 6.1 Results of SU-after-ICP vs GMW. Length of stay in the WGH. There was




Mean LOS (SD) in days 13.4(15.1) 13.6 (23.4)
Median LOS (lst-3rd quartile) 10(4-16) 5(2-15)
Minimum LOS 0 0
Maximum LOS 96 196
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Table 6.2 Numbers of patients who had the NIHSS and functional scores recorded




Modified Rankin score done 197(100%) 88 (100%)
NIH stroke score done 177 (90%) 82 (93%)
Between admission and day 5
Dead before day 5 11 (6%) 7 (8%)
Discharged before day 5 59 (30%) 37 (42%)
On day 5
Survivors on day 5 127 (64%) 44 (50%)
Modified Rankin score done 123/127 (97%) 42/44 (95%)
NIH stroke score done 112/127 (88%) 38/44 (86%)
Barthel index done 124/127 (98%) 41/44 (93%)
Table 6.3 Urinary catheterisation and the risk of developing urinary tract infection


















Figure 6.1 Results of SU-after-ICP vs GMW. Documentation in the first 24 hours.
Charts showing unadjusted results. Note: OR = odds ratio; black box = point estimate
of effect; horizontal line through black box = 95% confidence interval; vertical black
line = OR of 1 (line of unity), i.e. the point where the odds of the outcome occurring
are the same between the two groups. When the 95% CI overlaps the line of unity,
then the difference between the groups is not statistically significant at p<0.05 level;






























































Figure 6.2 Results of SU-after-ICP vs GMW. Immediate management. Charts






ARU BP done 197/197 87/88
ARU BM done 160/197 68/88
ARU 02 done 195/197 78/88
ARU temp done 190/197 85/88
ARU ECG 192/197 78/88
ARU CXR 95/197 42/88
ARU bloods 196/197 85/88
ARU swallow assess 17/197 6/88
ARU 02 supp 32/197 12/88
ARU insulin 7/197 2/88
ARU iv fluids 72/197 24/88
ARU antibiotics 8/197 5/88
ARU CT 44/197 20/88
thrombolysis 7/197 0/88
continue BP drug 71 /87 26/40


























Figure 6.3 Results of SU-after-ICP vs GMW. Process of care - use of investigations.
Charts showing unadjusted results (top) and adjusted results (bottom). Notes: see




CT scan - all 189/197 82/88
CT scan 0-1 day 163/197 66/88
CT scan 0-2 days 182/197 75/88
carotid duplex 96/197 45/88
echo (TTE/TOE) 55/197 34/88
MR/cath angio 2/197 1 /88
neurosurgery ref 7/197 9/88


















CT scan - all
CT scan 0-1 day









2.04 0.59 - 7.08
1.58 0.83 - 3.02
2.33 0.98 - 5.52
1.25 0.69 - 2.26
0.66 0.38 - 1.14
2.62 0.1 - 72.5
0.26 0.08 - 0.84




Figure 6.4 Results of SU-after-ICP vs GMW. Process of care - use ofmedications.
Charts showing unadjusted results (top) and adjusted results (bottom). Notes: see






anti-pit Rx same day 48/175 20/78
anti-pit Rx 0-1 day 104/175 41 / 78
anti-pit Rx 0-2 days 133/175 55/78
sc hepain 6/197 5/88
iv heparin 1 /197 0/88
new aspirin 75/175 32/78
new dipyridamole 8/175 5/78
new clopidogrel 3/175 5/78
new antihypertensive 6/197 8/88
new warfarin 4/197 1 /88
new statin 5/197 2/88
antipyretic 30/197 12/88
oral antibiotics 17/197 10/88
iv antibiotics 24/197 13/88






























0.92 0.41 - 2.07
0.64 0.27 - 1.54
0.55 0.22 - 1.36
1.26 0.65 - 2.45
0.1 1 10
GMW more SU-after-ICP more
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Figure 6.5 Results of SU-after-ICP vs GMW. Process of care - use of therapy and
nursing interventions. Charts showing unadjusted results (top) and adjusted results














speech therapy - all













































Physiotherapy - all a— 1.75 0.99 - 3.1
Physiotherapy 0-1 day —■— 0.57 0.29 - 1.15
Physiotherapy 0-3 days —a 1.84 0.55 - 6.23
Occupational therapy —a 0.77 0.42 - 1.42
Speech therapy - all —a— 2.32 1.28 - 4.2
Speech therapy 0-1 day a 1.27 0.47 - 3.44
Dietician referral 4.18 0.82 - 21.43
Urinary catheterisation a 0.28 0.12 - 0.64
Nasogastric feeding a 0.41 0.07 - 2.53
Any feeding a- 0.7 0.23 - 2.09
TED stockings a 0.26 0.09 - 0.71
0.01 0.1 1 10 100
GMW more SU-after-ICP more
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Figure 6.6 Results of SU-after-ICP vs GMW. Occurrence of complications. Charts
showing unadjusted results (top) and adjusted results (bottom). Notes: see Figure 6.1






chest infection 21 /197 8/88
urine infection 10/197 5/88
pressure sore 5/197 2/88
DVT 2/197 0/88
fall 19/197 5/88
fever - all 46/197 26/88
fever - no cause 26/197 17/88
constipation 24/197 9/88
mood disturbance 26/197 10/88
seizure 7/197 4/88
stroke progression 14/112 5/38
other complications 12/197 7/88





































1.11 0.44 - 2.83
0.39 0.11 - 1.43
0.63 0.11 - 3.72
Not estimable
1.70 0.6 - 4.82
0.53 0.28 - 0.99
0.48 0.24 - 0.97
0.93 0.39 - 2.19
1.28 0.58 - 2.85
0.80 0.21 - 3.07
0.59 0.18 - 1.99
0.59 0.2 - 1.70
0.83 0.48 - 1.45
0.1 10
GMW more SU-after-ICP more
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Figure 6.7 Results of SU-after-ICP vs GMW. Death, discharge destination and
dependency. Charts showing unadjusted results (top) and adjusted results (bottom).




death by day 5 11 /197 7/88
death in hosp 25/197 9/88
disch inst by day 5 16/197 10/88
disch inst from hosp 69/197 25/88
disch home by day 5 43/197 27/88
disch home from hosp 103/197 54/88
mRS >2 on day 5 108/123 35/42

















Adjusted or case mix
Death by day 5
Death in hospital —
Discharge to institution by day 5
Discharge to institution at end of hosp
Discharge to home by day 5
Discharge to home at end of hosp
Modified Rankin score 3-5 on day 5
Barthel index 19-20 on day 5
0.1
OR 95%CI
0.43 0.12 - 1.52
0.66 0.23 - 1.9
0.71 0.3 - 1.66
1.08 0.6 - 1.95
0.82 0.41 - 1.65
1 0.52 - 1.91
1.06 0.36 - 3.09
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CHAPTER SEVEN
EVALUATION OF THE STROKE UNIT STAFF'S EXPERIENCE OF USING
THE INTEGRATED CARE PATHWAY AT THE WGH: RESULTS OF TWO
QUESTIONNAIRE SURVEYS
7.1 Background
7.2 Methods of the surveys
7.3 Results of the surveys
7.4 Discussion
7.5 Summary of this chapter
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7.1 Background
As I discussed in Chapter 2, an ICP can be regarded as a complex intervention and
the methodological difficulties associated with evaluating such an intervention can
be considerable (Campbell et al 2000). In the light of the results ofmy assessment of
the effects of introducing an ICP at the WGH, it was apparent that the intervention
being studied was more than the ICP document itself. Rather, the intervention might
be more appropriately regarded as 'ICP care', which includes the use of the ICP
document plus the process of its introduction. The process of introducing an ICP
provided opportunities for education and training in stroke management, review of
current practice and national guidelines, reorganisation, team building, and
discussions. These changes - separately or in combination - could significantly
influence the process of care and hence patient outcome. Any evaluation of a
complex intervention such as an ICP should therefore include a survey of the staff
implementing and using the ICP. Qualitative studies such as interviews of staffmay
provide useful additional information, such as whether the ICP is acceptable and
whether it is feasible to implement it across many hospitals.
Staffs attitude and expectation toward an ICP could have an impact on the
compliance with the ICP document, and possibly on other aspects ofpatient care.
What the staff expect the ICP to achieve may be very different from what they
actually experience. Expectation and experience may also vary between disciplines
and different levels of previous training; surveys of this kind should therefore include
staff from different backgrounds in order for the results to be generalisable.
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With this in mind, I sought to assess: a) what the stroke unit staff expected from
using the ICP when it was first introduced; b) their experience of using the ICP; and
c) any difference between what was expected and what was experienced.
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7.2 Methods of the surveys
Study design
I conducted two cross-sectional questionnaire-based surveys. The first one was
conducted one month after the introduction of the ICP (i.e. April 2000), and the
second one was conducted six months later (i.e. October 2000). The first survey was
designed to assess what the staff expected from using the ICP when it was first
introduced. I chose to conduct the first one at one month because the staff would
have had some time to become familiar with the ICP and develop some expectations
ofwhat it could achieve. The second survey was designed to assess their views once
they have had more experience of using the ICP.
Questionnaire design and distribution
I designed the questionnaires for both surveys with the advice ofmy supervisors. I
wrote down a long list of variables that an ICP might in any way influence. I then
turned this list of items into a series of simple questions. The questionnaires were
then circulated and modified in the light of any comments (see Appendix 6).
The one-month survey questionnaire contained 37 questions which explored the
staffs expectation in five main areas: a) process of care; b) communication; c)
quality of care; d) patient outcomes; e) personal issues; and f) general working
environment. There were also four questions about the use of ICPs in general. The
seven-month survey questionnaire contained 60 questions which explored the staffs
experience in the same areas as the one-month survey (with some additional
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questions in each area), plus a new set of questions on the design and implementation
of the ICP.
For the majority of the questions, the participants were asked to score each question
using a five-point scale; for the four questions on the use of ICPs in general, the three
possible answers were 'yes', 'no', or 'don't know'. There was also a section at the
end of the questionnaire for the participant to add any free text. The participant was
asked to record his or her discipline but remained anonymous.
Every participant received the same questionnaire regardless of his or her discipline.
This was because I aimed to assess everyone's opinion about each other's, as well as
their own, discipline. For each survey, one questionnaire was sent to each participant
with a personalised and signed cover letter explaining the aims of the study. The
participant was asked to answer every question and not leave any blanks, even
though not every question would be directly relevant to his or her discipline. The
participant was given my telephone number for contact if there was any query. If the
participant did not reply within one month, I sent a reminder letter. If there was still
no reply after one month, no further reminder letter was sent and I counted the
participant as a non-responder. It was necessary to do this because time was passing
and the time gap between the two surveys would otherwise have become too short.
Participants in the surveys
I surveyed all the permanent members of the nursing and therapy staff (including
physiotherapists, occupational therapists, speech therapists, and dieticians) working
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on the stroke unit. The junior doctors were not surveyed because the pre-registration
house officers rotated through the unit every one to two months, and the senior house
officers rotated every two to four months. This meant that, firstly, they would only
have had limited experience with using the ICP, and secondly, they could not take
part in the seven-month survey. Furthermore, I did not include the two stroke
consultants (MSD, RIL) since they were both personally involved in designing and
implementing the ICP, as well as ensuring its use on the stroke unit.
Changes in the service structure between the first and second surveys
Between the one-month and seven-month surveys, there was a turnover of nursing
and therapy staff. After the one-month survey, two nurses, one physiotherapist, one
occupational therapist and one dietician were replaced by new people. In addition,
the stroke unit gained an extra physiotherapist.
Statistical methods and reporting of results
The questionnaires were returned by post and I entered the data into an Excel
spreadsheet. The data were thoroughly checked before analyses. Missing answers in
the questionnaire were scored as missing data. Where the same question had been
answered by the same person in both surveys, I calculated the difference in the
scores. All calculations were carried out using SPSS for Windows (version 10.1).
In this chapter, I shall report the results of both surveys and the comparison between
the two surveys. Because of the small number of participants, and for the sake of
clarity of presentation, I have transformed the data from the original five-point scale
351
to a simpler three-point scale (see Figure 7.1). I have also divided the results into
two groups: a) nurses and b) therapists - including physiotherapists, occupational
therapists, dieticians and speech therapists.
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7.3 Results of the surveys
Description of the participants
For the one-month survey, I assessed a total of 17 nurses and eight therapists (four
physiotherapists, one occupational therapist, one dietician and two speech therapists)
For the seven-month survey, I assessed a total of 17 nurses and nine therapists (one
extra physiotherapist). Of the 17 nurses in both surveys, two were senior nurses and
15 were junior nurses (ofwhom four were permanently on night duty). None of the
participants had previously managed stroke patients using ICPs. All the participants
were female except one junior nurse. The characteristics of the participants are
summarised in Table 7.1.
Response rates and completeness of questionnaires
See Table 7.1. The response rate for the one-month survey was 100%. The response
rate for the seven-month survey was slightly lower at 81% (76% for nurses and 89%
for therapists). The majority of the questionnaires were returned within one to two
weeks of distribution; the longest delay was six weeks (by a nurse in the one-month
survey).
The completeness of the questionnaires was very high; in the one-month survey with
43 questions, the mean (SD) completeness of the questionnaire was 99% (2%); and
in the seven-month survey with 60 questions, it was 96% (5%). The medians were
100% and 95%, respectively.
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Results of the surveys
The results for the individual questions in each survey, and the comparison between
the two surveys, are presented in Tables 7.2 - 7.5. In this section, I shall summarise
the general themes derived from the results of each survey under the following eight
headings.
1. Impact of the ICP on the process ofcare
When the ICP was first introduced, the nurses and therapists generally expected the
ICP to have a positive impact on the process of care. The majority of staff expected
the ICP to increase the thoroughness and efficiency of patient care. In particular, they
expected the ICP to speed up documentation, performance of routine CT scans, and
transfer of patients between the stroke unit and other wards. The majority of staff
also expected the ICP to facilitate and improve the quality of audit, multidisciplinary
team meetings, and the decision-making process regarding the patient's resuscitation
status. However, the staff did not believe that the ICP would affect the speed of
discharge or the number of investigations, drug errors or accidents occurring in the
unit.
After having used the ICP for seven months, the staffs experience was generally in
keeping with what they had expected. Overall, the therapists appeared less impressed
than the nurses about the impact of the ICP on the efficiency of patient care (i.e.
speed of documentation, performance ofCT scans, and transfer of patients between
wards). In the seven-month survey, the majority of nurses and therapists thought that
active treatments of deranged physiological variables, such as the use of insulin for
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hyperglycaemia, were more commonly practised. Moreover, about half of the nurses
believed that urinary catheters were used less often, whereas the other half believed
that their use have not changed. Overall, the staff did not feel that the ICP had any
impact on the overall amount of time treating patients or early mobilisation of
patients.
2. Impact of the ICP on the communication in the stroke unit
The majority of nurses and therapists expected the ICP to improve communication
between disciplines, as well as between staff, patients and relatives. Furthermore, the
staff expected the ICP to improve the quality of information provided for patients
and relatives, but they did not believe that the patient's and relatives' expectation
would simultaneously increase (which might lead to more complaints).
The seven-month survey showed that the staffs experience was somewhat different
from what had been expected. Although 86% of the therapists thought that
communication between disciplines had improved, 58% of the nurses did not think
so. The majority of nurses and therapists also did not feel that the ICP had any
impact on communication between staff and patients or relatives. Nevertheless, 62%
of nurses believed that the quality of information provided for patients and relatives
had improved. Overall, the staff did not think that the patient's and relatives'
expectation, or the number of complaints received by the unit, had changed after the
introduction of the ICP.
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3. Impact ofthe ICP on the quality ofcare
Nearly all of the nurses and therapists expected the ICP to improve the quality of
nursing care, medical care, and therapy in the stroke unit, including the care of
younger stroke patients and those with unusual strokes (but not those with
behavioural or cognitive problems). The quality of discharge planning was also
expected to improve, but the quality of stroke care in other medical wards was
expected to remain the same.
At seven months, the majority of the staff felt that the quality of nursing and medical
care had actually improved, but the quality of therapy was felt not to have changed.
The staff did not think that the ICP had improved the quality of care for younger
stroke patients or those with unusual strokes, behavioural or cognitive problems. The
quality of discharge planning, and the quality of stroke care in the other wards, were
thought to have been unchanged. When I compared the results on quality of care
from the two surveys, I found that what was experienced was mainly similar as what
had been expected.
4. Impact of the ICP on the patient outcomes
When the ICP was introduced, the nurses and therapists did not expect it to have a
major impact on patient outcomes including death, disability, or the occurrence of
complications. After seven months of using the ICP, this view remained the same.
Moreover, the staff did not think that patient satisfaction had been affected.
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5. Impact of the ICP on the staff's personal development
In general, the staff expected the ICP to improve their knowledge of stroke, clinical
acumen in managing patients, and confidence in explaining clinical information to
the patient or relative. Furthermore, the staff expected to be more enthusiastic to
learn about stroke and maintain their autonomy in clinical decision-making.
After seven months of using the ICP, the majority of the nurses and therapists
thought that the ICP has had no significant impact on their personal development,
although the therapists seemed to be slightly more positive than the nurses regarding
the impact of the ICP on their knowledge of stroke, clinical acumen, and enthusiasm
to learn about stroke. Lastly, 23% of the nurses and 29% of the therapists thought
that the introduction of the ICP had increased their overall job satisfaction.
6. Impact of the ICP on the general working environment
There was only one question about the general working environment in the one-
month survey; the majority of the nurses, but not the therapists, thought that
introducing the ICP would improve the appeal of the stroke unit for healthcare
professionals applying for a job on the unit. The seven-month survey found that this
view had not changed. In addition, the general morale of the staff and the profile of
stroke in the WGH were not believed to have changed after the introduction of the
ICP.
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7. Opinions on the design and implementation ofthe ICP
There was a wide variety of opinions regarding the design and implementation of the
ICP. In general, the majority of the therapists were satisfied with all the different
aspects of design and implementation. Amongst the nurses, the majority were
satisfied with the overall design of the ICP, the size of the document, the clinical
relevance, and the amount of information contained in the ICP. However, 46-70% of
the nurses were dissatisfied with the large number of signatures required and the
difficulty with finding information. Almost half of the nurses felt dissatisfied with
the low level of involvement in the design process, and a third of the nurses felt
dissatisfied with the overall process of implementation - they felt that there was
inadequate explanation ofwhy the ICP was introduced, and a lack of practical
guidance on how to complete the document.
8. Opinions on the use ofICPs in general
See Table 7.5. Questions regarding the use of ICPs in general were asked in the one-
month survey only. The responses were very similar between the nurses and
therapists. Half of the staff believed that patients should be selected for management
using the ICP; for example, patients with rapidly resolving symptoms (i.e. probably a
TIA) or those requiring palliative care only should not be managed with an ICP. 82%
of the nurses and all the therapists thought that the natural course of stroke was not
too unpredictable or complicated for ICP care. 80% of the nurses and 75% of the
therapists felt that there should be a 'patient pathway', i.e. there should a simplified
version of the ICP that is given to the patients and relatives at regular intervals or on
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discharge. Opinions were mixed about whether an electronic version of the ICP
should be implemented.
Information given as free text
In the one-month survey, 15/25 (60%) participants (12 nurses and three therapists)
provided further information using free-text. In the seven-month survey, 11/21 (52%)
participants (six nurses and five therapists) did so. I shall now report the general
themes that were extracted from the free-text responses, whilst quoting the exact
wordings by the participants, so as to minimise any potential bias associated with my
own interpretation of the free-text.
Problems with managingpatients with multiple pathologies
One nurse remarked that the ICP was not designed to manage patients with multiple
medical problems because the ICP "diverts attention to the stroke only, and other
problems are then notfocussed upon in the same detail. Perhaps we need optional
parts ofthe ICP which could be included only when a patientpresents with other
problems besides stroke
Problems with patients transferredfrom the general medical wards
Patients transferred from the AMAU or other general medical wards usually did not
have an ICP completed prior to transfer. This initially led to some confusion of
whether an ICP should be started in these patients, especially if they had been
transferred one or two days after admission.
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Confidentiality could be compromised
1. Because the ICP was usually kept by the patient's bedside, four nurses expressed
concern that the patient's confidentiality could be compromised. One wrote,
"how do we know whether an unconscious patient would choose to allow a friend
or relative to read his or her notes?
2. However, one nurse had a different view; she wrote "I really like the openness of
the access ofthe ICP to the patient andfamily, which is empoweringfor them - it
makes them part ofthe team
3. Because the ICP was kept at the patient's bedside, this might have influenced the
information recorded by doctors, nurses and therapists. For example, sensitive
information might not have been written down.
Risks ofdrug error
1. Since the drug chart was part of the ICP document, one nurse commented how
drug errors could occur if the ICP was not available during 'drug rounds' (e.g. if
the therapist was using it). She recalled two occasions when she "left the ICP in
the treatment room for intravenous drugs to be prepared. The ICP was then
taken out ofthe room by doctorsfor the ward round". She suggested keeping the
drug chart separate from the rest of the ICP document.
2. The ICP did not make it clear whether the patient was allergic to any medication.
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Problems with transferring patients to the stroke rehabilitation unit
Since the stroke unit was the only ward that used the ICP, one nurse remarked that
"transfer ofpatients to the rehabilitation unit is more complex as staffthere do not
understand the ICP - training needed?
Only one person could use the ICP at any one time
Since only one person could write in the ICP at any one time, people sometimes had
to wait for their turn. One nurse observed that "a lot of time is wasted trying to track
down ICPs
Patients were screenedfor dysphagia
One nurse commented that "you always know ifdysphagia screen has been done - if
patientfailed assessment, they almost always have a venflon and an iv prescription
sheet
Referral to the therapists was more efficient
One nurse noticed that referral of patients to occupational therapists, physiotherapists
and speech therapists were "more efficient".
Impact ofICP on nursing documentation
One nurse commented that the ICP "provides a more uniform method ofreporting on
patient needs, condition and care
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Team work was enhanced
One nurse remarked that it was easy to find out what the other members of the
multidisciplinary team have recorded, hence facilitating inter-ward transfers.
Design of the TCP could be improved
1. Two nurses remarked that the ICP was not user friendly.
2. Some questions related to nursing and medical treatments were "difficult or
impossible to answer
3. Some information was difficult to extract (e.g. information on the social services'
involvement prior to stroke).
4. Some information could not be obtained on admission, for example because the
patient was drowsy and there was no family who could answer questions.
Reminders of these potential gaps later in the admission could be helpful.
5. Certain sections were difficult to read because the font sizes were too small, but
the use of colour-coded pages for different disciplines was welcomed.
6. The design of the ICP should have "involved more senior staffnurses
Implementation of the ICP could have been better
1. Parts of the ICP required specific training and explanation because of the
complexity of the design. Because of this, one therapist thought that this would
make the ICP "less likely to be used by other areas that occasionally admit
stroke patients " and "less likely to achieve objective of improvingpatient care
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2. One nurse commented that "staffshould have been given ownership (ofthe ICP)
and empowerment to putforward ideas ...nursing staffofvarious grades should
have had some say in development, implementation and evaluation ".
Lack ofintegration ofpaperwork
Even though the sections of different disciplines were bound together in one folder,
the sections remained separate. Three therapists felt that this design led to
fragmented documentation and did not encourage truly integrated care. It would have
been better to have "sub-sections related to the patient - not different professions
Problems with compliance with the ICP
One therapist remarked that the ICP was a "brilliant idea presumingpeople are very
meticulous atfilling in all the sections
Comparing the results of the survey with those of the non-randomised study
Table 7.6 summarises and compares the results of the non-randomised studies with
the results of the seven-month survey. For most of the outcome measures, the
opinion of the stroke unit staffwas similar to the findings of the non-randomised
studies. However, for several outcome measures (i.e. use of antipyretic agents, use of
nasogastric feeding, risk of developing complications, and the overall chance of
recovery), there was a discrepancy between what was experienced and what was
found in the studies.
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7.4 Discussion
Limitations of the study
Potential sources of bias
Recall bias
When responding to a question about a particular aspect of an intervention, the
participant has to recall specific events, abstract the relevant experience, and arrive at
a generalised conclusion. These processes could be compromised by memory failure,
imprecise recall due to distorted memory, and selective recall due to the frequency,
timing and significance of an event (Hughes & Preski 1997). Events that are more
frequent or perceived as more significant tend to be over-reported (Huber & Power
1985). For example, nurses in the stroke unit might vividly recall the occurrence of a
recent drug error that led to the death of a patient, and even though the frequency of
drug errors might not have changed, some nurses might respond by stating that drug
errors have become more frequent after the introduction of the ICP. Furthermore,
memory could be distorted because of the participants' attitude, preconceptions and
group discussions (i.e. nurses or therapists influencing each other).
In the surveys, the participants were also asked to make inferences or conclusions
about abstract organisational properties (e.g. communication between disciplines,
quality of discharge planning). The cognitive processes required to perform such a
task is thought to be more difficult than those required to provide factual information
(Hughes & Preski 1997). Recall bias might have influenced the findings of this
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survey, but it is unlikely to be significant since Table 7.6 shows that the survey
findings and the non-randomised studies' results were broadly similar.
Non-response bias
Interpretation of survey results should take into account the many possible sources of
bias (Hughes & Preski 1997). In this study, although all the participants were
unselected and every member of staffwas included, not every participant responded.
The response rate was 100% for the one-month survey and 81% in the seven-month
survey. The non-responders in the second survey were four junior nurses and one
physiotherapist. It could be possible that those participants did not respond because
they were particularly negative (or less likely, positive) about the use of the ICP, and
an absence of such data might have distorted the overall results, especially when
such small numbers of nurses and therapists had been surveyed overall. In retrospect,
I should have contacted these five members of staff and examined their expectations
and experiences (e.g. by telephone). Previous surveys of healthcare professionals
have found differences in the characteristics between responders and non-responders
to the questionnaires, with possible influence on the survey findings (Hovland et al
1980; Hill et al 1997).
Investigator bias
Surveys based on face-to-face interviews are prone to 'interviewer bias', which is the
influence of the interviewer's personal attributes, experience, and preconception on
the questioning of the interviewee (Salazar 1990; Rogers et al 1998). However, since
this study did not use interviews, this type of bias was absent. Nevertheless,
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'investigator bias' could have been present in this study because the wording of the
questions were designed by myself. In a previous survey of healthcare professionals
on the impact of ICPs, the participants were simply asked whether they agreed or
disagreed with a list of statements, such as "ICPs have reduced the duplication of
information or "ICPs have improved communication between staffandpatients "
(Bryson & Browning 1999). In the present study, I did not ask such leading
questions. Instead, I asked open questions, such as "How has the ICP affected the
following? and the participants answered using a five-point scale and had an option
of additional free-text. The wording of the questions were carefully chosen to
minimise ambiguity or bias. The tick-box format was used to standardise the
participants' responses and minimise any potential bias associated with the
interpretation of answers by the investigator (myself).
Position bias
Position bias refers to the consistent under or over-reporting of events as a result of
the participants' rank or grade (Hughes & Preski 1997). For example, responses to
questionnaires by junior nurses might be significantly different from responses by
more senior nurses. Possible reasons could include: a) junior nurses might be less
willing to express negative feelings about a change in policy, in case the senior
nurses or consultants are offended; b) junior nurses with less experience might view
any situation with lower level of insight and maturity; and c) senior nurses usually
have an active role in the implementation of interventions in the ward - this may
result in a more positive attitude towards the intervention. Any of these factors might
lead to less accurate reporting and biased results. In this study, two senior nurses and
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15 junior nurses were surveyed, and it was apparent that one of the senior nurses
consistently gave very positive answers; it transpired that this senior nurse was
closely involved with the design of the nursing part of the ICP document.
In both surveys, I found that the responses by the therapists to certain questions were
significantly different from those by the nurses. This was to be expected because the
two disciplines had different roles in the management of stroke patients, and the
nurses' and therapists' sections of the ICP were very different. Furthermore, the
therapists were more involved with the design than the usage of the ICP.
In this study, it was extremely unlikely that the characteristics of the participants
other than their discipline and position would have influenced the responses to the
questions (i.e. 'rater-trait interaction' bias). In particular, the age and gender of the
participants were unlikely to have played an important role.
Potential confounding factors
Changes in staffing
Between the one-month and seven-month surveys, two nurses and three therapists
were replaced and the stroke unit gained an extra physiotherapist. Unfortunately, I
did not record how long the new members of staff had been working in the unit
before responding to the seven-month survey. If a participant had only been working
in the unit for a one or two weeks, he or she might provide invalid and unreliable
answers to the survey questions. Moreover, there may be reasons why certain
members of staff have been replaced, for example, due to disharmony or
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dissatisfaction with the job. It would have been interesting to interview those who
had been replaced to examine the reasons for their departure (e.g. was the
introduction of the ICP partly responsible?).
Other organisational changes with time
Other changes might have occurred between the one-month and seven-month
surveys, such as changes in medical, nursing and therapy policies, opening of the
Acute Medical Assessment Unit (AMAU), introduction of a non-stroke unified
patient record, and the start of the third International Stroke Trial (see Chapter 5).
Some or all of these changes might have influenced the general working environment
in the stroke unit.
Choice ofquestions
There are several important issues that have not been investigated by the questions
asked in the surveys. These included: a) concerns regarding breach of confidentiality
with a bedside record; b) how the ICP could be used as an educational tool; c) how
the design and implementation of the ICP could be improved; and d) other factors
that could affect the responses to the questions (e.g. level of staffing, training
opportunities, previous experience in stroke management). Future surveys of
healthcare staff could include such questions.
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Interpretation of results
What did the staff think were the effects of introducing the integrated care
pathway in the stroke unit at the WGH?
The nurses and therapists in the stroke unit had high expectations for the ICP and
hoped that it would improve the process of care, quality of care, communication and
their general working environment. It is clearly important to inspire and 'win over'
the staff when an ICP is introduced, for example, by promoting its many potential
benefits. However, it is also important to be realistic about what could be achieved in
practice.
The nurses and therapists realised that, seven months after its introduction, many of
their expectations of the ICP had not been realised. In particular, they felt that there
had been no substantial improvement in: a) communication with patients and
relatives; b) quality of therapy; c) quality of discharge planning; and d) their
confidence in explaining information to patients and relatives. However, they felt
that the process and quality of care had improved after the introduction of the ICP,
and that ICP care was not associated with any obvious harm. The survey was useful
in revealing several areas where the design and implementation of the ICP could
have been better.
How do the results of this study compare with those of other studies?
The only previously published questionnaire survey of staff on the use of ICPs was
conducted at the West Glasgow Hospitals and Law Hospital in 1999 (Bryson &
Browning 1999). In this project, which was funded by the Clinical Resource and
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Audit Group (CRAG) in Scotland, 422 questionnaires were sent out to healthcare
staff in these hospitals to examine their experience of using non-stroke ICPs. This
single mail shot achieved a response rate of only 51%; the findings of this CRAG
study might therefore have been severely influenced by non-responder bias.
This CRAG study found that nurses were generally much more positive than the
doctors and therapists in their opinions regarding the impact of ICPs. Overall, the
majority of the nursing staff felt that ICPs could: a) improve the documentation of
patient care; b) help to introduce guidelines- and evidence-based practice; c)
standardise patient care; and d) be used as an educational tool for new staff.
Although the questions in my study were different from those in the previous study,
the findings point to similar impact on the process and quality of patient care.
Furthermore, both the CRAG study and my study found that the introduction of ICPs
did not affect communication between staff and patients, or the staffs autonomy in
decision-making. Interestingly, the CRAG study found that 41% of doctors and 23%
of nurses and therapists did not think that ICPs should be continued to be used or
developed in their Health Trusts.
Unfortunately, meaningful comparisons between the CRAG study and my study
cannot be made. The main reason is that the CRAG study did not survey any staff
who cared for stroke patients. In addition, the CRAG study did not describe the
characteristics of the participants apart from their disciplines, and there was no
indication on who the non-responders might be.
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Use of the ICP and patient confidentiality
Although the present study did not specifically examine the issues surrounding
patient confidentiality, several nurses raised concerns about this issue. Interestingly,
the CRAG study also included a questionnaire survey of patients to investigate the
issue of confidentiality. In the CRAG study, selected inpatients who were "well or
coherent enough" were given a questionnaire by the ward staff. Of a total of 600
patients given the questionnaires, only 107 (18%) responded. The following were
found by the survey:
■ 37% of patients thought that the ICP should be by the bedside, but 38% thought
that it should be at the bedside only if the patient wished so;
■ 71% of patients read the ICP once or twice during the admission, 15% read it
frequently;
■ 63% of patients said that their relatives had read the ICP, 13% said that other
visitors had read the ICP, and 9% said that fellow patients had read their ICP;
■ 87% of patients did not prefer to have more control over who could look at the
ICP;
■ 100% of therapists and 54% of nurses thought that having the ICP by the bedside
had deterred them from writing sensitive information that they would otherwise
have written in the usual case notes.
The conclusion was that the patients were less concerned than the healthcare staff
about where the ICP was kept, but the most worrying finding was that a significant
proportion of ICPs had been read by people other than the healthcare staff and the
patients themselves. This type of practice is clearly in breach of patient
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confidentiality and action should be taken to prevent it. Many stroke patients, who
often suffer from communication difficulties as a consequence of their stroke, would
be unable to express whether they wish their ICPs to be read by their relatives or
other visitors. In response to this concern, the policy in the stroke unit (WGH) has
changed so that ICPs are now kept in a trolley by the nurses' station.
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7.5 Summary of this chapter
■ I conducted two questionnaire surveys of the stroke unit staff to assess their
experience of using the ICP during the first seven months of its introduction. The
first survey was performed at one month after the introduction of the ICP and the
second survey was performed six months later.
■ The nurses and therapists in the stroke unit had high expectations for the ICP and
hoped that it would improve the process of care, quality of care, communication
and their general working environment.
■ After having used the ICP for seven months, the staff felt that the process and
quality of care had improved after the introduction of the ICP, and that ICP care
was not associated with any obvious harm.
■ After having used the ICP for seven months, the staff did not report any
substantial improvement in: communication with patients and relatives; quality of
therapy; quality of discharge planning; and their confidence in explaining
information to patients and relatives.
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Table 7.1 Characteristics of the participants and response rate in each survey.
Survey Discipline No. surveyed No. responded
1-month survey Nurses (F and G grades) 2 2
(April 2000) Nurses (D and E grades) 15 15
Physiotherapists 4 4
Occupational therapists 1 1
Speech therapists 2 2
Dieticians 1 1
Total 25 25 (100%)
7-month survey Nurses (F and G grades) 2 2
(October 2000) Nurses (D and E grades) 15 11
Physiotherapists 5 4
Occupational therapists 1 1
Speech therapists 2 2
Dieticians 1 1
Total 26 21 (81%)
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Table 7.2 Results of the one-month survey. Nurses' (n=17) and therapists' (n=8)
expectation ofwhat the ICP could achieve. The highest percentages are lightly
shaded.
Question:
"How do vou expect the ICP to
influence thefollowing?"







Nurse Therap Nurse Therap Nurse Therap
Process ofcare in the stroke unit
Thoroughness in managing patients 15(88) 8(100) 2(12) - - -
Speed of doctors clerking patients 12(71) 5(63) 3(18) 2(25) 2(12) 1 (13)
Speed ofN&T completing paperwork 15 (88) 5(63) - 1 (13) 2(12) 2(25)
Speed of obtaining routine CT scans 12(71) 3 (38) 5(29) 4(50) - 1(13)
Speed of discharge to institution 6(35) 1 (13) 11 (65) 6(75) - 1(13)
Speed & ease of transfer from ARU 15(88) 6(75) 1 (6) 2(25) 1(6) -
Speed & ease of transfer to rehab unit 10(59) 5(63) 4(24) 3 (38) 1(6) -
Total length of stay in hospital 1(6) - 9(56) 4(50) 6(38) 1(13)
Number of investigations 9(56) 3 (38) 7(44) 5(63) - -
Number of drug errors 1(6) - 14 (82) 4(50) 2(12) 4(50)
Number of accidents on the unit 1(6) 1(13) 12(71) 3 (38) 4(24) 4(50)
Ease ofmaking resuscitation decisions 12(71) 4(50) 5(29) 4(50) - -
Quality & ease of auditing 13 (81) 7(87) 3(19) 1(13) - -
Quality ofmultidisciplinary meetings 16(93) 6(75) 1(6) 2(25) - -
Communication
Communication between disciplines 15(88) 8(100) 2(12) - - -
Communication with patients/relatives 12(71) 8(100) 5(29) - - -
Quality of information to patients/relat. 16(93) 8 (100) 1(6) - - -
Expectation from patients/relatives 6(35) 3 (38) 11 (65) 5(63) - -
Number of complaints by patients/relat. 1(6) - 8(50) 4(50) 7(44) 4(50)
Quality ofcare
Quality of nursing care on the unit 14(82) 6(75) 3(18) 2(25) - -
Quality of medical care on the unit 13 (86) 7(87) 4(24) 1 (13) - -
Quality of therapy on the unit 13 (86) 5(63) 4(24) 3 (38) - -
Care of patients with unusual strokes 10(59) 7(87) 7(41) 1(13) - -
Care of younger stroke patients 11 (65) 4(50) 6(35) 4(50) - -
Care of pts. with behavioural problems 5(29) 3 (38) 12(71) 5(63) - -
Care of pts. with cognitive problems 6(37) 2(25) 10(63) 6(75) - -
Quality of discharge planning 11 (65) 7(87) 4(24) 1(13) 2(12) -
Quality of stroke care in other wards 1(7) 2(25) 12(80) 6(75) 2(13) -
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Question:
"How do vou expect the ICP to
influence thefollowing?"







Nurse Therap Nurse Therap Nurse Therap
Patient outcomes
Risk of death or disability at 1 month 3(18) - 10(59) 5(63) 4(24) 3 (38)
Risk of death or disability at 1 year 1(6) - 12(71) 7(88) 4(24) 1(13)
Risk of complications 1(6) - 8(50) 4(50) 7(44) 4(50)
Personal issues
General knowledge of stroke 14 (82) 7(87) 3(18) 1(13) - -
Clinical acumen in managing stroke 16(94) 5(63) 1(6) 3 (38) - -
Enthusiasm to learn about stroke 12(71) 5(63) 5(29) 3 (38) - -
Confidence in explaining information 13(76) 5(63) 4(24) 3 (38) - -
Confidence in managing stroke 6(38) 6(75) 7(44) 2(25) 3(18) -
Autonomy in decision-making 8(47) 1(13) 8(47) 7(88) 1(6) -
General working environment
Appeal of the unit to job applicants 10(59) , 4 (50) 7(41) 4(50) - -
Notes:
The denominator used to calculate each percentage = number of response for that question
(not the number of participants surveyed).
Therap. = therapists




Table 7.3 Results of the seven-month survey. Nurses' (n=13) and therapists' (n=8)
experience of using the ICP on the stroke unit.
Answer to each question
yMwHI/f• •
"Fromyour experience, how has







Nurse Therap Nurse Therap Nurse Therap
Process ofcare in the stroke unit
Thoroughness in managing patients 10 (77) 6(75) 3(23) 2(25) - -
Speed of doctors clerking patients 5 (56) 2(29) 2(22) 5(71) 2(22) -
Speed ofN&T completing paperwork 9(69) 3 (38) 3(23) 4(50) 1(8) 1(13)
Speed of obtaining routine CT scans 11 (85) 3 (38) 2(15) 5(63) - -
Speed of discharge to institution 3(23) 2(25) 10(77) 6(75) - -
Speed & ease of transfer from ARU 8(61) 2(25) 4(31) 5(63) 1(8) 1 (13)
Speed & ease of transfer to rehab unit 7(54) 4(50) 5(39) 4(50) 1(8) -
Total length of stay in hospital - - 10(77) 6(75) 3 (23) 2(25)
Number of investigations 7(58) - 5(42) 6(100) - -
Number of drug errors - - 9(69) 6(100) 4(31) -
Number of accidents on the unit - 1(14) 10(77) 5(71) 3(23) 1(14)
Ease ofmaking resuscitation decisions 2(17) - 3(25) 3(43) 7(58) 4(57)
Quality of multidisciplinary meetings 6(50) 6(86) 6(50) 1(14) - -
Amount of time treating patients* 2(15) - 11 (85) 7(100) - -
Use of 02 when hypoxia* 10(77) 3(50) 3 (23) 3(50) - -
Use of insulin when high glucose* 9(69) 4(57) 4(31) 3(43) - -
Use of iv fluids* 10(77) 4(57) 3(23) 3(43) - -
Use of antipyretic when fever* 8(61) 4(57) 5(39) 3(43) - -
Use of urinary catheter* 1(8) 1(17) 6(46) 4(67) 6(46) 1(17)
Use of nasogastric feeding* 8(61) 4(57) 4(31) 3(43) 1(8) -
Treatment with early mobilisation* 9(69) 1(14) 4(31) 6(86) - -
Communication
Communication between disciplines 5(42) 6(86) 7(58) 1(14) - -
Communication with patients/relatives 4(31) 3 (38) 9(69) 5(63) - -
Quality of information to patients/relat. 8(62) 4(50) 5(39) 4(50) - -
Expectation from patients/relatives 3 (23) 3 (38) 10(77) 5 (63) - -
Number of complaints by patients/relat. - - 8(73) 7(88) 3 (27) 1 (13)
Quality ofcare
Quality of nursing care on the unit 7(54) 4(57) 6(46) 3(43) - -
Quality of medical care on the unit 7(58) 4(57) 5(42) 3(43) - -
Quality of therapy on the unit 6(50) 2(29) 6(50) 5(71) - -
Care of patients with unusual strokes 6(46) 3 (38) 7(54) 5(63) - -
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Question:
"Fromyour experience, how has
the ICP affected the following?"







Nurse Therap Nurse Therap Nurse Therap
Care of younger stroke patients 5(38) 3 (38) 8(62) 5(63) - -
Care of pts. with behavioural problems 2(15) 2(25) 11 (85) 6(75) - -
Care of pts. with cognitive problems 2(15) 1(13) 10(77) 6(75) 1(8) 1 (13)
Quality of discharge planning 6(46) 5(63) 7(54) 3(38) - -
Quality of stroke care in other wards 1(8) 3 (38) 9(75) 4(50) 2(17) 1 (13)
Patient outcomes
Overall chance of recovery* 6(46) 4(57) 6(46) 3(43) 1(8) -
Risk of complications 3 (23) 2(29) 8(62) 4(57) 2(15) 1(14)
Patient/relative satisfaction* 3(25) 3(43) 9(75) 4(57) - -
Personal issues
General knowledge of stroke 6(46) 5(63) 7(54) 3 (38) - -
Clinical acumen in managing stroke 4(33) 5(63) 8(67) 3 (38) - -
Enthusiasm to learn about stroke 6(50) 3 (60) 6(50) 2(40) - -
Confidence in explaining information 6(46) 2(25) 7(54) 6(75) - -
Confidence in managing stroke 3(23) 2(25) 10(77) 6(75) - -
Autonomy in decision-making 5(39) 2(25) 6(46) 6(75) 2(15) -
Overall job satisfaction* 3(23) 2(29) 10(77) 5(71) - -
General working environment
General morale of staff on the unit* 1(8) 2(29) 11(85) 5(71) 1(8) -
Profile of stroke care in WGH* 1(8) 4(50) 12(92) 4(50) - -
Appeal of the unit to job applicants 7(54) 3 (38) 6(46) 5(63) - -
Satisfactory 4 'Midpoint' Unsatisfactory
Nurse Therap Nurse Therap Nurse Therap
Design and implementation ofICP
Overall design* 5(42) 4(50) 4(33) 2(25) 3(25) 2(25)
Size of document* 6(46) 6(75) 6(46) 2(25) 1(8) -
Number of questions to answer* 6(46) 4(50) 2(15) 3 (38) 5(39) 1(13)
Number of signatures required* 2(15) 5(63) 2(15) 2(25) 9(70) 1(13)
Speed and ease of finding information* 5(39) 3 (38) 2(15) 2(25) 6(46) 3(38)
Involvement in the design process* 2(18) 5(63) 4(36) 2(25) 5(46) 1(13)
Clinical relevance of questions* 8(61) 4(50) 4(31) 2(25) 1(8) 2(25)
Explanation of aims of ICP* 4(33) 5(63) 4(33) 3 (38) 4(33) -
Education on how to use the ICP* 2(17) 5(63) 5(42) 2(25) 5(42) 1(13)
Mechanism for feedback of comments* 3(23) 5(63) 7(54) 3 (38) 3 (23) -
Overall process of implementation* 3(27) 4(50) 4(36) 3 (38) 4(36) 1(13)
Ease of getting used to the ICP* 4(31) 5(63) 7(54) 3 (38) 2(15) -
♦New questions compared with one-month survey.
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Table 7.4 Comparing what was initially expected with what was experienced during
the first seven months: comparing the results of nurses (n=12) and therapists (n=5)
who have completed both questionnaires.
During the seven months, what was experienced was...
Higher than what Same as what Lower than what
Item of interest was expected was expected was expected
n (%) n (%) n (%)
Nurse Therap Nurse Therap Nurse Therap
Process ofcare in the stroke unit
Thoroughness in managing patients 1(8) - 6(50) 1(20) 5(42) 4(80)
Speed of doctors clerking patients 2(25) - 2(25) 1(20) 4(50) 4(80)
Speed ofN&T completing paperwork 1(8) 1(20) 8(67) 2(40) 3(25) 2(40)
Speed of obtaining routine CT scans 3(25) 1(20) 7(58) 3 (60) 2(17) 1(20)
Speed of discharge to institution 2(17) 2(40) 7(58) 3(60) 3(25) -
Speed & ease of transfer from ARU - - 8(67) 2(40) 4(33) 3(60)
Speed & ease of transfer to rehab unit 2(17) - 8(67) 3 (60) 2(17) 2(40)
Total length of stay in hospital 4(33) 2(40) 5(42) 3 (60) 3(25) -
Number of investigations 2(18) - 6(55) 2(40) 3(27) 3 (60)
Number of drug errors 1(8) 4(80) 8(67) 1(20) 3(25) -
Number of accidents on the unit 3(25) 4(80) 7(58) - 2(17) 1(20)
Ease ofmaking resuscitation decisions 1(8) 1(20) 5(42) 3 (60) 6(50) 1(20)
Quality of multidisciplinary meetings - 1(20) 5(46) 1(20) 6(55) 3 (60)
Communication
Communication between disciplines - - 5(46) 3(60) 6(54) 2(40)
Communication with patients/relatives - - 8(67) 1(20) 4(33) 4(80)
Quality of information to patients/relat. - - 4(33) 2(40) 8(67) 3 (60)
Expectation from patients/relatives 1(8) 3 (60) 9(75) 2(40) 2(17) -
Number of complaints by patients/relat. 3(27) 3(60) 6(55) 2(40) 2(18) -
Quality ofcare
Quality of nursing care on the unit 3(25) - 4(33) 3 (60) 5(42) 2(40)
Quality of medical care on the unit 3(27) - 5(46) 2(40) 3(27) 3(60)
Quality of therapy on the unit 2(18) - 4(36) 2(40) 5(46) 3 (60)
Care of patients with unusual strokes 2(17) - 5(42) 1(20) 5(42) 4(80)
Care of younger stroke patients 1(8) - 6(50) 3 (60) 5(42) 2(40)
Care of pts. with behavioural problems 2(17) - 6(50) 4(80) 4(33) 1(20)
Care of pts. with cognitive problems 2(18) - 4(36) 3 (60) 5(46) 2(40)
Quality of discharge planning 2(17) 1(20) 5(42) 2(40) 5(42) 2(40)
Quality of stroke care in other wards 2(22) 2(40) 6(67) 2(40) 1(11) 1(20)
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During the seven months, what was experienced was...
Higher than what Same as what Lower than what
Item of interest was expected was expected was expected
n(%) n (%) n (%)
Nurse Therap Nurse Therap Nurse Therap
Patient outcomes
Risk of complications 5(42) 4(57) 4(33) 1(14) 3(25) 2(29)
Personal issues
General knowledge of stroke 2(17) 1(20) 5(42) 1(20) 5(42) 3(60)
Clinical acumen in managing stroke - - 4(36) 5(100) 7(64) -
Enthusiasm to learn about stroke 2(17) 2(40) 6(50) 1(20) 4(33) 2(40)
Confidence in explaining information 1(8) - 7(58) 1(20) 4(33) 4(80)
Confidence in managing stroke 1(9) - 7(64) 2(40) 3(27) 3 (60)
Autonomy in decision-making 1(8) 1(20) 7(58) 4(80) 4(33) -
General working environment
Appeal of the unit to job applicants 3(25) 1(20) 7(58) 3 (60) 2(17) 1(20)
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1. patients should be selected to be managed with the ICP? 8 (50) 6(38) 2(13)
2. the natural course ofstroke is too unpredictable and
3(18) 14(82)
complicatedfor management with an ICP?
3. there should be an electronic version ofthe ICP? 6(35) 4(24) 7(41)
4. there should be a 'patient pathwaywhich is a simplified
12 (80) 1(7) 2(13)









I. patients should be selected to be managed with the ICP? 4(50) 3 (38) 1(13)
2. the natural course ofstroke is too unpredictable and
8(100)
complicatedfor management with an ICP?
3. there should be an electronic version ofthe ICP? 3 (38) 2(25) 3 (38)
4. there should be a 'patientpathwaywhich is a simplified
6(75) 1(13) 1(13)
version ofthe ICP given to the patient/relatives?
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Table 7.6 Comparing the results of the non-randomised studies with those of the
seven-month survey. Notes: t indicates a finding of an increase in the outcome
measure as a result of introducing the ICP in the stroke unit, -l indicates a decrease,
and <-» indicates no change (a combination of these indicates mixed response in the
survey). In the middle two columns, NS = non-significant result, otherwise all other
results were statistically significant at p<0.05.












of 21 members of
SU staff
Speed of obtaining routine CT scans t t NS t
Length of stay in hospital <-» t <-»
Use of iv fluids <-> T NS t
Use of antipyretic when fever <-» <-> t
Use of urinary catheter I NS I <-» or f
Use of nasogastric feeding <-» <-» t
Treatment with early mobilisation* t t <-> or t
Risk of complications+ I I NS <->
Overall chance of recovery* <-» <-> or t
* Physiotherapy only
t Chance of suffering from a urinary tract infection - as an example
* Chance of being alive in hospital - as an example
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Figure 7.1 Transformation of the five-point scales to three-point scales. Please refer
to Appendix 6 for the layout and wording of the questions.
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1. Should integrated care pathways be used to manage patients with
acute stroke?




8.1 Should integrated care pathways be used to manage patients with
acute stroke?
Evidence from previous studies suggests that hospital management with a stroke ICP
may be associated with both beneficial and harmful effects (see Chapter 4). Positive
effects may include: fewer urinary tract infections; fewer readmissions to hospital;
and more patients receiving CT brain scans. Harmful effects may include lower
patient satisfaction and quality of life. There is no evidence so far to suggest that ICP
care is associated with significant benefit or harm on functional outcome such as
death, dependency or discharge destination.
At the WGH, the before-and-after study of 351 patients showed that the introduction
of the ICP in the stroke unit was associated with significant benefit on the quality of
documentation and several aspects ofpatient care (see Chapter 5). These benefits
included: more thorough immediate management of acute stroke (blood glucose and
oxygen saturation measurements, and information provision); more patients
receiving CT brain scans and physiotherapy; and fewer urinary tract infections. I
found no evidence of significant benefit or harm on death or discharge destination.
Also at the WGH, the prospective comparative study of 285 patients showed that,
compared with the general medical wards, the introduction of the ICP in the stroke
unit was associated with significant benefit on the quality of documentation and
several - but slightly different - aspects of patient care (see Chapter 6). These
benefit included: more thorough immediate management of acute stroke (oxygen
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saturation measurements, ECGs, continuation of antihypertensive medication, and
information provision); more patients receiving speech therapy; fewer urinary
catheterisations, and a lower risk of developing fever. However, there may also be
potentially harmful effects such as a lower usage of TED stockings (although the
evidence for this is weak) and longer duration of stay in the WGH. Similarly, I found
no evidence of significant benefit or harm on functional outcome including death,
dependency or discharge destination.
When the nurses and therapists in the stroke unit were surveyed, many of them had
high expectations for the ICP and hoped that it would improve the process of care,
communication and their general working environment. But after having used the
ICP for seven months, many of these expectations (except for process of care) had
not been realised (see Chapter 7).
Therefore, there is accumulating evidence from these three approaches to suggest
that the introduction of an ICP in a stroke unit can lead to better patient care and
documentation, even though there may be a small number of potential concerns. The
evidence is also concordant in suggesting that ICP care, despite its ability to improve
patient care, is unlikely to have an impact on functional outcome.
The introductory chapters have highlighted that an efficient and effective stroke
service requires at least a comprehensive structure, a team of enthusiastic and well
trained healthcare staff, and good organisation of care (see Chapters 1 & 2). From
the evidence so far, ICPs certainly have the potential to improve the process of care,
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especially during the acute phase of stroke where the process of assessment,
investigation, diagnosis and emergency treatment is highly complex, and where
speed is an essence if acute treatments such as thrombolysis is to be considered.
But there is a paradox. The design and implementation of an ICP is probably best
undertaken where the structure of the stroke service is already in place; for example,
where acute stroke patients are routinely admitted to the stroke unit where their
management is provided by a dedicated multidisciplinary team (see Chapter 4).
However, in an already well-structured service, and especially where the patient care
is well-coordinated, the ICP is less likely to provide significant additional benefit.
In my opinion, therefore, the beneficial effects of an ICP may be most apparent in
hospitals where the basic structure of the stroke service is in place but the patient
care is poorly organised. In many hospitals in the UK, this scenario is more
applicable to their acute stroke care than stroke rehabilitation. It has to be born in
mind, however, that the design and implementation of an ICP necessitates a
considerable amount of time, resources and dedication.
I conclude by making the following recommendations:
1. ICP highly recommended: in an acute stroke unit where the service structure is
in place but organisation is poor.
2. ICP recommended: in an acute stroke unit where the service structure is in place
and patient care is well organised.
3. ICP not recommended: in a stroke rehabilitation unit or general medical ward.
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8.2 How should the effects of integrated care pathways for acute stroke
be evaluated?
The methodological considerations when evaluating the effects of ICPs have been
examined in Chapter 2. The limitations of the research designs used to evaluate the
ICP for acute stroke in the WGH have also been discussed in detail in Chapters 5, 6
& 7. It is clear that there is no ideal research design that will overcome the many
problems of bias and confounding. But if future studies are to be carried out, how
should they be performed?
Here is a brief outline of one research design that could be used to evaluate the
effects of ICPs for acute stroke. This could be a UK-based multicentre before-and-
after study involving stroke units that have never used ICPs to manage patients with
acute stroke. Data would be collected prospectively, ideally using well-structured
methods of data collection and analysis - e.g. the national sentinel audit. Outcome
measures should be simple, few, and easy to collect. Each stroke unit would start
collecting data before the introduction of an ICP (there may already be several sets of
data from the previous rounds of national sentinel audit). The intervention to be
introduced should be a very simple ICP for acute stroke, which contains only the
core elements that are based on the best-available evidence and national clinical
guidelines (e.g. SIGN and RCP guidelines). Each centre is then encouraged to
modify the ICP according to local circumstances and policies in order to give them
'ownership', but the original core ICP should not be altered. Each centre would then
continue to collect data using the standard data set and collaborative data analysis
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would be performed by a third party at the end. Comparison between centres may
also be performed under the auspices of the British Association of Stroke Physicians
(e.g. the Benchmarking Survey).
As I discussed in Chapter 2, the methodology of such a study can be further
strengthened by employing a control group before and after the introduction of the
ICPs in the intervention group. This control group could consist of a number of
hospitals which are similar to the intervention group but without the introduction of
the ICPs.
There are several methodological difficulties associated with this type of study.
Firstly, it is likely to require many centres that have never introduced an ICP - many
hospitals in the UK are already using (or planning to use) ICPs to manage patients
with acute stroke. Secondly, it would probably have to last a long time in order to
recruit a large enough sample - probably in terms of thousands of patients; this
would invariably require a substantial amount of resources and a large team of
researchers. Finally, one has to question whether such a study is really necessary -




In this thesis, I used multiple approaches to evaluate the effects of ICPs for acute
stroke. These approaches have provided evidence that ICPs may be useful in
improving the process of care and quality of documentation, but not functional
outcome. However, more information is needed on the impact of ICPs on other
important outcomes such as quality of life, patient and carer satisfaction, and the cost
of their usage. Qualitative research may also provide additional information on the
best method of design, implementation and evaluation of ICPs.
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APPENDICES
A1. The ICP for acute stroke in the WGH
A2. Development of the ICP for acute stroke at the WGH
A3. Major developments in the stroke service at the WGH in the past
decade
A4. Inter-rater study of the clinical assessment of patients with acute
stroke
A5. Data collection forms used in the non-randomised studies and
surveys
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A1. The integrated care pathway for acute stroke at the WGH
Name:
Address:
Cons: msdn RILQ Other □
Other Cons: specify
Date Admitted to Pathway
(ifdifferent tn fl/ite nf Adm V / /
DOB: / / Already I/P? yes□, NOD Initial Ward number:
Age: Second Ward number:




& sign):History of Presenting Complaint
Symptom onset: Date: / / Time: : Designation:
Date: / /



























Vascular History Yes No If yes, give details
TIAs □ □
Stroke(s) □ □
Previous MI(s) □ □
Angina/Unstable angina □ □
Arrhythmia (eg AF) □ □
Heart failure □ □
Valve disease □ □
Cardiac surgery □ □
Peripheral vascular disease □ □
Diabetes □ □ IDDM □ NIDDM□
Hypertension □ □
Migraine with aura □ □
Epileptic seizures □ □
Lifestyle Yes No Complete details if requested
Current Smoker
(or. Never 1 1)
□ □ IfNo,Ex-smoker Q: cigs/day, for yrs, Date gave up smoking: / /
If Yes, cigs/day for yrs: Type of tobacco: cigs ED pipe EH cigars [j
Hypercholesterolemia □ □ (>5.0mmols/l) Last chol. Result: date:
Family history of IHD or
stroke
□ □ F< 60 □, M<55 □
Any Alcohol Intake □ □ Current Units/week, Tick if previous higher intake E~ i




Other Past Medical History / Family History
Drags on Admission Dose Freq. Drugs on Admission Dose Freq.
Source: patientO letterQ GP ED
DRUG SENSITIVITIES:






Physical Examination Specify Details
General:
Jaundice □ Pallor O Clubbing □ Cyanosis 1 1


















Yes, □ No □




Norm □ Abn f 1
Warm | | Cool Q










Leu nanaeaRight handed □
Glasgow Coma Scale (Ring level for each domain) Visuospatial
(f*cr c
Eye opening - Never 1
- To pain 2
- To sound 3
- Spontaneously 4
Best motor - None 1
- Extend to pain 2
- Abn flex to pain 3
- Flex to pain 4
- Localises pain 5
- Normal 6
(eg neglect, sensory or visual inattention)
Is there evidence of visuospatial dysfunction?
No O Left O Right O Unassessable O
Is the patient aware of their neurological deficit?
Yes □ No □






Draw a clock face Copy this picture Patient
Mental Test Score (Hodkinson) Communication
(tick correct answers) (written if not verbal)
Age cm
Time (nearest hour) cm Can the patient communicate normally?
42 West Street (ask patient to recall at end] 1
Name ofHospital □ [YES] [NO]
Year cm
Recognise two people (eg.Dr & Nurse) cm IfNO:
Date of Birth cm Dysphasia? [ ]
Dates ofWorld War II □ Dysarthria? [ ]
Present Monarch im Other [ ]
Count down 20 -> 1 cm None [ ]
Unable cm
Total =
(NB: If unable to complete give reason)
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Cranial Nerves:
Are the visual fields normal?
Yes □ No □ Unassessable □














Nurses should screen for swallowing problem - ask them for the result, so you can write up drugs
and fluids appropriately
Limbs:



























+ = with potentiation
++ = normal
+++ = increased












[ ] [ ]
[ ] [ ]




(As a minimum test, PINPRICK or LIGHT TOUCH and JOINT POSITION SENSE. Look for
sensory inattention) If not possible to test, give a reason.
Is there any sensory loss?
Yes [ ] No [ ] Unassessable [ ]
(If YES shade affected area on picture ->)
Is there sensory inattention?
Yes [ ] No [ ] Unassessable [ ]




Summary of neurological deficits
Where is the brain lesion?
Diagnosis
TIA U
Stroke/brain attack j j
Amaurosis fugax [_]










Total anterior circulation syndrome [_]
Partial anterior circulation syndrome [_]
Lacunar circulation syndrome [_]
Posterior circulation syndrome [_]
Uncertain u




Was the patient independent in ADL before stroke? [_J LJ
Did the patient live alone? [_] LJ
Can they talk? [_] LJ
Are they orientated in time, place, person? LJ LJ
Can they lift both arms off the bed? LJ LJ
Can they walk without help? LJ LJ
Investigations: (bold indicates for all patients)




























CT Date Echo Result Date
MR: Date Doppler Date





Cause of stroke uncertain?
Can patient take adequate
fluid orally?




Is 02 sat <95% on air?
If yes Further investigations organised
If no









Insert Venflon [ ]
Prescribe IV fluids
(check U&Es at least 2x/week)





Aspirin 300 mg stat, 75 mg daily [ ]






Stop any antithrombotic drugs unless
prosthetic heart valve
Reverse anticoagulation in consultation
with haematologist
Avoid heparin unless previous DVT/PE
or other strong indication
Consider for Stockings Trial (CLOTS)
[ ] If yes Prescribe supplemented 02 with %
[ J [_]
[ 1 [ ]
[ ] [ ]
[ ] [ ]
[ ] LJ
Has the patient a fever?
(at any time in 1st 5 days)
Is the blood sugar >11 mmol/1)?
Is BP elevated (>160/90)?
Have you explained diagnosis,
investigations and treatment
with patient or relatives?
If yes Prescribe regular paracetamol & fan
infection screen (think about endocarditis)
Give broad spectrum antibiotics if sick
[ ] If yes Start GKI infusion with hourly BMs
If yes Leave alone unless signs of accelerated
phase hypertension
Give normal antihypertensive treatment
if can swallow and SBP > 120mmHg.
If no Do so and document on communication
sheet
If N/A explain on variance sheet




Review ofManagement Plan - Admission +1 or 2 Date / /
Yes No Done N/A
Cause of stroke uncertain? [ ] [ ] If yes Further investigations organised [ ] [ ]
Can patient take adequate Done N/A
fluid orally? [ ] [ ] If no Insert Venflon [ ] [ ]




(check U&Es at least 2x/week)
Consider for FOOD trial - Early NG vs Delay
Yes
If no Is it needed?
If yes Alternative route organised
No
Done N/A
[ ] If yes Aspirin 300 mg stat, 75 mg daily [ ~
(Give by rectal suppository if unable to swallow)
Is 02 sat <95% on air?
If yes Stop any antithrombotic drugs unless
prosthetic heart valve
Reverse anticoagulation in consultation
with haematologist
If yes Prescribe supplemented 02 with %
[ ] [ ]
Has the patient a fever? [ ]
(at any time in 1st 5 days)
Is the blood sugar > 11 mmol/1)? [ ]
Is BP elevated (>160/90)?
Have you explained diagnosis,
investigations and treatment
with patient or relatives?
[ ] If yes Prescribe regular paracetamol & fan
infection screen (think about endocarditis)
Give broad spectrum antibiotics if sick
If yes Start GKI infusion with hourly BMs
If yes Leave alone unless signs of accelerated
phase hypertension
Give normal antihypertensive treatment
if can swallow and SBP > 120mmHg.
If no Do so and document on communication
sheet [ ]




Date Other problems Active +/- Actions Signature
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Addressograph
RECORD OF LABORATORY INVESTIGATIONS



































Date: / / Time: NURSIN(i ENQUIRY Ward:





Type of admission — tick one only
999 [_]
GP LJ





(if deteriorated from ARU or outwith range, inform doctor)
Is the: - Yes No
Temperature - >37.5°C T IT 1
Pule** ^>i nn r 1 r 1Marital status
Single [ ] Separated [ ]
Married/with partner
Divorced [ 1 Widowed [ |
rUlSc - -^lUU | s j 1
Systolic BP - <100 - >200mmHg j ;j |
O2 saturation - <92% j j f j
Respiratory rate - >20 <5 f 1 f 1
Social circumstances
Siblings Yes[ ] No[ ]
Dependants Yes[ ] No[ ]
Patient's occupation
Partner's occupation
Driver Yesf 1 Nof ]
vjids^ow LOmd ocore j j | j
(see front sheet)
Deterioration of >1 point from [ 1
ARU (inform doctor)
If abnormal, Doctor informed 1 ! !
Admission Barthel score i |
Medication Yes No
With patient [ 1 [ 1
Stored in drugs trolley/med cupboard [ | | |
Taken home [ ] i !
Dosette box used T IT 1
If a problem, specify:
Refer pharmacist: Yes [ ] No [ ]
Home Circumstances Yes No
Lives alone [ ] [ ]
District nurse [ ] [ ]
(specify days per week)
Home help [ ] [ ]
(specify days per week)
Nursing home [ ] [ ]
Residential care [ ] [ ]
Other services
Contact 1 - next of kin
Personal belongings Yes No
Clothing listed T 11 1







Relatives spoken to Yesf ] No[ ]
Documented on
Communication chart Yesf ] Nof ]
Identification band attached Yesf ] Nof ]
Nurse call system explained Yesf ] Nof ]











Please circle relevant score. Only select ONE score from each section.
Select the highest score that applies
SCORE
WEIGHT
Weight steady, intentional weight loss or weight gain 1
Gradual unexpected weight loss over past 6 months 2
Weight loss over past 4-6 weeks greater than 3.5Kg 3
Rapid weight loss and/or extremely thin and emaciated 4
APPETITE
Appetite good, able to finish most meals 1
Appetite poor eats only small meals or snacks/requires soft diet 2
Appetite poor manages only fluids or on free fluids 3
Appetite nil or virtually nil/unable to take anything orally has been NBM
for <4 meals 4
ABILITY TO EAT OR RETAIN FOOD
No difficulty eating, able to eat independently 1
Problems handling food, eg needs special cutlery. Frequent regurgitation
(or possetting) 2
Problems affecting food intake eg chewing, difficulty swallowing, requires modified
consistency, loose dentures, needs special help with feeding (eg physical handicap) 3
Unable to take food orally. Unable to swallow (complete dysphagia) 4
Unable to retain food eg vomiting or diarrhoea 5
MENTAL STATUS
Alert, Orientated, Co-operative 1
Apathetic, mildly confused 2
Confused, unco-operative, depressed 3
Comatose, unconscious 4






Date: / / Time: NURSING ENQUIRY Ward:
Pre admission On admission
BREA1fHING
Domiciliary oxygen Yesf 1 Nof ] Airway maintained Yesf 1 Nof ]
- nebuliser Yesf 1 Nof ] Suction required Yesf 1 Nof ]
Poor exercise tolerance Yes[ 1 Nof ] Oxygen required Yesf 1 Nof ]
If yes, specify If yes - prescribed Yesf 1 Nof ]
If >35% humidify Yesf 1 Nof ]
EYE : ARE
Blind Yes[ 1 Nof ] Spectacles with patient Yesf 1 Nof ]
Partially sighted Yes[ ] Nof ] If yes, spectacles listed Yesf ] Nof ]
Wears spectacles/contacts Yesf ] Nof ] and marked Yesf 1 Nof ]
- for reading Yesf 1 Nof ] Specify eye care requirements:
- for distance Yesf 1 Nof ]
Wears artificial eye Yesf 1 Nof 1
ORAL CARE
Own teeth Yesf 1 Nof ] Mouth care required Yesf ] Nof ]
Dentures Yesf ] Nof ] Detail specific care
Specify type: Frequency
Regime for cleaning teeth: If dentures - marked? Yesf ] Nof ]
Referred to dentist Yesf 1 Nof ]
Specify care of dentures
NUTRITION
Weight (patient's reported) Weight (patient's actual)
Height Height
Existing therapeutic diet Yesf 1 Nof ] IfNutritional Score >15,
If yes, specify referred to dietitian? Yesf 1 Nof ]
Appetite: Poorf ] GoodfJ Dysphagia screen completed
Food allergy or intolerance Yesf ] Nof ] (see sheet) Yesf 1 Nof ]
Particular foods avoided: Yesf 1 Nof ] If failed - put NBM
If yes, specify - refer to SLT Yesf 1 Nof ]
- parenteral fluids organised Yesf ] Nof ]
- alternative route for oral
medication organised Yesf ] Nof ]
If passed - needs supervision? Yesf ] Nof ]
Fluid balance chart started Yesf j Nof ]
SLEEPING
Sleeps well Yesf 1 Nof ] Restless Yesf 1 Nof ]
Takes sleeping tablet Yesf ] Nof ] Settled Yesf ] Nof ]





DYSPHAGIA SCREENING TEST - ACUTE NEUROLOGICAL PATIENTS
Name: Ward:
Date: Assessor:
Before you start: Is the patient fully conscious, alert & aware? Yes[ ]No[ ]
Able to produce normal voice and a voluntary cough Yes[ ]No[ ]
Swallow saliva spontaneously Yes[ ]No[ ]
If no, see criteria for dysphagia referral

























[ ] No attempt to swallow





[ ] wet/gurgly voice





[ ] wet/gurgly voice





[ ] wet/gurgly voice




Consider behaviour and level of
Supervision required
I
Normal diet with/without nursing supervision
Comments:
Signed:
[ ] spillage from mouth
[ ] pocketing in cheek
[ ] residue on tongue




[ ] wet/gurgly voice


















Date: / / Time: NURSING ENQUIRY Ward:
Pre admission On admission
MOBILITY
Independent Yes[ ] No[ ] Bed bound Yes[ J No[ ]
Transfers with i LJ 2[_J Mobile Yes[ j No[ ]
Walks with 1[_J 2 LJ Transfers with 1 [ ] 2 [_J Hoist[ ]
Manages stairs Yes[ ] No[ ] Sling colour
Housebound Yes[ ] No[ ] Walks with 1 [ ] 2 [ ]
Risk of injury Yes[ ] No[ ] Independent Yes[ ] No[ ]
If yes, specify Specific seating required Yes[ ] No[ ]
Wears appliance/prosthesis Yes[ ] No[ ] If yes, specify
If yes, specify Risk of injury Yes[ ] No[ ]
Uses walking stick Yes[ ] No[ ] If yes, specify action
Uses mobulator Yes[ ] No[ ]
Rec physio before admission Yes[ 1 No[ ] Referred to physiotherapist Yesr 1 No[ ]
SKIN
Skin intact Yes[ ] No[ ] Waterlow score (see over) Done[ ] Not done[_ )
Skin intact Yes[ ] No[ ]
If no, specify treatment Pressure sore Yes[ ] No[_
- Grade:




WASHING AN D DRESSING
Independent Yes[ ] No[ ] Fully independent Yes[ ] No[ ]
Requires assistance Yes[ ] No[ ] Bed bath Yes[ ] No[ ]
If yes, specify Washes top half Yesr 1 No[ ]
Totally dependent Yes[ ] No[ ] Washes bottom half Yesf 1 No[ ]
Likes bath Yes[ ] No[ ] Dresses top half Yesr 1 No[ ]
shower Yes[ ] No[ ] Dresses bottom half Yesr 1 NoLJ
Frequency: Daily[ ] Weekly[ j Other[ ] Requires maximum assistance Yesr 1 No[ ]
Aids used Yes[ ] No[ ] - minimum assistance Yesr 1 No[_J
If yes, specify Referred to OT Yesr 1 Nor 1
ELIMIb ATION
Continent (urine) Yes[ 1 Nor l Continent Yes[ ] No[_J
If no, specify nature of problem/aid used: Incontinent of urine Yesr 1 NoLJ
Incontinent of faeces Yesr 1 No[_J
Diarrhoea Yes[ ] No[ ] Toileting regime Yesr 1 No[_J
Constipation Yes[ ] No[ ] If yes, specify
Faecal incontinence Yes[ ] No[ ] Wearing pad and pants Yesr 1 No[_J
Stoma Yes[ ] No[ ] If yes, specify colour
Aperients used Yes[ ] No[ ] Catheterised Yesr 1 No[_]
If yes, specify If yes, why









WATERLOW PRESSURE SORE PREVENTION/
TREATMENT POLICY
Ring scores in table, add total - several score per category can be used
Build/weight for Skin type/visual Sex/age Mobility
height risk areas
Average 0 Healthy 0 Male 1 Fully 0
Above average 1 Tissue paper 1 Female 2 Restless/fidget 1
Obese 2 Dry 1 14-49 1 Apathetic 2
Below average 3 Oedematous 1 50-64 2 Restricted 3
Clammy (temp) 1 65-74 3 Inert/traction 4
Discoloured 2 75-80 4 Chairbound 5











































Date: / / Time: ADMISSION +1 Ward: Initials:
ASSESSMENT ACTIONS
Yes No DONEN/A PRINT/SIGN








Inform doctor if <95% on air







c Is temp>37.5? [_][_] If yes Inform medical staff











d Is systolic blood pressure










e Has Glasgow Coma Scale










f Has dysphagia screen been
passed since admission? [_][_] If no Put nil by mouth
Refer to SLT/rpt in 24hrs if drowsy
Parenteral fluids organised
Alternative route for oral medication
organised
Fluid balance chart started
If failed because of drowsiness repeat on







If yes Needs supervision UU
g Has the patient a venflon? LJ[_] if yes Site checked? LJLJ
h Therapeutic diet required? [_][_] If yes Refer to bedside swallowing regime
Specific instructions followed




iAble to wash independently? [_][_] If no Bed bathed
Assistance given to shower/bath
LJLJ
LJ L
j Is patient able to communicate
normally? [ ] [ ]If no Refer to Speech and Language Therapy LJLJ
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ASSESSMENT




[ ] [ ] If no Assistance given to dress [ ] [ ]
Referred to OT [ ] [ ]
[ ] [ ] If yes Inspect skin and change
position 2 hourly [ ] [ ]
Document at risk areas [ ] [ ]
Consider special mattress/cushion [ ] [ ]
PRINT/SIGN
mis patient independently [ ] [ ] If no Refer to physiotherapist [ ] [ ]
mobile? Specific techniques used for assisting
with mobility and transferring identified [ ] [ ]
If sitting up, specific seating and
pressure relieving cushion identified [ ] [ ]
If on bedrest, limbs positioned
according to hemiplegia chart [ ] [ ]
Safety sides in place to prevent from falling [ ] [ ]
n Continent of urine? [ ] [ ] If no Routine specimen tested [ ] [ ]
Midstream specimen obtained [ ] [ ]
Toilet 2 hourly [ ][ ]
Assisted to use commode/urinals by bedside [ ] [ ]
Commence bladder record chart [ ] [ ]
Size for pads and pants and arrange
according to manufacturers
recommendations [ ] [ ]
Ifmale appropriate size of urinary
drainage sheath applied [ ] [ ]
Output recorded on fluid balance chart [ ] [ ]
If Waterlow >10, catheterise if skin at risk [ ] [ ]
Leg bag applied when sitting up [ ] [ ]
Overnight bag attached when on bedrest [ ] [ ]
o Continent of faeces? [ ] [ ] If no
If yes
Rectal check performed LJ [_]
Size for pads and pants and arrange
according to manufacturers
recommendations [_] LJ
Medical staff informed LJ LJ
Specimen obtained if diarrhoea LJ LJ
Record frequency of bowel movements LJ LJ
Give laxative according to symptomatic
relief policy if bowels haven't moved
within 3 days LJ LJ
p Patient unable to sleep at night? [ ] [ ]If yes Assess for pain or discomfort [ ] [ ]
Give analgesia if required [ ] [ ]
Alter position in bed [ ] [ ]
Assess for other complications and
document on interdisciplinary
communication sheet [ ] [ ]
Assess need for sedative and consult
with doctors [ ] [ ]
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Date: / / Time: ADMISSION +2 Ward: Initials:
ASSESSMENT
a Patient is managing own
airway?
ACTIONS
Yes No Done N/A
[ ] [ ]If yes Remove airway [ ] [ ]
Give suction when required [ ] [ ]
Encourage to cough and expectorate [ ] [ ]
Refer for chest physio [ ] [ ]
Monitor oxygen saturations [ ] [ ]
Continue oxygen therapy as prescribed [ ] [ ]
If no Follow Admission +1 [ ] [ ]
PRINT/SIGN
b Remains pyrexial? [ ] [ ]If yes Follow Admission +1
Ensure infection screen has been
carried out




c Is systolic blood pressure
<100 or >200? [ ] [ ]If yes Record 2 hourly
Continue to follow admission +1




d Is Glasgow Coma Scale




[ 1 [ 1
LJLJ
e Patient is able to swallow
safely? [ ] [ ]If no Follow Admission +1 [ ] [ ]
Venflon reviewed [ ] [ ]
Further assessment by SLT [ ] [ ]
Review results and follow specific
instructions on Dysphagia Screening Test [ ] [ ]
If yes Give free fluids and normal diet [ ] [ ]
Remove venflon if intake over 2 litres [ ] [ ]
f Patient is able to wash
independently? [ ] [ ]If no Follow Admission +1 [ ] [ ]
If yes Offer shower, bath or basin at bedside
assisting as required [ ] [ ]
g Patient is able to dress
independently? [ ] [ ]If no Follow Admission +1 [ ] [ ]
Assist and reinforce dressing techniques




i Is patient independent?
j Continues to be incontinent of
urine/faeces?
k Patient is unable to sleep?
1 Patient is for further
rehabilitation?




[ ] [ ]If yes Follow Admission +1
If no Record weekly





[ ] [ ]If yes Continue to follow Admission +1 [ ] [ ]
Check specimens have been obtained [ ] [ ]
If no Ensure buzzer is within reach and toilet needs
are met (use of urinal, commode or toilet) [ ] [ ]
[ ] [ ]If yes Follow Admission +1 [ ] [ ]
Discuss with doctors needs for sedative LJLJ
[ ] [ ]If yes Refer to Stroke Rehabilitation Unit [ ] [ ]
[_] [ ]if yes
If no
Review information given on patient/relatives
communication sheet to ensure consistency [ ] [ ]
Arrange appointment with doctor [ ] [ ]
PRINT/SIGN
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Date: / / Time: ADMISSION +3 Ward: Initials:
ASSESSMENT






Encourage deep breathing exercises











[ ] [ ]
[ ][_]














e Patient is able to swallow safely? [ ] [ ]If no
If yes
Follow Admission +1 and refer to
Dysphagia Screening Test
Give normal diet and fluids




f Patient is able to wash






g Patient is able to dress
independently? [ ] [ ]If no Follow admission +1 and +2 [ ][_]
h Waterlow Score >10? [ ] [ ] if yes
If no




i Is patient independent? [ ] [ ]If no
If yes
Follow Admission +1
Initiate discharge planning checklist
LJ LJ
[_][_]
j Incontinent of urine/faeces
persists? f 1 LJIf yes
If no
Continue to follow Admission +1
Follow Admission +2 [ ][_]
k Patient is unable to sleep? [ ] [ ]if yes Follow Admission +1 and +2 [_][_]
1 Patient and relatives are fully





m Discharge planning initiated? [_] [ ]If no Refer to discharge planning sheet [ ][ ]
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Date: / / Time: ADMISSION +4 Ward: Initials:
ASSESSMENT






Encourage deep breathing exercises












c Blood pressure is within set






d Glasgow Coma Scale remains






e Patient is able to swallow safely? [ ][ ] f no
fyes
Follow Admission +1 and refer to
Dysphagia Screening Test
Give normal diet and fluids




f Patient is able to wash






g Patient is able to dress
independently? [_] [_] f no Follow admission +1 and +2 LJLJ
h Waterlow Score >10? L L f yes
f no




i Is patient independent? LJLJ f no
fyes
Follow Admission +1
Initiate discharge planning checklist
LJLJ
LJLJ
j Incontinent of urine/faeces
persists? [_] [_] fyes
f no




k Patient is unable to sleep? LJLJ fyes Follow Admission+1 and+2 LJLJ
1 Patient and relatives are fully





m Discharge planning initiated? LJLJ f no Refer to discharge planning sheet LJLJ
PRINT/SIGN
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Date: / / Time: ADMISSION +5 Ward: Initials:
ASSESSMENT ACTIONS
a Patient is managing own
airway?
Yes No
[_] [ ]If yes
If no
Encourage deep breathing exercises


























e Patient is able to swallow
safely? LJLJIfno
If yes
Follow Admission +1 and refer to
Dysphagia Screening Test
Give normal diet and fluids











g Patient is able to dress
independently? LJLJIfno Follow admission +1 and +2 LJLJ
h Waterlow Score >10? LJLJifyes
If no




i Is patient independent? LJLJIfno
If yes
Follow Admission +1
Initiate discharge planning checklist
LJLJ
LJLJ
j Incontinent of urine/faeces
persists? L_] LJif yes
If no




k Patient is unable to sleep? LJ[_]Ifyes Follow Admission +1 and +2 [_][_]
1 Patient and relatives are fully













1-occasionala cident(<lx/w ek) 2 -continent BLADDER 0-incontinent/catheter 1-occasionala cident(<lx24hrs) 2 -continent GROOMING 0 -needsh lp 1-independent(face,h irteethshaving) TOILETUS 0-dependent 1 -needssomeh lp 2 -independent(inclu ingl ani ) FEEDING 0-unable 1-needsh lp(cutting,spr ading) 2 -independent TRANSFER 0-unable(nosittingbalance) 1 -majorhelp,butc nsi 2 -minorhelp(physicalorverbal) 3-independent MOBILITY 0 -immobile 1 -wheelchairindep ndent 2 -walksithhelp(physicalorverbal) 3-independentbutmaysai DRESSING 0 -dependent 1 -needsh lp(candof) 2 -independent STAIRS 0-unable 1 -needsh lp 2 -independent BATHING 0 -dependent 1 -independent TOTALBAR HELSCORE
Addressograph
417
SPEECH AND LANGUAGE THERAPY
Addressograph
Referral to SLT received: / / Date first seen: / /
riODiem
Dysphasia
i es 1NO comments
Dysarthria
Dysphagia
Discharge from SLT: Reason for discharge:








Dysphagia Management Status - enter date of change
ORAL NG PEG
NBM with IV/subcut. fluids
Date: [ 1
NG only with oral hygiene
Date: \ 1
PEG only with oral hygiene
Date: I 1
NG with comfort feeding
Date: I 1
PEG with comfort feeding
Date: \ 1
Therapist trials only (IV fluids)
Date: T 1
NG with therapist trials
Date: \ 1
PEG with therapist trials
Date: \ 1
Restricted oral with strategies
and supervision +/- IV
Date: f 1
NG, restricted oral with
strategies and supervision
Date: r 1
PEG with restricted oral,
strategies and supervision
Date T 1
Restricted oral with strategies
+/- IV
Date: f 1
NG with restricted oral
strategies
Date: f ]
PEG with restricted oral and
strategies
Date: T 1
Restricted oral +/- IV
Date: [ 1
NG with restricted oral
Date: \ ]
PEG with restricted oral
Date: \ 1
Normal oral and strategies





Refer to bedside swallowing regime and SLT notes on interdisciplinary communication sheet for
current recommendations
Nutritional/Dietetic Action (tick those that apply)
Referral to Dietitian received: / / Patient seen: / /
Nutritional support Date started Texture modification Date started
Extra snacks/drinks Liquidised diet




Enteral feeding - overnight Liquids: none
Enteral feeding - total Liquids: thickened syrup
Liquids: thickened custard
Liquids: normal
Food chart required - date: Trial diet required - date:
Discontinued - date: Discontinued - date:














Swallow Assessment □ □ □
Neurological Assessment □ □ □
Hemiplegic Shoulder Pain
Assessment □ □ □
Balance Assessment:
Sitting Balance □ □ □
Standing Balance □ □ □
Transfer Assessment □ □ □
Gait Assessment □ □ □
Stair Assessment □ □ □
Involvement with relatives
of treatment □ □ □
Refer to RVH:
Verbally □ □ □














If no, give reason & date completed
Physio signature:
Yes No Date achieved
N/A - indicates a professional decision that the assessment is not deemed appropriate at that time
YES - indicates that the assessment has been completed
No - indicates that the assessment has not been completed
420
OCCUPATIONAL THERAPY
Referral to OT: / /






















Washing/Grooming Assessment D D
□ □
□ □

























































All issues resolved □ □ IfNo have appropriate






Date referred to social work:
Date allocated to social worker:
Allocated worker:
Contact number:
Does anyone have power of attorney over
the patient?
Is patient aware of referral? Yes □ No □
If no, why not?
Is there a community social worker involved?
Give details:
Service Required
Residential/Nursing Home care (please tick)
Yes No
Patient self funding? □ □
Medical form completed? □ □
Is patient Part 4 fit? □ □
Is patient in agreement? □ □
Care at home (please tick)
Yes No
Restart of service required? □ □








Date on waiting list for funding:
Date funding awarded:
Details of any unmet needs/future follow up planned:
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SocialWork
CARE PLAN -Weekly timetable of tasks & services
Start date Review date

























For CPR: Yes □ No □












Medical - Consultant Present / Absent
SLT - Present / Absent




Date: / / Week
Barthel Index:
For CPR: Yes □ No □
Nursing - Present / Absent
Status




























Persons name: Spoken to by: Sign & print name
Relation to patient: Witnessed by:
Date:
Time:
Persons name: Spoken to by:
Relation to patient: Witnessed by:
Date:
Time:
Persons name: Spoken to by:
Relation to patient Witnessed by:
Date:
Time:
Persons name: Spoken to by:
Relation to patient Witnessed by:
Date:
Time:
Persons name: Spoken to by:
Relation to patient Witnessed by:
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PHARMACY
Discharge plan - nursing checklist
Action Date Time Signature
Treatment written □ / /
Send to pharmacy (24 hours required) □ / /
Pharmacist checked □ / /
Discharge medication explained to patient □ / /
Leaflet given □ / /
Referred to pharmacist □ / /
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A2. Development of the ICP for acute stroke at the WGH
In 1998, the 11-beded stroke unit opened within Ward 15, with a large number of
new healthcare staffjoining the unit. Dr Dennis had the initial idea to introduce an
acute stroke ICP in the unit, and a decision was made to develop an ICP after
discussions with Dr Lindley, the nursing sister and the rest of the multidisciplinary
team. At that time, the Trust was encouraging the development of ICPs across all the
medical and surgical specialities. The stroke team also saw the ICP as a potentially
useful method of standardising patient care in a new unit with new staff. Since Dr
Dennis has had previous experience in developing a stroke clerking proforma, which
has been shown to improve documentation of patient assessment, the team was keen
to introduce a similar documentation system. Moreover, it was felt that an ICP using
tick boxes would facilitate audit ofpatient care and outcome within a new unit.
In the WGH, another ICP was being developed by the cardiology department for the
management of acute myocardial infarction (AMI) in the coronary care unit (CCU).
The stroke team was encouraged by the Department of Clinical Audit and people
responsible for developing ICPs to emulate the ICP for AMI. Initially, this seemed
sensible since junior medical staff and some nurses rotated between medical wards
and the CCU, and having similar formats of ICPs might facilitate their use and
enhance compliance. However, soon after the introduction of the ICP for AMI, the
document was thought to be badly designed and difficult to use, and it was soon
abandoned. It was later replaced by a much shorter and simpler document.
The acute stroke ICP was designed by the members of the multidisciplinary team
working on the stroke unit: Drs Dennis and Lindley, Patricia Taylor (nursing sister),
Fiona Small (physiotherapist), Sheena Borthwick (speech therapist), and a number of
different occupational therapists. There was also input from the dietician, social
worker, and other people with an experience of developing ICPs (e.g. a clinical nurse
specialist). Team meetings, which were led by Dr Dennis, were held to discuss the
planning and design of the ICP. The team decided to focus on the acute stroke period
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because clinical assessments and investigations were similar in most stroke patients,
and the team's objective was to standardise acute stroke care during this period.
After the first few days, because stroke patients varied enormously with their clinical
and psychosocial needs, an ICP that delineated specific treatment pathways would
have been impractical. The team also explored the possibility of developing a stroke
rehabilitation ICP within the stroke rehabilitation unit at the Royal Victoria Hospital,
but the healthcare staff there were not enthusiastic and rejected the idea.
Although national guidelines recommendations were used to design the ICP, the
team did not need to specifically refer to the guidelines. This was because Drs
Dennis and Lindley had been very closely involved in the development of SIGN and
RCP guidelines, and they were very familiar with the recommendations. No extra
literature search was needed since the guidelines already contained comprehensive
systematic reviews of the literature on all the important aspects of stroke care. The
team also assessed five other stroke ICPs for comparison (e.g. from Glasgow,
Aberdeen and Tyneside), and the good and bad ideas were noted.
The ICP comprised of separate sections relating to the different disciplines. Each
discipline was responsible for the content of their section and wrote their own drafts.
Some disciplines' sections were integrated into others; for example, the speech
therapists' section contained material belonging to the dieticians. The ICP
incorporated national guideline recommendations on acute stroke management
within the first few days. However, in disciplines such as nursing, where there were
few such guidelines, the sections were more difficult to design. After about six team
meetings, the first draft of the complete ICP was circulated amongst the team
members and comments were fed back to the whole team. This process took some
time, especially for the medical and nursing sections because they contained many
more items and the documents were longer. When the whole team was satisfied with
the final version, it was piloted in real patients. Each discipline was responsible for
the implementation and maintenance of their own section of the ICP. For example,
Dr Dennis and Lindley were responsible for teaching the junior staffhow to use the
ICP when they first arrived on the unit. Since the junior doctors turned over every
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month, formal induction sessions to large numbers ofmedical staffwould not have
been practical. The nurses also held a number of educational sessions to explain how
to use the nursing section of the ICP. In general, the time and resources invested into
developing the ICP was relatively low, which may be due to the team's high level of
experience and background knowledge.
During the pilot phase, several interesting problems were encountered. One problem
was that the physiotherapy and occupational therapy departments insisted on
retaining their own departmental patient records. This meant that what the therapists
wrote in the ICP was only a summary of a more detailed report written in the
departmental records. Another problem was that it was difficult to judge how much
nurses should write down about patient care in addition to ticking the boxes in the
ICP. Some nurses argued that it was important to add in free text about certain
aspects of the patient's care, especially when some details were not covered by the
tick box questions and answers. Since the implementation, ongoing assessment of the
ICP has found that some parts of the ICP have been less well received. The nursing
section has also been found to be too complicated and is now being redesigned.
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A3. Major developments in the stroke service at the WGH in the past
decade
June 1990 Dr Dennis started. There was a 12-bedded medical admission ward
(Ward 25) from which patients with stroke were identified. Stroke
care was provided by the general physicians on general medical wards
(two 30-bedded wards) but there was no specialist stroke team.
Sept 1990 Lothian Stroke Register started - details of consecutive stroke patients
were entered into a database.
Nov 1992 Neurovascular clinic and inpatient stroke team were set up.
June 1993 A 15-bedded stroke rehabilitation unit (Ward 14) was set up. Acute
stroke care was provided by the stroke tern (led by Dr Dennis) on the
general medical wards. The Accident & Emergency Unit closed and
was replaced by the Acute Receiving Unit (ARU) and minor trauma
unit. The original medical admission unit (Ward 25) was abandoned
and it became a cardiology ward.
Nov 1996 Dr Lindley started. Acute stroke care was moved to Ward 11 (a
general medical ward) where Drs Dennis and Lindley shared the care.
Dr Dennis also managed the stroke rehabilitation unit, while Dr
Lindley managed Ward 15 which was a Geriatric Assessment Unit.
June 1998 Stroke rehabilitation Unit was moved to the Royal Victoria Hospital
(Ward 8, a 26-bedded unit), where Drs Dennis and Lindley shared the
care. All the nursing staffwere Tost' in the subsequent 18 months
from that unit. At the same time a 10-bedded acute stroke unit (Ward
15) was opened.
Mar 2000 An ICP was introduced in the acute stroke unit.
Sept 2002 The acute stroke unit was moved from Ward 15 into a purpose built
16-bedded acute stroke unit in another part of the WGH.
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A4. Inter-rater study of the clinical assessment of patients with acute
stroke
Aim of the study
To assess the inter-rater agreement of history taking, clinical examination, and
diagnosis of stroke between three qualified physicians with a special interest in
stroke.
Methods
Between February and May 2001, a medical student (JH) carried out an inter-rater
study to assess the reliability of the important elements used for clinical assessment
ofpatients with acute stroke. The study included 42 consecutive patients admitted to
the WGH with suspected stroke. Patients were assessed within two days of
admission. For each patient, two physicians (PJH or BL or myself) took a history and
carried out a neurological examination in turn. We then recorded the history findings,
clinical signs, and the diagnosis, using specially designed scoring sheets. Agreement
between the different assessors was examined using kappa statistics.
Results
Overall, there was moderate to good agreement in the history-related elements (risk
factors, neurological symptoms), neurological examination, and the diagnosis of
stroke (OCSP classification, anatomical site of lesion), as shown below.
























Time of onset 0.51 0.20-0.73
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Kappa value 95% Confidence interval
Improvement of symptoms 0.65 0.45-0.85
Focal neurological deficit 0.64 0.36-0.91
Motor deficit 0.72 0.51-0.92
Sensory loss 0.73 0.54-0.91
Speech impairment 0.54 0.31-0.77




Arm weakness 0.79 0.51-0.92
Hand weakness 0.84 0.59-0.95
Facial weakness 0.69 0.40-0.85
Leg weakness 0.60 0.30-0.79




Sensory loss 0.61 0.40-0.83
Visual neglect 0.62 0.41-0.83
Sensory neglect 0.67 0.47-0.87
Right side of body affected 0.80 0.54-0.92
Left side of body affected 0.85 0.60-0.95
Diagnosis ofstroke
Stroke or not 0.84 0.38-0.97
Left side of brain 1.00 0.81 - 1.00
Right side of brain 0.84 0.57-0.94
OCSP classification 0.71 0.53-0.89
Conclusion
Agreement between physicians was generally good for history-taking, examination
and making a diagnosis of stroke. This finding supports the methodology that I used
in the non-randomised studies, which involved the research fellows (PJH or myself)
conducting clinical assessments and recording the history and examination findings.
It also supports the use of the OCSP classification and stroke scales that were based
on clinical findings, such as the NIHSS.
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A5. Data extraction forms used in the non-randomised studies and surveys
Assessment of Acute Stroke Patients - Day 0
Admission Details (Insert N/A if unsure)
Date of stroke: Time of stroke onset (24 hr clock): : □ on waking
Date of admission: Time of admission (24 hr clock): :
Assessor's initials: Admit to Ward:
Patient Characteristics (Enter code in grey boxes)
1. NIH Stroke Scale:
2. Abbreviated Scandinavian Stroke Scale (NOW)
Consciousness Fully conscious 6
Somnolent, can be awakened to full consciousness 4
Reacts to verbal command, but is not fully conscious 2
Coma 0
Eye Movements No gaze palsy 4
Gaze palsy present 2
Conjugate eye deviation 0
ARM, Motor Power Normal strength 6
Raises arm with reduced strength 5
Raises arm with flexion in elbow 4 .
Can move, but not against gravity 2
Paralysis 0
LEG, Motor Power Normal strength 6
Raises leg with reduced strength 5
Raises leg with flexion of knee 4
Can move, but not against gravity 2
Paralysis 0
3. Glasgow Coma Score (on admission)




2. Best Motor None 1
Extend to pain 2
Abnormal flexion to pain 3
Flexion to pain 4
Localise pain 5
Normal 6





Unable to assess (dysphasic) 9






5. Side of body with neurological deficit (at patient's WORST)
□ Can't be lateralised □ Right □ Left □ Both
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6. Carl's prognostic variables (on admission)
Yes No
1. Was the patient independent before stroke? □ □
2. Can they lift both arms off the bed? □ □
3. Can they walk without help? □ □
7. Pre-stroke modified Rankin score
□ No symptoms at all
□ Minor symptoms, but no restriction to lifestyle
□ Symptoms causing some restriction to lifestyle, but look after themselves
I I Significant restriction to lifestyle and dependent on others for help
□ Severe handicap, dependent on others for help, but not requiring constant attention
□ Severe handicap, totally dependent, requiring attention night and day
□ Not known
8. Pre-stroke residence and level of support
(Home includes own home, relative's or friend's home, and warden-controlled housing. Support includes home help,
meals-on-wheels, and district nurse visits)
l~~l Home without social or nursing support





9. If living in "home", did the patient live alone?
EH Yes EH No EH Not known




Yes No Not known Name(s)?
□ □ □
□ □ □ Target INR:
□ □ □
11. Is there a definite previous history of stroke, TIA or subarachnoid haemorrhage?
EH Yes
□ No
12. If patient is NOT admitted to the stroke unit, why? (Tick one box only)
□ Stroke unit is full
□ Patient is MRSA +ve
□ Patient needs palliative care only




Day 5 Assessment Form
1. Patient Details & Diagnosis
t. On day 5, where is the patient?
□ Still in hospital
I I Discharged
□ Dead
2. If patient is still in hospital, which ward?
3. If patient discharged, what is the discharge residence and level of support?
(Home includes own home, relative's or friend's home, and warden-controlled housing. Support includes home
help, meals-on-wheels, and district nurse visits)
I I Home without social or nursing support





4. If patient has died, when and how?
Date of death:
Cause of death if known:
5. Has the patient been transferred between wards within the last 5 days?
n Yes From: To: Date?
□ No
6. What was the most likely final diagnosis?




□ Definite or probably NOT stroke What?




1. So far during this admission, who has been responsible for the patient's care?
EH Stroke team - whole of last 5 days
□ Stroke team - part of last 5 days
□ General Medical team - whole of last 5 days
EH Neurologist
EH Neurosurgical team
2. Has a CT scan or MRI been performed?
[H Yes Q No
3. Date of first brain scan:
4. If scanning has been performed, what is the CT or MRI diagnosis?
EH Infarct
EH Primary Intracerebral Haemorrhage
EH Subarachnoid Haemorrhage
EH Normal scan
I I Other pathology:
5. If scanning has NOT been performed, why?
EH Still waiting for it
EH Patient too unwell or died
EH Diagnosis ofTIA was made after admission
EH Diagnosis of stroke or TIA thought to be unlikely after admission
□ Other What?
EH Not known
6. Have the following been specifically recorded in the first 24 hours after admission?
Yes No
1. Conscious level (GCS, alert/oriented) □ □
2. Eye movements (dolls eye response if drowsy) □ □
3. Limb movements (response to pain if drowsy) □ □
7. Within 24 hours of admission, has a clear diagnostic description been made of:
Yes No
1. Likely anatomical site of cerebral lesion □ □
2. Pathological type of lesion □ □
(i.e. Infarct, haemorrhage, OCSP syndrome acceptable)
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8. If the patient is conscious, have the following been recorded?
For this question, "No, but.." if patient is drowsy or comatose
Yes No No, but..
1. Screening for swallowing disorder (not gag) Li □ □
2. Communication □ □ □
3. Truncal control or gait □ □ □
9. If the patient is alert and able to communicate, is there formal assessment of:
For this question, "No, but.." if patient is drowsy or comatose, or has impaired communication
Yes No No, but..
1. Mental ability (e.g. Mini-mental test) □ □ □
2. Visual fields □ □ □
3. Visual inattention □ □ □
4. Sensation □ □ □




USE OF INTEGRATED CARE PATHWAY
1. Have the following parts of the ICP been filled in?
Yes-fully Yes - partially No
1. ARU admission sheet CD CD CD
2. Doctors clerking proforma CD CD CD
3. Therapists CD CD CD
4. Social Worker CD CD CD
2. If patient managed with nursing ICP, during which days were they used?
Yes-fully Yes — partially No Discharged/Dead
1. Day of admission CD CD CD CD
2. Admission + 1 CD CD CD CD
3. Admission + 2 CD CD CD CD
4. Admission + 3 CD CD CD CD
5. Admission+ 4 CD CD CD CD
6. Admission + 5 CD CD CD CD
3. If nursing ICP has not been started, why?
CD Admitted to a medical ward and never transferred to the stroke unit < 5 days
CD Admitted to a medical ward and subsequently transferred to the stroke unit < 5 days
I I Admitted to the stroke unit with a TIA
CD Admitted to the stroke unit but diagnosis unclear or "NOT stroke"
CD Admitted to the stroke unit but received palliative care only
□ Other:
I I Not known
5. If the nursing ICP has been started but discontinued before 5th day, why?
CD Patient died





IMMEDIATE MANAGEMENT OF PATIENT (IN ARU)
1. Immediate Assessment & Investigation
Documented Not Documented
1. Blood Pressure / □ □
2. Blood Glucose □ □
3. Oxygen Saturation % □ □
4. Temperature C □ □
5. Informal Swallowing □ □
6. ECG AF? Y N □ □
7. CXR □ □
8. Blood Tests □ □
9. Immediate CT Brain □ □
2. Abnormal Physiological Variables
1. Hyperglycaemia (> 11.0 mmol/1)
2. Hypoglycaemia (< 4.0 mmol/1)
3. Hypertension (> 160/90 mmHg)
4. Hypotension (< 100/60 mmHg)
5. Hypoxia (< 95% on air)
6. Pyrexia (> 37.5C)
7. Hypothermia (< 35.0C)










3. Immediate Action Taken Done+ No or
Doc Not Doc N/A
1. GKIIV Infusion □ □ □
2. 50% Glucose IV □ □ □
3. Reduction ofBP □ □ □
4. Continue usual antihypertensive drug(s) □ □ □
5. Supplemental Oxygen □ □ □
6. Paracetamol for pyrexia □ □ □
7. Antibiotic(s) IV or PO □ □ □
8. Fluids IV or SC □ □
4. Has it been documented that the diagnosis/management/prognosis has been explained to patient and/or
relative?
□ Yes □ No
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NEUROLOGICAL & FUNCTIONAL STATUS
1. NIH Stroke Scale (NOW) Patient discharged □ Patient died □
Total Score:
2. Abbreviated Scandinavian Stroke Scale (NOW) Patient discharged □ Patient died Q
Consciousness Fully conscious 6
Somnolent, can be awakened to full consciousness 4
Reacts to verbal command, but is not fully conscious 2
Coma 0
Eye Movements No gaze palsy 4
Gaze palsy present 2
Conjugate eye deviation 0
ARM, Motor Power Normal strength 6
Raises arm with reduced strength 5
Raises arm with flexion in elbow 4
Can move, but not against gravity 2
Paralysis 0
LEG, Motor Power Normal strength 6
Raises leg with reduced strength 5
Raises leg with flexion of knee 4
Can move, but not against gravity 2
Paralysis 0
6. Barthel Index (NOW) Patient discharged □ Patient died □
Bowels Incontinent 0
Occasional accident (1 per week) 1
Continent 2
Bladder Incontinent or catheterised & unable to manage 0
Occasional accident (max 1 per 24 hours) 1
Continent for over 7 days 2
Grooming Needs help 0
Independent, face, hair, teeth, shaving 1
Toilet Use Dependent 0
Needs some help but can do something 1
-
Independent (on and off, dressing, wiping) 2
Feeding Unable 0
Needs help cutting, spreading butter, etc 1
Independent 2
Transfer Unable 0
Major help (1-2 people, physical) 1
Minor help (verbal or physical) 2
Independent 3
Mobility Immobile 0
Wheelchair independent including corners, etc 1
Walks with help of 1 person (verbal or physical) 2
Independent (but may use any aid, e.g. stick) 3
Dressing Dependent 0
Needs help but can do half unaided 1 :
Independent 2
Stairs Unable 0
Needs help (verbal, physical, carrying aid) 1




5. Glasgow Coma Score (NOW) Patient discharged Q Patient died □




2. Best Motor None 1
Extend to pain 2
Abnormal flexion to pain 3
Flexion to pain 4
Localise pain 5
Normal 6





Unable to assess (dysphasic) 9
3. Glasgow Outcome Score Patient discharged □
□ Death
□ Persistent vegetative state
□ Severe disability (conscious but disabled)
I I Moderate disability (disabled but independent)
□ Resumption of normal life (there may be minor neurological or psychological deficits)
5. Carl's prognostic variables (Tick one box per item) Patient discharged Q Patient died □
Yes No
1. Can they lift both arms off the bed? □ □
2. Can they walk without help? □ □
4. Modified Rankin score (NOW) Patient discharged O
□ No symptoms at all
I I Minor symptoms, but no restriction to lifestyle
□ Symptoms causing some restriction to lifestyle, but look after themselves
□ Significant restriction to lifestyle and dependent on others for help
□ Severe handicap, dependent on others for help, but not requiring constant attention




INPATIENT MANAGEMENT (LAST 5 DAYS)




2. Reduced consciousness □
3. Incontinence (of urine or faeces) □
4. Bedbound □
2. Did the patient suffer the following complication(s)?
Yes + No or
Doc (1) Not Doc (2)
1. Pneumonia (clinical/proven) □ □
2. UTI (clinical/proven) □ □
3. DVT (clinically evident) □ □
4. PE (clinical/proven) □ □
5. Pressure sore (>Grade 2) □ □
6. Fall(s) □ □
7. Seizure (focal/general) □ □
8. Mood disturbance □ □
9. Constipation □ □
10. Pyrexia (> 37.5C) □ □
3. Did the patient receive the following "therapies ii?
Yes + No or
Doc (1) Not Doc (2)
1. Physiotherapy □ □
2. Occupational therapy □ □
3. Speech therapy □ □
4. Dietician review □ □
5. Psychologist review □ □









4. Has the patient been given any antiplatelet drug during this admission?
EH Yes
□ No
5. When, at what dose, and how was the antiplatelet drug FIRST administered?
Date: Agent: Dose: mg Route: □ PO □ PR
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6. If patient had stroke as final diagnosis but did NOT receive ANY antiplatelet drug, why?
□ Intracranial haemorrhage
□ Known intolerance (e.g. gastric irritation) or allergy
□ Too unwell or died soon after admission
□ Other What?
□ Not known
7. Did the patient receive the following "interventions" subsequent to admission (< 5 days)?
Yes + No or
Doc (1) Not Doc (2) Notes
1. Subcutaneous Heparin □ □
2. Intravenous Heparin □ □
3. Warfarin □ □
4. Dipyridamole MR □ □
5. Clopidogrel □ □
6. Statin □ □
7. Antihypertensive drug □ □ Date:
8. Oral Antibiotics □ □
9. Intravenous Antibiotics □ □
10. Antidepressant □ □
11. Antipyretic □ □
12. TED stockings □ □
13. Nasogastric feeding □ □ Date:
14. PEG feeding □ □ Date:
15. Fluids IV or SC □ □
16. Urinary catheter □ □ Date:
17. Thrombolysis □ □ IST-3?
18. Referral for neurosurgery □ □
8. Have the following tests been ordered or performed?
Order + Order But Not
Perform Not Perform
1. Carotid Duplex □ □ □
2. Transthoracic Echo □ □ □
3. Transoesophageal Echo □ □ □
4. Transcranial Doppler □ □ □
5. MR Angiography □ □ □
6. Cerebral Angiography □ □ □
7. Other: □ □ □
Date Performed
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3. Waterlow Score on Admission









Alert - keenly responsive
Drowsy - arousable by minor stimulation to obey, ansrwer, or respond
Stuporous - requires repeated stimulation to attend, or is obtunded and requires strong orpainful stimulation to make
movements (not stereotyped)






















Partial gaze palsy - gaze is abnormal in one or both eyes, no forced deviation/total gaze paresis
















Minor-flattened nasolabialfold, asymmetry on smiling
Partial - total or near totalparalysis oflowerface









No drift - holds limb at 90 degreesforfull 10 seconds
Drift - drifts down but does not hit bed
Some effort against gravity











No drift - holds limb at 90 degreesforfull 10 seconds
Drift - drifts down but does not hit bed
Some effort against gravity











No drift - holds limb at 45 degreesforfull 5 seconds
Drift - drifts down but does not hit bed
Some effort against gravity











No drift - holds limb at 45 degreesforfull 5 seconds
Drift - drifts down but does not hit bed
Some effort against gravity








Present in 1 limb






Partial loss - patientfeels pinprick is less sharp or is dull on affected side







Mild - moderate dysphasia - obvious loss offluency or comprehension, without significant limitation on ideas expressed or
form ofexpression. Makes conversation aboutprovidedmaterial difficult or impossible, e.g. examiner can identifypicture or
naming cardfrom patient's response.
Severe dysphasia - all communication is throughfragmentary expression; great needfor inference, questioning, and
guessing by the listener who carries burden ofcommunication. Examiner cannot identify materials providedfrompatient
response







Mild - moderate dysarthria-patient slurs some words, can be understood with some difficulty.







Partial neglect - Visual, tactile, auditory, spatial, orpersonal inattention or extinction to bilateral simultaneous stimulation in
one ofthe sensory modalities
Complete neglect - Profound hemi-inallention or hemi-inattention to more than one modality. Does not recognise own hand
or orients to only one side ofspace
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ICP - STAFF QUESTIONNAIRE 1-MONTH (WGH)
Please tick one box per question
Section 1
Are you aware of the integrated care pathway for acute stroke on the ward? Yes □ No □
Are you a: Nurse (D/E) □ Sister (F/G) □ Dietician □
SALT □ OT □ Physio □
Have you ever worked with an ICP before this one? Yes - in stroke □ Yes - not in stroke □ No □
Section 2
Please select the your answer by ticking the appropriate box. There are no right or wrong answers to these questions. We
would just like your honest opinions.




1. your general knowledge of stroke management? □ □ □ □ □
2. the speed of completing paperwork for nurses/physios/OTs/dieticians? □ □ □ □ □
3. the speed of clerking stroke patients and documenting for doctors? □ □ □ □ □
4. your clinical judgement and acumen in managing stroke patients? □ □ □ □ □
5. your enthusiasm to learn about stroke? □ □ □ □ □
Patient & Process Outcomes
6. the patient's chance of dying or being disabled at 1 month? □ □ □ □ □
7. the patient's chance of dying or being disabled at 1 year? □ □ □ □ □
8. the number of complications (e.g. pneumonia) during hospital stay? □ □ □ □ □
9. the total length of stay in hospital? □ □ □ □ □
10. the speed of getting routine CT scans? □ □ □ □ □
11. the speed patients get discharged to nursing or residential homes? □ □ □ □ □
12. the quality of information given to patients and relatives? □ □ □ □ □
13. the feedback from patients and relatives? □ □ □ □ □
14. your confidence in explaining to patients and relatives about stroke? □ □ □ □ □
15. vour confidence in manaaina stroke in the future without an ICP? □ □ □ □ □
16. the number of investigations (e.g. carotid duplex) performed per patient? □ □ □ □ □
17. the thoroughness in managing a stroke patient? □ □ □ □ □
18. the number of drug errors? □ □ □ □ □
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Higher No Change Lower
19. the number of accidents on the ward (e.g. from lifting and handling)? □ □ □ □ □
20. the expectations from patients and relatives? □ □ □ □ □
21. the number of complaints by patients or relatives? □ □ □ □ □
22. the quality of organisation for discharging stroke patients? □ □ □ □ □
Miscellaneous
23. the quality of care of patients with unusual strokes? □ □ □ □ □
24. the quality of care of younger stroke patients (< 65 years old)? □ □ □ □ □
25. the quality of care of patients with behavioural or emotional problems? □ □ □ □ □
26. the quality of care of patients with cognitive impairment (e.g. dementia)? □ □ □ □ □
27. the ease of making "Do Not Resuscitate" decisions? □ □ □ □ □
28. the attractiveness of the stroke unit for doctors/nurses applying for jobs? □ □ □ □ □
29. the speed and ease of transfer from ARU to stroke unit? □ □ □ □ □
30. the speed and ease of transfer from stroke unit to rehabilitation unit? □ □ □ □ □
31. the aualitv of stroke care in other wards? □ □ □ □ □
32. your autonomy and decision-making as an individual care-giver? □ □ □ □ □
General Quality of Care
33. the quality of nursing (stroke) care on the stroke unit? □ □ □ □ □
34. the quality of medical (stroke) care on the stroke unit? □ □ □ □ □
35. the quality of physio/OT/SALT/SW/Dietician care on the stroke unit? □ □ □ □ □
36. the quality and ease of auditing on the stroke unit? □ □ □ □ □
37. the quality of regular multidisciplinary team meetings? □ □ □ □ □
38. the communication/interaction between different disciplines? □ □ □ □ □
Section 3
Here are more general questions about stroke ICPs. Again, please be as frank as possible.
Do you think... Yes No Don't Knov
1. patients should be selected to "go on" an ICP (e.g. not TIAs or "TLC only")? □ □ □
2. the natural course of stroke is too unpredictable and complicated for ICP? □ □ □
3. there should be an electronic version of the ICP? □ □ □
4. there should be a "Patient Pathway", which is a simplified version of the ICP
which can be given to the relatives (and patients)?
I □ □ □
5. it is difficult for ICP to make a difference because most of the time-consuming
factors (e.g. waiting for investigations) are 'out of our hands'?
□ □ □
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Do you have any Other Comments?
Please write as much as you want and use a separate piece of paper if you need
Thank you very much for your time and attention!
Now, please put the completed questionnaire in the box marked "Completed ICP Questionnaires" in the Sister's




Research Fellow in Stroke Medicine
Department of Clinical Neurosciences
Any queries please contact me on 32903 or Dr Martin Dennis on 31719
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ICP - STAFF QUESTIONNAIRE 7-MONTHS (WGH)
Please tick one box per question
Have you used the integrated care pathway for acute stroke on the ward? Yes □ No □
lama: Nurse (D/E).... □ Sister (F/G).... □ Dietician.... □ Doctor.... □
SALT.... □ OT.... □ Physio.... □
Please select the your answer by ticking the appropriate box. There are no right or wrong answers to these questions. We
would just like your honest opinions.
From your experience, how has the ICP affected the following?
General Increased No Change Reduced
M ►
• Your level of knowledge of stroke management □ □ □ □ □
• The speed of completing paperwork for nurses/physios/OTs/dieticians □ □ □ □ □
• The speed of clerking stroke patients and documenting for doctors □ □ □ □ □
• Your clinical judgement and acumen in managing stroke patients □ □ □ □ □
• Your level of enthusiasm to learn about stroke □ □ □ □ □
Patient & Process Outcomes
• The patient's chance of recovery □ □ □ □ □
• The number of complications (e.g. pneumonia) during hospital stay □ □ □ □ □
• The number of days patients stay in the stroke unit □ □ □ □ □
• The speed patients get their routine CT brain scans □ □ □ □ □
• The speed patients get discharged to nursing or residential homes □ □ □ □ □
• Likelihood of patients being given oxygen if 02 saturation is below 95% □ □ □ □ □
• Likelihood of patients being given GKI if BM is over 11 □ □ □ □ □
• Likelihood of patients being given iv or subcutaneous fluids □ □ □ □ □
• Likelihood of patients being given Paracetamol if temperature is over 37.5 □ □ □ □ □
• Likelihood of patients being catheterised (urinary) □ □ □ □ □
• Likelihood of patients being fed by NG or PEG □ □ □ □ □
• Likelihood of patients being mobilised early by physiotherapist □ □ □ □ □
• The quality of information given to patients and relatives □ □ □ □ □
• The amount of feedback from patients and relatives □ □ □ □ □
• Your confidence in explaining to patients and relatives about stroke □ □ □ □ □
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■ Your confidence in managing stroke in the future without an ICP
• The number of investigations (e.g. carotid duplex) performed per patient
• The thoroughness in managing a stroke patient
• The number of drug errors
• The number of accidents on the ward (e.g. from lifting and handling)
• The expectations from patients and relatives
• The number of complaints by patients or relatives
• The quality of organisation for discharging stroke patients
Miscellaneous
• The quality of care of patients with unusual strokes
• The quality of care of younger stroke patients (< 65 years old)
• The quality of care of patients with behavioural or emotional problems
• The quality of care of patients with cognitive impairment (e.g. dementia)
• The ease of making "Do Not Resuscitate" decisions
• The attractiveness of the stroke unit for doctors/nurses applying for jobs
• The speed and ease of transfer from ARU or ward 26 to stroke unit
• The speed and ease of transfer from stroke unit to rehabilitation unit
• The quality of stroke care in other wards (e.g. 14, 11)
• Your autonomy in making day-to-day clinical decisions
General Quality of Care
• The quality of nursing (stroke) care on the stroke unit
• The quality of medical (stroke) care on the stroke unit
• The quality of physio/OT/SALT/SW/Dietician care on the stroke unit
• The quality of regular multidisciplinary team meetings
• The communication and interaction between different disciplines
452
Do you think using the ICP on the ward has affected the following in any way?
ritf
Higher No Change Lower
^
The amount of time you spend treating stroke patients □ □ □ □ □
The general morale of the staff working on the ward □ □ □ □ □
Satisfaction of patients and relatives □ □ □ □ □
The way others regard (i.e. the profile of) stroke care in the hospital □ □ □ □ □
Your overall job satisfaction □ □ □ □ □
at do you think of the following aspects of the ICP? Satisfactory Unsatisfactory
The way that you have been involved in the design process □ □ □ □ □
The way that you have been explained the benefits of ICPs □ □ □ □ □
The way that you have been taught how to fill in the forms □ □ □ □ □
The way that you feedback comments regarding the forms □ □ □ □ □
The way the ICP was implemented in general □ □ □ □ □
The design of the form (e.g. layout, number of pages, wording, colour, etc) □ □ □ □ □
The size (number of pages) of the documents □ □ □ □ □
The number of questions to answer each day □ □ □ □ □
The clinical relevance of the questions or checklists □ □ □ □ □
The number of times you have to sign each day □ □ □ □ □
The ease of getting used to the new system of documentation □ □ □ □ □
The ease and speed of finding the information you need □ □ □ □ □
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PLEASE TELL US MORE OF WHAT YOU THINK!
Feel free to write as much as you want and use a separate piece of paper if you need
THANK YOU!
Thank you very much for your time and attention!
Now, please put the completed questionnaire in the box marked "Completed ICP Questionnaires" in the Sister's




Any queries please contact me on 32903 or Dr Martin Dennis on 31719
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